,Start Date,Start Price,End Date,End Price,Weekly Returns,Bin Label,News,Basics
0,2023-06-04,154.60047912597656,2023-06-11,157.59458923339844,0.019366758268466455,U2,"[{""date"": ""20230604022807"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of June 4"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Click here to read the complete list.""}, {""date"": ""20230604104300"", ""headline"": ""2 Warren Buffett Stocks to Buy in June and Hold Forever"", ""summary"": ""These time-tested businesses produce reliable cash flows that they're committed to sharing with investors.""}, {""date"": ""20230604110300"", ""headline"": ""Morgan Stanley sees broader MedTech impact from weight loss drugs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230604113600"", ""headline"": ""1 Ultra-Elite Dividend Stock to Buy Hand Over Fist in June"", ""summary"": ""Johnson & Johnson\u00a0(NYSE: JNJ) is one of the best dividend stocks on the planet.  The healthcare behemoth has increased its dividend each year for over six decades, putting it in the super-elite class of Dividend Kings.  The company currently offers a roughly 3% dividend yield, which is almost double that of an S&P 500\u00a0Index Fund (recently around 1.6%).""}, {""date"": ""20230604141500"", ""headline"": ""2 Dividend Kings Down 12% and 14% You'll Regret Not Buying on The Dip"", ""summary"": ""Dividend Kings are among the most steady corporations on the market.  While many businesses don't even last a decade, these companies have survived and thrived and raised their payouts for at least 50 consecutive years to become a member of this elite group.  Case in point: Abbott Laboratories (NYSE: ABT) and Johnson & Johnson (NYSE: JNJ) are two members of this prominent clique that have lagged the market recently, partly due to company-specific concerns.""}, {""date"": ""20230604142149"", ""headline"": ""The 3 Best Bargain Stocks to Buy in June 2023"", ""summary"": ""The stock market has been barging its way higher so far this year. The S&P 500 is up about 10% in 2023, while the Nasdaq sports a year-to-date gain of 25%. That may have many investors assuming that most stocks have already rallied. However, that\u2019s not the case. So what are the best bargain stocks to buy? Surprisingly, just a handful of stocks are driving almost all of the gains in the S&P 500. In fact, market breadth is concerningly low for some investors, as they wonder whether big tech has en""}, {""date"": ""20230605022500"", ""headline"": ""Biotech stocks could soon get a M&A boost. Here are 3 likely takeover plays."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230605074700"", ""headline"": ""Janssen announces results from Phase 2 NORSE, Phase 2 RAGNAR studies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230605074900"", ""headline"": ""Janssen announces Cohort 1 of the Phase 3 THOR study reached primary endpoint"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230605101300"", ""headline"": ""Janssen announces results from Phase 3 CARTITUDE-4 study of Carvykti"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230605101700"", ""headline"": ""FDA revokes EUA for J&J's Covid-19 vaccine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230605120400"", ""headline"": ""Janssen presents longer-term data for Tecvayli"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230605144500"", ""headline"": ""IN BRIEF: J&J says Carvykti cuts risk of disease progression in study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230605161536"", ""headline"": ""Analysis-Stelara patent deal puts J&J back on path to $57 billion 2025 revenue forecast"", ""summary"": ""Johnson & Johnson's legal settlement with Amgen Inc to delay a biosimilar version of its blockbuster psoriasis treatment Stelara until January 2025 could make the drug a larger contributor to J&J\u2019s 2024 and 2025 sales than Wall Street is forecasting.""}, {""date"": ""20230605164506"", ""headline"": ""25 S&P 500 Dividend Aristocrats To Avoid"", ""summary"": ""In this article, we discuss 25 dividend aristocrats to avoid according to hedge funds. You can skip our detailed analysis of dividend stocks and their performance, and go directly to read 10 S&P 500 Dividend Aristocrats To Avoid. Over the years, there has been an observable shift in focus from growth stocks to dividend stocks [\u2026]""}, {""date"": ""20230605214523"", ""headline"": ""Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) closed at $158.32 in the latest trading session, marking a +0.86% move from the prior day.""}, {""date"": ""20230606041200"", ""headline"": ""Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: Sight Sciences (SGHT), Johnson & Johnson (JNJ) and Ultragenyx Pharmaceutical (RARE)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230606050500"", ""headline"": ""Alkermes receives final award from arbital tribunal in proceedings with Janssen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230606051000"", ""headline"": ""Alkermes reiterates profitability targets for 2024, 2025"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230606054500"", ""headline"": ""Narrow market proving a headwind for mutual funds, opportunity for hedge funds"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230606094655"", ""headline"": ""20 Most Respected Professions in the World"", ""summary"": ""This article covers the 20 most respected professions in the world. It will also explore the emerging trends in professions worldwide and the key players making a difference at the global level for various professions. If you want to skip our detailed analysis on the topic, you can head straight to the 5 Most Respected [\u2026]""}, {""date"": ""20230606095500"", ""headline"": ""Stifel ups Alkermes price target to $33 after final award in Janssen arbitration"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230606141635"", ""headline"": ""Tylenol Maker Kenvue Goes From Sure Bet to Question Mark After Year\u2019s Biggest IPO"", ""summary"": ""(Bloomberg) -- Kenvue Inc. looked like a winner following its May spinoff from Johnson & Johnson in the year\u2019s biggest IPO. But just a few weeks after the stock\u2019s initial surge, Wall Street is urging investors to avoid the shares.Most Read from BloombergUkraine Dam Blast Blamed on Russia Tips War Into New PhaseApple Headset Looks Sleek in Person But Battery Pack Stands OutApple\u2019s $3,499 Vision Pro Headset Will Test Marketing MightCoinbase Sued by SEC for Breaking US Securities RulesA Wall Street""}, {""date"": ""20230606173100"", ""headline"": ""Johnson & Johnson stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slid 0.09% to $158.18 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20230606195047"", ""headline"": ""Alkermes Raises FY23 Outlook Following Arbitration Award from Janssen Agreements"", ""summary"": ""Alkermes plc (NASDAQ: ALKS) increased its FY23 outlook by $425 million to reflect a final award the company received from arbitration proceedings related to two licensing agreements with Janssen Pharmaceutica N.V., a subsidiary of Johnson & Johnson (NYSE: JNJ). The updated guidance reflects the payment of back royalties of ~$194 million related to 2022 U.S. net sales of the long-acting Invega products and Cabenuva and anticipated royalty revenues related to 2023 sales. \""We are gratified to have""}, {""date"": ""20230606203000"", ""headline"": ""Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results"", ""summary"": ""NEW BRUNSWICK, N.J., June 06, 2023--Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Thursday, July 20th to review second-quarter results. Joaquin Duato, Chairman of the Board and CEO, Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Jessica Moore, Vice President, Investor Relations will host the call.""}, {""date"": ""20230607033300"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230607035400"", ""headline"": ""Johnson & Johnson Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230607045700"", ""headline"": ""Johnson & Johnson (JNJ) Gets a Buy from SVB Securities"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230607054500"", ""headline"": ""Alkermes price target raised to $40 from $36 at Mizuho"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230607092100"", ""headline"": ""3 No-Brainer Stocks to Buy With $300 Right Now"", ""summary"": ""A reasonably small amount of money can go a long way when it's invested in industry-leading businesses.""}, {""date"": ""20230607103200"", ""headline"": ""5 Top Dividend Stocks For June 2023"", ""summary"": ""I look for high-quality stocks trading at great long-term entry points. Find out 5 top dividend stocks to buy in the month of June.""}, {""date"": ""20230607112512"", ""headline"": ""Top 16 Dividend Stocks To Buy According To Hedge Funds"", ""summary"": ""In this article, we will discuss top 16 dividend stocks to buy according to hedge funds. You can skip our detailed analysis of dividend stocks and their performance, and go directly to read Top 5 Dividend Stocks To Buy According To Hedge Funds. Dividends can be a significant component of hedge funds\u2019 overall investment strategy [\u2026]""}, {""date"": ""20230607112900"", ""headline"": ""J&J's Abiomed unit recalls Impella 5.5 heart pumps over safety concerns"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230607132817"", ""headline"": ""3 Defensive Stocks to Guard Against Too Much Market Optimism"", ""summary"": ""Defensive stocks, such as utilities, healthcare, and consumer staples, are known for their resilience during economic downturns. These sectors have consistently outperformed the market in 2022 as consumers tend to maintain their spending on these essential products regardless of economic conditions. In times of economic hardship, defensive stocks are favored by investors for their resilience. These stocks are less vulnerable to the broader economic downturn and offer a sense of stability. As int""}, {""date"": ""20230607163100"", ""headline"": ""Alkermes (ALKS) Gets Final Award in Janssen Arbitration, Ups View"", ""summary"": ""Alkermes (ALKS) receives final award in arbitration proceedings with partner Janssen. It also raises its financial outlook for 2023.""}, {""date"": ""20230607173100"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.21% higher to $158.52 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""20230607182901"", ""headline"": ""Mizuho Maintains Johnson & Johnson (JNJ) Prior Recommendation"", ""summary"": """"}, {""date"": ""20230608033300"", ""headline"": ""Johnson & Johnson stock rises Thursday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230608090123"", ""headline"": ""DJD: Attractive Valuation, Average Quality And Return"", ""summary"": ""DJD holds 27 stocks of the Dow Jones paying a dividend. Valuation and dividend growth look attractive, but quality and historical return are average. Read more here.""}, {""date"": ""20230608100000"", ""headline"": ""JNJ July 28th Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230608103023"", ""headline"": ""The 3 Best Long-Term Dividend Stocks to Buy in June"", ""summary"": ""The stock market is finally giving us hope of better days ahead, with the U.S. debt ceiling debacle behind us. However, investors who are in it for the long-term understand that the market can be volatile, and it is important to pick companies that are stable and reliable. If you are investing for the long-term, do not focus on an individual stock, but rather on the underlying business. A solid balance sheet and reliable business can generate big returns for investors over time. That said, a div""}, {""date"": ""20230608103333"", ""headline"": ""3 Blue-Chip Stocks to Buy for 100% Returns"", ""summary"": ""The stock market has been led higher by just a handful of names so far this year. Unfortunately, that means many stocks have performed poorly vs. the indices. On the plus side though, that means there are many names that still have plenty of upside. Specifically, we can look for the best blue-chip stocks for high returns. Investors can look for high yield blue-chip stocks or they can look for blue-chip stocks with high potential. They can also look in between for a more balanced approach. Either""}, {""date"": ""20230608110058"", ""headline"": ""Investors in Johnson & Johnson (NYSE:JNJ) have seen favorable returns of 48% over the past five years"", ""summary"": ""When you buy and hold a stock for the long term, you definitely want it to provide a positive return. But more than...""}, {""date"": ""20230608132345"", ""headline"": ""Johnson & Johnson Relinquishes Top Spot To Eli Lilly, Shares Undervalued Amid Technical Risks"", ""summary"": ""Eli Lilly has surpassed Johnson & Johnson in market cap for the first time. Click here to see our take on JNJ stock.""}, {""date"": ""20230608154728"", ""headline"": ""3 Bargain Stocks to Buy in June Before They Bounce"", ""summary"": ""Now that Memorial Day is in the rearview mirror, investors are thinking about summer. This is historically a quieter time for markets. That may be the case in 2023. But first, the markets have to digest news on inflation and interest rates. And that\u2019s a reason to look for some bargain stocks to buy for the summer season. A month ago, the Federal Reserve was widely expected to pause (or \u201cskip\u201d) interest rate hikes in June. But after a hot headline number on the jobs report, some analysts are incr""}, {""date"": ""20230608173100"", ""headline"": ""Johnson & Johnson stock underperforms Thursday when compared to competitors despite daily gains"", ""summary"": ""Shares of Johnson & Johnson rose 1.10% to $160.26 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20230608180000"", ""headline"": ""How To Allocate $25,000 Among My Top 20 Dividend Income Stocks For June 2023"", ""summary"": ""This article shows how to build a portfolio by combining one ETF with high dividend yield and dividend growth companies. Find out more about this portfolio here.""}, {""date"": ""20230608201319"", ""headline"": ""15 Healthcare Stocks Billionaires Are Loading Up On"", ""summary"": ""In this article, we discuss 15 best healthcare stocks billionaires are loading up on. You can skip our detailed discussion on the healthcare sector and its performance, and go directly to read 5 Healthcare Stocks Billionaires Are Loading Up On. The healthcare sector in the US is a multifaceted industry that plays a crucial role [\u2026]""}, {""date"": ""20230608214229"", ""headline"": ""10 Reliable Dividend Stocks Billionaires Are Loading Up On"", ""summary"": ""In this article, we discuss 10 reliable dividend stocks billionaires are loading up on. You can skip our detailed analysis of dividend stocks and their performance, and go directly to read 5 Reliable Dividend Stocks Billionaires Are Loading Up On. Dividends have been one of the potential income sources for wealthy investors. According to a [\u2026]""}, {""date"": ""20230609010500"", ""headline"": ""Federal judge tosses 3M earplug unit's bankruptcy filing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230609035600"", ""headline"": ""Blackrock Rolls Out Climate Conscious ETF, Paralleling NYC's Smoky Skies From Canadian Fires"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230609080001"", ""headline"": ""Retailers are gamifying shopping with virtual storefronts to boost engagement, loyalty"", ""summary"": ""J. Crew and a string of other retailers are turning to gamified shopping in virtual storefronts to boost engagement and customer loyalty. ""}, {""date"": ""20230609083300"", ""headline"": ""AbbVie, Amgen among firms targeted for Medicare inflation penalties"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230609095500"", ""headline"": ""Cantor Fitzgerald biotech analyst to hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230609111029"", ""headline"": ""PFM: There Are Better Dividend Growth ETFs"", ""summary"": ""Invesco Dividend Achievers ETF holds over 400 U.S. dividend-growth stocks and is well-diversified. Click for my review of PFM ETF and its prospects.""}, {""date"": ""20230609130012"", ""headline"": ""Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know"", ""summary"": ""Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.""}, {""date"": ""20230609173000"", ""headline"": ""Johnson & Johnson stock falls Friday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slipped 0.16% to $160.01 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""20230609180800"", ""headline"": ""Pharmaceutical Giants Set $19 Billion Opioid Settlement as States Debate How to Spend It"", ""summary"": ""Teva, Allergan, CVS and Walgreens said enough states agreed to final agreements, adding to the billions flowing to communities.""}, {""date"": ""20230609213844"", ""headline"": ""US judge rejects 3M effort to resolve earplug lawsuits in bankruptcy"", ""summary"": ""A U.S. judge on Friday dismissed the bankruptcy of 3M subsidiary Aearo Technologies, rejecting an effort to resolve nearly 260,000 lawsuits alleging that 3M military earplugs caused hearing loss for veterans and U.S. service members.""}, {""date"": ""20230610093000"", ""headline"": ""Blue Chip Bargain Hunting: 2 Top Stocks to Buy Now"", ""summary"": ""If you say there's not much to like about a bear market, you're right. Last year, all three indexes touched bear territory. And many of us felt the impact on our portfolios. But there actually are two things to like about these sorts of markets: First, they always lead to bull markets.""}, {""date"": ""20230610093000"", ""headline"": ""5 Relatively Safe And Cheap Dividend Stocks To Invest In - June 2023"", ""summary"": ""We go over our filtering process to select just five conservative DGI stocks from more than 7,500 companies that are traded on U.S. exchanges. Read more here.""}, {""date"": ""20230610123000"", ""headline"": ""Dividend Stock Watch List: Lanny's June 2023 Edition"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230611095151"", ""headline"": ""Kinnate Biopharma: Trading Below Cash Value"", ""summary"": ""Kinnate Biopharma is advancing a couple of early stage compounds but has hit some bumps in the road since coming to public. Read more on KNTE stock.""}, {""date"": ""20230611202520"", ""headline"": ""7 Top Blue-Chip Stocks to Buy in June 2023"", ""summary"": ""The market probably feels like the movie Groundhog\u2019s Day for many investors. The major indexes continue to trade within a range, which is frustrating both bulls and bears. And with the market entering what is usually a quieter period, it may stay this way until Labor Day. However, one key strategy for profiting in a market like this is to look for some top blue-chip stocks to buy. Blue-chip stocks are large-cap companies that offer investors predictable revenue and earnings growth. Many of these""}]",{}
1,2023-06-11,157.59458923339844,2023-06-18,161.75088500976562,0.026373340586025362,U3,"[{""date"": ""20230611095151"", ""headline"": ""Kinnate Biopharma: Trading Below Cash Value"", ""summary"": ""Kinnate Biopharma is advancing a couple of early stage compounds but has hit some bumps in the road since coming to public. Read more on KNTE stock.""}, {""date"": ""20230611202520"", ""headline"": ""7 Top Blue-Chip Stocks to Buy in June 2023"", ""summary"": ""The market probably feels like the movie Groundhog\u2019s Day for many investors. The major indexes continue to trade within a range, which is frustrating both bulls and bears. And with the market entering what is usually a quieter period, it may stay this way until Labor Day. However, one key strategy for profiting in a market like this is to look for some top blue-chip stocks to buy. Blue-chip stocks are large-cap companies that offer investors predictable revenue and earnings growth. Many of these""}, {""date"": ""20230612024900"", ""headline"": ""COVID shots should be updated for XBB variants, FDA says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230612030000"", ""headline"": ""The First Vaccines for RSV Are Coming Soon. What to Know."", ""summary"": ""The U.S. is on the brink of rolling out a number of shots designed to prevent RSV in young children and in older adults.""}, {""date"": ""20230612033300"", ""headline"": ""Johnson & Johnson stock outperforms competitors despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230612041000"", ""headline"": ""Alvotech, Teva reach settlement with Johnson & Johnson for AVT04"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230612061000"", ""headline"": ""Alvotech & Teva secure AVT04 license date, for proposed Stelara biosimilar"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230612070000"", ""headline"": ""Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara\u00ae"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230612070300"", ""headline"": ""Teva, Alvotech in pact with Johnson & Johnson over Stelara knockoff"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230612134005"", ""headline"": ""Here's Why Johnson & Johnson (JNJ) is a Strong Value Stock"", ""summary"": ""Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.""}, {""date"": ""20230612173000"", ""headline"": ""Johnson & Johnson stock falls Monday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slumped 0.07% to $159.90 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""20230612174200"", ""headline"": ""Top Research Reports for Johnson & Johnson, Oracle & HSBC"", ""summary"": ""Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Oracle Corporation (ORCL) and HSBC Holdings plc (HSBC).""}, {""date"": ""20230612195555"", ""headline"": ""Build a Millionaire\u2019s Portfolio With These 3 Dividend-Paying Stocks"", ""summary"": ""Stock market corrections can be unnerving, but history shows these are often the best time to buy. Millionaire investors know this, so they usually choose wealth-building dividend stocks for their portfolios. When uncertainty and volatility are rising, dividend stocks come into their own. Companies that pay investors to own them are typically profitable, have a clearly defined long-term growth story, and have often been through similar turmoil. Several years ago, J.P. Morgan Asset Management fou""}, {""date"": ""20230612214518"", ""headline"": ""Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) closed the most recent trading day at $159.90, moving -0.07% from the previous trading session.""}, {""date"": ""20230613040000"", ""headline"": ""300% Dividend Growth, 15% Yields From These \u201cAnti-AI\u201d Stocks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230613041100"", ""headline"": ""The stock market is in a bull market? What bull market?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230613075003"", ""headline"": ""Nicholas Ward's Dividend Growth Portfolio: April And May Review"", ""summary"": ""My passive income stream increased by 25.59% YoY in April 2023 and 40.02% YoY in May 2023, with a YTD growth of 29.99%. See the full April & May update here.""}, {""date"": ""20230613083900"", ""headline"": ""Experts say the stock market is in a bull market. What bull market?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230613100455"", ""headline"": ""15 Most Profitable Drugs In The World"", ""summary"": ""In this article, we will be taking a look at the 15 most profitable drugs in the world. If you wish to see the top ones, feel free to skip our detailed analysis of the pharma industry and head straight to the 5 Most Profitable Drugs In The World. The pharmaceutical industry has long been [\u2026]""}, {""date"": ""20230613105215"", ""headline"": ""Top 20 Most Profitable Pharmaceutical Companies In The World"", ""summary"": ""In this article, we will be covering the top 20 most profitable pharmaceutical companies in the world. If you wish to see the top ones, head straight to the Top 5 Most Profitable Pharmaceutical Companies In The World. Undoubtedly, the pharmaceutical industry stands as one of the most financially rewarding and essential sectors worldwide, leading [\u2026]""}, {""date"": ""20230613122700"", ""headline"": ""The Zacks Analyst Blog Highlights Johnson & Johnson, Oracle, HSBC, NVIDIA and The Cigna Group"", ""summary"": ""Johnson & Johnson, Oracle, HSBC, NVIDIA and The Cigna Group are part of the Zacks top Analyst Blog.""}, {""date"": ""20230613124200"", ""headline"": ""Could Johnson & Johnson Stock Help You Become a Millionaire?"", ""summary"": ""A fantastic dividend stock with promising opportunities ahead, is it also a no-brainer buy for growth-oriented investors?""}, {""date"": ""20230613133154"", ""headline"": ""SCHV: Well Diversified, But Still Lagging Competitors"", ""summary"": ""Schwab US Large-Cap Value ETF holds more than 500 stocks with value characteristics. Click here to see how SCHV compares to SPY and how it has performed.""}, {""date"": ""20230613141454"", ""headline"": ""Vast utility for weight loss drugs will more than pay for themselves, says Eli Lilly CEO David Ricks"", ""summary"": ""Eli Lilly CEO David Ricks joins CNBC's Bertha Coombs and 'The Exchange' live from the World Medical Innovation Forum to discuss Eli Lilly's alzheimer's treatment, concerns over coverage reimbursement schemes, and upcoming drug price negotiations.""}, {""date"": ""20230613142745"", ""headline"": ""3 High-Yielding Dividend Stocks That Can Help You Save For Retirement"", ""summary"": ""Inflation increases the difficulty of saving for retirement, but it also highlights why it's extremely important to keep saving.  Three income stocks that can help you save for your retirement are Johnson & Johnson\u00a0(NYSE: JNJ),\u00a0Toronto-Dominion Bank\u00a0(NYSE: TD), and\u00a0Verizon Communications\u00a0(NYSE: VZ).  Let's find out a bit more about these three high-yielding dividend stocks that can help you save for retirement.""}, {""date"": ""20230613151950"", ""headline"": ""Johnson & Johnson Spinoff Kenvue Is Worth Owning - But Maybe Not Yet"", ""summary"": ""Kenvue, a consumer health spin-off of J&J, has a diversified portfolio of brands and offers a dividend yield of just over 3%. Read more here.""}, {""date"": ""20230613183400"", ""headline"": ""Johnson & Johnson stock rises Tuesday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.53% higher to $160.74 Tuesday, on what proved to be an all-around positive trading session for the stock market, with...""}, {""date"": ""20230613192243"", ""headline"": ""Cramer's Lightning Round: PayPal is \""too cut-throat\"""", ""summary"": ""\""Mad Money\"" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.""}, {""date"": ""20230613194005"", ""headline"": ""Johnson & Johnson (JNJ) Presents at Goldman Sachs 44th Annual Global Healthcare Conference (Transcript)"", ""summary"": ""Johnson & Johnson (NYSE:NYSE:JNJ) Goldman Sachs 44th Annual Global Healthcare Conference Call June 13, 2023 4:20 PM ETCompany ParticipantsBiljana Naumovic - Worldwide Vice President,...""}, {""date"": ""20230613205114"", ""headline"": ""Lightning Round: Too much competition in the Fintech space for PayPal, says Jim Cramer"", ""summary"": ""'Mad Money' host Jim Cramer weighs in on stocks including: Hubbell, PayPal, Viasat, Biohaven, Transocean, Johnson & Johnson, Advance Auto Parts and C3.ai.""}, {""date"": ""20230614020000"", ""headline"": ""FedEx, Booking, and 6 Other Stocks That Show Being Average Is Just Fine"", ""summary"": ""Barron's tried to apply the Goldilocks principle to stock-picking. We came up with eight ideas.""}, {""date"": ""20230614032300"", ""headline"": ""Johnson & Johnson exec Wengel sells 12,465 common shares"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230614033300"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230614045900"", ""headline"": ""Biggest stock movers today: MicroVision, UnitedHealth and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230614075700"", ""headline"": ""Amgen reportedly hires Moderna chief medical officer as new CMO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230614091000"", ""headline"": ""My Dividend Stock Portfolio: New All-Time Dividend Record - 99 Holdings With 25 Buys"", ""summary"": ""US stocks ended May with solid gains and extended their strong performance into June, boosted by positive labor market data and the debt ceiling bill's progress.""}, {""date"": ""20230614092600"", ""headline"": ""Nearing Retirement? These Stocks Will Pay You For Life"", ""summary"": ""Every retired investor deserves passive income and peace of mind. These stocks will help achieve that.""}, {""date"": ""20230614093000"", ""headline"": ""2 Unstoppable Warren Buffett Stocks That Can Turn Sitting Cash into Growing Wealth"", ""summary"": ""Warren Buffett doesn't measure the success of his favorite companies by short-term stock performance.  Instead, unstoppable Buffett stocks are ones that have delivered earnings and share price performance over time.  Dividend growth often is an additional plus.""}, {""date"": ""20230614093800"", ""headline"": ""RGA Investment Advisors Q1 2023 Investment Commentary"", ""summary"": ""RGA Investment Advisors published their Q1 2023 investment commentary recently. Click here to read more about RGAIA's views.""}, {""date"": ""20230614095100"", ""headline"": ""Johnson & Johnson wins conditional nod for prostate cancer therapy in Canada"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230614125233"", ""headline"": ""Stryker: Good Prospects"", ""summary"": ""Stryker's near-term prospects positive due to positive trends in procedure demand and hospital spend on capital products. Find out our recommendation on SYK.""}, {""date"": ""20230614130029"", ""headline"": ""Johnson & Johnson's (NYSE:JNJ) Stock Been Rising: Are Strong Financials Guiding The Market?"", ""summary"": ""Most readers would already know that Johnson & Johnson's (NYSE:JNJ) stock increased by 4.1% over the past three months...""}, {""date"": ""20230614152147"", ""headline"": ""3 Long-term Healthcare Stocks to Add to Your Portfolio"", ""summary"": ""One of the greatest changes in the American landscape going forward will be demographics. The Baby Boomers make up the largest generation in the country\u2019s history. With the large amount of wealthy older Americans, there will be more demand than ever for cutting edge pharmaceutical drugs, medical devices, and cutting-edge treatments and therapies. This is a great time to buy reliable healthcare stocks for your portfolio. The healthcare industry has faced some bumps in the road in recent years. Th""}, {""date"": ""20230614172353"", ""headline"": ""Why The Fed Has Just One Core Problem After The Rate Skip"", ""summary"": ""Markets swooned and then ended flat after the Fed paused raising interest rates. Read why investors should focus on inflation and employment numbers.""}, {""date"": ""20230614173000"", ""headline"": ""Johnson & Johnson stock underperforms Wednesday when compared to competitors despite daily gains"", ""summary"": ""Shares of Johnson & Johnson inched 0.51% higher to $161.56 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""20230615062400"", ""headline"": ""BeiGene Sinks after AbbVie Alleges Patent Violation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230615062700"", ""headline"": ""What Are the 3 Top Dividend Aristocrat Stocks That Are Too Cheap to Ignore?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230615072600"", ""headline"": ""NVIDIA, Johnson & Johnson And 2 Other Stocks Insiders Are Selling"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230615093000"", ""headline"": ""If I Had $1,000 to Invest Between Amazon, Johnson & Johnson, and Tesla Stocks, Here's How I'd Do It"", ""summary"": ""Right now, I would scoop up two that offer fantastic growth prospects -- and a third that offers the security of rising dividend payments and a business that can weather any economy.  First, let's talk a bit about Amazon.  The company dominates in two high-growth industries: e-commerce and cloud computing.""}, {""date"": ""20230615102500"", ""headline"": ""AbbVie Says BeiGene's Flagship Blood Cancer Drug Infringes Imbruvica Patent"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230615173100"", ""headline"": ""Johnson & Johnson stock underperforms Thursday when compared to competitors despite daily gains"", ""summary"": ""Shares of Johnson & Johnson rose 1.34% to $163.73 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""20230615183930"", ""headline"": ""The only group that bull market buyers aren't buying right now is tech, says Jim Cramer"", ""summary"": ""'Mad Money' host Jim Cramer breaks down the four camps of bull market buyers in the current market.""}, {""date"": ""20230615195339"", ""headline"": ""Cramer explains how four different camps of buyers see mixed messages in the Fed's rate strategy"", ""summary"": ""CNBC's Jim Cramer detailed four different buyers' schools of thought following the Fed's rate news on Wednesday.""}, {""date"": ""20230615203117"", ""headline"": ""CAVA buyers are drawn in by FOMO, says Jim Cramer"", ""summary"": ""'Mad Money' host Jim Cramer breaks down the four camps of bull market buyers in the current market.""}, {""date"": ""20230615204731"", ""headline"": ""10 A-Rated Stocks Billionaires Are Loading Up On"", ""summary"": ""In this piece, we will take a look at ten A-rated stocks billionaires are loading up on. For more stocks, head on over to 5 A-Rated Stocks Billionaires Are Loading Up On. The stock market is made up of thousands of companies. Combined with the fact that the regular, retail investor has an unprecedented amount [\u2026]""}, {""date"": ""20230616014400"", ""headline"": ""FDA panel recommends updated COVID-19 vaccines targeting XBB.1.5 subvariant"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230616114500"", ""headline"": ""AbbVie's (ABBV) Skyrizi Meets Ulcerative Colitis Study Goals"", ""summary"": ""AbbVie's (ABBV) Skyrizi achieves statistical significance with its primary endpoint of clinical remission in a late-stage study as a maintenance treatment for ulcerative colitis.""}, {""date"": ""20230616123800"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230616144300"", ""headline"": ""Mersana (MRSN) Down on Partial Ovarian Cancer Study Hold"", ""summary"": ""Mersana's (MRSN) shares decline on partial clinical hold by the FDA on UP-NEXT and UPGRADE-A studies evaluating upifitamab rilsodotin to treat platinum-sensitive ovarian cancer.""}, {""date"": ""20230616171044"", ""headline"": ""3 Stocks to Buy for Long-Term, Life-Changing Returns"", ""summary"": ""Investors are always on the hunt for long-term wealth stocks. You know, the kind that you can buy and hold for years (or decades) and generate market-beating returns. We\u2019re all after that \u2014 that\u2019s why we read articles like this one. When investing for the future, readers have to look under the hood and find high-quality businesses. At the same time, it can be hard when looking for long-term investment stocks. That\u2019s because so many of the best stocks have already generated the life-changing retu""}, {""date"": ""20230616173100"", ""headline"": ""Johnson & Johnson stock underperforms Friday when compared to competitors despite daily gains"", ""summary"": ""Shares of Johnson & Johnson inched 0.31% higher to $164.23 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P...""}, {""date"": ""20230616184000"", ""headline"": ""Alkermes and Cogent Biosciences Stock See Action From Activist Investors"", ""summary"": ""Sarissa Capital is pushing for change at biopharmaceutical firm Alkermes. Fairmount Funds lifted its investment in Cogent Biosciences.""}, {""date"": ""20230616195325"", ""headline"": ""Why Shares of Fate Therapeutics Soared This Week"", ""summary"": ""Shares of Fate Therapeutics (NASDAQ: FATE) were up by 23.7% for the week as of Friday afternoon, after being as high as 30.8% for the week, according to data provided by S&P Global Market Intelligence.  The company focuses on cellular immunotherapies to treat cancers and immune disorders.  Late last week, the stock received an upgrade from Mizuho (NYSE: MFG) analyst Mara Goldstein, who maintained her buy rating with a price target of $12.""}, {""date"": ""20230617090000"", ""headline"": ""How To Become Financially Independent, Stress-Free"", ""summary"": ""Retirees need to be financially independent. However, even for folks years away from retirement, it can offer great benefits. Click for our dividend strategy.""}, {""date"": ""20230617101000"", ""headline"": ""3 Bargain Stocks to Buy on the Dip"", ""summary"": ""Three Motley Fool contributors think they've identified stocks that are great candidates to buy on the dip right now.  Here's why they picked Bristol Myers Squibb (NYSE: BMY), Pfizer (NYSE: PFE), and Teva Pharmaceutical Industries (NYSE: TEVA).  Prosper Junior Bakiny (Bristol Myers Squibb): Every once in a while, even the most prominent biopharmaceutical companies go through a period during which they have to deal with the loss of patent exclusivity for some key products.""}, {""date"": ""20230617110000"", ""headline"": ""INSIGHT-For groups fighting U.S. opioid crisis, settlement money can be hard to come by"", ""summary"": ""A series of landmark settlements since 2021 with top drug distributors, pharmacies and drugmakers including Johnson & Johnson set compensation at a total of more than $50 billion nationwide.  More than 900,000 people have died of drug overdoses in the United States since 1999, with opioids playing an outsized role, according to data from the U.S. Centers for Disease Control and Prevention.  Reuters reached out to all 50 states and the District of Columbia to ask whether they had a process for non-governmental organizations to apply for funding from the settlements.""}, {""date"": ""20230618141500"", ""headline"": ""Got $1,000? 3 Elite Dividend Stocks to Buy Right Now"", ""summary"": ""While most stocks have bounced from their bear market lows, many remain well below their highs from when the sell-off started 18 months ago.  Many top-quality dividend stocks now offer attractive dividend yields.  Coca-Cola\u00a0(NYSE: KO),\u00a0Prologis\u00a0(NYSE: PLD), and\u00a0Johnson & Johnson\u00a0(NYSE: JNJ) are among the dividend elite.""}]",{}
2,2023-06-18,161.75088500976562,2023-06-25,162.9820098876953,0.0076112404445598525,U1,"[{""date"": ""20230618141500"", ""headline"": ""Got $1,000? 3 Elite Dividend Stocks to Buy Right Now"", ""summary"": ""While most stocks have bounced from their bear market lows, many remain well below their highs from when the sell-off started 18 months ago.  Many top-quality dividend stocks now offer attractive dividend yields.  Coca-Cola\u00a0(NYSE: KO),\u00a0Prologis\u00a0(NYSE: PLD), and\u00a0Johnson & Johnson\u00a0(NYSE: JNJ) are among the dividend elite.""}, {""date"": ""20230619090000"", ""headline"": ""Tech Ruled The First Half Of 2023, The Industry You Need To Watch In The Second Half"", ""summary"": ""Tech stocks have staged a massive comeback in 2023, but value investors should consider looking into currently unloved sectors like healthcare. See my top picks.""}, {""date"": ""20230620012700"", ""headline"": ""Discovering The Top Dogs: A Guide To Woofing Up Your Returns With Dogs Of The Dow Investing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230620070002"", ""headline"": ""Drugmakers aim to strike down Medicare drug-price negotiations at Supreme Court "", ""summary"": ""The lawsuits are the opening salvo in a historic and potentially decisive battle over Medicare's efforts to bring rising drug prices under control. ""}, {""date"": ""20230620090705"", ""headline"": ""Pfizer, Moderna and Novavax gear up for fall Covid vaccine rollout with an important head start"", ""summary"": ""The FDA's strain selection puts Pfizer, Moderna and Novavax on track to deliver updated coronavirus shots in time for the fall. ""}, {""date"": ""20230620130007"", ""headline"": ""How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings"", ""summary"": ""Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.""}, {""date"": ""20230620130010"", ""headline"": ""Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It"", ""summary"": ""Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.""}, {""date"": ""20230620173100"", ""headline"": ""Johnson & Johnson stock falls Tuesday, still outperforms market"", ""summary"": ""Shares of Johnson & Johnson dropped 0.06% to $164.13 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P...""}, {""date"": ""20230620214522"", ""headline"": ""Johnson & Johnson (JNJ) Stock Moves -0.06%: What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) closed at $164.13 in the latest trading session, marking a -0.06% move from the prior day.""}, {""date"": ""20230621023500"", ""headline"": ""Looking At Johnson & Johnson's Recent Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230621091400"", ""headline"": ""GE HealthCare, Johnson & Johnson unit announce collaboration"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230621100800"", ""headline"": ""Top pharma lobby sues U.S. govt. over Medicare drug pricing negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230621165852"", ""headline"": ""2seventy bio: Nothing Properly Explains The Low Valuation"", ""summary"": ""2seventy bio, Inc. has a good cash position, a decent early stage pipeline, and strong collaborations. But we have our doubts about TSVT stock. Read more here.""}, {""date"": ""20230621170848"", ""headline"": ""Pharmaceutical trade group sues Biden administration over Medicare drug price negotiations "", ""summary"": ""PhRMA's lawsuit is the fourth legal challenge to the law after separate suits from Merck, Bristol Myers Squibb and the U.S. Chamber of Commerce. ""}, {""date"": ""20230621173100"", ""headline"": ""Johnson & Johnson stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slid 0.15% to $163.88 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""20230622043000"", ""headline"": ""How artificial intelligence can make hiring bias worse"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230622045600"", ""headline"": ""SVB Securities Sticks to Their Buy Rating for Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230622053100"", ""headline"": ""J&J talc bankruptcy unit to establish $750M trust fund with insurers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230622070600"", ""headline"": ""Psychedelics Company Silo Pharma Working On Time-Release And Dosage Ketamine Implant And Topical, Hoping To Deliver Steady Pain Relief For Four Million Fibromyalgia Sufferers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230622070900"", ""headline"": ""Cidara Therapeutics receives U.S. FDA fast track designation for CD388"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230622075300"", ""headline"": ""Cidara gains as FDA grants fast track status for flu candidate"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230622091143"", ""headline"": ""HEQ: Deep Discount On This Low Beta Fund"", ""summary"": ""The John Hancock Hedged Equity & Income Fund is designed to hedge one's portfolio. Click here to learn why I view HEQ CEF as one to be traded tactically.""}, {""date"": ""20230622093000"", ""headline"": ""AI May Transform Healthcare: 2 Top Stocks to Buy Now"", ""summary"": ""It's no surprise that some healthcare companies are going all-in on this exciting technology.  In the last quarter of that year, it filed more patents -- a total of 48 -- linked to AI than any other healthcare company, according to GlobalData.""}, {""date"": ""20230622121000"", ""headline"": ""Will Johnson & Johnson Be a Trillion-Dollar Stock by 2038?"", ""summary"": ""With a $427 billion market capitalization, Johnson & Johnson (NYSE: JNJ) is currently the 15th largest publicly traded business on the planet.  Let's examine the pharmaceutical industry and J&J's fundamentals to decide.  Before considering Johnson & Johnson's potential, it's important to consider the state of the industry in which J&J primarily operates (pharmaceuticals).""}, {""date"": ""20230622134500"", ""headline"": ""Ranking These 5 Dividend Kings From Highest to Lowest Quality"", ""summary"": ""These Dividend Kings are among the most consistent dividend growers on the market. In today's video, I rank five Dividend King stocks from highest quality to lowest. One of those must-own companies is Johnson & Johnson (NYSE: JNJ).""}, {""date"": ""20230622173100"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Johnson & Johnson advanced 1.06% to $165.62 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P...""}, {""date"": ""20230623033300"", ""headline"": ""Johnson & Johnson stock outperforms competitors despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230623034000"", ""headline"": ""The AI Tool That Beat Out Top Wall Street Analysts"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230623071800"", ""headline"": ""Cramer Says Datadog Will 'Put Up Some Good Numbers,' And 9 More Stock Takes From 'Mad Money' Host"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230623110658"", ""headline"": ""IWD: A Well-Diversified Value ETF With A Few Weaknesses"", ""summary"": ""iShares Russell 1000 Value ETF invests in large and mid-cap stocks with low price-to-book and low growth. Find out if the IWD ETF is right for your portfolio.""}, {""date"": ""20230623173000"", ""headline"": ""Johnson & Johnson stock outperforms market despite losses on the day"", ""summary"": ""Shares of Johnson & Johnson sank 0.08% to $165.48 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""20230623233039"", ""headline"": ""10 Companies Likely to be Dividend Aristocrats in the Future"", ""summary"": ""In this article, we discuss 10 companies likely to be Dividend Aristocrats in the future. You can skip our detailed analysis of dividend growers and their performance, and go directly to read 5 Companies Likely to be Dividend Aristocrats in the Future. Dividend Aristocrats are a group of stocks in the S&P 500 that have [\u2026]""}, {""date"": ""20230624040000"", ""headline"": ""Hershey: Durable Business, Stretched Valuation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230624092300"", ""headline"": ""3 Reliable Dividend Stocks to Buy Now and Hold Forever"", ""summary"": ""Like a lot of investors, I'm a big fan of dividend-paying stocks for more reasons than one. I'm a busy guy, so receiving regular cash payments for doing nothing more than holding a stock appeals to me.""}, {""date"": ""20230624095000"", ""headline"": ""Expect a Roaring S&P 500 Bull Market? Here Are the 10 Stocks You'll Want to Own"", ""summary"": ""Is a new bull market here for the S&P 500? It depends on whom you ask.\u00a0 Yes, the index has jumped more than 20% above its previous bear market low. That's enough to qualify as a new bull market for many investors.""}, {""date"": ""20230624130000"", ""headline"": ""How To Build A Dividend Portfolio With $25,000 Among June's Top 30 Stocks"", ""summary"": ""A dividend income-oriented investment portfolio can earn you extra income via dividend payments. Find out my June top 10 picks to build an investment portfolio.""}, {""date"": ""20230624163850"", ""headline"": ""Top 30 S&P 500 Stocks by Index Weight"", ""summary"": ""In this article, we discuss the top 30 S&P 500 stocks by index weight. If you want to skip our detailed discussion on the stock market and the S&P 500 index, head over to Top 5 S&P 500 Stocks by Index Weight. The S&P 500 Index, as well as the tech-heavy NASDAQ, edged higher after [\u2026]""}, {""date"": ""20230624191941"", ""headline"": ""11 Best Medical\u00a0 Stocks Under $10"", ""summary"": ""In this piece, we will take a look at the eleven best medical stocks under $10. If you want to skip our analysis of the medical industry and recent trends, head on over to 5 Best Medical Stocks Under $10. The medical industry is one of the most capitally intensive and competitive sectors in the [\u2026]""}, {""date"": ""20230625110300"", ""headline"": ""What is behind big pharma's underperformance?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230625130900"", ""headline"": ""Got $500? 3 Magnificent Dividend Stocks to Buy Without Hesitation Right Now"", ""summary"": ""Historically, dividend growth stocks have been magnificent long-term investments.  Coca-Cola\u00a0(NYSE: KO),\u00a0Johnson & Johnson (NYSE: JNJ), and Walgreens Boots Alliance\u00a0(NASDAQ: WBA) are three of the best at growing their dividends.  Coca-Cola is an elite dividend stock.""}]",{}
3,2023-06-25,162.9820098876953,2023-07-02,163.0214080810547,0.00024173338754707174,U1,"[{""date"": ""20230625110300"", ""headline"": ""What is behind big pharma's underperformance?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230625130900"", ""headline"": ""Got $500? 3 Magnificent Dividend Stocks to Buy Without Hesitation Right Now"", ""summary"": ""Historically, dividend growth stocks have been magnificent long-term investments.  Coca-Cola\u00a0(NYSE: KO),\u00a0Johnson & Johnson (NYSE: JNJ), and Walgreens Boots Alliance\u00a0(NASDAQ: WBA) are three of the best at growing their dividends.  Coca-Cola is an elite dividend stock.""}, {""date"": ""20230626035700"", ""headline"": ""Bears Negotiating A Truce As Tech Option Activity Heats Up"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230626094000"", ""headline"": ""Chart Of The Day: Is Johnson & Johnson Poised For A Breakout?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230626100700"", ""headline"": ""Johnson & Johnson's Janssen Pharma Touts Positive Results in Nipocalimab Phase 2 Trial"", ""summary"": ""By Ben Glickman Johnson &amp; Johnson said Monday that its drug, nipocalimab, had positive results in a Phase 2 clinical trial. The Spring House, Penn.-based...""}, {""date"": ""20230626101600"", ""headline"": ""J&J submits application to EMA for combination PAH drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230626104000"", ""headline"": ""Dow falls 109 points on losses for Amgen, Johnson & Johnson shares"", ""summary"": ""Behind losses for shares of Amgen and Johnson & Johnson, the Dow Jones Industrial Average is down Monday morning. The Dow was most recently trading 109...""}, {""date"": ""20230626114500"", ""headline"": ""2 Best Buffett Stocks to Buy for the Long Haul"", ""summary"": ""Investors follow what stocks Warren Buffett's Berkshire Hathaway picks for a simple reason.  Since Buffett took over the company in the 1960s, it has become the largest financial stock in the U.S. market and has delivered a five-year return of 79% and a 10-year return of 202% versus 60% and 173%, respectively, for the S&P 500 index.  The best way to see which stocks Berkshire Hathaway is buying or selling is by following the company's 13F reports with the Securities and Exchange Commission.""}, {""date"": ""20230626121200"", ""headline"": ""Take the Zacks Approach to Beat the Market: Shopify, Oracle, Uber in Focus"", ""summary"": ""Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.""}, {""date"": ""20230626125400"", ""headline"": ""Post-COVID-19: How the COVAX Initiative Could Redirect its $2.6B Surplus to Fight Future Pandemics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230626135527"", ""headline"": ""My Highest Quality Dividend Champions"", ""summary"": ""The article presents the highest-quality Dividend Champions, which are companies listed on U.S. exchanges. Click here to read more.""}, {""date"": ""20230626173000"", ""headline"": ""Johnson & Johnson stock falls Monday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson shed 1.12% to $163.63 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""20230626214518"", ""headline"": ""Johnson & Johnson (JNJ) Dips More Than Broader Markets: What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) closed the most recent trading day at $163.63, moving -1.12% from the previous trading session.""}, {""date"": ""20230626234318"", ""headline"": ""California man tells jury of getting cancer after using J&J baby powder"", ""summary"": ""A California man suing Johnson & Johnson told jurors on Monday how his life was upended by a cancer diagnosis that he blames on using the company's baby powder since childhood, as the first trial over the product in nearly two years neared its end.  \""I just turned into a scared little kid,\"" Emory Hernandez, fighting back tears, said of his 2022 mesothelioma diagnosis while testifying in Alameda County Superior Court, according to an online broadcast of the trial by Courtroom View Network.  J&J has denied that its baby powder contained asbestos or causes cancer.""}, {""date"": ""20230627033300"", ""headline"": ""Johnson & Johnson stock underperforms Tuesday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230627085418"", ""headline"": ""10 Dow Stocks Billionaires Are Loading Up On"", ""summary"": ""In this article, we will take a look at the 10 Dow stocks billionaires are loading up on. To see more such companies, go directly to 5 Dow Stocks Billionaires Are Loading Up On. In Tony Robbins\u2019 Money \u2013 Master The Game, there\u2019s a chapter titled Invest Like the .001%: The Billionaire\u2019s Playbook. The chapter mentions the [\u2026]""}, {""date"": ""20230627100000"", ""headline"": ""J&J\u2019s Push to End Cancer Suits Meets Trial in Bankruptcy Court"", ""summary"": ""(Bloomberg) -- Johnson & Johnson is facing a key test of its plan to use the US bankruptcy system to end more than 60,000 claims that a talc-based baby powder it sold for years causes cancer.Most Read from BloombergPutin Blasts Wagner \u2018Traitors\u2019 as Prigozhin Defends RevoltPutin Says Russia Avoided \u2018Civil War\u2019 as Mutiny Case ClosedStudent Loan-Relief Backers Warn Biden \u2018Failure Isn\u2019t an Option\u2019Pickleball Injuries May Cost Americans Nearly $400 Million This Year, According to UBSRussia Latest: Mut""}, {""date"": ""20230627100409"", ""headline"": ""J&J's $8.9 billion talc settlement faces US bankruptcy test"", ""summary"": ""Johnson & Johnson's proposed $8.9 billion settlement of thousands of lawsuits alleging that its talc products cause cancer faces a crucial hurdle this week as a U.S. bankruptcy judge in New Jersey considers whether or not a J&J subsidiary may resolve them by filing for bankruptcy a second time.  J&J subsidiary LTL Management's first attempt to do that was dismissed in April after a U.S. appeals court ruled that it was not in sufficient financial distress to be eligible for bankruptcy protection.""}, {""date"": ""20230627124900"", ""headline"": ""Johnson & Johnson's Talc Cancer Claims Saga: $8.9B Settlement Under Scrutiny"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230627173100"", ""headline"": ""Johnson & Johnson stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson sank 0.21% to $163.29 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""20230628020700"", ""headline"": ""Google Accused of Breaching Promised Ad Standards, Big Brands and Government Agencies Affected"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230628093000"", ""headline"": ""The Best Stocks to Invest $20,000 in Right Now"", ""summary"": ""Market leaders, dividend stocks, young and up-and-coming players, and recovery stories all make good candidates.  Intuitive Surgical (NASDAQ: ISRG) is the global leader in robotic surgery.  Most surgeons train on Intuitive's Da Vinci system -- and that's another reason the company probably will maintain its leadership.""}, {""date"": ""20230628094500"", ""headline"": ""Johnson & Johnson call volume above normal and directionally bullish"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230628105000"", ""headline"": ""Johnson & Johnson Unusual Options Activity For June 28"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230628120040"", ""headline"": ""Calculating The Intrinsic Value Of Johnson & Johnson (NYSE:JNJ)"", ""summary"": ""Key Insights The projected fair value for Johnson & Johnson is US$201 based on 2 Stage Free Cash Flow to Equity With...""}, {""date"": ""20230628121800"", ""headline"": ""Noteworthy Wednesday Option Activity: JNJ, UAL, DE"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230628132553"", ""headline"": ""12 Best Long-Term Dividend Stocks To Buy Now"", ""summary"": ""In this article, we discuss 12 best long-term dividend stocks to buy now. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read 5 Best Long-Term Dividend Stocks To Buy Now. Last year was challenging for the overall stock market and particularly for growth stocks. On [\u2026]""}, {""date"": ""20230628133200"", ""headline"": ""1 Sickly Dividend Stock to Avoid Like the Plague Right Now (and 2 Much Healthier Ones to Buy Instead)"", ""summary"": ""Medical Properties Trust\u00a0(NYSE: MPW) currently offers a 12.5% dividend yield.  Instead, income-seeking investors should focus their attention on healthier\u00a0dividend stocks.  Johnson & Johnson\u00a0(NYSE: JNJ) and\u00a0Community Healthcare Trust\u00a0(NYSE: CHCT) currently stand out as much safer options.""}, {""date"": ""20230628161016"", ""headline"": ""Avantor: Promising Long-Term Buy With Potential For Opportunistic Entry"", ""summary"": ""Avantor faces near-term challenges amid macro headwinds and revenue growth uncertainties due to continuing COVID roll-off. Read my analysis of AVTR stock here.""}, {""date"": ""20230628173000"", ""headline"": ""Johnson & Johnson stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slumped 0.20% to $162.96 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P...""}, {""date"": ""20230628231121"", ""headline"": ""Cancer plaintiffs drill down on J&J's support for $8.9 bln talc deal"", ""summary"": ""The lead negotiators for Johnson & Johnson's proposed $8.9 billion settlement of thousands of talc lawsuits faced intense questioning in U.S. bankruptcy court on Wednesday about how much support the company has for the deal.  During a multi-day court hearing in Trenton, New Jersey, attorneys for plaintiffs alleging that J&J's baby powder and other talc products sometimes contained asbestos and caused ovarian cancer and mesothelioma drilled down on J&J's public statements that it has \""secured commitments from over 60,000 current claimants\"" for the settlement, and that the \""majority\"" of talc claimants support it.""}, {""date"": ""20230628232106"", ""headline"": ""Cancer plaintiffs drill down on J&J's support for $8.9 billion talc deal"", ""summary"": ""The lead negotiators for Johnson & Johnson's proposed $8.9 billion settlement of thousands of talc lawsuits faced intense questioning in U.S. bankruptcy court on Wednesday about how much support the company has for the deal.  During a multi-day court hearing in Trenton, New Jersey,  attorneys for plaintiffs alleging that J&J's baby powder and other talc products sometimes contained asbestos and caused ovarian cancer and mesothelioma drilled down on J&J's public statements that it has \""secured commitments from over 60,000 current claimants\"" for the settlement, and that the \""majority\"" of talc claimants support it.""}, {""date"": ""20230629020000"", ""headline"": ""This Top-Performing Small-Cap Manager Is Betting Big on China"", ""summary"": ""The Matthews Emerging Markets Small Companies fund has delivered a 15.1% annualized three-year return, landing it in the top 1% of its peers. Here\u2019s what...""}, {""date"": ""20230629033300"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230629041200"", ""headline"": ""Morgan Stanley shakes up its global dividend portfolio"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230629041400"", ""headline"": ""The Supreme Court knocked down affirmative action in colleges \u2014 and companies could feel the effects too"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230629054144"", ""headline"": ""Haleon: Leading Business In An Attractive Industry"", ""summary"": ""Haleon's margins are comparably strong in the market. Click here to see why HLN stock is a Buy.""}, {""date"": ""20230629070000"", ""headline"": ""Johnson & Johnson call buyer realizes 12% same-day gains"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230629070000"", ""headline"": ""Retire Rich With 'Dividend King' Royalty"", ""summary"": ""The rate-hike cycle will end (sooner rather than later). Then, dividends should drop and shares should go to normal valuation levels. Click for my top picks.""}, {""date"": ""20230629072900"", ""headline"": ""The 3 Most Undervalued Dow Stocks to Buy Now: June 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230629130700"", ""headline"": ""The Stock Market Is Getting Scary. What to Buy Instead of Holding Cash."", ""summary"": ""The S&P 500 has gained just over 20% from a major low point hit in early October, making it much pricier.""}, {""date"": ""20230629133115"", ""headline"": ""OmniAb: Plenty Of Potential"", ""summary"": ""OmniAb shares have recovered marginally from their SPAC-birthed debut. Read more to see a full investment analysis of OABI stock.""}, {""date"": ""20230629134556"", ""headline"": ""Sell THW, Buy XLV Or THQ"", ""summary"": ""Tekla World Healthcare Fund is closed end fund and one that makes it clear that it is focused on producing income. Click here to see our take on THW.""}, {""date"": ""20230629140000"", ""headline"": ""5 High-Yielding Dividend Stocks That Are Bargain Buys"", ""summary"": ""If you're in search of bargain stocks to buy, the healthcare industry is a great place to start looking.  Among them are Johnson & Johnson (NYSE: JNJ),\u00a0AbbVie\u00a0(NYSE: ABBV), Bristol Myers Squibb (NYSE: BMY),\u00a0Amgen (NASDAQ: AMGN), and\u00a0Pfizer (NYSE: PFE) -- all of which pay dividends and offer great value.""}, {""date"": ""20230629140700"", ""headline"": ""Where Will Johnson & Johnson Be in 5 Years?"", ""summary"": ""The stock's returns over the past decade haven't been great -- should investors expect that to change?""}, {""date"": ""20230629153103"", ""headline"": ""Johnson & Johnson: Pay Yourself 7% With This Bond-Like Exposure"", ""summary"": ""Johnson & Johnson may well be the ultimate Sleep-Well-At-Night, or SWAN, stock. Click here for my take on JNJ stock and its prospects.""}, {""date"": ""20230629173100"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.70% higher to $164.10 Thursday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""20230629180000"", ""headline"": ""Is Johnson & Johnson Stock a Strong Buy?"", ""summary"": ""Large-cap pharmaceuticals stocks that pay dividends frequently generate market-beating returns over the long term.  For instance, healthcare behemoth Johnson & Johnson (NYSE: JNJ) hasn't outperformed the broader markets in six years.  J&J also launched several potential blockbuster drugs over the last 12 months.""}, {""date"": ""20230629181706"", ""headline"": ""Moody's: Pharma outlook stable for next 12-18 months, but with caveats"", ""summary"": ""Moody's, in a note, sees a stable outlook for the drug industry. But there are a few headwinds that might mess up the semi-optimistic picture.""}, {""date"": ""20230629204959"", ""headline"": ""7 Up-and-Coming Stocks to Buy for the Next Decade"", ""summary"": ""In arguably most cases involving expert financial advice, you will encounter guidance toward established enterprises, not up-and-coming stocks to buy. While the latter category certainly dials up the heat in terms of overall sexiness, some folks just can\u2019t handle adventurous portfolios. And that\u2019s totally fine \u2013 we\u2019re all different. Nevertheless, for those that have the patience and the tolerance for risk, they may find greater satisfaction with long-term stocks. By that, I\u2019m not talking about b""}, {""date"": ""20230629232648"", ""headline"": ""Johnson & Johnson: Buy The Market (Technical Analysis)"", ""summary"": ""Johnson & Johnson (JNJ) is strategically shifting towards high-growth sectors like pharmaceuticals and medical devices. See why JNJ stock is rated buy.""}, {""date"": ""20230630060100"", ""headline"": ""Like shoppers at a retail store, IPO investors are demanding discounts and displaying price sensitivity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230630063400"", ""headline"": ""Like choosy shoppers at a retail store, IPO investors are demanding discounts and displaying price sensitivity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230630084100"", ""headline"": ""The Supreme Court ended affirmative action at colleges. That could harm companies\u2019 diversity efforts."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230630092100"", ""headline"": ""5 Genius Safe Stocks to Buy for the Second Half of 2023"", ""summary"": ""As of the closing bell on June 27, 2023, the benchmark S&P 500 and growth-powered Nasdaq Composite were up by 14% and 29.5%, respectively, for the year.  Although history would suggest the phenomenal start to the new year will continue, there's no shortage of economic indicators and metrics pointing to downside for the U.S. economy and/or stock market.  What follows are five genius safe stocks -- \""safe\"" in the sense that they're profitable, time-tested, and have the ability outperform in any economic environment -- you can confidently buy for the second half of 2023.""}, {""date"": ""20230630093800"", ""headline"": ""Ranking These 5 Dividend Kings From Highest Quality To Lowest"", ""summary"": ""A Dividend King is any stock that has raised their dividend for 50+ consecutive years. See five Dividend Kings ranked from highest to lowest quality.""}, {""date"": ""20230630110800"", ""headline"": ""15 Stocks Up, 15 Stocks Down: A Look At The Dow Jones Industrial Average Halfway Through 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230630114500"", ""headline"": ""Medicare revises guidance on drug price negotiations amid lawsuits"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230630120104"", ""headline"": ""FVAL: Smarter Than Most Value ETFs"", ""summary"": ""Fidelity Value Factor ETF holds 126 stocks with value characteristics. FVAL has rules for the banking industry, so financials are not overweight. Click here for more.""}, {""date"": ""20230630121700"", ""headline"": ""Like shoppers, IPO investors are demanding discounts and showing price sensitivity"", ""summary"": ""IPO investors, much like shoppers in the current inflationary environment, are demanding discounts, according to Renaissance Capital.""}, {""date"": ""20230630122500"", ""headline"": ""If You Invested $5,000 In Johnson & Johnson In 2018, This Is How Much You Would Have Today"", ""summary"": ""As one of the most prominent healthcare companies on Earth, Johnson & Johnson (NYSE: JNJ) is a stock that's much loved by investors on account of its metronome-like consistent returns.  Between its gradually increasing dividend and plenty of reasons to expect that the business will be more valuable tomorrow than it is today, it's easy to assume that it has a knack for beating the market.  If you invested $5,000 in Johnson & Johnson in mid-2018 and reinvested all your dividends, you'd currently be enjoying a total return of 53%, which means you'd have around $7,640.""}, {""date"": ""20230630125300"", ""headline"": ""Check Out What Whales Are Doing With JNJ"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230630131502"", ""headline"": ""Sage Therapeutics: Zuranolone August Approval Likely, Opportunity Uncertain"", ""summary"": ""Sage Therapeutics should find out in August whether its drug, zuranolone, will be approved. Click here to see our take on SAGE stock.""}, {""date"": ""20230630173100"", ""headline"": ""Johnson & Johnson stock rises Friday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.87% higher to $165.52 Friday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""20230630181334"", ""headline"": ""Medicare releases updated guidance ahead of drug price negotiations"", ""summary"": ""CMS released revised guidance on Friday, adding transparency to the Medicare negotiation process it is engaging in with drug makers as part of the Inflation Reduction Act.""}, {""date"": ""20230630203452"", ""headline"": ""3 Dividend Stocks to Buy Right This Minute"", ""summary"": ""Since the second half of 2022, the economy has been volatile and this has led to many investors looking for safe and stable stocks to invest in. The market was in a rout and no industry has been spared but after all the uncertainty, we are finally looking at better days ahead. There are still concerns about a looming recession and it could have an impact on the market but there are some dividend stocks to buy now that can thrive even if there is a recession. Investors looking to build a stable p""}, {""date"": ""20230630224700"", ""headline"": ""Companies Stick to Workplace Diversity Despite End of Affirmative Action"", ""summary"": ""The Supreme Court's decisions not only dealt a blow to the higher-education system, but to America's private sector as well.""}, {""date"": ""20230702054200"", ""headline"": ""Supreme Court ended affirmative action at colleges. That could harm companies\u2019 diversity efforts."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230702190915"", ""headline"": ""10 Best Dividend Penny Stocks to Buy Now"", ""summary"": ""In this article, we will discuss 10 best dividend penny stocks to buy now. You can skip our detailed analysis of dividend stocks and their past performance, and go directly to read 5 Best Dividend Penny Stocks to Buy Now. As we move into the second half of the year, the stock market continues to [\u2026]""}]",{}
4,2023-07-02,163.0214080810547,2023-07-09,156.8460693359375,-0.03788053862255192,D4,"[{""date"": ""20230702054200"", ""headline"": ""Supreme Court ended affirmative action at colleges. That could harm companies\u2019 diversity efforts."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230702190915"", ""headline"": ""10 Best Dividend Penny Stocks to Buy Now"", ""summary"": ""In this article, we will discuss 10 best dividend penny stocks to buy now. You can skip our detailed analysis of dividend stocks and their past performance, and go directly to read 5 Best Dividend Penny Stocks to Buy Now. As we move into the second half of the year, the stock market continues to [\u2026]""}, {""date"": ""20230703030400"", ""headline"": ""3 Long-Term Stocks to Make Your \u2018Get Rich\u2019 Dreams Come True"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230703113200"", ""headline"": ""Johnson & Johnson psoriasis pill disappoints in phase 2 trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230703130605"", ""headline"": ""Face to Face - 'Fail Your Way to Success', Says Prof Behind Pioneering Drug Discovery Group At UCT"", ""summary"": ""Inside Professor Kelly Chibale's office the bookshelves are packed with awards. On the walls, framed photographs include his class photo at Cambridge University in the United Kingdom, dated...""}, {""date"": ""20230703140023"", ""headline"": ""With 65% institutional ownership, Johnson & Johnson (NYSE:JNJ) is a favorite amongst the big guns"", ""summary"": ""Key Insights Institutions' substantial holdings in Johnson & Johnson implies that they have significant influence over...""}, {""date"": ""20230703214519"", ""headline"": ""Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) closed at $163.35 in the latest trading session, marking a -1.31% move from the prior day.""}, {""date"": ""20230703224015"", ""headline"": ""10 Best July Dividend Stocks To Buy"", ""summary"": ""In this article, we discuss 10 best July dividend stocks to buy. You can skip our detailed analysis of dividend capture strategy and performance of dividend stocks, and go directly to read 5 Best July Dividend Stocks To Buy. The investment landscape is undergoing substantial shifts this year as investors explore different strategies to make [\u2026]""}, {""date"": ""20230704072100"", ""headline"": ""Protagonist says JNJ-2113 met efficacy endpoints in psoriasis study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230704121400"", ""headline"": ""3 Spectacular Dividend Stocks to Buy in July"", ""summary"": ""Here's why they picked AbbVie (NYSE: ABBV), Bristol Myers Squibb (NYSE: BMY), and Johnson & Johnson (NYSE: JNJ).  Keith Speights (AbbVie): If you're in the market for a high dividend yield, AbbVie could be right up your alley.""}, {""date"": ""20230704203958"", ""headline"": ""Long-Term Stock Portfolio: Best Stocks for 20 Years"", ""summary"": ""In this piece, we will take a look at the best stocks for the next 20 years. For more stocks on this list, head on over to Long-Term Stock Portfolio: 5 Best Stocks for 20 Years. The world of investments is not for those that are prone to panicking easily. Over a few years, stocks [\u2026]""}, {""date"": ""20230704223717"", ""headline"": ""15 Best Places to Retire in the Caribbean"", ""summary"": ""In this article, we will take a look at the 15 best places to retire in the Caribbean. If you wish to skip our detailed analysis on a million-dollar retirement, and retiring in the Caribbean, you may go to 5 Best Places to Retire in the Caribbean. A Million Dollar Retirement Previously, a comfortable retirement in [\u2026]""}, {""date"": ""20230705033300"", ""headline"": ""Johnson & Johnson stock falls Wednesday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230705064200"", ""headline"": ""Protagonist data suggests 'very strong profile' for JNJ-2113, says Jefferies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230705081200"", ""headline"": ""Wells Fargo expects Ventyx Biosciences' shares to work into 2H23 catalysts"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230705090600"", ""headline"": ""Johnson & Johnson Unusual Options Activity For July 05"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230705094400"", ""headline"": ""J&J FRONTIER 1 Phase 2 leaves door open for Ventyx's VTX-958, says Oppenheimer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230705110700"", ""headline"": ""Sorrento sees promising phase 2 results for abivertinib for lymphoma"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230705114123"", ""headline"": ""Here\u2019s Why Johnson & Johnson (JNJ) Declined in Q1"", ""summary"": ""ClearBridge Investments, an investment management company, released its \u201cClearBridge Large Cap Value Strategy\u201d first quarter 2023 investor letter. A copy of the same can be downloaded here. The strategy underperformed its benchmark, the Russell 1000 Value Index, in the first quarter. On an absolute basis, the strategy gained from 5 of the 11 sectors in which [\u2026]""}, {""date"": ""20230705123900"", ""headline"": ""What The World's Top Investors Are Buying And Selling, The Sequel"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230705133337"", ""headline"": ""Protagonist Therapeutics-Janssen Partnered Psoriasis Candidate Fall Short Of Rival Treatment"", ""summary"": ""Protagonist Therapeutics Inc (NASDAQ: PTGX) announced topline results from the Phase 2b FRONTIER 1 trial of the oral interleukin-23 receptor (IL-23R) antagonist JNJ-2113 (formerly PN-235) in adult patients with moderate-to-severe plaque psoriasis presented at World Congress of Dermatology in Singapore. JNJ-2113 is being developed by Janssen Biotech Inc, a unit of Johnson & Johnson (NYSE: JNJ). In March, Protagonist released preliminary results from the trial, saying it had outperformed the place""}, {""date"": ""20230705135100"", ""headline"": ""Can Eli Lilly's (LLY) Continue its Ride on Obesity Drug Wave?"", ""summary"": ""Lilly (LLY) continues to raise the bar on obesity drugs as latest data show that participants treated with these experimental drugs achieved mean weight reduction of up to 24%.""}, {""date"": ""20230705173100"", ""headline"": ""Johnson & Johnson stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson shed 0.33% to $162.81 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""20230705192041"", ""headline"": ""Cramer examines the worst performers from the first half of 2023, explains why the market seems narrow"", ""summary"": ""CNBC's Jim Cramer told investors on Wednesday that if they're waiting for the market to broaden for a rally, they might be waiting forever.""}, {""date"": ""20230705195852"", ""headline"": ""Go with what's working instead of waiting for what is not working, says Jim Cramer"", ""summary"": ""'Mad Money' host Jim Cramer takes a closer look at market underperformers and what they say about the economy at large.""}, {""date"": ""20230705204106"", ""headline"": ""Moderna announces China investment as country opens doors to foreign pharma"", ""summary"": ""China signals a warmer welcome for Western pharma giants just as Treasury Secretary Janey Yellen leaves for Beijing.""}, {""date"": ""20230705213454"", ""headline"": ""15 Countries With The Best Healthcare In The World"", ""summary"": ""In this article, we will be taking a look at the 15 countries with the best healthcare in the world. If you wish to see the top ones, head straight to the 5 Countries With The Best Healthcare In The World. When it comes to ensuring the well-being of their citizens, some countries like Switzerland, [\u2026]""}, {""date"": ""20230706015400"", ""headline"": ""The 3 Best Defensive Stocks to Buy Now (and Never Sell)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230706022600"", ""headline"": ""Johnson & Johnson (JNJ) Gets a Buy from SVB Securities"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230706033300"", ""headline"": ""Johnson & Johnson stock falls Thursday, still outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230706060800"", ""headline"": ""Bausch + Lomb buys J&J's Blink eye and contact lens drops product line"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230706070100"", ""headline"": ""Notable Thursday Option Activity: JNJ, TXN, BAC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230706100800"", ""headline"": ""August 25th Options Now Available For Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230706105600"", ""headline"": ""3 Super-Safe Dividend Stocks to Buy for the Rest of 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230706120500"", ""headline"": ""Johnson & Johnson: A Safe and Undervalued Dividend Aristocrat"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230706130012"", ""headline"": ""Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.""}, {""date"": ""20230706140000"", ""headline"": ""2 Best Biotech Stocks to Buy in July"", ""summary"": ""The pharmaceutical industry can be especially lucrative for investors.  Here are two giant drugmakers for income investors to consider buying this month that look equipped to continue thriving in the future.  When many people think of Johnson & Johnson (NYSE: JNJ), the first thing that comes to mind is consumer health brands under the separate, but 90% company-owned entity, Kenvue (NYSE: KVUE).""}, {""date"": ""20230706140705"", ""headline"": ""Voya Global Equity Dividend: 9.2% Yield, What's Not To Like?"", ""summary"": ""The Voya Global Equity Dividend CEF generates a big yield. Read if this fund is a good way to play defense in a volatile market.""}, {""date"": ""20230706144832"", ""headline"": ""Johnson & Johnson: Supplemental BLA Of Carvykti Gives Great Growth Opportunity"", ""summary"": ""Johnson & Johnson's Supplemental Biologics Licensing Application of CARVYKTI was filed; approval would give JNJ a great growth opportunity. Click here for more on JNJ.""}, {""date"": ""20230706173100"", ""headline"": ""Johnson & Johnson stock outperforms market despite losses on the day"", ""summary"": ""Shares of Johnson & Johnson slipped 0.74% to $161.60 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""20230706181424"", ""headline"": ""Bausch + Lomb Expands OTC Eye Care Portfolio, Acquires JNJ's Blink"", ""summary"": ""Bausch + Lomb Corporation (NYSE: BLCO) has acquired Johnson & Johnson's (NYSE: JNJ) eye and contact lens drops brand Blink for $106.5 million to bolster its position in over-the-counter (OTC) consumer products for eye care. The deal marks its second in two weeks to bolster the contact lens maker's portfolio of eye care products. The Blink portfolio of eye drops consists of various eye drops and contact lens rewetting drops that provide immediate and long-lasting symptom relief. According to a 20""}, {""date"": ""20230706204052"", ""headline"": ""Bausch + Lomb Buys Blink Brands to Expand Eye Drop Portfolio"", ""summary"": ""Bausch + Lomb purchased Blink brands from a J&J subsidiary for $106.5 million to expand its over-the-counter offerings.""}, {""date"": ""20230707031200"", ""headline"": ""Rose's Income Garden 80 Stock Portfolio: Update H1 2023 Green With 7 June Raises"", ""summary"": ""Rose's Income Garden portfolio saw 39 companies pay dividends in June, with seven raises and one cut. Click here for a detailed analysis.""}, {""date"": ""20230707051000"", ""headline"": ""3 Beaten-Down Dividend Stocks Primed for a Profitable Comeback"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230707080000"", ""headline"": ""VONV: Attractive Valuation, Average Performance"", ""summary"": ""Vanguard Russell 1000 Value Index Fund ETF favors stocks with low price-to-book, low sales growth, low projected earnings growth. Click for more on VONV ETF.""}, {""date"": ""20230707100000"", ""headline"": ""2 Reasons to Buy Johnson & Johnson, and 1 Reason to Sell"", ""summary"": ""Johnson & Johnson (NYSE: JNJ) is one of the most recognized healthcare companies around.  J&J also has pharmaceutical and medtech units.  All of this means investors may feel comfortable adding shares of J&J to their portfolios.""}, {""date"": ""20230707120114"", ""headline"": ""Rare autoantibody diseases : an innovative targeted pathway"", ""summary"": ""Dr Katie Abouzahr, Vice President, Autoantibody Portfolio Development Leader at the Janssen Pharmaceutical Companies of Johnson & Johnson, outlines how precision targeting in drug development...""}, {""date"": ""20230707140030"", ""headline"": ""Is Johnson & Johnson (NYSE:JNJ) A Risky Investment?"", ""summary"": ""The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...""}, {""date"": ""20230707173000"", ""headline"": ""Johnson & Johnson stock falls Friday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slid 1.45% to $159.25 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""20230707202031"", ""headline"": ""25 US Companies With The Highest Profit Margins"", ""summary"": ""In this article, we will be taking a look at the 25 US companies with the highest profit margins. If you wish to see the top ones, head straight to the 5 US Companies With The Highest Profit Margins. In the dynamic landscape of the United States business sector, several companies like JP Morgan, Apple, [\u2026]""}, {""date"": ""20230708025900"", ""headline"": ""Passive Income: 3 Dividend Kings Worth A Look"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230708031500"", ""headline"": ""June 2023 Passive Income Update"", ""summary"": ""I was happy to see such a jump in the trailing 12-month return until I compared everything.""}, {""date"": ""20230708090000"", ""headline"": ""5 Relatively Safe And Cheap Dividend Stocks To Invest In - July 2023"", ""summary"": ""This is our monthly series where we highlight 5 companies that are large-cap, relatively safe, dividend-paying, with large discounts. Click for our exclusive list.""}, {""date"": ""20230708112000"", ""headline"": ""Is Johnson & Johnson Stock a Buy?"", ""summary"": ""Let's take a look at this Dividend King after its spin-off of Kenvue and its proposed $8.7 billion litigation settlement.""}, {""date"": ""20230709095835"", ""headline"": ""SPLV: Slowing Down Entering The Potential Storm For Stocks Ahead"", ""summary"": ""SPLV's sector allocations play a crucial role in its ability to mitigate market fluctuations. Click here to read more.""}, {""date"": ""20230709110000"", ""headline"": ""Goldman Sachs sees rays of hope in underperforming health sector"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230709114500"", ""headline"": ""Is Johnson & Johnson Stock a Buy Now?"", ""summary"": ""If size were a guarantee of performance, Johnson & Johnson (NYSE: JNJ) would be one of the best healthcare stocks to buy, being one of the largest by market cap in the sector.  The new J&J still has many qualities that made it successful, but is it worth investing in the drugmaker?  J&J completed the spinoff of its consumer health division earlier this year.""}]","{""assetTurnoverTTM"": 0.4592, ""bookValue"": 75149, ""cashRatio"": 0.14768321949418498, ""currentRatio"": 1.1181, ""ebitPerShare"": 2.2345, ""eps"": 1.9969, ""ev"": 462321.78, ""fcfMargin"": 0.1731, ""fcfPerShareTTM"": 5.5993, ""grossMargin"": 0.7309, ""inventoryTurnoverTTM"": 2.2226, ""longtermDebtTotalAsset"": 0.1769, ""longtermDebtTotalCapital"": 0.2808, ""longtermDebtTotalEquity"": 0.4511, ""netDebtToTotalCapital"": 0.3114, ""netDebtToTotalEquity"": 0.5004, ""netMargin"": 0.2912, ""operatingMargin"": 0.3258, ""payoutRatioTTM"": 0.6871, ""pb"": 5.6517, ""peTTM"": 32.5356, ""pfcfTTM"": 29.1964, ""pretaxMargin"": 0.3258, ""psTTM"": 4.932, ""ptbv"": 14.6947, ""quickRatio"": 0.8359, ""receivablesTurnoverTTM"": 5.2324, ""roaTTM"": 0.0696, ""roeTTM"": 0.1756, ""roicTTM"": 0.1117, ""rotcTTM"": 0.1231, ""salesPerShare"": 6.8583, ""sgaToSale"": 0.2691, ""tangibleBookValue"": 28903, ""totalDebtToEquity"": 0.6068, ""totalDebtToTotalAsset"": 0.2379, ""totalDebtToTotalCapital"": 0.3777, ""totalRatio"": 1.6449, ""period"": ""2023-07-02""}"
5,2023-07-09,156.8460693359375,2023-07-16,157.45669555664062,0.003893156030549072,U1,"[{""date"": ""20230709095835"", ""headline"": ""SPLV: Slowing Down Entering The Potential Storm For Stocks Ahead"", ""summary"": ""SPLV's sector allocations play a crucial role in its ability to mitigate market fluctuations. Click here to read more.""}, {""date"": ""20230709110000"", ""headline"": ""Goldman Sachs sees rays of hope in underperforming health sector"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230709114500"", ""headline"": ""Is Johnson & Johnson Stock a Buy Now?"", ""summary"": ""If size were a guarantee of performance, Johnson & Johnson (NYSE: JNJ) would be one of the best healthcare stocks to buy, being one of the largest by market cap in the sector.  The new J&J still has many qualities that made it successful, but is it worth investing in the drugmaker?  J&J completed the spinoff of its consumer health division earlier this year.""}, {""date"": ""20230710033600"", ""headline"": ""Johnson & Johnson's Janssen signs licensing agreement with Nanobiotix"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230710042900"", ""headline"": ""Nanobiotix announce global licensing pact with Johnson & Johnson for NBTXR3"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230710052100"", ""headline"": ""Nanobiotix jumps 56% to $7.85 after global licensing pact with Janssen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230710061400"", ""headline"": ""Nanobiotix\u2019s stock soars after entering licensing, development deal with J&J\u2019s Janssen Pharmaceutica"", ""summary"": ""Shares of Nanobiotix SA shot up 52.1% toward a 17-month high in premarket trading Monday, after the France-based biotechnology company announced a global...""}, {""date"": ""20230710062700"", ""headline"": ""Nanobiotix Shares Soar on Licensing Deal With J&J Unit >NBTX"", ""summary"": ""By Colin Kellaher U.S.-listed shares of Nanobiotix surged in premarket trading Monday after the clinical-stage biotechnology company said it inked a...""}, {""date"": ""20230710064300"", ""headline"": ""100-Year-Old Survivors' Quest For Tulsa Race Massacre Reparations Ends In Dismissal: Politico"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230710065000"", ""headline"": ""Dividend Stocks: Here\u2019s Where to Invest $1,000 Right Now"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230710085900"", ""headline"": ""Johnson & Johnson Bolsters Its Oncology Pipeline With Nanobiotix Radiotherapy Pact"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230710090001"", ""headline"": ""Major business group slams disclosure rules as House Republicans probe ESG investing"", ""summary"": ""House Republicans scheduled several hearings this month to probe ESG investing, which has become a big target on the right.""}, {""date"": ""20230710093000"", ""headline"": ""Should You Buy the First Half's Worst-Performing Sector?"", ""summary"": ""After a tough 2022, the first half of this year was like a breath of fresh air for investors.  First, let's talk about why healthcare stocks stumbled recently.  Instead, it's part of a general movement toward stocks that may excel in a bull market.""}, {""date"": ""20230710093400"", ""headline"": ""Meta's Threads Hits 100M Users In Five Days, Foxconn Pulls Out From $19.5B Semiconductor India JV, Novo Nordisk's Weight-Loss Medications Under European Investigation Over Suicidal Risks: Today's Top Stories"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230710101304"", ""headline"": ""Cramer\u2019s Mad Dash on Johnson & Johnson: Wait to see how they do on the talc lawsuit"", ""summary"": ""CNBC\u2019s Jim Cramer delivers his daily Mad Dash.""}, {""date"": ""20230710131000"", ""headline"": ""James Lewis, the suspect in the 1982 Tylenol poisonings that killed 7 in the Chicago area, has died"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230710140500"", ""headline"": ""Lone suspect in Chicago's decades-old Tylenol murders found dead at 76"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230710140837"", ""headline"": ""Nanobiotix ADRs Jump Over 50% After Agreement With J&J's Janssen Pharmaceutical"", ""summary"": ""American depositary receipts of Nanobiotix jumped over 50% in early trading on Monday after signing an agreement with J&J's Janssen Pharmaceutical to work on co-developing a drug to treat head and neck cancer tumors.""}, {""date"": ""20230710163201"", ""headline"": ""Johnson & Johnson to Participate in the UBS MedTech, Tools and Genomics Summit"", ""summary"": ""Johnson & Johnson  will participate in the UBS MedTech, Tools and Genomics Summit on Tuesday, August 15th, at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, CA. Celine Martin,...""}, {""date"": ""20230710173000"", ""headline"": ""Johnson & Johnson stock rises Monday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.16% higher to $159.51 Monday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""20230710214950"", ""headline"": ""25 States with the Lowest Poverty Rates in America"", ""summary"": ""In this article, we look at 25 states with the lowest poverty rates in America. You can skip our detailed analysis on poverty in the United States, and head over directly to the 10 States with the Lowest Poverty Rates in America. Poverty rate in the United States has continued to steadily decline over the [\u2026]""}, {""date"": ""20230710220838"", ""headline"": ""Jurors urged to impose heavy punitive damages in J&J talc trial"", ""summary"": ""Lawyers for a California man who says he developed a rare cancer from exposure to asbestos in Johnson & Johnson's talc-based baby powder on Monday urged a jury to order the company to pay heavy punitive damages, calling its conduct negligent and \""despicable.\""  \""A reasonably careful corporation would not sell a product that allowed carcinogens to be applied to babies,\"" Joseph Satterley, a lawyer for Emory Hernandez Valadez, said in a closing argument at the end of a six-week trial in Alameda County Superior Court in California.  J&J has consistently denied that its now-discontinued talc baby powder contains asbestos or causes cancer.""}, {""date"": ""20230711014300"", ""headline"": ""See Which Of The Latest 13F Filers Holds Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230711022800"", ""headline"": ""JNJ Crosses Above 3% Yield Territory"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230711092100"", ""headline"": ""Meet Wall Street's Greatest Dividend Stock: A Small-Cap Company 99.9% of Investors Have Probably Never Heard Of"", ""summary"": ""This company has been consistently paying a dividend since James Madison was president of the United States... in 1816.""}, {""date"": ""20230711120024"", ""headline"": ""Investing in Johnson & Johnson (NYSE:JNJ) five years ago would have delivered you a 46% gain"", ""summary"": ""When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Better yet, you'd...""}, {""date"": ""20230711121209"", ""headline"": ""Newly Released J&J Bankruptcy Plan For Compensating Talcum Powder Cancer Claims Includes Canadian Claims"", ""summary"": ""A Johnson & Johnson subsidiary that is pursuing a US bankruptcy to resolve thousands of talcum powder lawsuits has filed its plan for compensating cancer victims with pending claims, and the proposed...""}, {""date"": ""20230711124400"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230711143143"", ""headline"": ""Johnson & Johnson Asbestos Claims Continue: California Man Alleges Baby Powder Led to Rare Cancer"", ""summary"": ""A California man, Emory Hernandez Valadez, claims he developed a rare form of cancer due to exposure to asbestos in Johnson & Johnson's (NYSE: JNJ) talc-based baby powder. Lawyers for Valadez are urging a jury to order Johnson & Johnson to pay heavy punitive damages, citing the company's conduct as negligent and \""despicable.\"" Attorney Joseph Satterley, representing Valadez, stated that a careful corporation wouldn't sell a product that allows carcinogens to be applied to babies. Related: Johnson""}, {""date"": ""20230711151442"", ""headline"": ""U.S. FDA classifies recall of J&J's electrosurgical tools as most serious"", ""summary"": ""The U.S. Food and Drug Administration (FDA) on Tuesday classified the recall of certain electrosurgery tools manufactured by a Johnson & Johnson unit as the most serious, saying their use could lead to injuries or death.  The U.S. health regulator said it had received reports of pediatric and adult patients suffering burn injuries when the tools, sold under the brand names MEGA 2000 and MEGA SOFT Reusable Patient Return Electrodes, were used on them.  The tools are soft pads that conduct an electric current through the patient's body during electrosurgical procedures to heat or cut tissue, or stop bleeding.""}, {""date"": ""20230711152314"", ""headline"": ""US FDA classifies recall of J&J's electrosurgical tools as most serious"", ""summary"": ""The U.S. Food and Drug\nAdministration  on Tuesday classified the recall of certain\nelectrosurgery tools manufactured by a Johnson & Johnson unit\nas most serious, saying their use could lead...""}, {""date"": ""20230711154208"", ""headline"": ""Morgan Stanley Maintains Johnson & Johnson (JNJ) Equal-Weight Recommendation"", ""summary"": """"}, {""date"": ""20230711163100"", ""headline"": ""Johnson & Johnson stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slid 0.55% to $158.63 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20230711190853"", ""headline"": ""Johnson & Johnson's Unit Recalls Certain Electrosurgical Tools Due Risk Of Burn Injuries"", ""summary"": ""The FDA classified the recall of certain electrosurgery tools manufactured by a Johnson & Johnson (NYSE: JNJ) unit as the most serious, saying their use could lead to injuries or death. Megadyne is recalling MEGA 2000 and MEGA SOFT reusable patient return electrodes after receiving reports of patients receiving burn injuries from use in both pediatric and adult patients. These burns may be as serious as third-degree burns requiring medical intervention and may lead to a longer hospital stay, sca""}, {""date"": ""20230711192314"", ""headline"": ""UPDATE 1-US FDA classifies recall of J&J's electrosurgical tools as most serious"", ""summary"": ""The U.S. Food and Drug Administration (FDA) on Tuesday classified the recall of certain electrosurgery tools manufactured by a Johnson & Johnson unit as \""most serious\"", saying their use could lead to injuries or death.  The U.S. health regulator said it had received reports of pediatric and adult patients suffering burn injuries when the tools, sold under the brand names MEGA 2000 and MEGA SOFT Reusable Patient Return Electrodes, were used on them.  The tools were recalled by Megadyne Medical Products, which was acquired in 2017 by Ethicon Endo-Surgery, a unit of J&J MedTech.""}, {""date"": ""20230711204727"", ""headline"": ""Dow Jones Today: Index Jumps 300 Points"", ""summary"": ""The Dow Jones led all indexes by moving higher by nearly 1%, as investors anticipate tomorrow\u2019s key inflation data.""}, {""date"": ""20230712060915"", ""headline"": ""ABA-Creating long-term change through storytelling"", ""summary"": ""Difference-making thought-leader Tamsen Webster is the opening keynote at the ABA Bank Marketing Conference in September.\nAs an author, public speaker and messaging strategist, Tamsen Webster helps...""}, {""date"": ""20230712090600"", ""headline"": ""3 Dow Stocks That Are Stand-Out Buys for July (and Beyond)"", ""summary"": ""For the past 127 years, the iconic Dow Jones Industrial Average (DJINDICES: ^DJI) has been one of Wall Street's most-followed indexes, and a barometer for the health of the stock market.  Although the Dow Jones is far from perfect -- it's a share price-weighted index, rather than market cap-weighted -- its 30 components are generally profitable on a recurring basis, time-tested in the sense that they've navigated their fair share of recessions, and multinational.  In other words, these are businesses investors don't have to worry about when they go to sleep at night.""}, {""date"": ""20230712102800"", ""headline"": ""FDA classifies J&J electrode recall as most serious type"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230712105900"", ""headline"": ""How to Turn $10,000 Into $1,000,000 by Retirement"", ""summary"": ""There's no big secret to earning outsize gains -- simply invest in quality businesses for the long haul.""}, {""date"": ""20230712150330"", ""headline"": ""What Stocks To Buy Today? 3 Good Dividend Stocks In Focus"", ""summary"": ""Good dividend stocks to watch in the stock market now.""}, {""date"": ""20230712160500"", ""headline"": ""Will Q2 Earnings Drive Dow ETFs Higher?"", ""summary"": ""Nearly one-fourth of the blue-chip firms are expected to announce results this week and the next.""}, {""date"": ""20230712161832"", ""headline"": ""20 Most Hated Brands in the World"", ""summary"": ""In this piece, we will take a look at the 20 most hated brands in the world. If you are not interested in reading the details, head straight to the 5 Most Hated Brands in the World. Starting a business in the US is the first step in building a global brand since it is [\u2026]""}, {""date"": ""20230712163100"", ""headline"": ""Johnson & Johnson stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slumped 0.35% to $158.08 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the...""}, {""date"": ""20230712214518"", ""headline"": ""Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""In the latest trading session, Johnson & Johnson (JNJ) closed at $157.97, marking a -0.42% move from the previous day.""}, {""date"": ""20230713010300"", ""headline"": ""Expert Ratings for Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230713025502"", ""headline"": ""2-year Treasury yield continues to slide after cool June CPI figure"", ""summary"": ""U.S. Treasury yields were mostly lower on Thursday after June's inflation print came in cooler than expected.""}, {""date"": ""20230713071600"", ""headline"": ""Johnson & Johnson (JNJ) Receives a Buy from Cantor Fitzgerald"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230713093500"", ""headline"": ""Is Johnson & Johnson Stock Overvalued?"", ""summary"": ""Johnson & Johnson (NYSE: JNJ) is a favorite of long-term investors everywhere, and it's no surprise why.  Thanks to its diversified business, steady dividend payout, and an ultra-lengthy history of profitable operation, the stock is at home in most retirement portfolios.  Let's analyze its valuation and find out if you are getting a deal when buying the stock right now.""}, {""date"": ""20230713100000"", ""headline"": ""Interesting JNJ Put And Call Options For March 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230713123500"", ""headline"": ""Psychedelic Stocks: Don't Bet On Just 1 Company"", ""summary"": ""Will tough times continue for psychedelic stocks? Analyst Alex Carchidi shares his views on the sector and specific stocks like Compass Pathways, Atai and Cybin.""}, {""date"": ""20230713140100"", ""headline"": ""Johnson & Johnson (JNJ) Reports Next Week: Wall Street Expects Earnings Growth"", ""summary"": ""Johnson & Johnson (JNJ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.""}, {""date"": ""20230713155504"", ""headline"": ""Cantor Fitzgerald Reiterates Johnson & Johnson (JNJ) Overweight Recommendation"", ""summary"": """"}, {""date"": ""20230713161742"", ""headline"": ""Johnson & Johnson sues researchers who linked talc to cancer"", ""summary"": ""Johnson & Johnson has sued four doctors who published studies citing links between talc-based personal care products and cancer, escalating an attack on scientific studies that the company alleges are inaccurate.  J&J's subsidiary LTL Management, which absorbed the company's talc liability in a controversial 2021 spinoff, last week filed a lawsuit in New Jersey federal court asking it to force three researchers to \""retract and/or issue a correction\"" of a study that said asbestos-contaminated consumer talc products sometimes caused patients to develop mesothelioma.  One of the researchers, Richard Kradin, declined to comment.""}, {""date"": ""20230713163100"", ""headline"": ""Johnson & Johnson stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.46% higher to $158.81 Thursday, on what proved to be an all-around positive trading session for the stock market, with...""}, {""date"": ""20230713181446"", ""headline"": ""Exclusive: Rose Health founder Kavi Misri launches new venture to help employers keep workers healthy"", ""summary"": ""For Kavi Misri, a routine visit to the doctor earlier this year brought an unexpected diagnosis \u2014 and sparked the idea for what\u2019s now a Johnson & Johnson Innovation portfolio company planning to raise millions to help keep the local workforce healthy.  The D.C. entrepreneur, who founded Rose Health in 2018 and led that company to an exit last fall, learned in March he had prediabetes, requiring him to change his diet and exercise \u2014 and, he said, leaving him without much of a game plan beyond that.  It collects and analyzes health data for screening and prevention; provides access to clinicians and experts \u2014 including primary care physicians, registered nurses and registered dietitians \u2014 and offers chef-prepared meals through a delivery service with an undisclosed partner.""}, {""date"": ""20230713235700"", ""headline"": ""Johnson & Johnson Sues Doctors Over Studies Linking Talc-Based Products and Cancer"", ""summary"": ""Company says the studies played a significant role in lawsuits over its Baby Powder and Shower to Shower products.""}, {""date"": ""20230714020200"", ""headline"": ""Catalyst Watch: Microsoft-Activision Blizzard drama, Splunk event and Nasdaq 100 rebalancing countdown"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230714024254"", ""headline"": ""My Dividend Growth Portfolio - Q2 2023 Summary"", ""summary"": ""In 2015, I started publishing updates regarding my dividend growth portfolio, and I keep doing so every quarter. Read here for a summary of Q2 of 2023.""}, {""date"": ""20230714035503"", ""headline"": ""Nicholas Ward's Dividend Growth Portfolio: June 2023 Review"", ""summary"": ""The significant dividend growth is attributed to rapid rise in interest rates over past 12-18 months, with cash position now yielding nearly 5%. Read more here.""}, {""date"": ""20230714042033"", ""headline"": ""Treasury yields moderate after two-day slide on light inflation data"", ""summary"": ""U.S. Treasury yields climbed on Friday, reversing some of the sharp declines seen in the last two sessions on the back of cooler-than-expected inflation prints.""}, {""date"": ""20230714043600"", ""headline"": ""SVB Securities Remains a Buy on Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230714062200"", ""headline"": ""7 Failing Dividend Stocks to Stay Far, Far Away From"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230714085800"", ""headline"": ""Earnings This Week: Tesla, Netflix And Bank Of America"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230714094500"", ""headline"": ""Dow up 130 points on gains in shares of UnitedHealth, JPMorgan Chase"", ""summary"": ""The Dow Jones Industrial Average is trading up Friday morning with shares of UnitedHealth and JPMorgan Chase delivering the strongest returns for the index....""}, {""date"": ""20230714095000"", ""headline"": ""3 Best Buffett Stocks to Buy for the Long Haul"", ""summary"": ""Warren Buffett owns plenty of great stocks. These could be the best to buy and hold over the long run.""}, {""date"": ""20230714110700"", ""headline"": ""Bank Domination: Earnings Season Kicks Off With A Hat Trick As Three Major Banks Post Beats"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230714124100"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230714133000"", ""headline"": ""3 Healthcare Stocks for Long-Term Dividend Growth"", ""summary"": ""The U.S. health care sector is attractive for long-term investors, in part because of the growth of the U.S.' population of people in their 60s and older.  The industry is expected to grow going forward, at a rate above gross domestic product growth.  Johnson & Johnson  is a diversified health care company and a leader in the area of pharmaceuticals (~49% of sales), medical devices (~34% of sales) and consumer products (~17% of sales).""}, {""date"": ""20230714144855"", ""headline"": ""The Bond Bandit - Seize The Anti-ESG Premium"", ""summary"": ""The article compares a set of 14 companies with different credit ratings (Aaa to Baa2) and representative bond portfolios. Click here to read my picks and much more.""}, {""date"": ""20230714150758"", ""headline"": ""Tech hiring is rough now \u2013 except in one area (and you\u2019ve probably guessed it)"", ""summary"": ""Though layoffs have roiled tech giants, there's one area where tech talent, especially developers, remain in high demand \u2013 Yes, you guessed it, AI.""}, {""date"": ""20230714163100"", ""headline"": ""Johnson & Johnson stock rises Friday, outperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.67% higher to $159.87 Friday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""20230714191045"", ""headline"": ""COMPASS: The Landscape Is Changing Quickly; Risk Is Up And Potential Down"", ""summary"": ""COMPASS is short on cash but has major investment house backing. Click here to read why I rate CMPS stock a Sell.""}, {""date"": ""20230714201500"", ""headline"": ""Dividend Income Update June 2023"", ""summary"": ""The beginning of every month is exciting for all dividend income investors as we look back at the previous month and see how much passive dividend income our portfolios generated. ""}, {""date"": ""20230715093000"", ""headline"": ""2 Warren Buffett Stocks to Buy Hand Over Fist"", ""summary"": ""Buffett's strategy involves buying top companies for reasonable prices -- and holding on to them.""}, {""date"": ""20230715093100"", ""headline"": ""Why You Should Aim For $3 Million For Retirement (Gen X'ers And Millennials)"", ""summary"": ""Saving early and regularly, investing wisely, and budgeting expenses are keys to a wealthy retirement. Read why it's a good time for younger generations to look at retirement scenarios.""}, {""date"": ""20230716044900"", ""headline"": ""Tesla, Netflix, Goldman Earnings Hit The Deck As Q2 Reporting Season Starts In Earnest: Key Companies To Watch In Week Ahead"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230716072600"", ""headline"": ""Tesla, Netflix, Goldman Earnings To Hit The Deck As Q2 Reporting Season Starts In Earnest: Key Companies To Watch In Week Ahead"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230716101500"", ""headline"": ""3 Dividend Growth Stocks to Buy and Hold"", ""summary"": ""Wayne Gretzky probably had no idea how much one thing he said would be repeated through the years.  With this in mind, three Motley Fool contributors identified dividend growth stocks they think are great picks to buy and hold.  Here's why they chose AbbVie (NYSE: ABBV), Johnson & Johnson (NYSE: JNJ), and Pfizer (NYSE: PFE).""}, {""date"": ""20230716180000"", ""headline"": ""Psychedelic Stocks = Super-Risky Biotechs Low On Cash. Make Small Bets."", ""summary"": ""Analyst Alex Carchidi updates investors on the psychedelics industry. Super-risky biotech companies low on cash - don't bet on just 1 company.""}]","{""assetTurnoverTTM"": 0.4592, ""bookValue"": 75149, ""cashRatio"": 0.14768321949418498, ""currentRatio"": 1.1181, ""ebitPerShare"": 2.2345, ""eps"": 1.9969, ""ev"": 462321.78, ""fcfMargin"": 0.1731, ""fcfPerShareTTM"": 5.5993, ""grossMargin"": 0.7309, ""inventoryTurnoverTTM"": 2.2226, ""longtermDebtTotalAsset"": 0.1769, ""longtermDebtTotalCapital"": 0.2808, ""longtermDebtTotalEquity"": 0.4511, ""netDebtToTotalCapital"": 0.3114, ""netDebtToTotalEquity"": 0.5004, ""netMargin"": 0.2912, ""operatingMargin"": 0.3258, ""payoutRatioTTM"": 0.6871, ""pb"": 5.6517, ""peTTM"": 32.5356, ""pfcfTTM"": 29.1964, ""pretaxMargin"": 0.3258, ""psTTM"": 4.932, ""ptbv"": 14.6947, ""quickRatio"": 0.8359, ""receivablesTurnoverTTM"": 5.2324, ""roaTTM"": 0.0696, ""roeTTM"": 0.1756, ""roicTTM"": 0.1117, ""rotcTTM"": 0.1231, ""salesPerShare"": 6.8583, ""sgaToSale"": 0.2691, ""tangibleBookValue"": 28903, ""totalDebtToEquity"": 0.6068, ""totalDebtToTotalAsset"": 0.2379, ""totalDebtToTotalCapital"": 0.3777, ""totalRatio"": 1.6449, ""period"": ""2023-07-02""}"
6,2023-07-16,157.45669555664062,2023-07-23,167.6209259033203,0.06455254449959802,U5+,"[{""date"": ""20230716044900"", ""headline"": ""Tesla, Netflix, Goldman Earnings Hit The Deck As Q2 Reporting Season Starts In Earnest: Key Companies To Watch In Week Ahead"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230716072600"", ""headline"": ""Tesla, Netflix, Goldman Earnings To Hit The Deck As Q2 Reporting Season Starts In Earnest: Key Companies To Watch In Week Ahead"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230716101500"", ""headline"": ""3 Dividend Growth Stocks to Buy and Hold"", ""summary"": ""Wayne Gretzky probably had no idea how much one thing he said would be repeated through the years.  With this in mind, three Motley Fool contributors identified dividend growth stocks they think are great picks to buy and hold.  Here's why they chose AbbVie (NYSE: ABBV), Johnson & Johnson (NYSE: JNJ), and Pfizer (NYSE: PFE).""}, {""date"": ""20230716180000"", ""headline"": ""Psychedelic Stocks = Super-Risky Biotechs Low On Cash. Make Small Bets."", ""summary"": ""Analyst Alex Carchidi updates investors on the psychedelics industry. Super-risky biotech companies low on cash - don't bet on just 1 company.""}, {""date"": ""20230717012800"", ""headline"": ""Monday's Market Minute: This Week It's All About Earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230717013400"", ""headline"": ""Electric Week Ahead: Tesla Earnings Among Highlights Along With Retail Sales, But Soft China Growth In Focus"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230717020400"", ""headline"": ""Johnson & Johnson Unusual Options Activity For July 17"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230717031700"", ""headline"": ""S&P, Dow kick off busy earnings week with small gains, Nasdaq rises nearly 1%"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230717044700"", ""headline"": ""Biggest stock movers today: BridgeBio Pharma, Zai Lab, argenx and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230717071345"", ""headline"": ""5 things to know before the stock market opens Monday"", ""summary"": ""Here are the most important news items that investors need to start their trading day.""}, {""date"": ""20230717072900"", ""headline"": ""Biggest stock movers today: Chewy, BridgeBio Pharma, Acumen Pharmaceuticals and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230717092000"", ""headline"": ""Biggest stock movers today: Ford, BridgeBio Pharma, Acumen Pharmaceuticals and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230717093000"", ""headline"": ""2 Monster Stocks to Buy Without Any Hesitation"", ""summary"": ""Vertex Pharmaceuticals (NASDAQ: VRTX) brings in billions of dollars annually thanks to its cystic fibrosis (CF) treatments.  Vertex's Trikafta has the ability to treat 90% of CF patients today.  Vertex also is studying another candidate in pivotal trials that could even beat Trikafta.""}, {""date"": ""20230717105159"", ""headline"": ""Johnson & Johnson Stock Q2 Earnings Preview: News On Kenvue Distribution Expected?"", ""summary"": ""Johnson & Johnson will release its Q2 earnings report on July 20 before the market opens. Read why I didn't add my position in JNJ and holding Kenvue stock.""}, {""date"": ""20230717113400"", ""headline"": ""3 Healthcare Stocks to Buy as the Market Gets Defensive"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230717115200"", ""headline"": ""LONDON MARKET CLOSE: Stocks slip as Chinese growth data disappoints"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230717161500"", ""headline"": ""NEW YORK MARKET CLOSE: Stocks higher at start of big earnings week"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230717163100"", ""headline"": ""Johnson & Johnson stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Johnson & Johnson sank 0.50% to $159.07 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""20230717165200"", ""headline"": ""IN BRIEF: J&J's Rybrevant plus chemo shows improvement in lung cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230717194334"", ""headline"": ""Warren Buffett\u2019s 12 Longest Held Stocks"", ""summary"": ""In this piece, we will take a look at Warren Buffett\u2019s 12 longest held stocks. If you want to skip our introduction of the billionaire investor, his life, and investment strategy, then head on over to Warren Buffett\u2019s 5 Longest Held Stocks. Warren Buffett is the richest investor in the world. While his firm, Berkshire [\u2026]""}, {""date"": ""20230717205018"", ""headline"": ""12 Best Dividend Stocks Under $10"", ""summary"": ""In this article, we discuss 12 best dividend stocks under $10. You can skip our detailed analysis of dividend stocks and their performance, and go directly to read 5 Best Dividend Stocks Under $10. Despite facing various challenges, such as banking sector instability and concerns about the economy, the U.S. stock market has shown remarkable [\u2026]""}, {""date"": ""20230717233100"", ""headline"": ""3 Quarterly Reports Investors Can't Ignore This Week"", ""summary"": ""We've got a loaded slate, including quarterly results from Netflix, American Express, and Johnson & Johnson. But how do estimates stack up heading into their respective prints?""}, {""date"": ""20230718011000"", ""headline"": ""Top Yielding Dividend Aristocrats"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230718015900"", ""headline"": ""LONDON MARKET EARLY CALL: Stocks to tread water despite New York gains"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230718032900"", ""headline"": ""What You Missed On Wall Street On Tuesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230718033300"", ""headline"": ""Johnson & Johnson stock underperforms Tuesday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230718035100"", ""headline"": ""Johnson & Johnson Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230718052200"", ""headline"": ""3 Biotech Stocks for Getting Rich in 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230718062900"", ""headline"": ""J&J ordered to pay $18.8M over baby powder claims, Bloomberg reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230718063200"", ""headline"": ""J&J  requried to pay $18.8M over man's talc-cancer claim, jury rules"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230718063800"", ""headline"": ""J&J ordered to pay $18.8M over man's talc-cancer claim, jury rules"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230718065000"", ""headline"": ""J&J ordered to pay $18.8M over baby powder cancer claim, jury rules"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230718065800"", ""headline"": ""LONDON MARKET MIDDAY: Ocado leads way but FTSE 100 flat"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230718070900"", ""headline"": ""LianBio partner NANOBIOTIX enters license agreement with JanssenJohnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230718073600"", ""headline"": ""J&J ordered to pay $18.8M over baby powder cancer claim, jury rules (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230718091546"", ""headline"": ""My Dividend Stock Portfolio: New June Dividend Record - 99 Holdings With 28 Buys"", ""summary"": ""The broad S&P500 edged up 1.2% in June, while the Dow Jones rose slightly by 0.8% during the month. Click here to see my complete dividend stock portfolio list.""}, {""date"": ""20230718094511"", ""headline"": ""Janssen Pharmaceutical - Treatment with RYBREVANT plus Chemotherapy Resulted in Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival"", ""summary"": ""RARITAN - The Janssen Pharmaceutical Companies of Johnson & Johnson today announced positive topline results from the Phase 3 PAPILLON study evaluating RYBREVANT  in combination with chemotherapy  in...""}, {""date"": ""20230718104700"", ""headline"": ""Video: Dow Analyst Moves: JNJ"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230718104700"", ""headline"": ""J&J files suit against HHS, CMS over drug pricing provisions of IRA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230718104800"", ""headline"": ""See How Johnson & Johnson Ranks Among Analysts' Top Dow 30 Picks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230718114249"", ""headline"": ""Johnson & Johnson files litigation to challenge Inflation Reduction Act"", ""summary"": ""Johnson & Johnson on Tuesday\nfiled a litigation against the U.S. Department Of Health And\nHuman Services and the Centers Medicare And Medicaid Services\nchallenging the Inflation Reduction Act.\n       ...""}, {""date"": ""20230718123121"", ""headline"": ""Johnson & Johnson: Q2 Earnings Will Satisfy Market, But May Mask Wider Issues"", ""summary"": ""Johnson & Johnson is reinventing itself as a pharmaceuticals specialist after spinning out consumer health division. Read what to expect for earnings from JNJ.""}, {""date"": ""20230718123900"", ""headline"": ""J&J becomes latest Big Pharma to sue over Medicare drug pricing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230718130747"", ""headline"": ""Johnson & Johnson sues Biden administration over Medicare drug price negotiations"", ""summary"": ""Merck, Bristol Myers Squibb, the U.S. Chamber of Commerce and PhRMA filed separate lawsuits against the provision last month. ""}, {""date"": ""20230718130906"", ""headline"": ""12 Best Dividend Stocks Under $25"", ""summary"": ""In this article, we discuss 12 best dividend stocks under $25. You can skip our detailed analysis of the market outlook and importance of dividend stocks, and go directly to read 5 Best Dividend Stocks Under $25. Over the years, various stock market patterns have been observed. What may be effective in one market environment [\u2026]""}, {""date"": ""20230718155600"", ""headline"": ""J&J (JNJ) to Begin Q2 Earnings Season for Drug, Biotech Sector"", ""summary"": ""Growth in J&J's (JNJ) Pharma unit is expected to have been driven by drugs like Darzalex. In the MedTech segment, recovery in surgical procedures and new product launches are likely to have pushed sales growth.""}, {""date"": ""20230718155613"", ""headline"": ""UPDATE 3-J&J sues in latest bid to halt Medicare drug price negotiations"", ""summary"": ""Johnson & Johnson sued the U.S. government on Tuesday, becoming the latest drugmaker seeking to block a program that gives the Medicare government health insurance plan the power to negotiate lower drug prices.  The pharmaceutical industry says the drug price negotiation program under President Joe Biden's signature Inflation Reduction Act law will curtail profits and compel drugmakers to curb development of groundbreaking new treatments.  With Americans paying more for prescription medicines than any other country, the Biden administration hopes to save $25 billion annually by 2031 by having Medicare negotiate prices for some of the costliest medicines used by its beneficiaries, who are 65 and older.""}, {""date"": ""20230718164000"", ""headline"": ""Johnson & Johnson joins Merck, others, in fighting Medicare drug-price program"", ""summary"": ""Johnson & Johnson has joined companies such as Merck & Co. Inc. Bristol Myers Squibb Co. and other entities in suing the federal government over Medicare\u2019s...""}, {""date"": ""20230718173200"", ""headline"": ""Johnson & Johnson sues Biden administration over drug-pricing policies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230718194405"", ""headline"": ""J&J Is Latest Drug Maker to Sue Over Medicare Price Rules"", ""summary"": ""Johnson & Johnson joined others in the pharmaceutical industry suing the government over new Medicare prescription drug price rules.""}, {""date"": ""20230718231631"", ""headline"": ""J&J must pay $18.8 mln to California cancer patient in baby powder suit"", ""summary"": ""Johnson & Johnson's must pay $18.8 million to a California man who said he developed cancer from exposure to its baby powder, a jury decided on Tuesday, a setback for the company as it seeks to settle thousands of similar cases over its talc-based products in U.S. bankruptcy court.  The jury ruled in favor of Emory Hernandez Valadez, who filed suit last year in California state court in Oakland against J&J, seeking monetary damages.  Hernandez, 24, has said he developed mesothelioma, a deadly cancer, in the tissue around his heart as a result of heavy exposure to the company's talc since childhood.""}, {""date"": ""20230718232105"", ""headline"": ""J&J must pay $18.8 million to California cancer patient in baby powder suit"", ""summary"": ""(Reuters) -Johnson & Johnson's must pay $18.8 million to a California man who said he developed cancer from exposure to its baby powder, a jury decided on Tuesday, a setback for the company as it seeks to settle thousands of similar cases over its talc-based products in U.S. bankruptcy court.  The jury ruled in favor of Emory Hernandez Valadez, who filed suit last year in California state court in Oakland against J&J, seeking monetary damages.  Hernandez, 24, has said he developed mesothelioma, a deadly cancer, in the tissue around his heart as a result of heavy exposure to the company's talc since childhood.""}, {""date"": ""20230718232406"", ""headline"": ""UPDATE 2-J&J must pay $18.8 mln to California cancer patient in baby powder suit"", ""summary"": ""Johnson & Johnson's must pay $18.8 million to a California man who said he developed cancer from exposure to its baby powder, a jury decided on Tuesday, a setback for the company as it seeks to settle thousands of similar cases over its talc-based products in U.S. bankruptcy court.  The jury ruled in favor of Emory Hernandez Valadez, who filed suit last year in California state court in Oakland against J&J, seeking monetary damages.  Hernandez, 24, has said he developed mesothelioma, a deadly cancer, in the tissue around his heart as a result of heavy exposure to the company's talc since childhood.""}, {""date"": ""20230719022900"", ""headline"": ""Johnson & Johnson Stock (NYSE:JNJ): Medicare Negotiations and Q2 Earnings in Focus"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230719063600"", ""headline"": ""Wall Street Breakfast Podcast: Microsoft Unveils Pricing For AI Tool"", ""summary"": ""Microsoft hits all-time high after unveiling pricing for AI tool, Copilot. J&J ordered to pay $18.8M over baby powder cancer claim, jury rules. Carvana drops after moving earnings date.""}, {""date"": ""20230719065500"", ""headline"": ""Johnson & Johnson's First Talc-Related Trial In Two Years: Court Orders To Pay Around $19M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230719074429"", ""headline"": ""Goldman Sachs, Johnson & Johnson fall premarket; Carvana, Microsoft rise"", ""summary"": ""Investing.com -- U.S. futures traded largely unchanged Wednesday, consolidating after recent strong gains as investors digest a deluge of important corporate earnings.""}, {""date"": ""20230719074700"", ""headline"": ""Wall Street Breakfast: Scorching Summer"", ""summary"": ""Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.""}, {""date"": ""20230719081232"", ""headline"": ""Johnson & Johnson - Protecting the Healthcare Innovation Ecosystem"", ""summary"": ""Johnson & Johnson and its Janssen pharmaceutical companies have delivered transformative medicines to patients for more than 130 years.\nOur ability to deliver these breakthroughs is possible because...""}, {""date"": ""20230719092100"", ""headline"": ""3 No-Brainer Stocks to Buy With $400 Right Now"", ""summary"": ""Despite never knowing (with any certainty) when corrections will begin, how long they'll last, or how steep the ultimate decline will be in the major U.S. stock indexes, history has shown that every sizable drop was eventually put in the rearview mirror by a bull market rally.  With the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite still well below their all-time highs, bargains can still be had.  The first phenomenal stock that makes for a surefire buy with $400 right now is healthcare conglomerate Johnson & Johnson (NYSE: JNJ), which is perhaps better known as J&J.""}, {""date"": ""20230719101900"", ""headline"": ""Notable earnings before Thursday's open"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230719110000"", ""headline"": ""IYH: Healthcare Dashboard For July"", ""summary"": ""Pharmaceuticals/biotechnology is the most attractive subsector for value and quality scores. Fast facts on iShares U.S. Healthcare ETF, click for more on IYH.""}, {""date"": ""20230719114200"", ""headline"": ""Notable companies reporting before tomorrow's open"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230719115400"", ""headline"": ""NGO urges Johnson & Johnson to not enforce tuberculosis drug patents"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230719134829"", ""headline"": ""Drug Pricing Negotiation Program: Johnson & Johnson Joins Legal Battle Against US Government"", ""summary"": ""Johnson & Johnson (NYSE: JNJ) has reportedly taken legal action against the U.S. government, following the lead of other pharmaceutical companies aiming to obstruct a program that empowers the Medicare government health insurance plan to negotiate lower prices for medication. The pharmaceutical sector asserts that President Joe Biden's hallmark Inflation Reduction Act, which enables the drug price negotiation scheme, will limit profits and force companies to reduce the development of innovative""}, {""date"": ""20230719154716"", ""headline"": ""Johnson & Johnson, D.R. Horton, Taiwan Semi: 3 things to watch"", ""summary"": ""Investing.com -- Stocks were rising as investors took in a slew of corporate earnings, including a miss by Goldman Sachs (NYSE:GS) because of write-downs and a slump in investment banking.""}, {""date"": ""20230719160958"", ""headline"": ""Microsoft-Activision Adjust Deal Deadline Terms, Goldman Sachs' Q2 Profits Fall 60%, Johnson & Johnson Joins Legal Battle Against US Government On Drug Pricing Negotiation: Today's Top Stories"", ""summary"": ""Benzinga What's Going On With Microsoft-Activision Deal? Companies Adjust Deadline Terms Microsoft Corp (NASDAQ: MSFT) and Activision Blizzard Inc (NASDAQ: ATVI) stocks are grabbing attention amid reports of the companies extending the $69 billion takeover deal to October 18. The terms of the agreement include an increase in the termination fee payable to Activision Blizzard from $3.0 billion to $3.5 billion if the transaction is terminated after August 29, 2023, and to $4.5 billion if the trans""}, {""date"": ""20230719163100"", ""headline"": ""Johnson & Johnson stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slumped 0.20% to $158.74 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the...""}, {""date"": ""20230719173247"", ""headline"": ""20 Countries with Highest Rates of Infant Mortality"", ""summary"": ""In this detailed article, we will discuss 20 countries with the highest rates of infant mortality and the causes of such alarming numbers of deaths. If you want to skip the details, read 8 Countries with Highest Rates of Infant Mortality. Countries with the highest rates of infant mortality do not employ sufficient measures to make [\u2026]""}, {""date"": ""20230719175015"", ""headline"": ""Immunovant Stock: With Anti-FcRn Validation Continuing, This Is A Must-Watch"", ""summary"": ""Immunovant expects results from phase 2b study using batoclimab for treatment of patients with CIDP in first half of 2024. Click here to read more on IMVT stock.""}, {""date"": ""20230719180450"", ""headline"": ""Nasdaq 100 futures slip Wednesday evening after Netflix posts results: Live updates"", ""summary"": ""Stock futures TK Wednesday night as investors looked to key corporate earnings results.""}, {""date"": ""20230719190802"", ""headline"": ""Dow futures slip as Tesla, Netflix report"", ""summary"": ""Investing.com - Dow futures were trading lower during Wednesday's evening deals, after major benchmark averages extended fresh 15-month highs, with traders digesting quarterly earnings results from major companies throughout the session.""}, {""date"": ""20230719211409"", ""headline"": ""American Airlines, Travelers, Johnson & Johnson, housing data: What To Watch"", ""summary"": ""Yahoo Finance Live's Brian Sozzi looks ahead to Thursday, July 20, outlining the earnings reports and housing data due out tomorrow.""}, {""date"": ""20230719212104"", ""headline"": ""12 Highest Yielding Dow Jones Dividend Stocks"", ""summary"": ""In this article, we discuss 12 highest yielding Dow Jones dividend stocks. You can skip our detailed analysis of dividend stocks and their performance in the past, and go directly to read 5 Highest Yielding Dow Jones Dividend Stocks. The Dow Jones Industrial Average, commonly referred to as the Dow, is one of the most [\u2026]""}, {""date"": ""20230719225603"", ""headline"": ""Our Dividend Growth Portfolio Continues To Outpace The S&P 500"", ""summary"": ""The portfolio was designed to provide greater protection during recessions and severe bear markets, and began to pull away from the S&P 500 in 2020. Explore more here.""}, {""date"": ""20230719230005"", ""headline"": ""Teva Pharmaceutical: Lacking Capabilities For Strategic Investments"", ""summary"": ""Teva Pharmaceutical's growth is not impressive and it is valued at a significant discount to the rest of the sector. See why TEVA stock is a Sell.""}, {""date"": ""20230720040200"", ""headline"": ""Johnson & Johnson\u2019s Talc Worries Rear as Company Prepares for Earnings"", ""summary"": ""Johnson & Johnson  is slated to report its financial results for the second quarter on Thursday, amid new investor anxiety over the thousands of lawsuits the company faces over its talc-based products.  Johnson & Johnson (ticker: JNJ) stock briefly fell as much as 1.5% in premarket trading Wednesday, after a jury in a California state court decided late Tuesday that the company must pay $18.8 million to a 24-year-old man who says he developed cancer after using Johnson & Johnson\u2019s products.  Johnson & Johnson has been struggling to move past the talc cases, which it says are baseless.""}, {""date"": ""20230720052800"", ""headline"": ""Genmab reports Q2 worldwide net sales of DARZALEX $2.43B"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720052900"", ""headline"": ""Johnson & Johnson Non-GAAP EPS of $2.80 beats by $0.18, revenue of $25.53B beats by $860M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720053500"", ""headline"": ""Johnson & Johnson\u2019s stock up 2.4% premarket after earnings top estimates and company raises guidance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720060400"", ""headline"": ""JNJ Up as Q2 Results Beat Estimates, Raises Outlook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720061000"", ""headline"": ""Johnson & Johnson posts Q2 beat as Pharma, MedTech outperform"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720061500"", ""headline"": ""Nasdaq Futures Dragged Down By Tesla, Netflix After Q2 Prints: Analyst Sees Buying Spree Lasting Until Earnings 'Problems Show Up'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720062000"", ""headline"": ""Earnings Scheduled For July 20, 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720062042"", ""headline"": ""J&J raises annual profit forecast on medical devices, cancer drugs strength"", ""summary"": ""Johnson & Johnson raised its\n2023 profit forecast on Thursday, banking on the strength in its\nmedical devices business and demand for its cancer drugs such as\nDarzalex.\n              The company...""}, {""date"": ""20230720062102"", ""headline"": ""Johnson & Johnson Reports Q2 2023 Results"", ""summary"": ""2023 Second-Quarter reported sales growth of 6.3% to $25.5 Billion with operational growth of 7.5%* and adjusted operational growth of 6.2%*. Operational growth excluding COVID-19 Vaccine of...""}, {""date"": ""20230720063200"", ""headline"": ""Tylenol, Benadryl parent Kenvue tops earnings expectations, amid strength in pain care, cold and flu product demand"", ""summary"": ""Tylenol, Benadryl and Listerine brands parent Kenvue Inc. reported Thursday second-quarter profit and revenue that beat expectations, provided an upbeat...""}, {""date"": ""20230720064800"", ""headline"": ""LONDON MARKET MIDDAY: Commodities continue to give FTSE 100 boost"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720065305"", ""headline"": ""Johnson & Johnson : 2Q23 Other Financial Disclosures"", ""summary"": ""Second Quarter 2023\n      \n      \n        Other Financial Disclosures\n      \n      \n        Table of Contents\n      \n      \n        \n          \n            \n              Table 1:...""}, {""date"": ""20230720073000"", ""headline"": ""TOP NEWS: J&J ups full-year guidance after \""robust\"" second quarter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720073408"", ""headline"": ""Johnson & Johnson : FINAL - JNJ Earnings Presentation Q2 2023"", ""summary"": ""1\n      \n    \n    \n      \n        2nd Quarter 2023 Earnings Call\n      \n      \n        July 20, 2023\n      \n    \n    \n      \n        \n          Cautionary Note on Forward-looking...""}, {""date"": ""20230720073603"", ""headline"": ""Johnson & Johnson : 2023 Second-Quarter Press Release & Supplemental Schedules"", ""summary"": ""FOR IMMEDIATE RELEASE\n      \n      \n        \n          2023 Second-Quarter reported sales growth of 6.3% to $25.5 Billion with operational growth of 7.5%* and adjusted operational...""}, {""date"": ""20230720075600"", ""headline"": ""Fly Intel: Pre-market Movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720080100"", ""headline"": ""J&J says launch of Kenvue exchange offer could come as soon as 'coming days'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720080300"", ""headline"": ""J&J says to provide 'timely' new guidance when no longer Kenvue majority holder"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720081200"", ""headline"": ""Johnson & Johnson to seek appeal of talc case based on 'erroneous' rulings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720081600"", ""headline"": ""J&J says will be 'back in the torte system' if judge dismisses bankruptcy claims"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720081800"", ""headline"": ""Johnson & Johnson CEO says 'nothing has changed' with respect to MARIPOSA study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720082300"", ""headline"": ""Legend Biotech shares gain on multiple-myeloma drug sales"", ""summary"": ""Shares of Legend Biotech Corp. gained 3.7% premarket on Thursday after the company said its multiple myeloma therapy Carvykti, a collaboration with Johnson &...""}, {""date"": ""20230720082400"", ""headline"": ""J&J CFO says capital allocation priorities aren't changing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720082600"", ""headline"": ""4 stocks to watch on Thursday: Tesla, Johnson & Johnson and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720082727"", ""headline"": ""Johnson & Johnson 2023 Q2 - Results - Earnings Call Presentation"", ""summary"": ""The following slide deck was published by Johnson & Johnson in conjunction with their 2023 Q2 earnings call.""}, {""date"": ""20230720083900"", ""headline"": ""J&J CEO says Abiomed integration 'going really well'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720084000"", ""headline"": ""Unusually active option classes on open July 20th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720085500"", ""headline"": ""Early notable gainers among liquid option names on July 20th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720090400"", ""headline"": ""Johnson & Johnson, Zions Bancorporation, Heritage-Crystal Clean And Other Big Stocks Moving Higher On Thursday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720090900"", ""headline"": ""U.S. stocks mostly lower as Netflix, Tesla weigh on Nasdaq; IBM, J&J boost Dow"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720092900"", ""headline"": ""Johnson & Johnson (JNJ): A Comprehensive GF Score Analysis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720094100"", ""headline"": ""J&J CFO Joseph Wolk On Q2 Earnings Beat: We\u2019re In A Very Strong Position For Second Half Of 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720094500"", ""headline"": ""Johnson & Johnson, IBM share gains lead Dow's 150-point jump"", ""summary"": ""Led by positive gains for shares of Johnson & Johnson and IBM, the Dow Jones Industrial Average is climbing Thursday morning. Shares of Johnson & Johnson and...""}, {""date"": ""20230720095007"", ""headline"": ""Trending : J&J Raises Guidance as 2Q Results Top Street Views"", ""summary"": ""9:34 a.m. ET -- Johnson & Johnson is one of the most mentioned companies in the U.S. across all news items in the last 12 hours, according to Factiva data. The healthcare giant posted...""}, {""date"": ""20230720095800"", ""headline"": ""U.S. stocks mostly lower, though Dow heads for longest winning streak in nearly 6 years"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720100700"", ""headline"": ""Johnson & Johnson Breaks Above 200-Day Moving Average - Bullish for JNJ"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720104200"", ""headline"": ""Dow up 270 points, on track for longest winning streak in nearly 6 years; S&P 500, Nasdaq slide"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720104600"", ""headline"": ""J&J could reportedly launch Kenvue exchange offer in \""coming days\"""", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720104900"", ""headline"": ""Johnson & Johnson\u2019s stock jumps after earnings top estimates and company raises guidance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720105200"", ""headline"": ""Johnson & Johnson, IBM share gains lead Dow's nearly 250-point climb"", ""summary"": ""Led by strong returns for shares of Johnson & Johnson and IBM, the Dow Jones Industrial Average is up Thursday morning. Shares of Johnson & Johnson and IBM...""}, {""date"": ""20230720105300"", ""headline"": ""The stock rallies of the Dow\u2019s earnings reporters are adding 120 points to the Dow\u2019s price"", ""summary"": ""The shares of the three Dow Jones Industrial Average components that reported earnings are a big reason the Dow is up Thursday while the broader stock market...""}, {""date"": ""20230720105600"", ""headline"": ""Win Streak Threatened: Tesla, Netflix Results Bring Pressure As Housing, Leading Indicators Data Awaited"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720110600"", ""headline"": ""Dow On Track For 9 Straight After Johnson & Johnson Earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720111000"", ""headline"": ""Video: Thursday's ETF Movers: XLV, ARKK"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720111900"", ""headline"": ""Dow Surges 300 Points; Johnson & Johnson Posts Upbeat Earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720112301"", ""headline"": ""5 Things to Know Before Markets Open"", ""summary"": ""Tesla shares fell after reporting revenue that beat expectations but lower profit margins thanks to price cuts, and Netflix shares tumbled after it missed on revenue projections despite strong subscriber growth. Here\u2019s what investors need to know today.""}, {""date"": ""20230720113300"", ""headline"": ""These Stocks Are Moving the Most Today: Tesla, Netflix, Discover, D.R. Horton, Catalent, and More"", ""summary"": ""Tesla's gross profit margins decline in the second quarter, revenue comes up short at Netflix, Discover stock slumps after a steep profit drop, and D.R. Horton beats earnings expectations.""}, {""date"": ""20230720113502"", ""headline"": ""Johnson & Johnson (JNJ) Tops Q2 Earnings and Revenue Estimates"", ""summary"": ""Johnson & Johnson (JNJ) delivered earnings and revenue surprises of 7.28% and 3.43%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?""}, {""date"": ""20230720114436"", ""headline"": ""Stocks making the biggest moves midday: Netflix, American Airlines, Johnson & Johnson and more"", ""summary"": ""These are the stocks posting the largest moves in midday trading. ""}, {""date"": ""20230720115500"", ""headline"": ""Johnson & Johnson Stock Jumps on Earnings Beat. But Talc Worries Loom."", ""summary"": ""The company reports better-than-expected numbers, but ongoing litigation remains a concern for investors.""}, {""date"": ""20230720120100"", ""headline"": ""Most Active Equity Options For Midday - Thursday, July 20"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720120200"", ""headline"": ""LONDON MARKET CLOSE: FTSE 100 supported by mining stocks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720120600"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720121100"", ""headline"": ""Johnson & Johnson, Abbott rise; Discover Financial, Equifax fall, Thursday, 7/20/2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720122100"", ""headline"": ""Dow heads for longest winning streak in nearly 6 years; S&P 500, Nasdaq slide"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720123200"", ""headline"": ""Earnings > Inertia, At Least For Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720125300"", ""headline"": ""Nasdaq Crashes As Netflix And Tesla Sink, Dow Roars And Dollar Rallies: What's Driving Markets Thursday?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720125600"", ""headline"": ""Surge in Heart Procedures Helps Drive Johnson & Johnson Revenue"", ""summary"": ""A surge in heart procedures and higher demand for cold and flu medicines helped  Johnson & Johnson  report solid gains in revenue and profit for the second quarter.  J&J\u2019s quarterly earnings are regarded as a bellwether for healthcare because the company has large pharmaceutical, medical-device and consumer-health divisions.  The overall improvement in J&J\u2019s results suggests an easing of some of the challenges that have dogged health-product makers in recent years: supply-chain constraints, hospital staffing shortages and Covid-19 pandemic restrictions.""}, {""date"": ""20230720131500"", ""headline"": ""Johnson & Johnson: After an Earnings Beat, Here's What to Expect From the Stock"", ""summary"": ""Johnson & Johnson  reported an earnings beat Thursday morning as their Pharmaceutical and MedTech divisions outperformed estimates.  The On-Balance-Volume (OBV) line shows weakness since December suggesting that sellers of JNJ have been more aggressive than buyers.  The weekly OBV line is firming.""}, {""date"": ""20230720133021"", ""headline"": ""Here's What Key Metrics Tell Us About Johnson & Johnson (JNJ) Q2 Earnings"", ""summary"": ""Although the revenue and EPS for Johnson & Johnson (JNJ) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.""}, {""date"": ""20230720134705"", ""headline"": ""Stocks to Watch Thursday: Tesla, Netflix, J&J, TSMC"", ""summary"": ""\u2198\ufe0f [**Tesla (TSLA)**](https://www.wsj.com/market-data/quotes/TSLA): The electric car maker reported a [jump in second-quarter profit](https://www.wsj.com/articles/tesla-tsla-q2-earnings-report-2023-9be2b571), but [Elon Musk](https://www.""}, {""date"": ""20230720140200"", ""headline"": ""Q2 Beats for J&J, American; Jobless Claims, Philly Fed Lower"", ""summary"": ""Both J&J and American Airlines put up solid beats on top and bottom lines, while the labor market remains buoyant.""}, {""date"": ""20230720142700"", ""headline"": ""Johnson & Johnson, Goldman Sachs share gains contribute to Dow's 150-point jump"", ""summary"": ""Buoyed by positive gains for shares of Johnson & Johnson and Goldman Sachs, the Dow Jones Industrial Average is up Thursday afternoon. Shares of Johnson &...""}, {""date"": ""20230720143100"", ""headline"": ""Weekly Jobless Claims Below Expectations"", ""summary"": ""Weekly Jobless Claims Below Expectations.""}, {""date"": ""20230720143905"", ""headline"": ""Johnson & Johnson, Kenvue, Abbott Labs all beat earnings estimates"", ""summary"": ""Johnson & Johnson, Kenvue, and Abbott Labs posted second quarter results that topped analyst estimates. Yahoo Finance Live breaks down the market reaction to the reports.""}, {""date"": ""20230720150750"", ""headline"": ""2 Ultra-Safe Dividend Stocks Retirees May Want to Consider Buying"", ""summary"": ""The best dividend stocks for retirees combine a decent yield with a strong track record of dividend safety and growth.  Here is an overview of two ultra-safe dividend stocks that retirees may want to consider buying.  Target (NYSE: TGT) is one of the largest retailers in the U.S., with 1,954 stores across the country.""}, {""date"": ""20230720150847"", ""headline"": ""Why Johnson & Johnson Stock Is Rising Today"", ""summary"": ""Johnson & Johnson (NYSE: JNJ) is having a strong start to Thursday's trading session.  Ahead of the opening bell, J&J released 2023 second-quarter earnings that exceeded Wall Street's expectations on both top and bottom lines.  The second quarter of 2023 was a successful one for J&J, as the company reported strong growth in its pharmaceutical and medtech segments.""}, {""date"": ""20230720150904"", ""headline"": ""Tylenol Maker Kenvue Sinks on Looming J&J Exchange Offer"", ""summary"": ""(Bloomberg) -- Kenvue Inc., the consumer-focused spinoff of Johnson & Johnson that owns brands such as Band-Aid and Tylenol, fell on Thursday after J&J said it\u2019s preparing to launch an exchange offer for its majority stake. Most Read from BloombergApple Tests \u2018Apple GPT,\u2019 Develops Generative AI Tools to Catch OpenAIA $500 Billion Corporate-Debt Storm Builds Over Global EconomyNadella\u2019s Microsoft Payouts Top $1 Billion on 1,000% Stock BoomTesla Sinks as Musk Warns of More Blows to ProfitabilityMu""}, {""date"": ""20230720154350"", ""headline"": ""J&J Stock Roars Higher, Retaking Its 200-Day Line As Small Drugs Drive Big Beat"", ""summary"": ""Johnson & Johnson beat quarterly expectations Thursday, helped by its new cancer drug Carvykti, and JNJ stock surged.""}, {""date"": ""20230720154354"", ""headline"": ""Johnson & Johnson stock rises on earnings beat, guidance boost"", ""summary"": ""Johnson & Johnson's second quarter results beat analyst estimates on both the top and bottom line, thanks in part to strength in its MedTech business. The healthcare products company (JNJ) also raised its full-year guidance. Johnson & Johnson CFO Joe Wolk tells Yahoo Finance Live that things like people catching up on surgical procedures as well as new products boosted the company's results. On the company's legal challenge to the Inflation Reduction Act, Wolk referred to it as an \""assault on innovation,\"" arguing that it will hurt patients.""}, {""date"": ""20230720154357"", ""headline"": ""Kenvue separation from J&J has 'always been in the plan': CEO"", ""summary"": ""Johnson & Johnson spin-off Kenvue reported a strong earnings beat, maintaining an upbeat 2023 outlook after making its IPO debut in May. Kenvue CEO Thibaut Mongon joins Yahoo Finance's Anjalee Khemlani to discuss Kenvue's future of a fully separate company from Johnson & Johnson, with Mongon saying Kenvue's IPO \""released a lot of energy in the organization.\"" Mongon goes on to discuss Kenvue's forecast heading into volatile markets and its impact on stock performance.""}, {""date"": ""20230720154408"", ""headline"": ""Johnson & Johnson investors can soon swap their shares for Kenvue stock \u2014 here's what you need to know"", ""summary"": ""J&J owns nearly 90% of Kenvue shares and plans to reduce its stake in the company through an exchange offer that could launch \""as early as the coming days.\"" ""}, {""date"": ""20230720160038"", ""headline"": ""J&J Beats Estimates and Boosts Outlook as Medtech Product Demand Grows"", ""summary"": ""Shares of Johnson & Johnson advanced as the pharmaceutical and medical products firm posted better-than-expected results and raised its guidance on higher demand for its medtech products.""}, {""date"": ""20230720160600"", ""headline"": ""Johnson & Johnson Rips Off the Kenvue Band-Aid"", ""summary"": ""Johnson & Johnson  just rained on the parade of its own consumer health arm, and it is unclear what comes next.  In early May, the healthcare giant sold shares in  Kenvue  which makes brands such as Tylenol, Band-Aids and Listerine, in an initial public offering.  On Thursday, Kenvue reported its first quarterly results as a public company, and it beat analyst estimates on both the top and bottom lines.""}, {""date"": ""20230720160921"", ""headline"": ""Tesla Recalls Over 17K EVs Over Camera & Seat Belt Issues, University Research Uncovers Unexpected Fluctuations In ChatGPT Capabilities, Juul Seeks FDA Nod For Next-Generation Vaporizer: Today's Top Stories"", ""summary"": ""Benzinga Tesla Recalls More Than 17,000 EVs Over Camera, Seat Belt Issues Tesla Inc (NASDAQ: TSLA) has issued a recall for over 1,300 Model S, X, and Y vehicles made in 2023, citing an issue with the forward-facing front camera, and over 15,000 Model S and X vehicles for problems related to front-row seat belts. According to safety recall reports uploaded on the National Highway Traffic Safety Administration website, the front-facing camera might be misaligned on certain 2023 Model S, X, and Y v""}, {""date"": ""20230720161300"", ""headline"": ""NEW YORK MARKET CLOSE: Tesla, Netflix send tech lower but J&J shines"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720161600"", ""headline"": ""J&J (JNJ) Q2 Earnings & Sales Top, '23 View Upped, Stock Jumps"", ""summary"": ""J&J (JNJ) beats estimates for second-quarter earnings and sales. It raises full-year sales and earnings guidance.""}, {""date"": ""20230720161703"", ""headline"": ""Stock market today: Dow sidesteps tech wreck to keep winning streak alive"", ""summary"": ""Investing.com -- The Dow closed higher Thursday, wrapping its ninth straight day of gains and its longest winner streak since 2017 as a climb in Johnson and Johnson and IBM offset the wreck in tech amid a selloff in Tesla and Netflix.""}, {""date"": ""20230720163100"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Johnson & Johnson rallied 6.07% to $168.38 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...""}, {""date"": ""20230720163119"", ""headline"": ""What Stocks To Buy Today? 2 Dow Jones Industrial Average Stocks To Watch"", ""summary"": ""Dow Jones Industrial Average stocks to watch in the stock market right now.""}, {""date"": ""20230720163738"", ""headline"": ""Markets Mixed at Midday on Weaker Earnings Reports"", ""summary"": ""U.S. equites were mixed at midday on July 20, 2023 as weak earnings news, especially in the tech sector, held back gains.""}, {""date"": ""20230720170200"", ""headline"": ""Health Care Climbs as J&J Earnings -- Health Care Roundup"", ""summary"": ""Health-care companies rose after strong earnings gave Johnson &amp; Johnson a jolt. A sharp increase in heart procedures and higher demand for cold and flu...""}, {""date"": ""20230720180201"", ""headline"": ""Stock futures are little changed after Dow registers longest rally since 2017: Live updates"", ""summary"": ""Wall Street is coming off a mixed session.""}, {""date"": ""20230720180658"", ""headline"": ""Kenvue stock down despite strong first quarter as solo company"", ""summary"": ""Kenvue, the consumer brand spinoff of J&J, reporter its first every quarterly earnings as a solo company.""}, {""date"": ""20230720183022"", ""headline"": ""Johnson & Johnson (JNJ) Q2 2023 Earnings Call Transcript"", ""summary"": ""This is Jessica Moore, vice president of investor relations for Johnson & Johnson.  Joining me on today's call are Joaquin Duato, chairman of the board and chief executive officer; Joe Wolk, executive vice president, chief financial officer; and Erik Haas, worldwide vice president of litigation.  As a reminder, you can find additional materials including today's presentation and associated schedules on the Investor Relations section of the Johnson & Johnson website at investors.jnj.com.""}, {""date"": ""20230720183300"", ""headline"": ""These 2 Stocks Just Sent the Dow Jones Soaring"", ""summary"": ""Two notable Dow stocks moved higher.  Johnson & Johnson (NYSE: JNJ) and IBM (NYSE: IBM) both released their latest financial results, and investors were quite pleased with what they saw from both companies.  Shares of Johnson & Johnson were up 6.5% near midday on Thursday.""}, {""date"": ""20230720190200"", ""headline"": ""US STOCKS-Nasdaq, S&P fall as Tesla, Netflix weigh; Dow poised for ninth straight climb"", ""summary"": ""The S&P 500 and Nasdaq fell on Thursday, weighed down by drops in Tesla and Netflix following their quarterly results, but the Dow was higher for a ninth straight day thanks to gains in Johnson & Johnson following a strong annual forecast.  Tesla's shares tumbled 9.20% and were on track for their biggest daily percentage drop since April 20 after the electric-vehicle maker reported a drop in its second-quarter gross margins to a four-year low and CEO Elon Musk hinted at more price cuts.""}, {""date"": ""20230720191551"", ""headline"": ""Cramer picks his winners as the market starts to look outside of tech"", ""summary"": ""After a down day for tech stocks, CNBC's Jim Cramer picked winners he thinks will thrive in a broadening market.""}, {""date"": ""20230720193338"", ""headline"": ""Asia markets to mostly fall as Japan's inflation rises slightly in June"", ""summary"": ""Investors in will watch Japan's inflation numbers today, in preparation for the Bank of Japan's rate decision next Friday""}, {""date"": ""20230720194244"", ""headline"": ""CNBC Daily Open: Tech stocks were battered"", ""summary"": ""The Dow Jones Industrial Average outperformed other major indexes, in a stark reversal of the tech frenzy that's gripped markets since May.""}, {""date"": ""20230720200029"", ""headline"": ""US STOCKS-Tesla, Netflix pull Nasdaq and S&P lower, Dow ends higher"", ""summary"": ""The S&P 500 and Nasdaq fell on Thursday, weighed down by drops in Tesla and Netflix following their quarterly results, but the Dow advanced for a ninth straight day thanks to gains in Johnson & Johnson following a strong annual forecast.  Tesla's shares tumbled after the electric-vehicle maker reported a drop in its second-quarter gross margins to a four-year low and CEO Elon Musk hinted at more price cuts.""}, {""date"": ""20230720201236"", ""headline"": ""J&J CFO: Medicare and Health Dept. are 'going after the wrong target' to reduce drug price inflation"", ""summary"": ""J&J became the latest big pharma company to sue the federal government over Medicare price negotiations. CFO Joe Wolk explains why.""}, {""date"": ""20230720201550"", ""headline"": ""Stock Market Today: Nasdaq Spirals After Disappointing Netflix, Tesla Earnings"", ""summary"": ""While the Nasdaq slumped today, the Dow extended its longest win streak in years on solid Johnson & Johnson earnings. Stocks closed mixed Thursday as investors combed over the latest round of corporate earnings reports. While the Dow Jones Industrial Average extended its longest win streak in years thanks to strong results from Johnson & Johnson (JNJ), disappointing reports from Netflix (NFLX) and Tesla (TSLA) sent the Nasdaq Composite tumbling. Taking a closer look at the numbers, pharmaceutica""}, {""date"": ""20230720202533"", ""headline"": ""Johnson & Johnson's Stock Lifted the Dow Today"", ""summary"": ""Shares of Johnson & Johnson rose 6.1% after the healthcare company reported better-than-expected earnings and [boosted its full-year guidance](https://www.wsj.com/articles/surge-in-heart-procedures-help-drive-johnson-johnson-revenue-1d49d5c2).""}, {""date"": ""20230720203031"", ""headline"": ""Johnson & Johnson, Tesla, Netflix: Earnings movers"", ""summary"": ""Pharma company Johnson & Johnson's shares jump following its earnings beat. Tesla shares slide following an earnings miss and a disappointing earnings call with CEO Elon Musk. Netflix's stock falls on a revenue miss despite huge gains in subscriber growth figures. Yahoo Finance Live anchors Seana Smith and Alexandra Canal break down the earnings data on several top stocks.""}, {""date"": ""20230720204600"", ""headline"": ""Johnson & Johnson Stock Just Got A Surprising New Price Target"", ""summary"": ""Johnson & Johnson's stock hasn't performed as well as the broader stock market this year because of concerns lawsuits over its talc-based products could cost it billions. However, investors have grown increasingly optimistic lately.""}, {""date"": ""20230720211514"", ""headline"": ""S&P 500 Gains and Losses Today: Stocks Mixed After Latest Earnings Reports"", ""summary"": ""The Dow rose, but the S&P 500 slipped 0.7% on Thursday, July 20, 2023, while the Nasdaq tumbled almost 2% after the latest round of corporate earnings reports.""}, {""date"": ""20230720213112"", ""headline"": ""Mortgage rates, American Airlines, Johnson & Johnson: Top stories"", ""summary"": ""Yahoo Finance Live anchor Alexandra Canal breaks down the latest housing data while also taking a look at the stock performance of American Airlines and pharmaceutical company Johnson & Johnson after reporting earnings.""}, {""date"": ""20230721010900"", ""headline"": ""Notable Friday Option Activity: JNJ, QCOM, IBM"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230721025900"", ""headline"": ""Stock Gains as JNJ Goes on Legal Offensive"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230721033300"", ""headline"": ""Johnson & Johnson stock rises Friday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230721043800"", ""headline"": ""Johnson & Johnson Takes Over #12 Spot From Eli Lilly"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230721051200"", ""headline"": ""Analysts Have Conflicting Sentiments on These Healthcare Companies: Sangamo Biosciences (SGMO), Johnson & Johnson (JNJ) and Intuitive Surgical (ISRG)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230721052200"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Legend Biotech (LEGN) and Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230721052328"", ""headline"": ""Q2 2023 Johnson & Johnson Earnings Call"", ""summary"": ""Q2 2023 Johnson & Johnson Earnings Call""}, {""date"": ""20230721060400"", ""headline"": ""Johnson & Johnson price target raised to $175 from $170 at Credit Suisse"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230721065400"", ""headline"": ""GLOBAL BROKER RATINGS: Deutsche Bank cuts SiriusXM to 'sell'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230721072700"", ""headline"": ""Johnson & Johnson price target raised to $175 from $165 at Stifel"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230721075151"", ""headline"": ""5 things to know before the stock market opens Friday"", ""summary"": ""Here are the most important news items that investors need to start their trading day.""}, {""date"": ""20230721100300"", ""headline"": ""Johnson & Johnson\u2019s Inflection Point: What It Means For Investors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230721110850"", ""headline"": ""The Bristol-Myers Squibb Phenomenon: A Game Changer In The Pharmaceutical Industry"", ""summary"": ""On July 27, 2023, Bristol-Myers Squibb will release its financial report for the second quarter of 2023. Read more to see a detailed analysis on BMY stock.""}, {""date"": ""20230721114700"", ""headline"": ""J&J sues researchers who wrote talc powder linked to cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230721120000"", ""headline"": ""Stocks in Focus on Dow Jones ETF's First 9-Day Run Since 2017"", ""summary"": ""The Dow Jones index jumped more than 150 points on Jul 20, to log its first nine-day rally since 2017""}, {""date"": ""20230721121000"", ""headline"": ""Here's How Big Your Portfolio Can Get by Investing Just $50 a Week"", ""summary"": ""Investing is a long-term game, and even if you don't have a lot of money to invest right now, there's no better time to start.  Here's a look at just how big your portfolio could grow from investments of $50 every week.  At that rate of growth, an investment would double in value in a little over seven years, and would triple in value in less than 12 years.""}, {""date"": ""20230721123600"", ""headline"": ""Johnson & Johnson Medtech Business Has Promising Momentum, Analysts Say After Good Q2 Performance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230721132200"", ""headline"": ""Stock Market News for Jul 21, 2023"", ""summary"": ""Wall Street closed mixed on Thursday following mixed earnings results of second-quarter 2023.""}, {""date"": ""20230721140000"", ""headline"": ""AbbVie: Loss Of Exclusivity Is A Natural End Process"", ""summary"": ""AbbVie has had some big shoes to fill due to the loss of exclusivity for Humira after 20 years of monopoly and $200B in revenues. See why ABBV stock is a Hold.""}, {""date"": ""20230721140013"", ""headline"": ""Insiders At Johnson & Johnson Sold US$2.2m In Stock, Alluding To Potential Weakness"", ""summary"": ""In the last year, many Johnson & Johnson ( NYSE:JNJ ) insiders sold a substantial stake in the company which may have...""}, {""date"": ""20230721140314"", ""headline"": ""Dow Jones Leads Market Advance As Tesla, Netflix, Taiwan Semiconductor Hit Growth: Weekly Review"", ""summary"": ""The Dow Jones lead the market rally, while Tesla, Netflix and Taiwan Semiconductor hit growth stocks Thursday.""}, {""date"": ""20230721140500"", ""headline"": ""5 ETFs to Buy on JNJ's Q2 Earnings Strength"", ""summary"": ""Johnson & Johnson (JNJ) continued with its long streak of earnings beat. It topped the revenue estimate as well as lifted the full-year outlook.""}, {""date"": ""20230721164751"", ""headline"": ""Kenvue CEO says consumers are spending on brand-name health products even as they pull back in other areas"", ""summary"": ""Thibaut Mongon's remarks follow Kenvue's second-quarter earnings beat, which was fueled by resilient demand for brands like Band-Aid, Tylenol and Aveeno.  ""}, {""date"": ""20230721165500"", ""headline"": ""JNJ Has a Deal for Stockholders. Investors Will Need to Make a Call."", ""summary"": ""Johnson & Johnson will offer its holders to chance to swap their shares for Kenvue stock""}, {""date"": ""20230721170500"", ""headline"": ""AbbVie (ABBV) to Report Q2 Earnings: What's in the Cards?"", ""summary"": ""AbbVie's (ABBV) Q2 performance will likely reflect Skyrizi and Rinvoq sales trying to make up for the declining Humira sales following the loss of U.S. exclusivity.""}, {""date"": ""20230721205117"", ""headline"": ""Dow notches tenth straight day of gains"", ""summary"": ""The Dow Jones Industrial Average eked out a tenth straight day of gains, closing just 2.5 points higher on Friday. Yahoo Finance Live breaks down how earnings from components such as JPMorgan Chase and American Express impacted the index's action this week.""}, {""date"": ""20230721221045"", ""headline"": ""Johnson & Johnson : JNJ-Q2 2023 Transcript Final"", ""summary"": ""REFINITIV STREETEVENTS\n        \n        \n          EDITED TRANSCRIPT\n        \n        \n          JNJ.N - Q2 2023 Johnson & Johnson Earnings Call\n        \n        \n         ...""}, {""date"": ""20230722113637"", ""headline"": ""Morgan Stanley Reiterates Johnson & Johnson (JNJ) Equal-Weight Recommendation"", ""summary"": """"}, {""date"": ""20230722113638"", ""headline"": ""Credit Suisse Maintains Johnson & Johnson (JNJ) Neutral Recommendation"", ""summary"": """"}, {""date"": ""20230722113638"", ""headline"": ""JP Morgan Maintains Johnson & Johnson (JNJ) Neutral Recommendation"", ""summary"": """"}, {""date"": ""20230723070600"", ""headline"": ""On A Winning Streak! Many Market Signs Appear More Bullish"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230723110400"", ""headline"": ""Johnson & Johnson\u2019s Q2 is positive for MedTech - Baird"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230723193116"", ""headline"": ""Johnson & Johnson (NYSE:JNJ) Q2 2023 Earnings Call Transcript"", ""summary"": ""Johnson & Johnson (NYSE:JNJ) Q2 2023 Earnings Call Transcript July 20, 2023 Johnson & Johnson beats earnings expectations. Reported EPS is $2.8, expectations were $2.62. Operator: Good morning, and welcome to Johnson & Johnson\u2019s Second Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode until the question-and-answer session of the conference. [\u2026]""}]","{""assetTurnoverTTM"": 0.4592, ""bookValue"": 75149, ""cashRatio"": 0.14768321949418498, ""currentRatio"": 1.1181, ""ebitPerShare"": 2.2345, ""eps"": 1.9969, ""ev"": 462321.78, ""fcfMargin"": 0.1731, ""fcfPerShareTTM"": 5.5993, ""grossMargin"": 0.7309, ""inventoryTurnoverTTM"": 2.2226, ""longtermDebtTotalAsset"": 0.1769, ""longtermDebtTotalCapital"": 0.2808, ""longtermDebtTotalEquity"": 0.4511, ""netDebtToTotalCapital"": 0.3114, ""netDebtToTotalEquity"": 0.5004, ""netMargin"": 0.2912, ""operatingMargin"": 0.3258, ""payoutRatioTTM"": 0.6871, ""pb"": 5.6517, ""peTTM"": 32.5356, ""pfcfTTM"": 29.1964, ""pretaxMargin"": 0.3258, ""psTTM"": 4.932, ""ptbv"": 14.6947, ""quickRatio"": 0.8359, ""receivablesTurnoverTTM"": 5.2324, ""roaTTM"": 0.0696, ""roeTTM"": 0.1756, ""roicTTM"": 0.1117, ""rotcTTM"": 0.1231, ""salesPerShare"": 6.8583, ""sgaToSale"": 0.2691, ""tangibleBookValue"": 28903, ""totalDebtToEquity"": 0.6068, ""totalDebtToTotalAsset"": 0.2379, ""totalDebtToTotalCapital"": 0.3777, ""totalRatio"": 1.6449, ""period"": ""2023-07-02""}"
7,2023-07-23,167.6209259033203,2023-07-30,171.8461456298828,0.025206994316446574,U3,"[{""date"": ""20230723070600"", ""headline"": ""On A Winning Streak! Many Market Signs Appear More Bullish"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230723110400"", ""headline"": ""Johnson & Johnson\u2019s Q2 is positive for MedTech - Baird"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230723193116"", ""headline"": ""Johnson & Johnson (NYSE:JNJ) Q2 2023 Earnings Call Transcript"", ""summary"": ""Johnson & Johnson (NYSE:JNJ) Q2 2023 Earnings Call Transcript July 20, 2023 Johnson & Johnson beats earnings expectations. Reported EPS is $2.8, expectations were $2.62. Operator: Good morning, and welcome to Johnson & Johnson\u2019s Second Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode until the question-and-answer session of the conference. [\u2026]""}, {""date"": ""20230724015100"", ""headline"": ""From Snowball to Avalanche: Understanding Buffett's Approach to Compound Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230724034700"", ""headline"": ""Russia Is Seizing European Company Assets \u2014 What US Businesses Are Still At Risk?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230724042000"", ""headline"": ""Psyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa's Magic Pitch & More"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230724052018"", ""headline"": ""CEO of J&J spinoff Kenvue says big companies can lose focus: \u2018By definition you are little more remote from where the action is\u2019"", ""summary"": ""Kenvue, spun off from Johnson & Johnson in May, generated $15 billion in sales last year, enough to put it at rank 275 on 2022's Fortune 500 list.""}, {""date"": ""20230724052100"", ""headline"": ""Johnson & Johnson launches exchange offer for separation of Kenvue"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230724052400"", ""headline"": ""Kenvue to file S-4 registration statement in connection with JNJ exchange offer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230724054200"", ""headline"": ""Johnson & Johnson price target raised to $175 from $171 at Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230724054700"", ""headline"": ""Johnson & Johnson launches Kenvue exchange offer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230724055100"", ""headline"": ""Analysts Conflicted on These Healthcare Names: Alnylam Pharma (ALNY), Biogen (BIIB) and Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230724062900"", ""headline"": ""Johnson & Johnson to spin off at least 80.1% of Kenvue shares in an exchange offer"", ""summary"": ""Johnson & Johnson said Monday it is planning to spin off at least 80.1% of its shares of Kenvue Inc. through an exchange offer. The consumer goods and...""}, {""date"": ""20230724064400"", ""headline"": ""Johnson & Johnson launches exchange offer on Kenvue holding after IPO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230724065100"", ""headline"": ""Apple To Rally Over 17%? Here Are 10 Other Analyst Forecasts For Monday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230724065900"", ""headline"": ""GLOBAL BROKER RATINGS: UBS cuts Tesla to 'neutral' from 'buy'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230724070303"", ""headline"": ""Johnson & Johnson : Consolidated Financial Statements - Form 8-K"", ""summary"": ""The following are certain preliminary results of selected unaudited financial and other information of Johnson & Johnson for the fiscal three and six months ended July 2, 2023 and actual...""}, {""date"": ""20230724072502"", ""headline"": ""Mattel, AMC Entertainment, Chevron rise premarket; Tesla, Domino's fall"", ""summary"": ""Investing.com -- U.S. futures traded higher Monday, starting a crucial week, which includes more corporate earnings and a Federal Reserve meeting, on a positive note.""}, {""date"": ""20230724073100"", ""headline"": ""Syndax and Incyte gain after Phase 3 win for immune disorder therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230724073800"", ""headline"": ""Syndax and Incyte gain on mid-stage win for immune disorder therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230724073800"", ""headline"": ""Johnson & Johnson Launches Exchange Offer Regarding Separation of Kenvue"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230724080000"", ""headline"": ""Biosense Webster Launches the OPTRELL\u2122 Mapping Catheter with TRUEref\u2122 Technology for Mapping of Complex Cardiac Arrhythmias"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230724084700"", ""headline"": ""Teva Pharmaceuticals and Alvotech expand biosimilars partnership"", ""summary"": ""Teva Pharmaceuticals Industries Ltd. and Alvotech announced Monday that they are expanding their collaboration in the U.S. biosimilars market. Under the...""}, {""date"": ""20230724090342"", ""headline"": ""Johnson & Johnson to reduce its Kenvue stake by at least 80% through exchange offer"", ""summary"": ""J&J said it received a waiver that dismisses the share lockup period associated with Kenvue's initial public offering in May.""}, {""date"": ""20230724094020"", ""headline"": ""Janssen Receives Positive CHMP Opinions for Novel Bispecific Antibodies TALVEY and TECVAYLI for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma"", ""summary"": ""Belgium - The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the Committee for Medicinal Products for Human Use  of the European Medicines Agency  has recommended...""}, {""date"": ""20230724101700"", ""headline"": ""Johnson & Johnson, Chevron share gains contribute to Dow's 175-point climb"", ""summary"": ""The Dow Jones Industrial Average is trading up Monday morning with shares of Johnson & Johnson and Chevron delivering the strongest returns for the blue-chip...""}, {""date"": ""20230724101800"", ""headline"": ""Johnson & Johnson Launches Exchange Offer for Separation of Kenvue Inc."", ""summary"": ""NEW BRUNSWICK, N.J., July 24, 2023--Johnson & Johnson (NYSE: JNJ) today announced its intention to split-off at least 80.1% of the shares of Kenvue Inc. (NYSE: KVUE) (\""Kenvue\"") through an exchange offer. Kenvue, formerly Johnson & Johnson\u2019s Consumer Health business, completed its initial public offering (\""IPO\"") in May 2023. Through the planned exchange offer, Johnson & Johnson shareholders can exchange all, some or none of their shares of Johnson & Johnson common stock for shares of Kenvue commo""}, {""date"": ""20230724102200"", ""headline"": ""Kenvue To File Form S-4 Registration Statement in Connection with Johnson & Johnson Exchange Offer Announcement"", ""summary"": ""SKILLMAN, N.J., July 24, 2023--Kenvue Inc. (NYSE: KVUE) announced intent to file a Form S-4 Registration Statement today with the Securities and Exchange Commission.""}, {""date"": ""20230724103409"", ""headline"": ""UPDATE 2-J&J starts share exchange offer for consumer health spin-off Kenvue"", ""summary"": ""Johnson & Johnson said on Monday it had launched an exchange offer under which its stockholders can opt for shares of Kenvue, its newly listed consumer health unit.  J&J, which currently owns an 89.6% stake in Kenvue, said it intends to split off at least 80.1% of the consumer health company's shares as part of the offering.  The offering will help J&J move a step closer in its plan to spin off the unit and focus on its larger medical devices and pharmaceuticals businesses.""}, {""date"": ""20230724103811"", ""headline"": ""J&J starts share exchange offer for consumer health spin-off Kenvue"", ""summary"": ""J&J, which currently owns an 89.6% stake in Kenvue, said it intends to split off at least 80.1% of the consumer health company's shares as part of the offering.""}, {""date"": ""20230724110500"", ""headline"": ""Johnson & Johnson Lost Its Court Battle But Won The Q2 Match"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230724120300"", ""headline"": ""Johnson & Johnson Wants to Swap Kenvue Shares. Expect Details Today."", ""summary"": ""The company plans J&J plans on exchanging up to 1.5 million shares of Kenvue stock that it owns, for outstanding shares of J common stock.""}, {""date"": ""20230724123415"", ""headline"": ""Johnson & Johnson: Resilient, But Clarification On Liability Issue Is Needed"", ""summary"": ""Johnson & Johnson has seen solid second quarter results, triggering a modest hike in the full-year guidance. Read more about JNJ stock here.""}, {""date"": ""20230724125302"", ""headline"": ""Raymond James Maintains Johnson & Johnson (JNJ) Outperform Recommendation"", ""summary"": """"}, {""date"": ""20230724143716"", ""headline"": ""3 Ultrareliable Dividend Stocks to Buy and Hold for Decades"", ""summary"": ""These stocks have decades of annual dividend raises under their belts, and rising healthcare costs mean there could be plenty more to come.""}, {""date"": ""20230724145845"", ""headline"": ""Johnson & Johnson Offers Exchange for Shares of Spinoff Kenvue"", ""summary"": ""Johnson & Johnson offers its shareholders the choice to exchange its shares for Kenvue's, the consumer health company it spun off just two months ago.""}, {""date"": ""20230724150800"", ""headline"": ""Johnson & Johnson\u2019s Kenvue Stock Swap Is a Good Deal for Investors"", ""summary"": ""The company plans on exchanging up to 1.5 billion shares of Kenvue stock that it owns, for outstanding shares of J&J common stock.""}, {""date"": ""20230724150824"", ""headline"": ""Eli Lilly: Does 'Miracle' Weight Loss Franchise Justify Rising Price Tag?"", ""summary"": ""Eli Lilly's share price won't stop climbing on the promise of its miracle diabetes and weight loss drug, tirzepatide. Learn more about LLY stock here.""}, {""date"": ""20230724154505"", ""headline"": ""Are You Looking for a High-Growth Dividend Stock?"", ""summary"": ""Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.""}, {""date"": ""20230724161500"", ""headline"": ""NEW YORK MARKET CLOSE: Dow extends winning streak ahead of rate call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230724164507"", ""headline"": ""3 Reasons Why Growth Investors Shouldn't Overlook Johnson & Johnson (JNJ)"", ""summary"": ""Johnson & Johnson (JNJ) possesses solid growth attributes, which could help it handily outperform the market.""}, {""date"": ""20230724211513"", ""headline"": ""S&P 500 Gains and Losses Today: Oil Industry Stocks Surge as Oil Prices Rise"", ""summary"": ""U.S. equities gained after better-than-expected second quarter earnings reports, with the S&P 500 rising 0.4% on Monday, July 24, 2023.""}, {""date"": ""20230725004610"", ""headline"": ""12 Best Low Volatility Stocks to Buy Now"", ""summary"": ""In this article, we discuss the 12 best low volatility stocks to buy now. If you want to see more stocks in this selection, check out the 5 Best Low Volatility Stocks to Buy Now. In the first half of 2023, global economic growth picked up pace, reaching 2.8%. Up to this point, the impact of [\u2026]""}, {""date"": ""20230725053100"", ""headline"": ""Wall Street Goes the Irrational Route with Kenvue Stock (NYSE:KVUE)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230725072100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Tonix Pharma (TNXP) and Gilead Sciences (GILD)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230725090030"", ""headline"": ""AbbVie Q2 2023 Earnings Preview: Pharma Faces Toughest Test, Street Demands Answers"", ""summary"": ""AbbVie will announce its Q2 2023 earnings this Thursday, July 27. Check out if ABBV stock is a Buy, Sell, or Hold ahead of its upcoming earnings results.""}, {""date"": ""20230725093003"", ""headline"": ""Johnson & Johnson Launches Exchange Offer for Separation of Kenvue Inc"", ""summary"": ""NEW BRUNSWICK - Johnson & Johnson  today announced its intention to split-off at least 80.1% of the shares of Kenvue Inc.   through an exchange offer.\nKenvue, formerly Johnson & Johnson's Consumer...""}, {""date"": ""20230725112501"", ""headline"": ""Analysts Are Increasing Price Targets of These 10 Stocks"", ""summary"": ""In this article, we will discuss the 10 stocks whose price targets were recently raised by analysts. If you want to see more such stocks on the list, go directly to Analysts Are Increasing Price Targets of These 5 Stocks. As the Federal Reserve approaches the end of its rate-hiking cycle, investors are reconsidering shares of [\u2026]""}, {""date"": ""20230725112900"", ""headline"": ""GSK, J&J tout Cabenuva preference over Gilead's Biktarvy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230725113000"", ""headline"": ""Dividend Investors in This Unique Stock-Split Stock Have a Decision to Make"", ""summary"": ""Johnson & Johnson\u00a0(NYSE: JNJ) recently provided investors with details of the long-awaited split of its consumer healthcare business\u00a0Kenvue\u00a0(NYSE: KVUE).  It will split off at least 80.1% of its Kenvue shares through an exchange offer with investors.  Johnson & Johnson announced its intention to separate its consumer health business from its pharmaceutical and medical technology segments in November 2021.""}, {""date"": ""20230725122500"", ""headline"": ""3 Stocks You Can Keep Forever"", ""summary"": ""Parker Hannifin (NYSE: PH), Johnson & Johnson (NYSE: JNJ) and Lowe's Companies (NYSE: LOW) represent stability for investors.  The first two are Dividend Kings, meaning they have raised their quarterly dividends for 50 or more consecutive years, while Lowe's just increased its dividend for its 49th consecutive year.  Parker Hannifin, founded in 1917, isn't well-known to consumers because it sells its products to industry and government buyers, but the company's reach is huge.""}, {""date"": ""20230725125517"", ""headline"": ""Barclays Maintains Johnson & Johnson (JNJ) Equal-Weight Recommendation"", ""summary"": """"}, {""date"": ""20230725130011"", ""headline"": ""Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It"", ""summary"": ""Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.""}, {""date"": ""20230725133700"", ""headline"": ""Is Johnson & Johnson Stock a Buy Now?"", ""summary"": ""The gigantic healthcare conglomerate recently raised its outlook, suggesting its plan to slim down is working as intended.""}, {""date"": ""20230725140700"", ""headline"": ""2 Top Dividend Stocks to Buy and Hold Forever"", ""summary"": ""There are several reasons many investors gravitate toward dividend stocks.  Let's consider two of them: Johnson & Johnson (NYSE: JNJ) and Abbott Laboratories (NYSE: ABT).  Over the years, Johnson & Johnson has certainly been the precise kind of company dividend seekers gravitate toward.""}, {""date"": ""20230725181600"", ""headline"": ""4 Stocks to Buy Following Beat-and-Raise Quarters"", ""summary"": ""These companies beat expectations and raised their outlooks, undeniably a positive sign for investors. Is it time to buy following the better-than-expected results?""}, {""date"": ""20230726100000"", ""headline"": ""J&J's Medtech Business Is Soaring. Time to Buy the Stock?"", ""summary"": ""You may not automatically think of pharma giant Johnson & Johnson (NYSE: JNJ) as a high-growth company.  Yes, J&J is practically a household name, thanks to consumer products like Aveeno lotions and Band-Aid bandages.  Things are changing at J&J though -- and a new era of growth might have already started.""}, {""date"": ""20230726103800"", ""headline"": ""\u2018Set It and Forget It\u2019 With These 3 Stocks to Buy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230726120039"", ""headline"": ""Johnson & Johnson's (NYSE:JNJ) Stock Is Going Strong: Is the Market Following Fundamentals?"", ""summary"": ""Most readers would already be aware that Johnson & Johnson's (NYSE:JNJ) stock increased significantly by 8.6% over the...""}, {""date"": ""20230726123000"", ""headline"": ""3 No-Brainer Warren Buffett Stocks to Buy Right Now"", ""summary"": ""Each quarter, Warren Buffett's Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) is required to release a 13F.  This filing with the Securities and Exchange Commission (SEC) reveals any purchases or sales Buffett made in the Berkshire stock portfolio during the previous quarter.  It's important for investors not to make any trading decisions based on what Berkshire did, but the filing is interesting nonetheless.""}, {""date"": ""20230726134005"", ""headline"": ""Why Johnson & Johnson (JNJ) is a Top Value Stock for the Long-Term"", ""summary"": ""Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.""}, {""date"": ""20230726141000"", ""headline"": ""Like Growing Dividend Income? Buy This Dividend King"", ""summary"": ""No healthcare company embodies consistency more than Johnson & Johnson (NYSE: JNJ): The business has grown its dividend for 61 consecutive years, the lengthiest dividend growth streak in the entire healthcare sector.  This robust portfolio of medicines, medical devices, and consumer health products supports J&J's $435 billion market capitalization, which makes it the biggest pharmaceutical company in the world.  J&J's net sales grew by 6.3% over the year-ago period to $25.5 billion in the second quarter ended June 30.""}, {""date"": ""20230726173200"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.19% higher to $172.72 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""20230726173900"", ""headline"": ""Top Analyst Reports for Johnson & Johnson, Zoetis & Lam Research"", ""summary"": ""Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Zoetis (ZTS) and Lam Research Corporation (LRCX).""}, {""date"": ""20230726193039"", ""headline"": ""Allogene: I Am Less Sanguine About Allogeneic CAR-T's Prospects Than Before"", ""summary"": ""Allogene Therapeutics is the leading developer of allogeneic CAR-T. There was a time when its logic appealed to me. Click here to see my view of ALLO stock now.""}, {""date"": ""20230726220349"", ""headline"": ""Building The Dividend Growth Portfolio In 2023"", ""summary"": ""My US dividend growth portfolio, constructed in 2015, has outperformed the market by over 2% annually. Check out my dividend growth portfolio in 2023.""}, {""date"": ""20230727033300"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230727045600"", ""headline"": ""Johnson & Johnson exec Fasolo sells 20,000 common shares"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230727060100"", ""headline"": ""3 Biotech Stocks You Better Be Buying on Each and Every Dip"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230727084400"", ""headline"": ""7 Millionaire-Maker Healthcare Stocks to Buy Before the Window Closes"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230727085049"", ""headline"": ""A Historic Opportunity To Win Big With Dividend Stocks"", ""summary"": ""Dividend stocks are today offering a historic opportunity. Share prices are down and dividend yields are now materially higher. Click here for our dividend strategy.""}, {""date"": ""20230727090000"", ""headline"": ""The Zacks Analyst Blog Highlights Johnson & Johnson, Zoetis, Lam Research, Aon and Dominion Energy"", ""summary"": ""Johnson & Johnson, Zoetis, Lam Research, Aon and Dominion Energy are included in this Analyst Blog.""}, {""date"": ""20230727093000"", ""headline"": ""Better Medtech Buy: J&J vs. Medtronic"", ""summary"": ""If you're shopping for a healthcare stock that promises growth, the medical technology space could offer some good choices.  In fact, some medtech players are even posting impressive growth.  Two giants in the space are Johnson & Johnson (NYSE: JNJ) and Medtronic (NYSE: MDT).""}, {""date"": ""20230727095700"", ""headline"": ""September 8th Options Now Available For Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230727100700"", ""headline"": ""Johnson & Johnson upgraded to Buy from Hold at Spin-Off Research"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230727101900"", ""headline"": ""How Is The Market Feeling About Johnson & Johnson?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230727115500"", ""headline"": ""If You Invested $25,000 in Johnson & Johnson 20 Years Ago, This Is How Much You Would Have Today"", ""summary"": ""It's a big name in healthcare, but has Johnson & Johnson been a great investment over the past two decades?""}, {""date"": ""20230727122500"", ""headline"": ""3 Top Blue Chip Stocks to Ride the Dow Rally"", ""summary"": ""As the Dow continues to scale upward, it's prudent to invest in stocks such as JPMorgan (JPM), Walmart (WMT) and Johnson & Johnson (JNJ) that are listed on the said index and are financially sound.""}, {""date"": ""20230727122900"", ""headline"": ""Fed's July Rate Hike and Comments Match Expectations: 5 Picks"", ""summary"": ""We have narrowed our search to five U.S. corporate behemoths. These are: META, GOOGL, ISRG, JNJ, PEP.""}, {""date"": ""20230727134014"", ""headline"": ""AI Stocks Are Overpriced. The Next Big Growth Opportunity Could Instead Be in This Industry"", ""summary"": ""You would need to be extremely bullish on the growth prospects of these companies to be willing to buy stock at those kinds of premiums.  If you want to invest in a sector where there may be excellent growth opportunities to take advantage of right now and where stocks are at much more manageable valuations, you should take a look at the healthcare industry.  Many healthcare companies struggled in recent years as the COVID-19 pandemic weighed down their operations and dampened demand.""}, {""date"": ""20230727170500"", ""headline"": ""AbbVie (ABBV) Beats on Q2 Earnings & Sales, Raises '23 View"", ""summary"": ""AbbVie's (ABBV) second-quarter 2023 earnings and sales beat estimates. The company raises its EPS guidance. Stock rises post the announcement.""}, {""date"": ""20230727172400"", ""headline"": ""Company Updates and Marketing Lessons From the Grateful Dead"", ""summary"": ""Trends in travel and consumer spending based on results from United Airlines, American Airlines,\u00a0Discover, and American Express.  Motley Fool Money's Alex Friedman caught up with author David Scott about the lessons he and Hubspot co-founder Brian Halligan think businesses can borrow from the Grateful Dead.""}, {""date"": ""20230727173100"", ""headline"": ""Johnson & Johnson stock rises Thursday, outperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.56% higher to $173.69 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the...""}, {""date"": ""20230728010400"", ""headline"": ""Catalyst watch: Amazon earnings, jobs report and will Apple talk AI?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230728010900"", ""headline"": ""Catalyst Watch: Amazon earnings, jobs report, and will Apple talk AI?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230728020000"", ""headline"": ""Drugmakers Want to Crush Medicare\u2019s Pricing Power. They\u2019ll Probably Succeed."", ""summary"": ""The industry has launched a legal war against a new law that would let Medicare negotiate prices. The odds are in Big Pharma's favor.""}, {""date"": ""20230728022500"", ""headline"": ""Janssen submits supplemental application to FDA for Edurant"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230728033800"", ""headline"": ""Judge dismisses J&J cancer lawsuit strategy again, Bloomberg reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230728035400"", ""headline"": ""Judge dismisses J&J cancer lawsuit strategy for second time, Reuters says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230728040700"", ""headline"": ""J&J talc lawsuits bankruptcy plan rejected for a second time"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230728042000"", ""headline"": ""The 3 Best Blue-Chip Dividend Stocks to Buy for July"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230728043600"", ""headline"": ""J&J seeks pediatric indication for HIV drug Edurant"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230728050937"", ""headline"": ""13 Safe Stocks To Invest In"", ""summary"": ""In this article, we will be taking a look at 13 safe stocks to invest in. To skip our detailed analysis of current recession concerns in the US and more, you can go directly to see the 5 Safe Stocks To Invest In. The Federal Reserve\u2019s July interest rate hike of 25 basis points that [\u2026]""}, {""date"": ""20230728070000"", ""headline"": ""SLB, Johnson & Johnson And 2 Other Stocks Insiders Are Selling"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230728085100"", ""headline"": ""2seventy bio downgraded at Morgan Stanley after Abecma sales"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230728102900"", ""headline"": ""How Productive Assets Outshine Gold in Buffett's Investment Philosophy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230728112100"", ""headline"": ""Got $2,500? 2 Top Stocks You Can Buy and Hold for a Lifetime"", ""summary"": ""These two rock-solid stocks are rejigging their portfolios to boost dividends and overall shareholder returns.""}, {""date"": ""20230728123700"", ""headline"": ""3 Things About Johnson & Johnson Every Smart Investor Knows"", ""summary"": ""Johnson & Johnson (NYSE: JNJ) is a value investor's dream stock.  The company has been around for 137 years and has a well-deserved reputation for thriving even during economic downturns.  The company is popular in part because of its reliable quarterly dividend, which it has raised for 61 consecutive years, including a 5.3% bump this year to $1.19 a share, leaving a yield of around 2.78%.""}, {""date"": ""20230728124000"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230728125200"", ""headline"": ""Johnson & Johnson, Other Pharma Makers Anticipate Reformulated Injectable Drugs May Exclude Price Negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230728143100"", ""headline"": ""Dorian and Oxford Industries have been highlighted as Zacks Bull and Bear of the Day"", ""summary"": ""Dorian and Oxford Industries are part of the Zacks Bull and Bear of the Day article.""}, {""date"": ""20230728151236"", ""headline"": ""The 'lingering uncertainties' for Johnson & Johnson in talc legal fight"", ""summary"": ""A judge is expected to rule soon on whether J&J can use a controversial bankruptcy strategy to dispose of roughly 100,000 claims.""}, {""date"": ""20230728172600"", ""headline"": ""Johnson & Johnson effort to resolve talc cancer lawsuits in bankruptcy fails a second time "", ""summary"": ""The decision jeopardizes J&J's proposed $8.9 billion settlement that would stop new lawsuits over its talc baby powder and other products from being filed.""}, {""date"": ""20230728173100"", ""headline"": ""Johnson & Johnson stock rises Friday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.45% higher to $174.48 Friday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""20230728204114"", ""headline"": ""J&J effort to resolve talc lawsuits in bankruptcy fails a second time"", ""summary"": ""NEW YORK (Reuters) -A U.S. judge on Friday shot down Johnson & Johnson's  second attempt to resolve tens of thousands of lawsuits over its talc products in bankruptcy, imperiling a proposed $8.9 billion settlement that would stop new lawsuits from being filed.  U.S. Bankruptcy Judge Michael Kaplan in Trenton, New Jersey, ruled that a J&J company's second bankruptcy, like its first, must be dismissed because the talc lawsuits did not put it in immediate \""financial distress.\""  \""In sum, this Court smells smoke, but does not see the fire,\"" Kaplan wrote, referring to the J&J unit LTL.""}, {""date"": ""20230728204420"", ""headline"": ""UPDATE 3-J&J effort to resolve talc lawsuits in bankruptcy fails a second time"", ""summary"": ""A U.S. judge on Friday shot down Johnson & Johnson's  second attempt to resolve tens of thousands of lawsuits over its talc products in bankruptcy, imperiling a proposed $8.9 billion settlement that would stop new lawsuits from being filed.  U.S. Bankruptcy Judge Michael Kaplan in Trenton, New Jersey, ruled that a J&J company's second bankruptcy, like its first, must be dismissed because the talc lawsuits did not put it in immediate \""financial distress.\""  \""In sum, this Court smells smoke, but does not see the fire,\"" Kaplan wrote, referring to the J&J unit LTL.""}, {""date"": ""20230728232900"", ""headline"": ""Johnson & Johnson\u2019s Second Talc Bankruptcy Case Thrown Out"", ""summary"": ""A New Jersey bankruptcy judge threw out the second chapter 11 case that Johnson & Johnson filed to resolve its mass talc liabilities, again shutting down the healthcare-product company\u2019s plan to achieve an $8.9 billion settlement.""}, {""date"": ""20230728235457"", ""headline"": ""10 Recession-Proof Stocks Billionaires Are Loading Up On"", ""summary"": ""In this article, we will take a look at the 10 recession-proof stocks billionaires are loading up on. To see more such companies, go directly to 5 Recession-Proof Stocks Billionaires Are Loading Up On. Latest data on inflation has upped the hopes of investors as market naysayers who had been warning of recession for several [\u2026]""}, {""date"": ""20230729070700"", ""headline"": ""Bristol-Myers Squibb's Bright Future Unfolds Beyond Q2 2023 Turmoil"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230729090200"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ) and Zoetis (ZTS)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230729111357"", ""headline"": ""11 Best Magic Formula Stocks to Buy Now"", ""summary"": ""In this article, we will take a look at the 11 best magic formula stocks to buy now. To see more such companies, go directly to 5 Best Magic Formula Stocks to Buy Now. Magic Formula investing strategy was first described by legendary value investor Joel Greenblatt in his 2005 book entitled The Little Book [\u2026]""}, {""date"": ""20230729194602"", ""headline"": ""Johnson & Johnson : Notice of Possible Blackout Period and Regulation BTR Trading Restrictions - Form 8-K"", ""summary"": ""Notice of Possible Blackout Period and Regulation BTR Trading Restrictions\n          \n        \n      \n    \n    \n      This blackout notice  is being provided in...""}, {""date"": ""20230730075600"", ""headline"": ""Johnson & Johnson (JNJ) Gets a Buy from Citi"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230730092100"", ""headline"": ""Want $500 in Super Safe Annual Dividend Income? Invest $9,900 in the Following 3 Dividend Kings"", ""summary"": ""These truly rock-solid income stocks, which sport an average yield of 5.07%, can pad patient investors' wallets.""}, {""date"": ""20230730100400"", ""headline"": ""These 3 Dow Stocks Are Set to Soar in 2023 and Beyond"", ""summary"": ""Three iconic Dow stocks are sitting on huge catalysts and preparing themselves for big things to come.""}, {""date"": ""20230730104500"", ""headline"": ""4 Top Stocks and 3 Top Cryptocurrencies for August"", ""summary"": ""The stock market has rallied so far this year, particularly in the period between the last earnings season and this one.  Johnson & Johnson (NYSE: JNJ) and Pfizer (NYSE: PFE) stand out as two value-oriented plays, while Nike (NYSE: NKE) is a beaten-down name-brand stock that hasn't rallied like the broader market.  On the growth side of the spectrum, HubSpot (NYSE: HUBS) is a software company with room to run.""}, {""date"": ""20230730115900"", ""headline"": ""These 3 Quarterly Releases Positively Shocked The Market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230730120034"", ""headline"": ""Is There An Opportunity With Johnson & Johnson's (NYSE:JNJ) 24% Undervaluation?"", ""summary"": ""Key Insights The projected fair value for Johnson & Johnson is US$231 based on 2 Stage Free Cash Flow to Equity Johnson...""}, {""date"": ""20230730122700"", ""headline"": ""AstraZeneca's Q2 Earnings Exceed Expectations, Astonishing Investors (Rating Upgrade)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230730165914"", ""headline"": ""10 Best August Dividend Stocks To Buy"", ""summary"": ""In this article, we discuss 10 best August dividend stocks to buy. You can skip our detailed analysis of dividend stocks and the dividend capture strategy, and go directly to read 5 Best August Dividend Stocks To Buy. In the stock market, various strategies may gain popularity at different times, but investors consistently gravitate toward [\u2026]""}]",{}
8,2023-07-30,171.8461456298828,2023-08-06,166.48828125,-0.03117826332527951,D4,"[{""date"": ""20230730075600"", ""headline"": ""Johnson & Johnson (JNJ) Gets a Buy from Citi"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230730092100"", ""headline"": ""Want $500 in Super Safe Annual Dividend Income? Invest $9,900 in the Following 3 Dividend Kings"", ""summary"": ""These truly rock-solid income stocks, which sport an average yield of 5.07%, can pad patient investors' wallets.""}, {""date"": ""20230730100400"", ""headline"": ""These 3 Dow Stocks Are Set to Soar in 2023 and Beyond"", ""summary"": ""Three iconic Dow stocks are sitting on huge catalysts and preparing themselves for big things to come.""}, {""date"": ""20230730104500"", ""headline"": ""4 Top Stocks and 3 Top Cryptocurrencies for August"", ""summary"": ""The stock market has rallied so far this year, particularly in the period between the last earnings season and this one.  Johnson & Johnson (NYSE: JNJ) and Pfizer (NYSE: PFE) stand out as two value-oriented plays, while Nike (NYSE: NKE) is a beaten-down name-brand stock that hasn't rallied like the broader market.  On the growth side of the spectrum, HubSpot (NYSE: HUBS) is a software company with room to run.""}, {""date"": ""20230730115900"", ""headline"": ""These 3 Quarterly Releases Positively Shocked The Market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230730120034"", ""headline"": ""Is There An Opportunity With Johnson & Johnson's (NYSE:JNJ) 24% Undervaluation?"", ""summary"": ""Key Insights The projected fair value for Johnson & Johnson is US$231 based on 2 Stage Free Cash Flow to Equity Johnson...""}, {""date"": ""20230730122700"", ""headline"": ""AstraZeneca's Q2 Earnings Exceed Expectations, Astonishing Investors (Rating Upgrade)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230730165914"", ""headline"": ""10 Best August Dividend Stocks To Buy"", ""summary"": ""In this article, we discuss 10 best August dividend stocks to buy. You can skip our detailed analysis of dividend stocks and the dividend capture strategy, and go directly to read 5 Best August Dividend Stocks To Buy. In the stock market, various strategies may gain popularity at different times, but investors consistently gravitate toward [\u2026]""}, {""date"": ""20230731010100"", ""headline"": ""J&J falls after bankruptcy plan rejected for second time"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230731021641"", ""headline"": ""PRESS DIGEST-New York Times business news - July 31"", ""summary"": ""July 31  - The following are the top stories on\nthe New York Times business pages. Reuters has not verified\nthese stories and does not vouch for their accuracy.\n              \n         ...""}, {""date"": ""20230731025400"", ""headline"": ""7 Stocks to Buy Before They Surpass 2021 Highs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230731025800"", ""headline"": ""Johnson & Johnson (NYSE:JNJ) Latest Talc Trouble Sinks Shares"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230731030600"", ""headline"": ""Johnson & Johnson\u2019s (NYSE:JNJ) Latest Talc Trouble Sinks Shares"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230731033300"", ""headline"": ""Johnson & Johnson stock underperforms Monday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230731044500"", ""headline"": ""These Stocks Are Moving the Most Today: SoFi, Nikola, XPeng, Palantir, and More"", ""summary"": ""SoFi Technologies posts a narrower-than-expected second-quarter loss and raises guidance, Nikola receives a large order, New Relic is being acquired,...""}, {""date"": ""20230731055200"", ""headline"": ""Cidara antifungal drug Rezzayo launched in US by partner Melinta"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230731073100"", ""headline"": ""Citi expects further litigation rounds after J&J subsidiary ruling"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230731074212"", ""headline"": ""Walmart, Chevron, Adobe rise premarket; Johnson & Johnson, Carvana fall"", ""summary"": ""Investing.com -- U.S. futures edged higher Monday, at the start of a week that includes more earnings from tech giants as well as the important monthly jobs report.""}, {""date"": ""20230731075800"", ""headline"": ""Fly Intel: Pre-market Movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230731082600"", ""headline"": ""5 stocks to watch on Monday: J&J, ON Semiconductor, Yum China and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230731091900"", ""headline"": ""Video: Dow Movers: JNJ, CVX"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230731092100"", ""headline"": ""Video: S&P 500 Movers: JNJ, NWL"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230731101400"", ""headline"": ""Stocks Mixed, Jobs Data On Deck, Johnson & Johnson Talc Plans, Walmart In India, Yellow Bankruptcy - 5 Things To Know"", ""summary"": ""Stock futures mixed amid 'soft landing' hopes for U.S. economy; Week Ahead: jobs data in focus, earnings reports accelerate; Johnson & Johnson slides as talc bankruptcy plan rejected by judge; Walmart buys out Tiger Global, expands Flipkart stake and Yellow slides as Teamsters say trucking giant preparing for bankruptcy.""}, {""date"": ""20230731104431"", ""headline"": ""Johnson & Johnson Subsidiary to Appeal Bankruptcy Court Ruling that Deprived Talc Claimants of an Equitable and Efficient Resolution"", ""summary"": ""NEW BRUNSWICK - Johnson & Johnson   today announced its subsidiary LTL Management LLC  will appeal the ruling by the United States Bankruptcy Court for the District of New Jersey dismissing the...""}, {""date"": ""20230731104432"", ""headline"": ""Janssen Submits Supplemental New Drug Application to U.S. FDA Seeking Expanded Pediatric Indication for HIV-1 Therapy EDURANT"", ""summary"": ""TITUSVILLE - The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a supplemental New Drug Application  to the U.S. Food and Drug Administration  seeking to...""}, {""date"": ""20230731112100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: OrthoPediatrics (KIDS) and Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230731113039"", ""headline"": ""5 Things to Know Before Markets Open"", ""summary"": ""Shares of SoFi Networks surged ahead of its earnings report and trucking company Yellow shut down operations as it prepares for bankruptcy. Here\u2019s what investors need to know today.""}, {""date"": ""20230731113039"", ""headline"": ""US STOCKS-Futures inch up ahead of more megacap earnings, employment data"", ""summary"": ""U.S. stock index futures edged up on Monday with key benchmarks on track to end July higher, while investors awaited quarterly earnings from more megacap companies and a crucial employment report later this week.  All three main U.S. indexes ended last week higher as signs of cooling inflation and a resilient economy cemented investor bets on a soft landing for the country.  Upbeat quarterly earnings from megacap growth companies such as Alphabet, Meta Platforms as well as chipmakers Intel and Lam Research have also boosted investor sentiment.""}, {""date"": ""20230731124100"", ""headline"": ""US Stocks Take A Breather, Nasdaq Notches Fifth Straight Month Of Gains: Investors Gear Up For Pivotal Week"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230731130847"", ""headline"": ""US STOCKS-Wall St set to open higher, eyes monthly gain on U.S. soft landing hopes"", ""summary"": ""Wall Street futures rose on Monday with key benchmarks set to end July higher on upbeat company earnings and hopes of a soft landing for a resilient U.S. economy, while cooling inflation fuels bets on a rate-hike pause.  Second-quarter earnings for S&P 500 companies are now estimated to have fallen 6.4% year-over-year, according to Refinitiv data.  \""We've wrapped up a solid month ... and we're at a point in time where we clearly have seen enough of the earnings reports to know that they're going to come in better than feared,\"" said Art Hogan, chief market strategist at B Riley Wealth.""}, {""date"": ""20230731140606"", ""headline"": ""US STOCKS-Wall St rises, eyes monthly gain on U.S. soft landing hopes"", ""summary"": ""Wall Street rose on Monday with key benchmarks set to end July higher on upbeat company earnings and hopes of a soft landing for a resilient U.S. economy, while cooling inflation fuels bets on a rate-hike pause.  Investors await quarterly reports from Apple, Amazon.com and AMD later this week, while July ISM Manufacturing reading and three sets of employment data, including July's non-farm payrolls, are also in focus.""}, {""date"": ""20230731143000"", ""headline"": ""J&J Just Can\u2019t Seem to Solve Its Talc Problem. The Latest Setback."", ""summary"": ""The Monday selloff in Johnson & Johnson stock appears to have been sparked by an unfavorable ruling by a bankruptcy judge in New Jersey.""}, {""date"": ""20230731145553"", ""headline"": ""Cantor Fitzgerald Reiterates Johnson & Johnson (JNJ) Overweight Recommendation"", ""summary"": """"}, {""date"": ""20230731150403"", ""headline"": ""S&P 500 stutters on final day of trade for July"", ""summary"": ""Investing.com -- The S&P 500 was largely unchanged Monday as falling health care stocks capped upside momentum on the final day of trade in July ahead of another wave of earnings this week.""}, {""date"": ""20230731150700"", ""headline"": ""Nachawati Law Group Trial Lawyers Renew Commitment to Cancer Victims After Judge\u2019s Rejection of Johnson & Johnson\u2019s Proposed $8.9B Settlement"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230731150801"", ""headline"": ""Nachawati Law Group Trial Lawyers Renew Commitment to Cancer Victims After Judge's Rejection of Johnson & Johnson's Proposed $8.9B Settlement"", ""summary"": ""Trial Lawyers Press on with J&J Litigation, Justice for Cancer Victims\n\n...""}, {""date"": ""20230731151908"", ""headline"": ""Why Johnson & Johnson Stock Is Sinking Today"", ""summary"": ""Shares of Johnson & Johnson (NYSE: JNJ) were sinking 4.2% lower as of 11:04 a.m. ET on Monday.  Judge Michael Kaplan with the U.S. Bankruptcy Court for the District of New Jersey dismissed a bankruptcy case filed by J&J subsidiary LTL Management.  Johnson & Johnson created LTL Management in 2021 as a separate company to bear all of its talc liabilities.""}, {""date"": ""20230731154220"", ""headline"": ""US STOCKS-Wall St inches up, eyes monthly gain on U.S. soft landing hopes"", ""summary"": ""Wall Street rose on Monday with key benchmarks set to end July higher on upbeat company earnings and hopes of a soft landing for a resilient U.S. economy, while cooling inflation fuels bets on a rate-hike pause.  Second-quarter earnings for S&P 500 companies are now estimated to have fallen 6.4% year-over-year, according to Refinitiv data.  The tech-heavy Nasdaq led Wall Street higher last week as megacap growth companies such as Alphabet, Meta Platforms as well as chipmakers Intel and Lam Research posted strong quarterly earnings.""}, {""date"": ""20230731161122"", ""headline"": ""Stock market today: Dow wraps up second monthly gain in July as energy jumps"", ""summary"": ""Investing.com -- The Dow closed higher Monday to wrap up a second-straight positive month for July after shrugging off a dip in health care as energy stocks racked up gains.""}, {""date"": ""20230731162000"", ""headline"": ""NEW YORK MARKET CLOSE: Stocks climb to end strong month on upbeat note"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230731163000"", ""headline"": ""These Stocks Are Moving the Most Today: SoFi, New Relic, XPeng, Nikola, Palantir, Wayfair, and More"", ""summary"": ""SoFi Technologies posts a narrower-than-expected second-quarter loss and raises guidance, New Relic is being acquired, Nikola receives a large order, Palantir shares continue their rally, and Wayfair stock is upgraded.""}, {""date"": ""20230731171907"", ""headline"": ""Johnson & Johnson Is the Dow\u2019s Leading Decliner. Disney Stock Stands Out."", ""summary"": ""Johnson & Johnson stock was dropping, while Walt Disney was rising in midday trading Monday, with the three major stock indexes little changed. Johnson & Johnson (ticker: JNJ) shares fell 3.7% and were on pace for their largest percentage decrease since June 2020, according to Dow Jones Market Data.""}, {""date"": ""20230731172503"", ""headline"": ""Johnson & Johnson: second talc bankruptcy dismissal hits share price"", ""summary"": ""Johnson & Johnson is a very valuable company, notwithstanding its efforts to convince US federal judges of the contrary.  Late on Friday, a New Jersey bankruptcy court ruled that the big pharma company could not pursue a bankruptcy deal with tens of thousands of consumers who claim its talc powder caused serious illness.  The court said that a financially engineered J&J subsidiary \u2014 created through the so-called Texas two-step process \u2014 was \u201cnot sufficiently financially distressed to avail itself of bankruptcy\u201d.""}, {""date"": ""20230731173200"", ""headline"": ""Johnson & Johnson stock falls Monday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson shed 3.98% to $167.53 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""20230731184947"", ""headline"": ""US STOCKS-Wall St poised to end strong month with muted session"", ""summary"": ""The key stock indexes are on track to end the month higher on upbeat company earnings and hopes of a soft landing for a resilient U.S. economy, while cooling inflation fueled bets on a rate-hike pause.  The tech-heavy Nasdaq led Wall Street higher last week as megacap growth companies such as Alphabet, Meta Platforms as well as chipmakers Intel and Lam Research posted strong quarterly earnings.  Citigroup raised its 2023-end and mid-2024 S&P 500 targets to 4,600 and 5,000, respectively, to reflect a higher possibility of a soft landing.""}, {""date"": ""20230731193006"", ""headline"": ""J&J shares on track for biggest daily drop in 3 years on talc setback"", ""summary"": ""Johnson & Johnson has now failed twice to resolve talc suits by offloading the related liabilities into a new company and placing it into bankruptcy.  Lawsuits had alleged baby powder and other talc products sometimes contained asbestos and caused mesothelioma, ovarian cancer and other cancers.  J&J has said its talc products are safe and do not contain asbestos.""}, {""date"": ""20230731193739"", ""headline"": ""Jim Cramer walks through latest investing decisions for his Charitable Trust"", ""summary"": ""'Mad Money' host Jim Cramer breaks down the latest decisions affecting stocks in his Charitable Trust.""}, {""date"": ""20230731194226"", ""headline"": ""Jim Cramer's Trust just sold its position in Johnson & Johnson \u2014 Here's why"", ""summary"": ""'Mad Money' host Jim Cramer breaks down why his Charitable Trust sold off its position in Johnson & Johnson.""}, {""date"": ""20230731194646"", ""headline"": ""Cramer sours on Johnson & Johnson as lawsuits pile up"", ""summary"": ""CNBC's Jim Cramer on Monday explained his decision to cut Johnson & Johnson from the Investing Club's Charitable Trust.""}, {""date"": ""20230731200036"", ""headline"": ""US STOCKS-Wall St ends strong month on upbeat company earnings"", ""summary"": ""The tech-heavy Nasdaq led Wall Street higher last week as megacap growth companies such as Alphabet, Meta Platforms as well as chipmakers Intel and Lam Research posted strong quarterly earnings.  Citigroup raised its 2023-end and mid-2024 S&P 500 targets to 4,600 and 5,000, respectively, to reflect a higher possibility of a soft landing.""}, {""date"": ""20230731202614"", ""headline"": ""S&P 500: Entertainment Giants, AI Play Lead Monday's 5 Best; Medtech Firms Sicken"", ""summary"": ""Paramount and Disney, along with AI play Adobe, led the S&P 500. Dexcom and several medical products firms struggled.""}, {""date"": ""20230731202651"", ""headline"": ""J&J Leads Losses on the Dow After Court Rejects Bankruptcy Plans"", ""summary"": ""Johnson & Johnson shares dropped after a judge ruled against its plan to resolve talcum powder-related lawsuits.""}, {""date"": ""20230731203418"", ""headline"": ""US STOCKS-Wall St finishes strong month on upbeat company earnings"", ""summary"": ""Second-quarter earnings for S&P 500 companies are estimated to have fallen 6.4% year-over-year, Refinitiv data through Friday showed.  The tech-heavy Nasdaq led Wall Street higher last week as megacap growth companies such as Alphabet, Meta Platforms as well as chipmakers Intel and Lam Research posted strong quarterly earnings.""}, {""date"": ""20230731205643"", ""headline"": ""Dow Jones Today: Index Higher For Second Straight Month"", ""summary"": ""The Dow closed July with a gain of 3%, moving up 100 points, or 0.28% on the session, as investors watch earnings and prepare for Friday\u2019s job report.""}, {""date"": ""20230731220408"", ""headline"": ""S&P 500 Gains and Losses Today: Oil Industry Stocks Advance as Oil Prices Climb"", ""summary"": ""The S&P 500 was little changed to start the week on Monday, July 31, 2023, edging 0.2% higher as oil stocks gained on the back of higher oil prices.""}, {""date"": ""20230801085600"", ""headline"": ""The RBA Left The Interest Rate Unchanged Again. Rising Oil Prices Boost Energy Sector Growth"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230801091600"", ""headline"": ""Do Your Investments Pass the 5.45% Test? Here's How To Avoid Leaving Money On The Table"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230801105000"", ""headline"": ""3 Cheap Healthcare Stocks That Smart Investors Will Snap Up Now"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230801110000"", ""headline"": ""Companies Weigh Growing Power of Cloud Providers Amid AI Boom"", ""summary"": ""A wave of partnerships between AI model makers and cloud providers is leading tech chiefs to assess the benefits of convenience versus becoming too reliant on any one vendor.""}, {""date"": ""20230801122100"", ""headline"": ""DGRO: Consistent Dividend Growth For Patient Investors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230801124900"", ""headline"": ""Why Jim Cramer Sold One of His Favorite Pharma Stocks"", ""summary"": ""Johnson & Johnson  has been facing tens of thousands of lawsuits for several years now, alleging that the company's baby powder and other talc products sometimes contained asbestos and have caused a variety of cancers in the company's customers.  The company recently proposed a nearly $9 billion settlement plan that would involve a bankruptcy filing and prevent new lawsuits from being filed against it.  \""Normally when we sell a stock it's because something's changed at the company,\"" Cramer, whose charitable trust just sold all of it's J&J holdings, said.""}, {""date"": ""20230801132900"", ""headline"": ""Company News for Aug 1, 2023"", ""summary"": ""Companies in The News Are: XOM, JNJ, ON, NFLX""}, {""date"": ""20230801162800"", ""headline"": ""Merck (MRK) Beats on Q2 Earnings and Sales, Ups 2023 View"", ""summary"": ""Merck (MRK) beats Q2 estimates for earnings and sales. It raises its 2023 guidance. Stock rises in pre-market.""}, {""date"": ""20230801173000"", ""headline"": ""Top 25 S&P 500 Stocks by Index Weight for August 2023"", ""summary"": ""The Standard & Poor's 500 Index, or simply the S&P 500, is a market-capitalization-weighted index of roughly 500 large-cap U.S. stocks. The index accounts for 80% of the market value of the U.S. equities market.""}, {""date"": ""20230801182600"", ""headline"": ""Merck upgrades guidance on stronger 2023 outlook as COVID business declines"", ""summary"": ""Merck reported stronger-than-expected second quarter earnings.""}, {""date"": ""20230801191025"", ""headline"": ""Pfizer reports mixed quarterly results on uncertain COVID outlook"", ""summary"": ""Pfizer reports mixed second quarter earnings as uncertainty around COVID remains a headwind.""}, {""date"": ""20230801205159"", ""headline"": ""Dow Jones Today: Caterpillar Earnings Lift Index"", ""summary"": ""The price-weighted index rode gains from Caterpillar to move higher by 0.2%, or roughly 70 points, despite more than two-thirds of the index\u2019s stocks falling.""}, {""date"": ""20230802023700"", ""headline"": ""This Is What Whales Are Betting On Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802040554"", ""headline"": ""Time To Go Defensive With These ETFs"", ""summary"": ""The stock market has been on a tear lately, with the most volatile stocks crushing their defensive counterparts. Click here to read more about low-volatility investing.""}, {""date"": ""20230802043300"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802050832"", ""headline"": ""10 Recent IPOs in 2023 to Consider"", ""summary"": ""In this piece, we will take a look at ten recent IPOs in 2023. If you want to skip background activity in the sector this year, then head on over to 5 Recent IPOs in 2023 to Consider. Most companies don\u2019t list their shares on the stock market. While big ticket names such as Apple, [\u2026]""}, {""date"": ""20230802084900"", ""headline"": ""3 Consumer Staples Stocks to Dump ASAP"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802110900"", ""headline"": ""The timing may be perfect for this dividend-stock fund if the market is getting close to a top"", ""summary"": ""The TrueShares Low Volatility Equity Income ETF sailed through the 2022 bear market. It is actively managed to focus on quality, value and attractive yields.""}, {""date"": ""20230802120000"", ""headline"": ""Horizon Kinetics Q2 2023 Commentary"", ""summary"": ""Horizon Kinetics recently released its Q2 2023 commentary. Click here to read the full fund letter.""}, {""date"": ""20230802151757"", ""headline"": ""Why J&J's 'Texas-two step' setback could make it harder for companies to shed lawsuits"", ""summary"": ""A ruling against Johnson & Johnson raises new questions about a controversial bankruptcy tactic companies use to resolve costly claims.""}, {""date"": ""20230802152824"", ""headline"": ""2 Remaining AAA-Rated Companies Shine As U.S. Gets Downgraded"", ""summary"": ""Lawmakers are playing chicken with the debt ceiling. Luckily there are still two U.S. S&P 500 companies left with AAA credit ratings.""}, {""date"": ""20230802162900"", ""headline"": ""United Therapeutics (UTHR) Q2 Earnings & Sales Beat Estimates"", ""summary"": ""United Therapeutics' (UTHR) second-quarter 2023 earnings and sales beat estimates. Tyvaso sales continue to drive the company's top line.""}, {""date"": ""20230802180037"", ""headline"": ""J&J, Cancer Victims Agree to Quick Appeal of Bankruptcy Ruling"", ""summary"": ""(Bloomberg) -- Johnson & Johnson and a committee of cancer victims have agreed to speed up a court appeal of their fight regarding whether the health-care giant can use bankruptcy to end as many as 100,000 talc-related claims.Most Read from BloombergFitch\u2019s US Credit Downgrade Sparks Criticism Along With UneaseMissing Goldman Sachs Analyst Confirmed Dead by New York PoliceS&P 500 Drops 1% After Rally as Bond Yields Climb: Markets WrapPoland Sends Troops to Belarus Border After Airspace BreachWhy""}, {""date"": ""20230802190429"", ""headline"": ""J&J talc cancer plaintiffs want 6-month ban on further bankruptcy filings"", ""summary"": ""Lawyers for thousands of people who claim Johnson & Johnson's talc-based powders caused them to develop cancer on Wednesday urged a U.S. judge to temporarily block the company from seeking bankruptcy protection for a third time for its talc subsidiary.  J&J's attempt at resolving thousands of cancer lawsuits in bankruptcy court stumbled for a second time last week, when a judge ruled that the talc subsidiary, LTL Management, was not in the kind of immediate financial distress necessary to trigger bankruptcy protection.""}, {""date"": ""20230802203320"", ""headline"": ""Dow Jones Today: Index Dives on Rating Cut"", ""summary"": ""Investors reacted to the Fitch Rating agency\u2019s downgrade of U.S. credit, sending long-term bonds higher and the Dow Jones lower by about 1%, or 350 points.""}, {""date"": ""20230803004538"", ""headline"": ""U.S. Credit Rating Downgrade Won't Derail This Bull Market"", ""summary"": ""Stocks have intrinsic monetary value due to their ability to generate future free cash flows, unlike gold and Bitcoin. Click here for a detailed analysis.""}, {""date"": ""20230803033300"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803064200"", ""headline"": ""Goldman in, Microsoft out of BofA Alpha Surprise Portfolio"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803082600"", ""headline"": ""Buckle Up! 3 Healthcare Stocks Set to Soar to New Heights"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803090700"", ""headline"": ""JNJ Named Top 25 SAFE Dividend Stock Increasing Payments For Decades"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803100039"", ""headline"": ""Sell Alert: 3 Healthcare Stocks to Dump ASAP"", ""summary"": ""Healthcare stocks are generally thought of as safe or even recession-proof investments. This is because the underlying companies provide essential products and services that are required no matter what the broader economy is doing. While they may not offer the most exciting returns, they are usually considered to be solid long-term performers. That said, there are a few healthcare stocks to dump that we will look at today. From an investment perspective, some potential red flags that could signa""}, {""date"": ""20230803120132"", ""headline"": ""With 71% ownership of the shares, Johnson & Johnson (NYSE:JNJ) is heavily dominated by institutional owners"", ""summary"": ""Key Insights Given the large stake in the stock by institutions, Johnson & Johnson's stock price might be vulnerable to...""}, {""date"": ""20230803130200"", ""headline"": ""J&J\u2019s $40 Billion Kenvue Stock Swap:\u00a0What You Need to Know"", ""summary"": ""Johnson & Johnson is allowing shareholders to swap for shares of Kenvue, which has brands like Tylenol, at a discount.""}, {""date"": ""20230803152800"", ""headline"": ""Sarepta (SRPT) Q2 Loss Narrower Than Expected, Sales Miss"", ""summary"": ""Sarepta's (SRPT) second-quarter 2023 earnings beat estimates. Though total revenues register strong year-over-year growth during the quarter, the same misses the mark.""}, {""date"": ""20230803165900"", ""headline"": ""Q2 Earnings Season Scorecard and Research Reports for JNJ, Pioneer Natural & Others"", ""summary"": ""Today's Research Daily features a real-time Q2 scorecard and updated reports on JNJ (JNJ), General Dynamics (GD), Pioneer Natural Resources (PXD) and others.""}, {""date"": ""20230803171500"", ""headline"": ""Looking to Bet On Perfect AAA Credit Ratings? Play These ETFs"", ""summary"": ""In light of Fitch Ratings' downgrade of U.S. credit, investors might be interested in identifying companies and countries that still hold the desirable 'AAA' credit rating.""}, {""date"": ""20230803232457"", ""headline"": ""Buckle Up! 3 Blue-Chip Stocks Set to Soar to New Heights."", ""summary"": ""The U.S. stock market has been roaring higher lately, even though it has started off August on a tough note. While the S&P 500 has fallen about 2% so far this month, it\u2019s been on a strong run otherwise. Regardless of the next direction, investors should be looking at blue-chip stocks to buy. Blue-chip stocks should be on investors\u2019 radar whether the stock market is going up or down. The S&P 500 has enjoyed a five-month win streak, gaining more than 21% from the March low to the July high. At tha""}, {""date"": ""20230804033300"", ""headline"": ""Johnson & Johnson stock falls Friday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230804064500"", ""headline"": ""Ralph Lauren To Rally 17%? Here Are 10 Other Analyst Forecasts For Friday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230804080000"", ""headline"": ""Biosense Webster Receives FDA Approval for Multiple Atrial Fibrillation Ablation Products to be Used in a Workflow Without Fluoroscopy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230804094200"", ""headline"": ""5 Forever Dividend Stocks"", ""summary"": ""When it comes to investing, it is important to build a strong foundation of high-quality positions.""}, {""date"": ""20230804101400"", ""headline"": ""J&J says Biosense Webster gains US FDA approval for ablation products"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230804104900"", ""headline"": ""J&J gets expanded approval for cardiac ablation products"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230804110000"", ""headline"": ""Itching for a Good Trade? Johnson & Johnson Spinoff Kenvue Should Offer Relief"", ""summary"": ""Boasting brands like Band-Aid and Benadryl, Kenvue has now become the largest pure-play consumer health company, and it will soon offer two distinct -- and excellent -- opportunities.""}, {""date"": ""20230804120800"", ""headline"": ""The Zacks Analyst Blog Highlights Johnson & Johnson, General Dynamics, Pioneer Natural Resources, Alibaba Group and Autodesk"", ""summary"": ""Johnson & Johnson, General Dynamics, Pioneer Natural Resources, Alibaba Group and Autodesk are part of the Zacks top Analyst Blog.""}, {""date"": ""20230804122500"", ""headline"": ""Better Buy: Johnson & Johnson vs. Proctor & Gamble"", ""summary"": ""Dividend stocks are the best way to invest if stock market volatility scares you away from investing your hard-earned money.  The two companies I'll be discussing in this article are longtime dividend payers in the consumer and healthcare industries.  Both Proctor & Gamble (NYSE: PG) and Johnson & Johnson (NYSE: JNJ) have earned the title of Dividend King.""}, {""date"": ""20230804132326"", ""headline"": ""My Dividend Growth Portfolio: Mid-Summer Update"", ""summary"": ""Discover why the author sold Cardinal Health in favor of Home Depot, ADP, and CME Group. Also, learn about Blackstone's variable dividend and Johnson & Johnson's latest exchange offer.""}, {""date"": ""20230804134500"", ""headline"": ""Bruker (BRKR) Q2 Earnings and Revenues Top, '23 Sales View Up"", ""summary"": ""Bruker (BRKR) delivers better-than-expected earnings and revenues in the second quarter of 2023.""}, {""date"": ""20230804193557"", ""headline"": ""3 of the Safest Dividend Kings"", ""summary"": ""Income investors should focus on stocks that pay solid yields but also those that have sustainable payouts and strong business models. The Dividend Kings are an excellent place to look for stocks with sustainable dividends, as they have raised their dividends each year for more than 50 consecutive years. The following three Dividend Kings have low dividend payout ratios and recession-proof business models, meaning their dividends are well-covered even during a recession. Walmart (WMT) Source: fo""}, {""date"": ""20230805032600"", ""headline"": ""Atlantic Equities Sticks to Their Hold Rating for Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230805090000"", ""headline"": ""5 Relatively Safe And Cheap Dividend Stocks To Invest In - August 2023"", ""summary"": ""Discover five large-cap dividend-paying stocks that are currently offering substantial discounts, allowing investors to enjoy moderate to high yields.""}, {""date"": ""20230806114018"", ""headline"": ""25 Most Health-Conscious States in the US"", ""summary"": ""In this article, we will be taking a look at the 25 most health-conscious states in the U.S. If you wish to see the top ones, head straight to the 5 Most Health-Conscious States in the U.S. According to the Commonwealth Fund, healthcare spending in the United States is much greater than in other high-income [\u2026]""}]",{}
9,2023-08-06,166.48828125,2023-08-13,171.22567749023438,0.02845483300485685,U3,"[{""date"": ""20230806114018"", ""headline"": ""25 Most Health-Conscious States in the US"", ""summary"": ""In this article, we will be taking a look at the 25 most health-conscious states in the U.S. If you wish to see the top ones, head straight to the 5 Most Health-Conscious States in the U.S. According to the Commonwealth Fund, healthcare spending in the United States is much greater than in other high-income [\u2026]""}, {""date"": ""20230807062900"", ""headline"": ""IN BRIEF: Fresenius agrees on FYB202 US entry date with J&J"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230807100200"", ""headline"": ""WKLY: Want Weekly Dividends? Check Out This ETF from SoFi"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230807115500"", ""headline"": ""New Data May Push Insurers to Cover Novo, Lilly Obesity Drugs"", ""summary"": ""Results of a study show Novo Nordisk's Wegovy reduced the risk of heart attack and stroke in obese and overweight patients by a greater-than-expected degree.""}, {""date"": ""20230807130036"", ""headline"": ""Is Johnson & Johnson (NYSE:JNJ) A Risky Investment?"", ""summary"": ""The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...""}, {""date"": ""20230807134721"", ""headline"": ""August MDA Breakout Stocks Week 32 - 2023: High-Frequency Gainers To Give You An Edge"", ""summary"": ""Two new Breakout Stocks for Week 32 curated by the MDA model for 10% short-term upside and additional model selections. Click here to read more.""}, {""date"": ""20230807174422"", ""headline"": ""Future Prospects For Johnson & Johnson Following Strong Q2 Performance"", ""summary"": ""Johnson & Johnson, the mastodon of the healthcare sector, released its financial results for the 2nd quarter of 2023. Read why JNJ stock is a hold.""}, {""date"": ""20230807193001"", ""headline"": ""Johnson & Johnson to Participate in the 2023 Wells Fargo Securities Healthcare Conference"", ""summary"": ""Johnson & Johnson  will participate in the 2023 Wells Fargo Securities Healthcare Conference at the Encore Boston Harbor in Everett, MA on Thursday, September 7th. Ashley McEvoy, EVP, Worldwide...""}, {""date"": ""20230807204251"", ""headline"": ""Dow Jones Today: Index Rebounds with 400-Point Gain"", ""summary"": ""Following last week\u2019s downward turn, the Dow Jones Industrial Average bounced back, rising 407 points, or 1.2%, as investors readied for new inflation data to close out the week.""}, {""date"": ""20230807211014"", ""headline"": ""Johnson & Johnson Plans Exchange Offer for Kenvue"", ""summary"": ""It is a question of financial value""}, {""date"": ""20230808014800"", ""headline"": ""The 7 Best Warren Buffett Stocks to Buy for August 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230808070000"", ""headline"": ""Eli Lilly's stock soars toward best day in 23 years after strong earnings, upbeat Mounjaro outlook"", ""summary"": ""Eli Lilly's stock soared Tuesday toward its biggest gain in more than 20 years, following a strong earnings report and upbeat outlook for its Mounjaro drug.""}, {""date"": ""20230808070448"", ""headline"": ""Eli Lilly raises full-year guidance as drug pipeline drives second-quarter profit up 85%"", ""summary"": ""Eli Lilly's stock has been on a tear, driven by positive trial results for its Alzheimer's drug and progress with its promising obesity drug pipeline.\u00a0""}, {""date"": ""20230808080525"", ""headline"": ""Novavax shares jump after Covid vaccine maker posts surprise quarterly profit "", ""summary"": ""Novavax is working to strengthen its financial position after it raised doubts about its ability to stay in business earlier this year. ""}, {""date"": ""20230808091000"", ""headline"": ""My Dividend Stock Portfolio: New July Dividend Record - 99 Holdings With 26 Buys"", ""summary"": ""Investment activity remained robust, and dividend income hit a record high. Additionally, passive income equivalent to almost 5 weeks of work was earned in 2023.""}, {""date"": ""20230808091200"", ""headline"": ""Is Johnson & Johnson Stock a Buy Now?"", ""summary"": ""Healthcare giant Johnson & Johnson (NYSE: JNJ) has a lot going its way.  Should investors take this opportunity to pick up the company's shares on the dip, or are Johnson & Johnson's legal troubles enough of a reason to avoid the stock?  First, we need some background to understand the latest developments in Johnson & Johnson's long battle against these cases.""}, {""date"": ""20230808110700"", ""headline"": ""Eli Lilly\u2019s stock soars toward best day in 23 years after strong earnings, upbeat Mounjaro outlook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230808124200"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230808124700"", ""headline"": ""Cantor biotech/biopharma analysts to hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230808155400"", ""headline"": ""Perrigo (PRGO) Beats on Q2 Earnings & Sales, Reiterates '23 View"", ""summary"": ""Perrigo (PRGO) reports encouraging second-quarter 2023 results. Management reaffirms the financial guidance for 2023.""}, {""date"": ""20230808163200"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.05% higher to $173.18 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the...""}, {""date"": ""20230809024300"", ""headline"": ""What Makes A Hold-Forever Stock?"", ""summary"": ""Forever stocks are companies that diversify to reduce risk by not relying solely on one market or product for revenue. Check out the list of my forever stocks.""}, {""date"": ""20230809025000"", ""headline"": ""Looking At Johnson & Johnson's Recent Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230809035400"", ""headline"": ""Atai's Clinical Results Of R-Ketamine For Depression: Road To Subcutaneous At-Home Administration"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230809042100"", ""headline"": ""Kenvue to be added to S&P 500, date to be announced"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230809052900"", ""headline"": ""Kenvue set to join S&P500"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230809080600"", ""headline"": ""What Makes A Hold-Forever-Stock"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230809081900"", ""headline"": ""The Year\u2019s Top 3 Value ETFs as of August 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230809092100"", ""headline"": ""3 No-Brainer Stocks to Buy With $200 Right Now"", ""summary"": ""A reasonably small amount of money can go a long way when it's invested in game-changing companies.""}, {""date"": ""20230809110417"", ""headline"": ""22 Highest Paid Medical Specialties in the World"", ""summary"": ""In this article, we will look at the 22 highest-paid medical specialties in the world. We have also covered analysis on salaries for doctors in the US while discussing healthcare giants and their initiatives for global healthcare. If you want to skip our detailed analysis, head straight to the 5 Highest-Paid Medical Specialties in the [\u2026]""}, {""date"": ""20230809112800"", ""headline"": ""Medicare Part D drug price increases far exceed inflation - AARP"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230809120000"", ""headline"": ""A Bull Market Is Coming: 2 Warren Buffett Stocks to Buy and Hold Forever"", ""summary"": ""Few investors are better known than Warren Buffett, who is widely regarded as the greatest stock picker of all time.  One of Buffett's signature qualities is his long-term approach to investing.  It's not surprising then that his conglomerate, Berkshire Hathaway, has an investment portfolio full of stocks worth holding on to for good.""}, {""date"": ""20230809120400"", ""headline"": ""5 Defensive Stocks for Stable Returns Amid Recent Volatility"", ""summary"": ""We have narrowed our search to five stocks from defensive sectors. These are: JNJ, PEP, ISRG, KMB, ATO.""}, {""date"": ""20230809124500"", ""headline"": ""Johnson & Johnson's Talc Problems Aren't Going Away"", ""summary"": ""The biggest risk facing\u00a0Johnson & Johnson\u00a0(NYSE: JNJ) today is its exposure to talc-related lawsuits.  The company developed a plan to address the issue and limit its liability by creating a subsidiary that would then file for bankruptcy protection.  In 2021, Johnson & Johnson created a subsidiary, LTL Management.""}, {""date"": ""20230809134928"", ""headline"": ""Unusual Put Option Trade in Johnson & Johnson (JNJ)  Worth $11,600.00K"", ""summary"": """"}, {""date"": ""20230809144426"", ""headline"": ""Protagonist: Rusfertide Has Potential For Patients With Polycythemia Vera"", ""summary"": ""Protagonist Therapeutics is progressing with the use of rusfertide drug for polycythemia vera treatment in a phase 3 study. Find out why PTGX stock is a Strong Buy.""}, {""date"": ""20230809163100"", ""headline"": ""Johnson & Johnson stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Johnson & Johnson slumped 0.06% to $173.07 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P...""}, {""date"": ""20230809174900"", ""headline"": ""Kenvue, the J&J spinoff, will join the S&P 500 index"", ""summary"": ""Kenvue Inc., maker of Tylenol, Benadryl and other household names in health-care products, is joining the S&P 500 index, index provider S&P Dow Jones Indices...""}, {""date"": ""20230809181600"", ""headline"": ""Kenvue Will be Added to S&P 500 After J&J Exchange Offer"", ""summary"": ""The Johnson & Johnson spinoff is the consumer health company that makes Listerine and Tylenol.""}, {""date"": ""20230809224200"", ""headline"": ""Kenvue Set to Join S&P 500"", ""summary"": ""Kenvue Inc. (NYSE: KVUE) will be added to the S&P 500 effective prior to the open on a date to be announced conditioned upon the successful completion of a voluntary exchange offer being conducted by S&P 500 & S&P 100 constituent Johnson & Johnson (NYSE: JNJ). Johnson & Johnson announced its intention to split off at least 80.1% of Kenvue shares it owns through a voluntary exchange offer that expires Friday, August 18. Kenvue will replace an S&P 500 company to be named in a separate press releas""}, {""date"": ""20230810021853"", ""headline"": ""Tracking Yacktman Asset Management Portfolio - Q2 2023 Update"", ""summary"": ""Yacktman Asset Management's 13F portfolio value grows to $10.55B, with Canadian Natural Resources as largest holding. See here for additions and deletions.""}, {""date"": ""20230810034400"", ""headline"": ""Supreme Court to hear arguments on Purdue Pharma $6B bankruptcy settlement"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230810035000"", ""headline"": ""Supreme Court Halts Purdue Pharma's $6B Settlement: Sackler Family's Shield From Opioid Lawsuits Challenged"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230810042100"", ""headline"": ""The 7 Safest Stocks to Buy in August"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230810050000"", ""headline"": ""Want to Make $1,000 in 2 Weeks? Buy 99 Shares of J&J Stock."", ""summary"": ""Many individual investors are trying to do that by purchasing 99 shares of  Johnson & Johnson  to take advantage of the \u201codd-lot\u201d rule in the company\u2019s $40 billion exchange offer for  Kenvue  The potential payoff if things go right is more than $1,000.  The opportunity arises because the Johnson & Johnson (ticker: JNJ) exchange offer for Kenvue (KVUE), which holds the consumer health business formerly owned by J&J, allows holders of less than 100 shares of J&J stock\u2014or an odd lot \u2014to get a full allocation of Kenvue if they submit all their shares.  Other J&J shareholders are likely to be prorated, meaning they won\u2019t get a full allocation of Kenvue.""}, {""date"": ""20230810050805"", ""headline"": ""Post-IPO NeurAxis A Robust Contender To Earn Front Line Designation Treating Pediatric FAP And IBS ($NRXS)"", ""summary"": ""Successful IPO to NYSE-Amer market raises over $6 million to fuel expanding treatment reach of IB-Stim technologyNeurAxis scored a significant milestone on Wednesday, making its NYSE-American...""}, {""date"": ""20230810070500"", ""headline"": ""Johnson & Johnson Gets FDA OK of Talvey in Heavily Pretreated Multiple Myeloma >JNJ"", ""summary"": ""By Colin Kellaher Johnson &amp; Johnson has won U.S. Food and Drug Administration accelerated approval of its Talvey bispecific antibody for certain adults...""}, {""date"": ""20230810071000"", ""headline"": ""Johnson & Johnson wins FDA nod for new multiple myeloma therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230810072104"", ""headline"": ""Johnson & Johnson Gets FDA OK of Talvey in Heavily Pretreated Multiple Myeloma"", ""summary"": ""By Colin Kellaher Johnson & Johnson has won U.S. Food and Drug Administration accelerated approval of its Talvey bispecific antibody for certain adults with the incurable blood cancer multiple...""}, {""date"": ""20230810073639"", ""headline"": ""Disney, Capri, Sonos, Wynn Resorts rise premarket; Tapestry, Penn fall"", ""summary"": ""Investing.com -- U.S. futures rose Thursday, with investors awaiting a key inflation release which could provide clues towards future Federal Reserve interest rate decisions.""}, {""date"": ""20230810075500"", ""headline"": ""Notable open interest changes for August 10th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230810092100"", ""headline"": ""The Zacks Analyst Blog Highlights PepsiCo, Johnson & Johnson, Intuitive Surgical, Kimberly-Clark and Atmos Energy"", ""summary"": ""PepsiCo, Johnson & Johnson, Intuitive Surgical, Kimberly-Clark and Atmos Energy are included in this Analyst Blog.""}, {""date"": ""20230810092100"", ""headline"": ""3 Top Biotech Stocks Defying the Bear Market"", ""summary"": ""If you look at the S&P 500, which is up more than 18% this year, or the Nasdaq Composite, which is up more than 34% in 2023, it appears the markets are booming.  The iShares Biotechnology ETF is down more than 3% so far in 2023, and the SPDR S&P Biotech EFT is down more than 5%.  The two ETFs reflect negative market sentiment toward biotech stocks, in general, this year.""}, {""date"": ""20230810092600"", ""headline"": ""KVUE Stock Alert: Kenvue to Join the S&P 500"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230810102423"", ""headline"": ""X CEO Linda Yaccarino explains reason for getting rid of Twitter name"", ""summary"": ""X CEO Linda Yaccarino explained to CNBC on Thursday why the company decided to get rid of its Twitter branding.""}, {""date"": ""20230810104000"", ""headline"": ""FDA grants accelerated approval of Janssen's Talvey"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230810104714"", ""headline"": ""UPDATE 2-US FDA approves Johnson & Johnson's blood cancer therapy"", ""summary"": ""Johnson & Johnson said on Thursday the U.S. Food and Drug Administration had approved its antibody-based therapy for patients with a difficult-to-treat type of blood cancer.  The therapy, talquetamab-tgvs branded as Talvey, belongs to a class of treatments called bispecific antibodies designed to bring a cancer cell and an immune cell together so the body's immune system can kill the cancer.  Talvey was approved as a weekly or biweekly subcutaneous, or under-the-skin, injection to treat patients with relapsed multiple myeloma who have received at least four prior lines of treatment,  the company said.""}, {""date"": ""20230810111700"", ""headline"": ""Achieving Alpha By Investing In Current Wealth And Present Value"", ""summary"": """"}, {""date"": ""20230810132152"", ""headline"": ""These 10 medications are likely targets for Medicare price negotiations this fall"", ""summary"": ""It's still unclear which drugs Medicare will select, but several companies have revealed in court filings that four of their medications are targets.""}, {""date"": ""20230810163200"", ""headline"": ""Johnson & Johnson stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slipped 0.52% to $172.17 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P...""}, {""date"": ""20230810163400"", ""headline"": ""IN BRIEF: Johnson & Johnson's blood cancer therapy approved by FDA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230811035700"", ""headline"": ""Uber Crowded, Battleground and Sweet 16 stock portfolios from Jefferies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230811075500"", ""headline"": ""Notable open interest changes for August 11th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230811085834"", ""headline"": ""Janssen Pharmaceutical - U.S. FDA Approves TALVEY, a First-in-Class Bispecific Therapy for the Treatment of Patients with Heavily Pretreated Multiple Myeloma"", ""summary"": ""HORSHAM - The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration has granted accelerated approval of TALVEY , a first-in-class...""}, {""date"": ""20230811115800"", ""headline"": ""Boston Scientific's Farapulse Eyes Stronger US Market Position With Potential FDA Approval"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230811121100"", ""headline"": ""Most Active Equity Options For Midday - Friday, Aug. 11"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230811123300"", ""headline"": ""WHO names Eris a coronavirus variant of interest. Here\u2019s what you need to know."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230811125500"", ""headline"": ""Is Kenvue Stock a Buy After Earnings?"", ""summary"": ""If you've ever been to a convenience store, odds are that you've encountered products sold by Kenvue (NYSE: KVUE).  If that name doesn't sound familiar, it might be because until recently Kenvue's products were part of a larger conglomerate, Johnson & Johnson.  Kenvue just held its first earnings report as a stand-alone public company, and beat Wall Street expectations on both the top and bottom lines.""}, {""date"": ""20230811140042"", ""headline"": ""Johnson & Johnson (NYSE:JNJ) shareholders have earned a 8.2% CAGR over the last five years"", ""summary"": ""The main point of investing for the long term is to make money. Furthermore, you'd generally like to see the share...""}, {""date"": ""20230811153430"", ""headline"": ""Supreme Court temporarily blocks Purdue's $6B opioid settlement"", ""summary"": ""The Supreme Court has motioned to temporarily pause Purdue Pharma's $6 billion opioid settlement over a provision that would give the Sackler family immunity from lawsuits and liabilities. Yahoo Finance Health Care Reporter Anjalee Khemlani breaks down the story.""}, {""date"": ""20230811154511"", ""headline"": ""Johnson & Johnson (JNJ) Could Be a Great Choice"", ""summary"": ""Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.""}, {""date"": ""20230811155601"", ""headline"": ""The Low Budget Dividend Portfolio: August Update"", ""summary"": ""Discover insights into a personal dividend growth portfolio, including investment strategy, decision-making process, and lessons learned.""}, {""date"": ""20230811161500"", ""headline"": ""Pharma ETFs in Focus Post Q2 Earnings"", ""summary"": ""Second-quarter earnings beat ratio of 86.6% and revenue beat ratio of 84.9% for the healthcare sector are impressive.""}, {""date"": ""20230811163200"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.98% higher to $173.85 Friday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""20230811172403"", ""headline"": ""Janssen Pharmaceutical : Akeega Gets FDA Approval to Treat Prostate Cancer Patients"", ""summary"": ""By Stephen Nakrosis Janssen Pharmaceutical said Friday that the Food and Drug Administration approved Akeega as a treatment for a specific type of prostate cancer. Akeega, or niraparib and...""}, {""date"": ""20230812085300"", ""headline"": ""HD, MSFT, or JNJ: Which Blue Chip Stock Earns Wall Street\u2019s \u201cStrong Buy\u201d Rating?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230812090000"", ""headline"": ""How To Invest $100,000 Today: 5 Strategies Including The Near-Perfect Portfolio Strategy"", ""summary"": ""Discover five investment strategies, including the Near-Perfect Portfolio, aimed at capital preservation, sustainable income, and long-term growth. Click for more.""}, {""date"": ""20230812101500"", ""headline"": ""3 Unstoppable Dividend Stocks to Buy Right Now"", ""summary"": ""Income investors won't be happy with dividends that aren't sustainable.  Instead, they want to own dividend stocks that they can depend on.  Here's why they think AbbVie (NYSE: ABBV), Johnson & Johnson (NYSE: JNJ), and Novartis (NYSE: NVS) are unstoppable dividend stocks to buy right now.""}, {""date"": ""20230813010300"", ""headline"": ""Pharma under threat from bill to expand drug price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230813110400"", ""headline"": ""Inside COVID-19 vaccine makers: Hope vs hype"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
10,2023-08-13,171.22567749023438,2023-08-20,169.88619995117188,-0.00782287772894863,D1,"[{""date"": ""20230813010300"", ""headline"": ""Pharma under threat from bill to expand drug price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230813110400"", ""headline"": ""Inside COVID-19 vaccine makers: Hope vs hype"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230814021100"", ""headline"": ""Pfizer wins FDA nod for multiple myeloma therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230814024000"", ""headline"": ""7 Dividend Stocks to Buy as Investor Sentiment Falters"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230814025700"", ""headline"": ""IN BRIEF: Johnson & Johnson gets FDA approval for Akeega tablet"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230814033300"", ""headline"": ""Johnson & Johnson stock outperforms competitors despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230814050000"", ""headline"": ""Catalent accused of misleading investors in shareholder suit"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230814075500"", ""headline"": ""Notable open interest changes for August 14th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230814080400"", ""headline"": ""Johnson & Johnson wins FDA nod for new prostate cancer therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230814092100"", ""headline"": ""Meet the Only 2 Publicly Traded Companies With a Higher Credit Rating Than the U.S. Government"", ""summary"": ""In 1980, more than 60 public companies possessed the highly coveted AAA credit rating from Standard & Poor's. Today, only two remain.""}, {""date"": ""20230814094019"", ""headline"": ""Janssen Pharmaceutical - U.S. FDA Approves AKEEGA, the First-And-Only Dual Action Tablet for the Treatment of Patients with BRCA-Positive Metastatic Castration-Resistant Prostate Cancer"", ""summary"": ""HORSHAM - The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food & Drug Administration has approved AKEEGA , the first-and-only dual action tablet combining a...""}, {""date"": ""20230814094700"", ""headline"": ""Johnson & Johnson Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230814124100"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230814135026"", ""headline"": ""Tylenol Maker Kenvue\u2019s Share Swap Opens Door for\u00a0More Investors"", ""summary"": ""(Bloomberg) -- It\u2019s a decisive week for investors looking to get involved in Johnson & Johnson\u2019s record split-off of most of its $40 billion stake in Kenvue Inc., the maker of Tylenol and Listerine.Most Read from BloombergRussia Calls Emergency Key Rate Meeting as Ruble PlungesOutsider Milei Upends Argentina\u2019s Election With Primary WinBig Tech Takes the Lead in Thin Trading Session: Markets WrapChina Finance Giant\u2019s Missed Payments Alarm Regulators, MarketsZuckerberg Says \u2018Time to Move On\u2019 From""}, {""date"": ""20230814152200"", ""headline"": ""August MDA Breakout Stocks Week 33 - 2023: Facing The Largest Negative Signal Since February"", ""summary"": ""The Momentum Gauges and S&P 500 Gauges have turned negative. Read why this indicates a shift in market momentum and the need for caution in stock selection.""}, {""date"": ""20230814182700"", ""headline"": ""J&J Investors Need to Decide Soon if They Want Kenvue Stock"", ""summary"": ""The $40 billion exchange offer for shares of Kenvue expires Friday but brokerage firms want retail investors to make their instructions before then""}, {""date"": ""20230815014700"", ""headline"": ""This Is What Whales Are Betting On Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230815033300"", ""headline"": ""Johnson & Johnson stock falls Tuesday, still outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230815033400"", ""headline"": ""Nanobiotix announces expiration of HSR antitrust waiting period for NBTXR3 pact"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230815061505"", ""headline"": ""NeurAxis Earns $14 Price Target from GSCR Analyst Based on Potential to Revolutionize Pediatric FAP and IBS Treatments ($NRXS)"", ""summary"": ""NeurAxis stock is doing something many newly listed companies' shares aren't: trading higher. In fact, despite the bullish start by many in the past few months, short-selling investors have been...""}, {""date"": ""20230815074600"", ""headline"": ""See Which Of The Latest 13F Filers Holds Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230815075500"", ""headline"": ""Notable open interest changes for August 15th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230815084533"", ""headline"": ""Johnson & Johnson Stock: Outlook Amid Lawsuits"", ""summary"": ""There is renewed uncertainty in Johnson & Johnson's talc lawsuits settlement and its potential impact on JNJ stock. Check out the ramifications of recent events.""}, {""date"": ""20230815093204"", ""headline"": ""Thinking about trading options or stock in Advanced Micro Devices, Nuvei, Applied Optoelectronics, Johnson & Johnson, or Rigetti Computing?"", ""summary"": ""NEW YORK, Aug. 15, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AMD, NVEI, AAOI, JNJ, and RGTI. ...""}, {""date"": ""20230815095800"", ""headline"": ""Buffett\u2019s Builder Bet Beats the Curve. Why It Was Such a Bold Play."", ""summary"": ""China Cuts key rates as economy sours, Intel expands deal aimed at speeding chip manufacturing, and other news to start your day.""}, {""date"": ""20230815100600"", ""headline"": ""Citi opens 'positive catalyst watch' on Kenvue into split-off close"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230815102300"", ""headline"": ""Citi sees Kenvue stock outperforming after exchange offer closes"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230815110000"", ""headline"": ""Get In on This Skin Disease Drug Before Big Pharma Does"", ""summary"": ""Biotech MoonLake Immunotherapeutics is developing a drug that has shown great promise for inflammatory skin conditions.""}, {""date"": ""20230815113530"", ""headline"": ""15 Worst Performing Blue Chip Stocks in 2023"", ""summary"": ""In this piece, we will take a look at the 15 worst performing blue chip stocks in 2023. If you want to skip a background of what\u2019s been going on in this lucrative sector this year, then head on over to 5 Worst Performing Blue Chip Stocks in 2023. In traditional poker, a blue chip [\u2026]""}, {""date"": ""20230815121112"", ""headline"": ""Flames, Not Smoke : LTL Management LLC's Second Chapter 11 Filing Dismissed By The Bankruptcy Court For The District Of New Jersey For Lack Of Imminent And Immediate Financial Distress"", ""summary"": ""On July 28, 2023, Judge Michael Kaplan of the Bankruptcy Court for the District of New Jersey issued an opinion granting motions to dismiss LTL Management LLC's second chapter 11 case, finding that...""}, {""date"": ""20230815122000"", ""headline"": ""J&J\u2019s Kenvue Spinoff  Is Almost Here. What to Do Now."", ""summary"": ""The $40 billion exchange offer for shares of Kenvue expires Friday, but brokerage firms want retail investors to make their instructions before then.""}, {""date"": ""20230815122600"", ""headline"": ""What investors need to know about Johnson & Johnson, Kenvue exchange offer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230815133800"", ""headline"": ""Boston Scientific's (BSX) POLARx System Gets FDA Approval"", ""summary"": ""Boston Scientific's (BSX) POLARx enables doctors to expand and modify the new POLARx catheter to match a patient's unique anatomy during an ablation treatment.""}, {""date"": ""20230815153000"", ""headline"": ""Hims & Hers: Niche Telehealth Player With Huge Potential"", ""summary"": ""Hims & Hers Health beat expectations with strong Q2 results and raised revenue guidance. Find out why I see great potential in HIMS stock despite issues.""}, {""date"": ""20230815200106"", ""headline"": ""Johnson & Johnson (JNJ) Presents at UBS MedTech, Tools and Genomics Summit Conference (Transcript)"", ""summary"": ""Johnson & Johnson (NYSE:NYSE:JNJ) UBS MedTech, Tools and Genomics Summit Conference Call August 15, 2023 2:00 PM ETCompany ParticipantsCeline Martin - Group ChairmanJasmina Brooks \u00e2\u0080\u0093...""}, {""date"": ""20230815213500"", ""headline"": ""J&J\u2019s Kenvue Deal Could Be Too Popular. What Happens if It Is."", ""summary"": ""If demand is too high, J&J holders who participate will be able to swap only part of their investments for Kenvue""}, {""date"": ""20230816022400"", ""headline"": ""Federal Court Rules To Prohibit Access To Abortion Pill: Supreme Court To Weigh In"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230816031600"", ""headline"": ""The 3 Most Undervalued Retirement Stocks to Buy Now: August 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230816033300"", ""headline"": ""Johnson & Johnson stock falls Wednesday, still outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230816055500"", ""headline"": ""Johnson & Johnson says final exchange ratio 8.0324 in split-off of Kenvue"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230816075500"", ""headline"": ""Notable open interest changes for August 16th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230816085200"", ""headline"": ""Live Off The Fat Of The Land With These Two Stocks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230816095000"", ""headline"": ""A New Stock Is About to Join the S&P 500. Does History Show That Buying It Now Could Pay Off?"", ""summary"": ""Want to know one of the great things about investing in an S&P 500 index fund?  A new stock is about to join the S&P 500.  Johnson & Johnson (NYSE: JNJ) announced in November 2021 that it planned to spin off its consumer health unit.""}, {""date"": ""20230816100000"", ""headline"": ""Interesting JNJ Put And Call Options For November 17th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230816114500"", ""headline"": ""Cantor biotech/biopharma analysts to hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230816125228"", ""headline"": ""Kenvue Split-Off: Still Undecided? 3 (And A Half) Aspects To Consider"", ""summary"": ""I explain my reasons for not participating in Johnson & Johnson's (JNJ) Kenvue (KVUE) stake split-off despite attractive incentives. Click here to read more.""}, {""date"": ""20230816130011"", ""headline"": ""Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.""}, {""date"": ""20230816151900"", ""headline"": ""Nearing Retirement? These Stocks Are as Safe as They Come"", ""summary"": ""Most people nearing retirement can't afford the risk of owning stocks that could decline significantly in the face of an economic downturn and never recover.  Johnson & Johnson\u00a0(NYSE: JNJ) and\u00a0Coca-Cola\u00a0(NYSE: KO) are two of the safest stocks in the world.  Johnson & Johnson is one of the safest companies out there.""}, {""date"": ""20230816225200"", ""headline"": ""Johnson & Johnson Announces Final Exchange Ratio of 8.0324 in Split-Off of Kenvue Inc."", ""summary"": ""NEW BRUNSWICK, N.J., August 16, 2023--Johnson & Johnson (NYSE: JNJ) today announced the final exchange ratio for its previously announced split-off exchange offer to Johnson & Johnson shareholders to exchange their shares of Johnson & Johnson for shares of common stock of Kenvue Inc. (NYSE: KVUE) (\""Kenvue\"") currently held by Johnson & Johnson.""}, {""date"": ""20230817014000"", ""headline"": ""Johnson & Johnson finalizes an exchange ratio of 8.0324 in Kenvue split-off"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230817014100"", ""headline"": ""This Company\u2019s 10-Year Yield Beats Out The Average Bond"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230817033400"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230817053600"", ""headline"": ""Thoughts For Thursday: Slipsliding, Sideways"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230817054400"", ""headline"": ""Wall Street Breakfast Podcast: More Rate Hikes Ahead?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230817073000"", ""headline"": ""Johnson & Johnson Vs. Kenvue: The Better Dividend Aristocrat Might Shock You"", ""summary"": ""Kenvue Inc., the largest OTC drug company, may become a dividend king, but is it better than Johnson & Johnson? Click here for our comparison of KVUE and JNJ stock.""}, {""date"": ""20230817075500"", ""headline"": ""Notable open interest changes for August 17th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230817082900"", ""headline"": ""Beyond The Hustle: Embracing Ancient Chinese Wisdom To Combat Modern Day Burnout"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230817084500"", ""headline"": ""Cantor Fitzgerald biotech analyst to hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230817090600"", ""headline"": ""Opinion: The Fed Is Losing the Battle Against Inflation, and There's No Easy Fix"", ""summary"": ""Wall Street may be forced to \""take its medicine\"" to resolve stubbornly high core inflation.""}, {""date"": ""20230817092200"", ""headline"": ""Thoughts For Thursday: Slipsliding Sideways"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230817120400"", ""headline"": ""Most Active Equity Options For Midday - Thursday, Aug. 17"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230817132100"", ""headline"": ""J&J Holders to Get 8 Kenvue Shares for Each J&J Share in Exchange Offer"", ""summary"": ""Johnson & Johnson  will issue just over eight shares of  Kenvue  stock for each of its own shares in what is likely to be an oversubscribed exchange offer totaling nearly $40 billion.  The pricing period for the exchange offer ran from Monday through Wednesday.  Johnson & Johnson (ticker: JNJ) said late Wednesday that the exchange ratio has been set at roughly 8.03 shares of Kenvue (KVUE) for each of its own shares.""}, {""date"": ""20230817133327"", ""headline"": ""America\u2019s courts weigh in on how firms resolve liability claims"", ""summary"": ""The Supreme Court is reviewing Purdue Pharma\u2019s bankruptcy plan""}, {""date"": ""20230817143927"", ""headline"": ""Jim Cramer gives his view on what investors should do if they own J&J stock"", ""summary"": ""Jim Cramer talks about the Johnson & Johnson exchange offer for shares of its split off consumer unit Kenvue. In the CNBC Investing Club's Monthly Meeting, Jim gave his view of what do to about J&J.""}, {""date"": ""20230817152611"", ""headline"": ""4 moments from Jim Cramer's August Monthly Meeting of the CNBC Investing Club"", ""summary"": ""Here's a sneak peek.""}, {""date"": ""20230817154300"", ""headline"": ""AbbVie (ABBV) Gets EU Approval for Migraine Prevention Drug"", ""summary"": ""Following the approval, AbbVie's (ABBV) Aquipta is the first and the only oral CGRP receptor antagonist approved in the EU to prevent episodic and chronic migraines.""}, {""date"": ""20230817154700"", ""headline"": ""Here's Why it is a Good Time to Buy J&J's (JNJ) Stock Now"", ""summary"": ""J&J's (JNJ) Pharma sales are being driven by key drugs like Darzalex and new products. J&J's Pharma and MedTech units are likely to continue to drive sales growth in 2023.""}, {""date"": ""20230818033300"", ""headline"": ""Johnson & Johnson stock underperforms Friday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230818042800"", ""headline"": ""Tiny Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230818074800"", ""headline"": ""Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230818075500"", ""headline"": ""Notable open interest changes for August 18th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230818085900"", ""headline"": ""Dow down nearly 100 points on losses for shares of Johnson & Johnson, Microsoft"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230818110100"", ""headline"": ""Europe Approves Reduced Dosing For Johnson & Johnson's Cell Therapy For Multiple Myeloma"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230818122700"", ""headline"": ""IN BRIEF: EU approves reduced dosing frequency for J&J's Tecvayli"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230818130945"", ""headline"": ""Viatris Emerges As Challenger In Lucrative Anti-Obesity Drugs Market"", ""summary"": ""Viatris surpassed expectations in Q2 2023 with increased revenue and R&D spending. Click here to find out why VTRS stock is rated as a buy.""}, {""date"": ""20230818165600"", ""headline"": ""Tylenol Litigation Could Be a Headache for Kenvue"", ""summary"": ""The Johnson & Johnson spinoff faces suits alleging the painkiller can cause neurological disorders. Kenvue says Tylenol is safe.""}, {""date"": ""20230818171100"", ""headline"": ""J&J\u2019s Swap Offer for Kenvue Is About to Expire. Proration Figure Will Be Key."", ""summary"": ""Wall Street is betting that the proration will be about 30%, meaning that participating J&J holders will get 30% of their stock converted into Kenvue.""}, {""date"": ""20230818171752"", ""headline"": ""Medical device at heart of $16.6B J&J acquisition recalled"", ""summary"": ""Just a few months after Johnson & Johnson Inc. acquired Danvers medical device maker Abiomed Inc. for a whopping $16.6 billion, the device at the heart of the acquisition \u2014 a minimally invasive heart pump \u2014 is being partially recalled.""}, {""date"": ""20230818173227"", ""headline"": ""Kenvue is a Timely Stock"", ""summary"": ""Kenvue is seperating from J&J giving shareholders a short term opportunity""}, {""date"": ""20230818201114"", ""headline"": ""AARP urges courts to keep drug pricing talks on track"", ""summary"": ""AARP is one of the few groups so far to have filed an amicus brief on supporting of the U.S. Department of Health and Human Services. The suit from the U.S. Chamber of Commerce and several pharmaceutical companies, including Merck (MRK) and Johnson & Johnson (JNJ), is asking the courts to delay the implementation of a new law that would let Medicare negotiate the prices of certain drugs. Yahoo Finance Health Care Reporter Anjalee Khemlani reports the details.""}, {""date"": ""20230819034000"", ""headline"": ""BUZZ Investing: A Shift In Market Leadership"", ""summary"": ""7 tech stocks accounted for almost 75% of the S&P 500's year-to-date gains, marking the technical start of a new bull market, even as investors raised concerns about narrow market breadth.""}, {""date"": ""20230819090000"", ""headline"": ""10 Dividend Growth Stocks For August 2023"", ""summary"": ""The article presents the ten highest-quality Dividend Radar stocks for further research and possible investment. Click here to read more.""}, {""date"": ""20230820035500"", ""headline"": ""The 7 Most Undervalued Dividend Stocks to Buy Now: August 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230820092439"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of August 20"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Click here to read the August 20 weekly update.""}, {""date"": ""20230820101500"", ""headline"": ""3 Stocks I Will \""Never\"" Sell"", ""summary"": ""For me, there are at least three stocks in my portfolio I don't anticipate getting rid of anytime soon: Johnson & Johnson (NYSE: JNJ), Meta Platforms (NASDAQ: META), and Amazon (NASDAQ: AMZN).  Johnson & Johnson needs no introduction -- it has been a leading healthcare company for a long time.  Second, we can point to Johnson & Johnson's solid fundamentals.""}, {""date"": ""20230820121847"", ""headline"": ""Should Income Investors Look At Johnson & Johnson (NYSE:JNJ) Before Its Ex-Dividend?"", ""summary"": ""Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Johnson...""}, {""date"": ""20230820180321"", ""headline"": ""Dow falls more than 200 points to start the week as rates march higher: Live updates"", ""summary"": ""Traders weighed a rise in yields to multiyear highs on Monday, fueling losses for the Dow.""}, {""date"": ""20230820183521"", ""headline"": ""Warren Buffett\u2019s 11 Growth Stock Picks"", ""summary"": ""In this piece, we will take a look at Warren Buffett\u2019s growth stock picks. If you want to skip our introduction to the investor and growth investing, then head on to Warren Buffett\u2019s 5 Growth Stock Picks. Warren Buffett is one of the most successful investors of our time. His investment strategy depends on identifying [\u2026]""}, {""date"": ""20230820202351"", ""headline"": ""10 Stocks ChatGPT Said Will Make Me Rich in 10 Years"", ""summary"": ""In this article, we will be taking a look at the 10 stocks ChatGPT said will make me rich in 10 years. To skip our detailed analysis of generative AI and its application in the field of investing, you can go directly to see the 5 Stocks ChatGPT Said Will Make Me Rich in 10 Years. [\u2026]""}]",{}
11,2023-08-20,169.88619995117188,2023-08-27,164.92922973632812,-0.029178180548322774,D3,"[{""date"": ""20230820035500"", ""headline"": ""The 7 Most Undervalued Dividend Stocks to Buy Now: August 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230820092439"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of August 20"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Click here to read the August 20 weekly update.""}, {""date"": ""20230820101500"", ""headline"": ""3 Stocks I Will \""Never\"" Sell"", ""summary"": ""For me, there are at least three stocks in my portfolio I don't anticipate getting rid of anytime soon: Johnson & Johnson (NYSE: JNJ), Meta Platforms (NASDAQ: META), and Amazon (NASDAQ: AMZN).  Johnson & Johnson needs no introduction -- it has been a leading healthcare company for a long time.  Second, we can point to Johnson & Johnson's solid fundamentals.""}, {""date"": ""20230820121847"", ""headline"": ""Should Income Investors Look At Johnson & Johnson (NYSE:JNJ) Before Its Ex-Dividend?"", ""summary"": ""Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Johnson...""}, {""date"": ""20230820180321"", ""headline"": ""Dow falls more than 200 points to start the week as rates march higher: Live updates"", ""summary"": ""Traders weighed a rise in yields to multiyear highs on Monday, fueling losses for the Dow.""}, {""date"": ""20230820183521"", ""headline"": ""Warren Buffett\u2019s 11 Growth Stock Picks"", ""summary"": ""In this piece, we will take a look at Warren Buffett\u2019s growth stock picks. If you want to skip our introduction to the investor and growth investing, then head on to Warren Buffett\u2019s 5 Growth Stock Picks. Warren Buffett is one of the most successful investors of our time. His investment strategy depends on identifying [\u2026]""}, {""date"": ""20230820202351"", ""headline"": ""10 Stocks ChatGPT Said Will Make Me Rich in 10 Years"", ""summary"": ""In this article, we will be taking a look at the 10 stocks ChatGPT said will make me rich in 10 years. To skip our detailed analysis of generative AI and its application in the field of investing, you can go directly to see the 5 Stocks ChatGPT Said Will Make Me Rich in 10 Years. [\u2026]""}, {""date"": ""20230821012200"", ""headline"": ""Johnson & Johnson Investors Pounce On Oversubscribed Kenvue Deal, How You Can Still Earn $500 A Month"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821013400"", ""headline"": ""Kenvue rises on exchange offer oversubscription; JNJ falls"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821022700"", ""headline"": ""Lawsuits unlikely to hinder Medicare drug price negotiations \u2013 UBS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821030200"", ""headline"": ""Lilly's market cap soared 36% in Q2, eclipsing J&J, Merck, Novo Nordisk"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821030500"", ""headline"": ""These Are the ONLY 7 Warren Buffett Stocks to Consider in August 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821033400"", ""headline"": ""Johnson & Johnson stock falls Monday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821033700"", ""headline"": ""Nasdaq Snaps Losing Streak; Dow Dragged Red"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821051700"", ""headline"": ""Kenvue to join S&P 500, replacing Advance Auto Parts"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821052400"", ""headline"": ""Johnson & Johnson reports preliminary results of Kenvue exchange offer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821055100"", ""headline"": ""Johnson & Johnson, Kenvue share exchange offer oversubscribed"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821062024"", ""headline"": ""Tracking Ray Dalio's Bridgewater Associates 13F Portfolio - Q2 2023 Update"", ""summary"": ""Bridgewater Associates' 13F portfolio value decreased by approximately 1% in Q2 2023. Click here to read the full Q2 2023 update.""}, {""date"": ""20230821063900"", ""headline"": ""Titan Medical enters license agreement with Auris Health"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821070100"", ""headline"": ""\u2018The sharks are still there.\u2019 Stock market\u2019s decline is just beginning, this top fund manager says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821073600"", ""headline"": ""Will The Bears Deliver The Knockout? Prepare For The Upcoming Week With Mando Trading!"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821074900"", ""headline"": ""Titan Medical Signs Licensing Agreement with Auris Health"", ""summary"": ""By Robb M. Stewart Canadian medical technology company Titan Medical entered a licensing agreement with Johnson &amp; Johnson's Auris Health business...""}, {""date"": ""20230821075400"", ""headline"": ""Fly Intel: Pre-market Movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821075500"", ""headline"": ""Notable open interest changes for August 21st"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821082300"", ""headline"": ""4 stocks to watch on Monday: Kenvue, VMware and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821091700"", ""headline"": ""Dow's 86-point fall led by losses for shares of Johnson & Johnson, Intel"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821093700"", ""headline"": ""J&J to accept 191.0 million shares as part of Kenvue exchange offer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821094600"", ""headline"": ""J&J says Kenvue tender offer was oversubscribed, expects 23.8% of tendered shares will be exchanged"", ""summary"": ""Johnson & Johnson said Monday that 802.7 million shares of its common stock were validly tendered and not validly withdrawn in a Kenvue Inc. tender offer...""}, {""date"": ""20230821100024"", ""headline"": ""European Commission Approves Reduced Dosing Frequency for Janssen's Bispecific Antibody TECVAYLI"", ""summary"": ""Belgium - The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the European Commission has granted the approval of a Type II variation application for TECVAYLI , providing...""}, {""date"": ""20230821101900"", ""headline"": ""Johnson & Johnson, Intel share losses contribute to Dow's nearly 200-point drop"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821102000"", ""headline"": ""Johnson & Johnson Announces Preliminary Results of Kenvue Inc. Exchange Offer"", ""summary"": ""NEW BRUNSWICK, N.J., August 21, 2023--Johnson & Johnson (NYSE: JNJ) today announced that, based on preliminary results, its previously announced offer to its shareholders to exchange their shares of Johnson & Johnson common stock for shares of Kenvue Inc. (NYSE: KVUE) (\""Kenvue\"") common stock owned by Johnson & Johnson was oversubscribed. The exchange offer expired at 12:00 midnight, New York City time, at the end of the day on August 18, 2023. Under the terms of the exchange offer, 8.0324 shares""}, {""date"": ""20230821104629"", ""headline"": ""J&J to hold 9.5% stake in Kenvue after share exchange offer"", ""summary"": ""Shares of the consumer health company rose 1.4% in premarket trading.  \u200dJ&J launched the exchange offer last month under which its stockholders could opt for shares of the former consumer health unit related to the spinoff.""}, {""date"": ""20230821105000"", ""headline"": ""Fed\u2019s Powell Will Walk an Economic Tightrope. Why Markets May Not Like It."", ""summary"": ""Retailers\u2019 earnings will show how eagerly consumers are spending, J&J spinoff Kenvue faces lawsuits over Tylenol ingredient, and other news to start your day.""}, {""date"": ""20230821110700"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821111200"", ""headline"": ""Dow Reverses Gains, Looks To Extend Slump"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821113600"", ""headline"": ""Video: Dow Movers: JNJ, CRM"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821115018"", ""headline"": ""J&J says it will retain 9.5% stake in Kenvue carve-out after exchange offer"", ""summary"": ""Investing.com -- Shares in Johnson&Johnson (NYSE:JNJ) slipped on Monday after the American healthcare giant said it will retain about a 9.5% stake in its consumer health carve-out Kenvue (NYSE:KVUE) following a share exchange offer.""}, {""date"": ""20230821115700"", ""headline"": ""Most Active Equity Options For Midday - Monday, Aug. 21"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821121000"", ""headline"": ""Johnson & Johnson, Nike share losses lead Dow's 100-point drop"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821122000"", ""headline"": ""Wall Street Lunch: Big Kenvue Demand"", ""summary"": ""J&J share swap offer for Kenvue is oversubscribed. Nvidia leads chip stocks up again as its earnings approach. See what J.P. Morgan\u00e2\u0080\u0099s AI sentiment model says. Listen now.""}, {""date"": ""20230821124300"", ""headline"": ""KVUE Stock Alert: Johnson & Johnson Reveals Results of Kenvue Exchange Offer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821135100"", ""headline"": ""5 Large Drug Stocks to Watch as New Drug Approvals & M&A Gain Pace"", ""summary"": ""Drug, biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), J&J (JNJ), Novo Nordisk (NVO), Novartis (NVS) and AstraZeneca (AZN) are worth retaining in your portfolio.""}, {""date"": ""20230821143100"", ""headline"": ""J&J\u2019s Kenvue Exchange Offer Was Too Popular. What Happens to Shares Now."", ""summary"": ""Johnson & Johnson investors who elected to participate in the swap will see just 23.8% of their shares converted into Kenvue stock""}, {""date"": ""20230821144321"", ""headline"": ""Tupperware, Kenvue, Earthstone Energy: Market Movers"", ""summary"": ""Tupperware Brands (TUP), a new addition to the meme stock roster, sees its shares surge after Federated Hermes (FHI) raises its stick in the company. Kenvue (KVUE) stock trends higher over demand on parent company Johnson & Johnson's (JNJ) stock swap it offered shareholders. Permian Resources (PR) is set to buy Earthstone Energy (ESTE) in a $4.5 billion deal scheduled to close by the end of 2023. Yahoo Finance Live host Julie Hyman highlights several of the top trending stocks following this morning's opening bell.""}, {""date"": ""20230821144940"", ""headline"": ""11 Most Profitable Biotech Stocks Today"", ""summary"": ""In this piece, we will take a look at the 11 most profitable biotechnology stocks to buy today. If you want to skip our introduction to the biotechnology industry and want to take a look at the top five stocks in this list, then head on over to 5 Most Profitable Biotech Stocks Today. Biotechnology [\u2026]""}, {""date"": ""20230821145700"", ""headline"": ""Momentum Mondays: Stocks Setting up for an Epic Dip Buying Opportunity?"", ""summary"": ""Want to start the week ahead of the pack? Check out Momentum Mondays!""}, {""date"": ""20230821153710"", ""headline"": ""Is Johnson & Johnson's Stock Fairly Valued? A Comprehensive Analysis"", ""summary"": ""A deep dive into the intrinsic value, financial strength, profitability, and growth of Johnson & Johnson (JNJ)""}, {""date"": ""20230821165832"", ""headline"": ""Medicare drug price negotiations unlikely to be derailed by lawsuits: UBS"", ""summary"": ""UBS believes there is little chance the lawsuits brought on by pharma companies will delay Medicare pricing negotiations.""}, {""date"": ""20230821174100"", ""headline"": ""Merck's (MRK) Welireg Meets Renal Cell Carcinoma Study Goals"", ""summary"": ""Based on interim data from a late-stage study, Merck's (MRK) Welireg achieves statistically significant improvements in one of the study's dual endpoints of progression-free survival.""}, {""date"": ""20230821175100"", ""headline"": ""J&J spinoff Kenvue to replace Advance Auto Parts on the S&P 500"", ""summary"": ""Kenvue Inc. the maker of Tylenol and Benadryl, will replace auto-parts retailer Advance Auto Parts Inc. on the S&P 500 Index S&P Dow Jones Indices said on...""}, {""date"": ""20230821201021"", ""headline"": ""Legend Biotech: Working On Supply Issues"", ""summary"": ""Carvykti's successful manufacturing ramp-up and clinical de-risking in earlier lines of multiple myeloma put Legend Biotech in a strong position. Learn more on LEGN stock here.""}, {""date"": ""20230821201801"", ""headline"": ""Moderna, Pfizer stocks rise amid new Covid variants"", ""summary"": ""Covid vaccine maker stocks including Moderna (MRNA), Pfizer (PFE), and BioNTech (BNTX), rose as concerns grow about new Covid variants.""}, {""date"": ""20230821220000"", ""headline"": ""Kenvue Set to Join S&P 500; Advance Auto Parts to Join S&P SmallCap 600"", ""summary"": ""Kenvue Inc. (NYSE: KVUE) will replace Advance Auto Parts Inc. (NYSE: AAP) in the S&P 500, and Advance Auto Parts will replace Emergent BioSolutions Inc. (NYSE: EBS) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, August 25. As previously announced on August 9, the addition of Kenvue is the result of S&P 500 and S&P 100 constituent Johnson & Johnson (NYSE: JNJ) offering to exchange the shares of Kenvue held for shares of Johnson & Johnson in a split-off exchange offer""}, {""date"": ""20230821223400"", ""headline"": ""Kenvue Will Join the S&P 500 Friday. It Could Boost the Stock."", ""summary"": ""The action could lift shares of Kenvue, but Johnson & Johnson stock could come under pressure due to index selling.""}, {""date"": ""20230821225632"", ""headline"": ""20 Cities With The Most Hispanics"", ""summary"": ""In this article, we look at 20 cities with the most Hispanics in the United States. You can skip our detailed analysis on the economic contributions of the Hispanic or Latino community and head over directly to the 5 Cities with the Most Hispanics. Hispanics are Americans who trace their roots to Spain, Mexico, Latin [\u2026]""}, {""date"": ""20230822010400"", ""headline"": ""Regeneron awarded $326M from U.S. for next-generation COVID antibody"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230822015400"", ""headline"": ""Regeneron, J&J receive millions to develop new COVID therapies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230822020300"", ""headline"": ""Where Johnson & Johnson Stands With Analysts"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230822033300"", ""headline"": ""Did Apple Shower Warren Buffett With $645M This Year? Yes, They Did: The Power Of Dividends"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230822043629"", ""headline"": ""Tracking Jeremy Grantham's GMO Capital Portfolio - Q2 2023 Update"", ""summary"": ""Jeremy Grantham's 13F portfolio value increased by 10% this quarter, reaching $21.60B. Check out GMO Capital's holdings and trades for Q2 2023.""}, {""date"": ""20230822055407"", ""headline"": ""NeurAxis Is Changing The Pediatric IBS And FAP Treatment Landscape To Drug-Free ($NRXS)"", ""summary"": ""NeurAxis is doing something other companies can't or won't do: provide a drug-free way to treat debilitating pediatric conditions, including Irritable Bowel Syndrome and Functional Abdominal Pain ....""}, {""date"": ""20230822090000"", ""headline"": ""Johnson & Johnson announces European approval of Talvey in myeloma"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230822102501"", ""headline"": ""Johnson & Johnson to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference"", ""summary"": ""Johnson & Johnson will participate in the Morgan Stanley 21st Annual Global Healthcare Conference at the Sheraton New York Hotel in New York on Wednesday, September 13th. Joaquin Duato, Chairman of...""}, {""date"": ""20230822111833"", ""headline"": ""5 Things to Know Before Markets Open"", ""summary"": ""Microsoft submitted a new proposal to U.K. regulators for its stalled acquisition of Activision Blizzard, and Zoom shares rose after the video conferencing provider beat earnings projections on strength in its enterprise business. Here\u2019s what investors need to know today.""}, {""date"": ""20230822113800"", ""headline"": ""Zacks Industry Outlook Highlights Eli Lilly, J&J, Novo Nordisk, Novartis and AstraZeneca"", ""summary"": ""Eli Lilly, J&J, Novo Nordisk, Novartis and AstraZeneca are part of the Zacks Industry Outlook article""}, {""date"": ""20230822120400"", ""headline"": ""5 Blue-Chip Stocks for a Stable Portfolio Amid Volatility"", ""summary"": ""We have narrowed our search to five blue-chip such stocks with strong growth potential for the rest of 2023. These are: WMT, JPM, JNJ, CAT, MCD.""}, {""date"": ""20230822142600"", ""headline"": ""J&J (JNJ) to Keep 9.5% Stake in Kenvue Post Share Exchange"", ""summary"": ""J&J's (JNJ) offer to exchange its shares for the shares of Kenvue, its recently-separated consumer healthcare business, gets oversubscribed. The exchange ratio is 8.0324 for every share of J&J.""}, {""date"": ""20230822143241"", ""headline"": ""Cantor Fitzgerald Reiterates Johnson & Johnson (JNJ) Overweight Recommendation"", ""summary"": """"}, {""date"": ""20230822163200"", ""headline"": ""Johnson & Johnson stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slid 0.79% to $166.02 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""20230822172458"", ""headline"": ""Health care stocks: What the market technicals show"", ""summary"": ""Why are UnitedHealth (UNH), Merck & Company (MRK), Johnson & Johnson (JNJ), and Amgen (AMGN), this strategist's top health care stock picks? Freedom Capital Markets Chief Global Strategist Jay Woods joins Yahoo Finance Live to discuss and break down the market technicals of health care stocks.\u00a0 Woods says he focuses on those four health care stocks, \""because they're in Dow Jones Industrial Average. If you're looking for reasons why the Dow can rally, I give you health care.\""\u00a0 The Health Care Select Sector (XLV) \""continues to make higher lows, as it goes along,\"" Woods notes. \""If you're a little skittish on the overall market, health care is a safety sector,\"" Woods says.""}, {""date"": ""20230822192600"", ""headline"": ""J&J\u2019s Exchange Offer for Kenvue Is Tricky From a Tax Standpoint. What to Do."", ""summary"": ""J&J holders who participated in the exchange offer can choose which J shares they want to use for their cost basis in Kenvue.""}, {""date"": ""20230822195055"", ""headline"": ""12 Best Cheap Dividend Stocks To Buy Now"", ""summary"": ""In this article, we discuss 12 best cheap dividend stocks to buy now. You can skip our detailed analysis of dividend stocks and their performance, and go directly to read 5 Best Cheap Dividend Stocks To Buy Now. Investing in cheap stocks is like finding a great deal at a store \u2013 it\u2019s about picking [\u2026]""}, {""date"": ""20230823021500"", ""headline"": ""J&J\u2019s Janssen said to be closing much of Dutch vaccine division"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230823032600"", ""headline"": ""Cantor Fitzgerald Reaffirms Their Buy Rating on Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230823052200"", ""headline"": ""Johnson & Johnson reports final results from Kenvue exchange offer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230823052700"", ""headline"": ""Kenvue becomes fully independent company"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230823060700"", ""headline"": ""Johnson & Johnson completes Kenvue separation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230823064100"", ""headline"": ""Kenvue becomes \u2018fully independent\u2019 after final separation from J&J"", ""summary"": ""Kenvue Inc. kicks off life as a fully independent public company Wednesday after completing its separation from Johnson & Johnson the company said in a...""}, {""date"": ""20230823064800"", ""headline"": ""J&J Accepts 191M Shares in Exchange for 1.53B Kenvue Shares, Finalizing Separation"", ""summary"": ""By Adriano Marchese Johnson &amp; Johnson will exchange 191 million of its stock in exchange for 1.53 billion shares of Kenvue, the operator of brands such...""}, {""date"": ""20230823071200"", ""headline"": ""Megacap stocks setting up for potential breakout - Wells Fargo"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230823100000"", ""headline"": ""J&J-backed startup raises $150M in VC for neuroscience drugs"", ""summary"": ""Less than six months after it made its public debut, a new startup working on precision medicines for brain disorders has bagged another $150 million.""}, {""date"": ""20230823102000"", ""headline"": ""Johnson & Johnson Announces Final Results of Exchange Offer and Finalizes Separation of Kenvue Inc."", ""summary"": ""NEW BRUNSWICK, N.J., August 23, 2023--Johnson & Johnson (NYSE: JNJ) today announced the final results of its previously announced offer to its shareholders to exchange their shares of Johnson & Johnson common stock for shares of Kenvue Inc. (NYSE: KVUE) (\""Kenvue\"") common stock owned by Johnson & Johnson. The exchange offer expired at 12:00 midnight, New York City time, at the end of the day on August 18, 2023.""}, {""date"": ""20230823103400"", ""headline"": ""Check Out What Whales Are Doing With JNJ"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230823110942"", ""headline"": ""European Commission Approves TALVEY, Janssen's Novel Bispecific Therapy for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma"", ""summary"": ""Belgium - The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the European Commission has granted conditional marketing authorisation of TALVEY as monotherapy for the...""}, {""date"": ""20230823125000"", ""headline"": ""J&J Makes It Official: Kenvue Stock Swap Was a Huge Hit With Shareholders"", ""summary"": ""Johnson & Johnson investors were able to exchange less than a quarter of their shares for the consumer split off. The company will update financial guidance next week""}, {""date"": ""20230823160807"", ""headline"": ""J&J's Janssen to close part of its vaccine division"", ""summary"": ""Johnson & Johnson's Dutch business Janssen, which helped to develop the single-dose COVID-19 vaccine, will close almost its entire vaccine division, the company said on Wednesday, confirming Dutch media reports.  Johnson & Johnson confirmed in an emailed response that it is exiting some of its vaccine research and development, which it said it had disclosed in its 2023 second-quarter results.  Dutch daily De Telegraaf reported that 2,500 people worked at Janssen, a quarter of which were in the section specialising in infectious diseases and vaccines.""}, {""date"": ""20230823161039"", ""headline"": ""J&J's Janssen to close part of its vaccine division -Telegraaf"", ""summary"": ""AMSTERDAM (Reuters) -Johnson & Johnson's Janssen division, which helped to develop its single-dose COVID-19 vaccine, will close much of its vaccine research and development operations in the Netherlands, newspaper De Telegraaf reported.  In an emailed response on Wednesday, Johnson & Johnson confirmed plans to exit some of its vaccine research and development programmes, which it said it had initially disclosed in its 2023 second-quarter results.  \""We also continually assess our global footprint, including in the Netherlands, to ensure it meets our current and evolving scientific needs,\"" Johnson & Johnson said, adding that its facility in Leiden, Netherlands was an \""important site\"".""}, {""date"": ""20230823163054"", ""headline"": ""UPDATE 2-J&J's Janssen to close part of its vaccine division -Telegraaf"", ""summary"": ""Johnson & Johnson's Janssen division, which helped to develop its single-dose COVID-19 vaccine, will close much of its vaccine research and development operations in the Netherlands, newspaper De Telegraaf reported.  In an emailed response on Wednesday, Johnson & Johnson confirmed plans to exit some of its vaccine research and development programmes, which it said it had initially disclosed in its 2023 second-quarter results.  \""We also continually assess our global footprint, including in the Netherlands, to ensure it meets our current and evolving scientific needs,\"" Johnson & Johnson said, adding that its facility in Leiden, Netherlands was an \""important site\"".""}, {""date"": ""20230823163200"", ""headline"": ""Johnson & Johnson stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson sank 0.90% to $164.53 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""20230824012500"", ""headline"": ""Bridgewater's Approach: Stocks for an Upcoming Recession"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230824022026"", ""headline"": ""Bristol-Myers Squibb: Top Defensive Pick During Recessions With A Value Proposition"", ""summary"": ""Discover why Bristol-Myers is a strong investment, undervalued with a promising dividend yield. After a slow start, expect a bullish turnaround.""}, {""date"": ""20230824054800"", ""headline"": ""Thanks For The Bounce, Nvidia!"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230824084600"", ""headline"": ""Drugs picked for Medicare price negotiations to be announced on Tuesday \u2013 Politico"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230824085140"", ""headline"": ""Johnson & Johnson Announces Final Results of Exchange Offer and Finalizes Separation of Kenvue Inc"", ""summary"": ""Johnson & Johnson today announced the final results of its previously announced offer to its shareholders to exchange their shares of Johnson & Johnson common stock for shares of Kenvue Inc. ...""}, {""date"": ""20230824091900"", ""headline"": ""Johnson & Johnson goes ex-dividend tomorrow"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230824095500"", ""headline"": ""Goldman Sachs, Johnson & Johnson share gains contribute to Dow's nearly 125-point jump"", ""summary"": ""The Dow Jones Industrial Average is trading up Thursday morning with shares of Goldman Sachs and Johnson & Johnson delivering strong returns for the index....""}, {""date"": ""20230824100000"", ""headline"": ""Galapagos cut to Neutral at Citi on lack of catalysts"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230824101900"", ""headline"": ""Kenvue is called cheap by Goldman Sachs on a valuation basis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230824132000"", ""headline"": ""Johnson & Johnson: Kenvue Separation Won't Impact Dividends"", ""summary"": ""Johnson & Johnson recently completed the Kenvue spinoff. Read why I see a stable profitability and growth path ahead for JNJ.""}, {""date"": ""20230824132700"", ""headline"": ""5 Defensive Stocks to Buy Amid Lingering Market Volatility"", ""summary"": ""Volatility has gripped Wall Street again. So, investing in defensive stocks like McKesson Corporation (MCK), Entergy Corporation (ETR), PepsiCo, Inc. (PEP), Johnson & Johnson (JNJ) and Atmos Energy Corporation (ATO) is a safe bet.""}, {""date"": ""20230824150310"", ""headline"": ""CVS Health launches new brand Cordavis to target $100 billion biosimilar market"", ""summary"": ""CVS is launching a new business segment that will negotiate with drugmakers to produce private label products for it to sell, the healthcare giant said Wednesday.""}, {""date"": ""20230824163200"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.34% higher to $165.09 Thursday, on what proved to be an all-around poor trading session for the stock market, with the...""}, {""date"": ""20230824205350"", ""headline"": ""AARP to join US government in two more lawsuits over Medicare drug pricing negotiations"", ""summary"": ""AARP is gearing up for legal battles brought by pharma companies against Medicare drug pricing negotiations that impact its members.""}, {""date"": ""20230825035500"", ""headline"": ""Kenvue to replace Advance Auto Parts in S&P 500 at open on 8/25"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230825064500"", ""headline"": ""The Nvidia Distraction Is Over. Jackson Hole, Powell, Bonds Take Center Stage."", ""summary"": ""Hawaiian Electric suspends dividend as troubles build, fast-fashion rivals Shein and Forever 21 team up, and other news to start your day.""}, {""date"": ""20230825072200"", ""headline"": ""Janssen submits sBLA for expanded Rybrevant approval to FDA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230825080700"", ""headline"": ""J&J submits sBLA for Rybrevant for first-line non-small cell lung cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230825090704"", ""headline"": ""The Buffett List: 6 Dividend Buys In August"", ""summary"": ""Analyst-augured top-ten net gains from Buffett\u00e2\u0080\u0099s August dividend dogs ranged 19.12%-56.48% from CVX, COF, DHI, LPX, KHC, BAC, PARA, ALLY, C, and top pick GM per YCharts data. Read more here.""}, {""date"": ""20230825093250"", ""headline"": ""Alkermes: A Complicated Story Right Now"", ""summary"": ""Alkermes is a drugmaker focused on neuroscience & oncology with a market cap of $4.9B. Read why I'm withholding any investment recommendation around ALKS stock.""}, {""date"": ""20230825093300"", ""headline"": ""Johnson & Johnson's Janssen submits supplemental biologics application"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230825095200"", ""headline"": ""Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230825100200"", ""headline"": ""As Medicare picks 10 drugs for price negotiations, 50 million people stand to benefit \u2014 even if their drugs aren\u2019t on the list"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230825105600"", ""headline"": ""AstraZeneca latest drugmaker to challenge Medicare drug price negotiation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230825120000"", ""headline"": ""Pro Take: Corporate Venture Capital Provides Path for Long-Term Tech Strategy"", ""summary"": ""Companies that make venture-capital investments can get an inside view of where markets and technology are headed.""}, {""date"": ""20230825125300"", ""headline"": ""Pharma Giants Unite Against Drug Price Negotiation: AstraZeneca Latest To Challenge The Government"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230825141900"", ""headline"": ""Johnson & Johnson, Salesforce share gains lead Dow's nearly 250-point jump"", ""summary"": ""Shares of Johnson & Johnson and Salesforce are seeing strong returns Friday afternoon, sending the Dow Jones Industrial Average into positive territory. The...""}, {""date"": ""20230825150733"", ""headline"": ""AstraZeneca files lawsuit against U.S. over drug pricing"", ""summary"": ""AstraZeneca (AZN) joins Johnson & Johnson (JNJ), Merck (MRK), and Bristol-Myers (BMY) in a lawsuit against the U.S. Department of Health and Human Services (HHS) over certain provisions on prices found in President Biden's Inflation Reduction Act (IRA). Yahoo Finance Health Care Reporter Anjalee Khemlani joins the Live show to break down the lawsuit and what to expect moving forward.""}, {""date"": ""20230825152200"", ""headline"": ""J&J\u2019s Kenvue Exchange Offer Was a Big Win for the Little Guy"", ""summary"": ""Small investors earned a nice payday of more than $1,000 if they tendered 99 shares of stock in the swap, which expired last week.""}, {""date"": ""20230825153600"", ""headline"": ""Emergent BioSolutions (EBS) Down 12% in a Week: Here's Why"", ""summary"": ""Shares of Emergent (EBS) are on a downward trajectory since the ticker was dropped from the S&P SmallCap 600 index.""}, {""date"": ""20230825154100"", ""headline"": ""Novo Nordisk's (NVO) Shares Jump 17% in a Month: Here's Why"", ""summary"": ""Novo Nordisk's (NVO) commercial and pipeline progress with its popular obesity drug, Wegovy, continues to drive the share price momentum.""}, {""date"": ""20230825163200"", ""headline"": ""Johnson & Johnson stock rises Friday, outperforms market"", ""summary"": ""Shares of Johnson & Johnson advanced 1.43% to $166.25 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20230825183239"", ""headline"": ""Johnson & Johnson : Acquisition/Asset Disposal - Form 8-K"", ""summary"": ""jnj-20230823 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ...""}, {""date"": ""20230826010400"", ""headline"": ""Crohn's disease drugmakers set to benefit from expected rise in cases"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230826142001"", ""headline"": ""Ken Fisher\u2019s Top 15 Healthcare Stock Picks"", ""summary"": ""In this article, we discuss the top 15 healthcare stock picks of Ken Fisher. If you want to skip our detailed discussion about the healthcare industry, head directly to Ken Fisher\u2019s Top 5 Healthcare Stock Picks. The healthcare sector was forever changed by the COVID-19 pandemic. While it highlighted the weaknesses in the global medical [\u2026]""}, {""date"": ""20230827013400"", ""headline"": ""7 Very Oversold Warren Buffett Stocks to Buy Right Now"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230827110100"", ""headline"": ""Wall Street lists potential targets for Medicare drug price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230827112000"", ""headline"": ""Is It Too Late to Buy Eli Lilly Stock?"", ""summary"": ""Stock for the drugmaker Eli Lilly (NYSE: LLY) is up more than 49% in 2023, making it one of the hottest mega-cap stocks of the year.  Let's delve into Eli Lilly's fundamentals and valuation to see if an answer can be found.  As you'd expect for a stock that has rallied, Eli Lilly's underlying fundamentals are very strong: Through the first half of 2023, the company has had seven products on pace to each generate at least $1 billion in revenue in 2023.""}, {""date"": ""20230827134500"", ""headline"": ""3 Stocks to Buy That Can Beat a Bear Market"", ""summary"": ""Look for companies that can generate revenue -- and turn it into a profit -- regardless of the economic environment.""}, {""date"": ""20230827134744"", ""headline"": ""13 Best Defensive Stocks To Buy Now"", ""summary"": ""In this article, we will take a look at the 13 best defensive stocks to buy now. To see more such companies, go directly to 5 Best Defensive Stocks To Buy Now. The US stock markets are jumpy amid analyst firms downgrading banks and some analysts suggesting the economy is still not out the recession [\u2026]""}]",{}
12,2023-08-27,164.92922973632812,2023-09-03,159.20506286621094,-0.03470680654525826,D4,"[{""date"": ""20230827013400"", ""headline"": ""7 Very Oversold Warren Buffett Stocks to Buy Right Now"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230827110100"", ""headline"": ""Wall Street lists potential targets for Medicare drug price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230827112000"", ""headline"": ""Is It Too Late to Buy Eli Lilly Stock?"", ""summary"": ""Stock for the drugmaker Eli Lilly (NYSE: LLY) is up more than 49% in 2023, making it one of the hottest mega-cap stocks of the year.  Let's delve into Eli Lilly's fundamentals and valuation to see if an answer can be found.  As you'd expect for a stock that has rallied, Eli Lilly's underlying fundamentals are very strong: Through the first half of 2023, the company has had seven products on pace to each generate at least $1 billion in revenue in 2023.""}, {""date"": ""20230827134500"", ""headline"": ""3 Stocks to Buy That Can Beat a Bear Market"", ""summary"": ""Look for companies that can generate revenue -- and turn it into a profit -- regardless of the economic environment.""}, {""date"": ""20230827134744"", ""headline"": ""13 Best Defensive Stocks To Buy Now"", ""summary"": ""In this article, we will take a look at the 13 best defensive stocks to buy now. To see more such companies, go directly to 5 Best Defensive Stocks To Buy Now. The US stock markets are jumpy amid analyst firms downgrading banks and some analysts suggesting the economy is still not out the recession [\u2026]""}, {""date"": ""20230828041900"", ""headline"": ""Johnson & Johnson seeks full approval of Balversa for bladder cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828053900"", ""headline"": ""Hedge and mutual funds rotate from tech; see the stocks they love and shun"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828060545"", ""headline"": ""August MDA Breakout Stocks Week 35 - 2023: High-Frequency Gainers To Give You An Edge"", ""summary"": ""Two new sample Breakout Stocks for Week 35 curated by the MDA model for a 10% short-term upside along with a Dow pick. Click here for a detailed analysis.""}, {""date"": ""20230828060900"", ""headline"": ""Medicenna Therapeutics appoints Jeff Caravella as CFO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828070000"", ""headline"": ""Biden Administration to Reveal Which Pharma Blockbusters Medicare Will Pay Less For"", ""summary"": ""Drugmakers like Eli Lilly and Pfizer could see profits fall if their blockbuster medicines are on the list.""}, {""date"": ""20230828090300"", ""headline"": ""7 Reliable Retirement Stocks to Secure a Golden Future"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828091000"", ""headline"": ""A Step Closer To Cheaper Drugs For Americans: Price Negotiation And Its Implications"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828092100"", ""headline"": ""3 Widely Owned Dow Stocks Prominent Billionaires Are Selling"", ""summary"": ""Some of Wall Street's most-successful billionaire money managers are paring down or parting ways with a trio of top-tier companies.""}, {""date"": ""20230828093800"", ""headline"": ""Hawaiian Electric Says Power Lines Not Responsible For Deadly Lahaina Fire, China Targets Stock Market Revival, FTC Pauses Legal Battle With Amgen's $28B Horizon Deal: Today's Top Stories"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828094000"", ""headline"": ""The 7 Most Promising Blue-Chip Stocks to Own Now"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828101900"", ""headline"": ""Video: Dow Movers: JNJ, MMM"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828114521"", ""headline"": ""Janssen Submits Supplemental Biologics License Application to the U.S. Food and Drug Administration Seeking Approval of RYBREVANT in Combination with Chemotherapy for the First-line Treatment of Patients with Locally Advanced or Metast"", ""summary"": ""RARITAN - The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a supplemental Biologics License Application to the U.S. Food and Drug Administration seeking...""}, {""date"": ""20230828121400"", ""headline"": ""Viridian Chart Of The Week: How Capital Intensive Is Cannabis?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828123700"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828131850"", ""headline"": ""16 Best Dividend Paying Stocks To Buy Now"", ""summary"": ""In this article, we discuss 16 best dividend paying stocks to buy now. You can skip our detailed analysis of dividend stocks and their performance, and go directly to read 5 Best Dividend Paying Stocks To Buy Now. The investment landscape is continuously evolving this year. It started with the rise of tech stocks. Seven [\u2026]""}, {""date"": ""20230828153720"", ""headline"": ""Johnson & Johnson (JNJ): A Modestly Undervalued Gem in the Healthcare Sector?"", ""summary"": ""A Comprehensive Analysis of its Market Value""}, {""date"": ""20230828153800"", ""headline"": ""J&J (JNJ) Seeks Full FDA Nod for Rybrevant in Lung Cancer"", ""summary"": ""J&J's (JNJ) FDA filing is based on a late-stage study showing that treatment with Rybrevant plus chemotherapy improved progression-free survival in certain NSCLC patients.""}, {""date"": ""20230828163200"", ""headline"": ""Johnson & Johnson stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson shed 1.18% to $164.29 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20230828180224"", ""headline"": ""ADVENT Offers Up An Early Present For Boston Scientific Investors"", ""summary"": ""Boston Scientific surprised the Street with better-than-expected ADVENT study results. Click here to read more.""}, {""date"": ""20230828193521"", ""headline"": ""Unusual Put Option Trade in Johnson & Johnson (JNJ)  Worth $69,225.00K"", ""summary"": """"}, {""date"": ""20230829000400"", ""headline"": ""10 drugs targeted for Medicare price negotiations as Biden pitches cost reductions"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829000400"", ""headline"": ""See which drugs President Biden is targeting first for Medicare price-lowering talks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829013500"", ""headline"": ""Drug Companies Mixed as Medicare Plans to Negotiate"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829023300"", ""headline"": ""Republicans say Medicare drug negotiations will mean fewer new meds"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829024800"", ""headline"": ""Cannabis Industry's Capital Crunch: Why It Needs More Funds Than Other Industries, Will Fed Legalization Change This?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829033300"", ""headline"": ""Johnson & Johnson stock rises Tuesday, still underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829033500"", ""headline"": ""What You Missed On Wall Street On Tuesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829050400"", ""headline"": ""How To Earn $500 A Month From Johnson & Johnson Stock"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829052904"", ""headline"": ""Drug-Free Way To Treat Pediatric IBS And FAP Earns NeurAxis A $14 Price Target ($NRXS)"", ""summary"": ""NeurAxis is a low-float, under-the-radar biotech worthy of investors' attention. It has, after all, earned analysts, including the lead at Goldman Smallcap Research, who published a decidedly...""}, {""date"": ""20230829065000"", ""headline"": ""Medicare lists first ten drugs selected for pricing negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829065100"", ""headline"": ""Biden unveils first 10 drugs subject to Medicare price negotiation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829072300"", ""headline"": ""Beaten Down COVID-19 Vaccine Partner Stock Catalent Finalizes Deal With Activist Investor, Reports Mixed Q4 Earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829075000"", ""headline"": ""Merck, Amgen, AbbVie products among first 10 drugs selected for Medicare price negotiations"", ""summary"": ""Medicare on Tuesday announced the first 10 drugs selected for price negotiations, launching a historic and highly contentious process with big implications...""}, {""date"": ""20230829075900"", ""headline"": ""SPLG: The Market\u2019s Lowest-Cost S&P 500 ETF"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829083500"", ""headline"": ""Biden Targets Cancer, Diabetes Drugs In Controversial Medicare Price Battle"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829095600"", ""headline"": ""Eliquis, Jardiance among first 10 drugs selected for Medicare price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829102900"", ""headline"": ""White House names first 10 drugs eligible for Medicare price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829102900"", ""headline"": ""Biden administration announces first 10 drugs eligible for Medicare price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829114125"", ""headline"": ""UPDATE 5-US names first 10 drugs for Medicare price negotiation"", ""summary"": ""The Biden administration on Tuesday released its list of 10 prescription medicines that will be subject to the first-ever price negotiations by the U.S. Medicare health program that covers 66 million people, with big-selling blood thinner Eliquis from Bristol Myers Squibb and Pfizer among them.  President Joe Biden\u2019s signature Inflation Reduction Act (IRA), signed into law last year, allows the Medicare health program for Americans aged 65 and over to negotiate prices for some of its most costly drugs.  \""There is no reason why Americans should be forced to pay more than any developed nation for life-saving prescriptions just to pad Big Pharma\u2019s pockets,\"" Biden said in a statement.""}, {""date"": ""20230829114618"", ""headline"": ""Biden Administration targets drugs from J&J, Merck for controversial Medicare price negotiations"", ""summary"": ""The Biden administration revealed the first 10 drugs that will face the Medicare negotiation process under the Inflation Reduction Act.""}, {""date"": ""20230829120400"", ""headline"": ""US President Biden fires new salvo in war on prescription drug costs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829123600"", ""headline"": ""JPMorgan says time to buy MedTech based on past"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829130011"", ""headline"": ""Is Most-Watched Stock Johnson & Johnson (JNJ) Worth Betting on Now?"", ""summary"": ""Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.""}, {""date"": ""20230829130100"", ""headline"": ""The 10 Drugs Medicare Can Negotiate Were Just Announced. These Pharma Stocks Are Impacted."", ""summary"": ""The Inflation Reduction Act gives Medicare the ability to directly negotiate the prices of certain drugs for the first time.""}, {""date"": ""20230829132412"", ""headline"": ""Best Buy results, Medicare negotiations list, Hurricane Idalia: Top stories"", ""summary"": ""Best Buy (BBY) lowers its full-year sales outlook despite topping earnings estimates. The Biden administration has shared its list of ten prescription drugs that will be subject to pricing negotiations between manufacturers and Medicare. Tropical Storm Idalia has officially been upgraded to a hurricane. It's expected to make landfall on Florida's west coast on Wednesday.Yahoo Finance Live's Brad Smith highlights three of this morning's biggest stories.""}, {""date"": ""20230829142100"", ""headline"": ""Medicare Drugs Targeted Under Inflation Reduction Act"", ""summary"": ""Last year, these 10 drugs made up $50 billion, about 20%, of Medicare part D costs.""}, {""date"": ""20230829144735"", ""headline"": ""Biden admin unveils ten drugs picked for Medicare price negotiations"", ""summary"": ""The Biden administration has released the list of the first ten drugs that will be subject to Medicare price negotiations. The Center for Medicare Director Dr. Meena Seshamani tells Yahoo Finance Live that they are looking at \""the benefits that a drug brings to populations. Does it address an unmet need? Does it address different populations that have needs?\"" When it comes to why some drugs were chosen Dr. Seshamani says the organization followed the criteria written in the Inflation Reduction Act, adding that the list will not change. These are the ten drugs Medicare will be negotiating the prices of:Eliquis- Bristol-Myers Squibb (BMY), Pfizer (PFE) Jardiance- Boehringer Ingelheim, Eli Lilly (LLY) Xarelto- Bayer (BAYRY), Johnson & Johnson (JNJ) Januvia- Merck (MRK) Farxiga- AstraZeneca (AZN) Entresto- Novartis (NVS) Enbrel- Amgen (AMGN) Imbruvica- Johnson & Johnson (JNJ), AbbVie (ABBV) Stelara- Johnson & Johnson (JNJ) Fiasp, NovoLog- Novo Nordisk (NVO)""}, {""date"": ""20230829150000"", ""headline"": ""Eli Lilly and Other Pharma Stocks Are Ignoring Medicare\u2019s 10 Drug List"", ""summary"": ""The Inflation Reduction Act gives Medicare the ability to directly negotiate the prices of certain drugs for the first time.""}, {""date"": ""20230829153700"", ""headline"": ""Expensive Drugs Targeted for First U.S. Price Negotiations"", ""summary"": ""Lower prices would take effect in 2026 depending on the talks between the U.S. and drugmakers and the outcome of industry lawsuits.""}, {""date"": ""20230829154510"", ""headline"": ""Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now"", ""summary"": ""Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.""}, {""date"": ""20230829171400"", ""headline"": ""J&J (JNJ) Seeks Full FDA Nod for Balversa in Urothelial Cancer"", ""summary"": ""J&J (JNJ) submits a supplemental new drug application to the FDA for full approval of Balversa to treat urothelial carcinoma.""}, {""date"": ""20230829210000"", ""headline"": ""What Impact Will Medicare Price Negotiations Have on Big Pharma Stocks?"", ""summary"": ""Investors appear to be yawning for the most part at the latest news on Medicare drug price negotiations.""}, {""date"": ""20230830032400"", ""headline"": ""What You Missed On Wall Street On Wednesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230830033300"", ""headline"": ""Johnson & Johnson stock falls Wednesday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230830034000"", ""headline"": ""The Most-Sold Guru Stocks of the 2nd Quarter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230830053600"", ""headline"": ""Johnson & Johnson revises FY23 adjusted EPS view to $10.00-$10.10"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230830053900"", ""headline"": ""Johnson & Johnson sees FY23 adjusted operational sales growth 6.2%-7.2%"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230830054000"", ""headline"": ""Johnson & Johnson maintains its quarterly dividend of $1.19 per share"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230830063300"", ""headline"": ""Johnson & Johnson updates financials and outlook after Kenvue separation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230830064600"", ""headline"": ""Crypto Scores Big Win Over the SEC. Why the Battle\u2019s Far From Over."", ""summary"": ""HP\u2019s results show effects of weaker demand and soft pricing, the 10 drugs on Medicare\u2019s price negotiating list, and other news to start your day.""}, {""date"": ""20230830065000"", ""headline"": ""J&J revises 2023 sales, profit outlook lower after Kenvue separation, will maintain dividend"", ""summary"": ""Johnson & Johnson updated on Wednesday its 2023 financial guidance in the wake of the Kenvue Inc. separation that was completed last week. The drug maker now...""}, {""date"": ""20230830071600"", ""headline"": ""Johnson & Johnson (JNJ) Gets a Buy from Cantor Fitzgerald"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230830072749"", ""headline"": ""HP, Peloton, Rite Aid fall premarket; Nvidia gains"", ""summary"": ""Investing.com -- U.S. futures traded with small losses Wednesday, handing back some of the recent gains ahead of the release of more important labor market economic data.""}, {""date"": ""20230830072800"", ""headline"": ""Kenvue Fits Right In With Other Dividend Aristocrats"", ""summary"": ""Kenvue (ticker: KVUE) is the new addition, which is a strange thing to say about a 135-plus-year-old consumer health company that sells iconic brands such as Tylenol, Band-Aid, Listerine, and Neutrogena.  The stock was just spun out by Johnson & Johnson (JNJ) to shareholders in an exchange offer.  The stock is now in the aristocrats index and exchange-traded funds that track the index, such as the  ETF (NOBL) and the  ETF (KNG).""}, {""date"": ""20230830075600"", ""headline"": ""Johnson & Johnson (JNJ) Gets a Hold from Bank of America Securities"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230830080300"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Patterson Companies (PDCO), BioMarin Pharmaceutical (BMRN) and Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230830081000"", ""headline"": ""4 stocks to watch on Wednesday: Salesforce, Texas Instruments and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230830081000"", ""headline"": ""Analysts\u2019 Top Healthcare Picks: Johnson & Johnson (JNJ), PTC Therapeutics (PTCT)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230830091802"", ""headline"": ""Johnson & Johnson : Janssen Submits Supplemental New Drug Application to the U.S. Food and Drug Administration Seeking Full Approval of BALVERSA\u00ae (erdafitinib) for the Treatment of Patients with Locally Advanced or Metastatic Urothelial Carcinoma and Selected Fibroblast Growth Factor Receptor Gene Alterations"", ""summary"": ""News Release Media Contacts: Suzanne Frost Phone: +1 416-317-0304 Ania DiAntonio ...""}, {""date"": ""20230830095203"", ""headline"": ""Johnson & Johnson : Final - JNJ Guidance Webcast"", ""summary"": ""Johnson & Johnson Updated Financials & 2023 Guidance August 30, 2023 Cautionary Note on Forward-looking Statements ...""}, {""date"": ""20230830095204"", ""headline"": ""Johnson & Johnson : Guidance Press Release with attachments"", ""summary"": ""FOR IMMEDIATE RELEASE Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue Separation ...""}, {""date"": ""20230830095602"", ""headline"": ""Johnson & Johnson : Guidance Call Transcript - Updated"", ""summary"": ""Johnson & Johnson Updated Financials and 2023 Guidance Published August 30, 2023 Slide 1: Johnson & Johnson Updated Financials & 2023...""}, {""date"": ""20230830103000"", ""headline"": ""Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue Separation"", ""summary"": ""NEW BRUNSWICK, N.J., August 30, 2023--Johnson & Johnson (NYSE: JNJ) (\""the Company\"") today announced updates to its financials and 2023 guidance which reflect its operations as a company focused on transformational innovation in Pharmaceutical and MedTech. The Company has published a recorded webinar for investors to provide additional context behind the updated financials and 2023 guidance found in this release, which may be accessed by visiting the Investors section of the Company's website at""}, {""date"": ""20230830104400"", ""headline"": ""Johnson & Johnson Reveals Updated 2023 Projections After Finalizing Biggest Shake Up In 135 Years"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230830105033"", ""headline"": ""UPDATE 2-J&J expects double-digit 2023 profit growth after Kenvue spinoff"", ""summary"": ""Johnson & Johnson on Wednesday forecast double-digit  profit growth for 2023 after spinning off consumer health company Kenvue, unveiling the first outlook for its standalone drugs and medical device businesses.  J&J finalized the biggest shake-up in its 137-year history earlier this month through an exchange of its shares with Kenvue's, leaving the pharmaceutical giant with a reduced 9.5% stake in its former unit.  Kenvue debuted on the New York Stock Exchange in May and has a market capitalization of nearly $79 billion, with J&J generating $13.2 billion in cash proceeds as a result of its debt offering and initial public offering.""}, {""date"": ""20230830110600"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230830111745"", ""headline"": ""Genmab Is Down To Attractive Levels"", ""summary"": ""Genmab's stock is down 15% since late 2022 highs. Dependence on Darzalex will decrease considerably in the following years. Find out why GMAB stock is a Buy.""}, {""date"": ""20230830120700"", ""headline"": ""TOP NEWS: J&J forecasts strong growth in earnings after Kenvue split"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230830122500"", ""headline"": ""Pharma Giant Johnson & Johnson, Lupin Offer Significant Price Cuts On Tuberculosis Drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230830124500"", ""headline"": ""1 Top Dividend Stock to Buy Hand Over Fist Right Now"", ""summary"": ""If you're looking for a reliable dividend stock that can deliver consistent income and growth, you should consider Kenvue (NYSE: KVUE), the consumer healthcare spin-off from Johnson & Johnson (NYSE: JNJ).  Kenvue is one of the leading players in the consumer healthcare industry, with a portfolio of well-known brands such as Aveeno, Tylenol, Listerine, Neutrogena, and Band-Aid.  Kenvue has a long history of innovation, quality, and customer loyalty, as well as a solid financial performance and dividend policy.""}, {""date"": ""20230830134243"", ""headline"": ""Tracking Tweedy, Browne Portfolio - Q2 2023 Update"", ""summary"": ""Tweedy, Browne's 13F portfolio value increased by 4% to $1.91B, with 46 holdings. Click here to read more.""}, {""date"": ""20230830141100"", ""headline"": ""Johnson & Johnson Revises Guidance After Kenvue Spinout. There\u2019s Good News on the Dividend."", ""summary"": ""Johnson & Johnson maintained its quarterly dividend of $1.19 a share after spinning out consumer-health company Kenvue.""}, {""date"": ""20230830141548"", ""headline"": ""J&J, India's Lupin cut prices for tuberculosis drug in lower-income countries"", ""summary"": ""The United Nations-backed Stop TB Partnership said J&J's new price of $130 and Lupin's price of $194 for a six-month course of the treatment represented a 55% and 33% price reduction, respectively.  Bedaquiline is one of the three new drugs developed against tuberculosis (TB) in more than half a century, and it is a key part of recommended treatment regimens for drug-resistant TB infections.""}, {""date"": ""20230830153330"", ""headline"": ""Medicare price negotiation list: What it means for pharma companies"", ""summary"": ""On Tuesday, the Biden administration listed ten drugs subject to Medicare price negotiations. Yahoo Finance Health Care Reporter Anjalee Khemlani breaks down the list and how this may impact the pharmaceutical companies who profit from these drugs.\u00a0\u00a0 The ten drugs and pharma companies impacted are:\u00a0 Eliquis - Bristol-Myers Squibb (BMY), Pfizer (PFE) Jardiance - Boehringer Ingelheim, Eli Lilly (LLY) Xarelto- Bayer (BAYRY), Johnson & Johnson (JNJ) Januvia - Merck (MRK) Farxiga - AstraZeneca (AZN) Entresto - Novartis (NVS) Enbrel - Amgen (AMGN) Imbruvica - Johnson & Johnson (JNJ), AbbVie (ABBV) Stelara - Johnson & Johnson (JNJ) Fiasp, NovoLog - Novo Nordisk (NVO)""}, {""date"": ""20230830155100"", ""headline"": ""Merck's (MRK) Keytruda Receives EU Nod in Gastric Cancer"", ""summary"": ""Following the approval, Merck's (MRK) Keytruda is the first immunotherapy approved in the EU for first-line treatment for HER2-positive advanced gastric cancer in adults whose tumors express PD-L1.""}, {""date"": ""20230830161500"", ""headline"": ""NEW YORK MARKET CLOSE: Stocks rise again as hopes for rate pause build"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230830163136"", ""headline"": ""Johnson & Johnson Forecasts Double-Digit Earnings Growth After Kenvue Spin-Off"", ""summary"": ""Johnson & Johnson on Wednesday released its first earnings forecast as a standalone pharmaceutical and medical devices company, estimating double-digit growth in earnings this year.""}, {""date"": ""20230830172549"", ""headline"": ""Medicare's drug pricing list didn't impact company stocks \u2014 here's why"", ""summary"": ""Company stocks were unaffected by the Biden Administration's historic announcement Tuesday of Medicare's first list of drugs for negotiating prices.""}, {""date"": ""20230830213641"", ""headline"": ""Set and Forget: 3 Dividend Stocks Perfect for Your IRA"", ""summary"": ""Dividend stocks provide essential passive income for many investors. For those heading into retirement, this is especially true. Companies that pay dividends are generally more stable, with consistent and predictable cash flow growth allowing such companies to return capital to shareholders. For the long-term investor, such companies are often better bets from a risk perspective. Those entering or nearing retirement may want to know that their capital is safe. Thus, for those with capital preser""}, {""date"": ""20230830224209"", ""headline"": ""Unusual Put Option Trade in Johnson & Johnson (JNJ)  Worth $82,260.00K"", ""summary"": """"}, {""date"": ""20230831033300"", ""headline"": ""Johnson & Johnson stock underperforms Thursday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230831053100"", ""headline"": ""Johnson & Johnson price target lowered to $186 from $195 at Wells Fargo"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230831053300"", ""headline"": ""Timeless Wisdom of 4 Legendary Investors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230831061000"", ""headline"": ""When ChatGPT Misses the Mark: 3 Stocks It Got Very Wrong"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230831091300"", ""headline"": ""Video: Dow Movers: JNJ, CRM"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230831093000"", ""headline"": ""Medicare Will Soon Negotiate Some Drug Prices. Is This a Threat to Johnson & Johnson's Earnings?"", ""summary"": ""The healthcare giant's immunology drug Stelara brought in more than $9 billion in revenue last year.""}, {""date"": ""20230831093700"", ""headline"": ""2 Dividend Kings That Face Massive Legal Risks"", ""summary"": ""Investing in dividend growth stocks has proven to be a great long-term strategy for investors.  Dividend Kings have that designation because they managed to raise their payouts annually for at least 50 consecutive years.  A couple of Dividend Kings that investors may want to think twice about investing in right now are 3M (NYSE: MMM) and Johnson & Johnson (NYSE: JNJ).""}, {""date"": ""20230831101200"", ""headline"": ""Johnson & Johnson Just Cut an Entire Division. Is It Still a Buy?"", ""summary"": ""Johnson & Johnson (NYSE: JNJ) plans to cut or dramatically scale down its vaccine and infectious disease division.  The move comes roughly around the same time the company finalizes the spinoff of its consumer health division, called Kenvue.  Given these changes, some investors have reason to question the behemoth's growth prospects, as J&J can no longer expect to boost its revenue with new commercialized vaccines or through new personal care products.""}, {""date"": ""20230831105100"", ""headline"": ""This Is What Whales Are Betting On Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230831111722"", ""headline"": ""Novo Nordisk: Super Focused Pharma Company For The Long Run"", ""summary"": ""Novo Nordisk is one of the most qualitative big pharma companies globally. Read why I am bullish on NVO stock with the long-term investment horizon here.""}, {""date"": ""20230831125900"", ""headline"": ""J&J (JNJ) Updates 2023 Guidance After Final Kenvue Separation"", ""summary"": ""With the complete separation of the Consumer Health segment, J&J (JNJ) is now a two-sector company focused on the Pharmaceutical and MedTech fields.""}, {""date"": ""20230831152058"", ""headline"": ""Cantor Fitzgerald Reiterates Johnson & Johnson (JNJ) Overweight Recommendation"", ""summary"": """"}, {""date"": ""20230831152058"", ""headline"": ""Morgan Stanley Maintains Johnson & Johnson (JNJ) Equal-Weight Recommendation"", ""summary"": """"}, {""date"": ""20230831152212"", ""headline"": ""Big Pharma's biggest ally gets trolled on X for attacking Medicare drug pricing list"", ""summary"": ""Drug lobbying firm PhRMA faced backlash on social media for its attempt to call Medicare pricing negotiations unfair.""}, {""date"": ""20230831165406"", ""headline"": ""25 Countries With The Worst Healthcare System"", ""summary"": ""In this article, we will determine which countries have the worst healthcare systems in the world and delve into the implications of challenges in this sector. If you wish to see the list directly, head to 8 Countries With The Worst Healthcare System. Despite the surge of healthcare innovations in this era, it\u2019s disheartening to [\u2026]""}, {""date"": ""20230831183314"", ""headline"": ""3 Brilliant Blue-Chip Stocks for Lucrative Long-Term Growth"", ""summary"": ""Most investors agree that finding a brilliant blue-chip stock can do wonders for a portfolio. Knowing that stock in a large, well-capitalized, reputable company gives investors some sense of calm. Blue-chip companies have been in business for significant years, have reliable earnings, plenty of free cash flow, and tend to pay dividends to stockholders. Prime examples of blue-chip stocks include Walmart (NYSE:WMT), McDonald\u2019s (NYSE:MCD) and Johnson & Johnson (NYSE:JNJ). These can anchor a portfol""}, {""date"": ""20230831203202"", ""headline"": ""Wells Fargo Maintains Johnson & Johnson (JNJ) Overweight Recommendation"", ""summary"": """"}, {""date"": ""20230901025900"", ""headline"": ""Pete Davidson Reveals He's Tried Ketamine To Cope With Depression"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901031010"", ""headline"": ""10 Best September Dividend Stocks To Buy"", ""summary"": ""In this article, we discuss 10 best September dividend stocks to buy. You can skip our detailed analysis of dividend stocks and dividend capture strategy, and go directly to read 5 Best September Dividend Stocks To Buy. Dividend investing is a popular way to increase your earnings and generate income through investments. While it might [\u2026]""}, {""date"": ""20230901033300"", ""headline"": ""Johnson & Johnson stock falls Friday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901070800"", ""headline"": ""GLOBAL BROKER RATINGS: UBS cuts Volkswagen and Renault to 'sell'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901095100"", ""headline"": ""EU regulators warn pregnant women not to use topiramate"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901103300"", ""headline"": ""As Medicare drug-price negotiations inch forward, some states are flexing new powers to cut costs for a broader swath of drugs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901113000"", ""headline"": ""As Medicare drug-price negotiations inch forward, some states are flexing new powers to cut costs for a broader swath of drugs\u00a0"", ""summary"": ""States like Colorado are looking to set upper payment limits on certain drugs as soon as next year.""}, {""date"": ""20230901115500"", ""headline"": ""7 Cash Cow Stocks for Recession-Resilient Dividends"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901144852"", ""headline"": ""CDC: Dividend ETF With Unconventional Market Timing"", ""summary"": ""VictoryShares US EQ Income Enhanced Volatility Wtd is a defensive ETF with unconventional market timing and lower risk in drawdowns. Learn more about CDC here.""}, {""date"": ""20230901201330"", ""headline"": ""Novartis sues US government over Medicare drug price regulation"", ""summary"": ""Swiss drugmaker Novartis on Friday said it had sued the U.S. government in an attempt to halt the Medicare drug-price negotiation program, which includes its top-selling heart-failure medicine Entresto.  The lawsuit, filed in federal court in New Jersey, is the first since the Biden administration on Tuesday released its list of 10 prescription medicines that will be subject to price negotiations by the Medicare health program, which covers 66 million people.  Other drugs selected were Bristol Myers Squibb and Pfizer\u2019s blood thinner Eliquis, Merck's diabetes drug Januvia, and Eliquis rival Xarelto from Johnson & Johnson .""}, {""date"": ""20230901214515"", ""headline"": ""Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""In the latest trading session, Johnson & Johnson (JNJ) closed at $160.48, marking a -0.74% move from the previous day.""}, {""date"": ""20230901233300"", ""headline"": ""J&J Dividend Decision Shows Power of Free Cash Flow"", ""summary"": ""J&J plans to maintain its quarterly dividend even after separating its Kenvue business. It didn't have to do that to keep its status as a Dividend Aristocrat.""}, {""date"": ""20230902010500"", ""headline"": ""Lilly, Novo Nordisk top pharma performers in August; AstraZeneca, Roche lag"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230902090000"", ""headline"": ""5 Relatively Safe And Cheap Dividend Stocks To Invest In - September 2023"", ""summary"": ""In addition to the primary list that yields just under 3%, we present two other groups of 5 DGI stocks each, with moderate to high yields. Read more here.""}, {""date"": ""20230902103808"", ""headline"": ""20 Best Companies to Work For in 2023"", ""summary"": ""In this article, we will look at the 20 best companies to work for in 2023. If you want to skip our in-depth analysis, head straight to the 5 Best Companies to Work for in 2023. As we step into 2023, the adage \u201cpeople are a company\u2019s greatest asset\u201d has never rung truer. The competitive [\u2026]""}, {""date"": ""20230902105100"", ""headline"": ""8 Pharma Stocks Affected by New  Drug Price Negotiation Rules"", ""summary"": ""Which companies have the most to lose now that Medicare can negotiate directly with them on the prices of some of the most widely used drugs?""}, {""date"": ""20230902113000"", ""headline"": ""Is This Incredible Dividend Stock Still a Buy Following Its Recent Split?"", ""summary"": ""The healthcare behemoth has increased its dividend payment for 61 straight years.  A big driver of\u00a0Johnson & Johnson's\u00a0ability to steadily increase its payout is the durability of its diversified business model.  Johnson & Johnson has been working on the separation of its consumer health business for years.""}, {""date"": ""20230903081922"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of September 3"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Click here to read the full September 3 weekly update.""}, {""date"": ""20230903090600"", ""headline"": ""Stifel Nicolaus Sticks to Its Hold Rating for Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230903110000"", ""headline"": ""Why is big pharma unmoved despite Medicare pricing threat?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230903114000"", ""headline"": ""Is It Too Late to Buy Veeva Systems Stock?"", ""summary"": ""Veeva Systems' (NYSE: VEEV) stock price jumped 8% on Aug. 31 after the cloud software specialist posted its latest earnings report. For the second quarter of fiscal 2024, which ended on July 31, its revenue grew 10% year over year to $590 million and exceeded analysts' estimates by $8 million.""}, {""date"": ""20230903134500"", ""headline"": ""4 Warren Buffett Stocks That Could Join the Trillion-Dollar Club by 2032"", ""summary"": ""Let's consider several companies that fit this description: Johnson & Johnson (NYSE: JNJ), Visa (NYSE: V), Mastercard (NYSE: MA), and Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B).  And here's one thing they have in common: They all have a vote of confidence from Warren Buffett, arguably the greatest investor of all time, who has famously said that his favorite holding period is forever.""}]",{}
13,2023-09-03,159.20506286621094,2023-09-10,159.28443908691406,0.0004985784953952521,U1,"[{""date"": ""20230903081922"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of September 3"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Click here to read the full September 3 weekly update.""}, {""date"": ""20230903090600"", ""headline"": ""Stifel Nicolaus Sticks to Its Hold Rating for Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230903110000"", ""headline"": ""Why is big pharma unmoved despite Medicare pricing threat?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230903114000"", ""headline"": ""Is It Too Late to Buy Veeva Systems Stock?"", ""summary"": ""Veeva Systems' (NYSE: VEEV) stock price jumped 8% on Aug. 31 after the cloud software specialist posted its latest earnings report. For the second quarter of fiscal 2024, which ended on July 31, its revenue grew 10% year over year to $590 million and exceeded analysts' estimates by $8 million.""}, {""date"": ""20230903134500"", ""headline"": ""4 Warren Buffett Stocks That Could Join the Trillion-Dollar Club by 2032"", ""summary"": ""Let's consider several companies that fit this description: Johnson & Johnson (NYSE: JNJ), Visa (NYSE: V), Mastercard (NYSE: MA), and Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B).  And here's one thing they have in common: They all have a vote of confidence from Warren Buffett, arguably the greatest investor of all time, who has famously said that his favorite holding period is forever.""}, {""date"": ""20230904052200"", ""headline"": ""3 Dow Stocks to Sell in September Before They Crash and Burn"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230904093000"", ""headline"": ""J&J\u2019s $40 Billion Split-Off Sets Stage for Pharma, Medical Tech Expansion \ufeff"", ""summary"": ""The healthcare giant\u2019s separation of its consumer-health business arms it with billions in cash for allocating capital in the remaining businesses.""}, {""date"": ""20230904110600"", ""headline"": ""AI to represent 11% of healthcare budgets in 2024 - Morgan Stanley"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230904112300"", ""headline"": ""Despite a slower Q2, Needham sees medtech market growing 7% in 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230905031800"", ""headline"": ""Check Out What Whales Are Doing With JNJ"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230905042300"", ""headline"": ""Addex Therapeutics announces ADX71149 study readout expected in 2Q24"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230905072051"", ""headline"": ""September Dogs Of The Dow: Walgreens Now Tops All By Yield"", ""summary"": ""There were two Dow Index stocks showing dividends exceeding single share price this month. Click here for a detailed analysis.""}, {""date"": ""20230905072700"", ""headline"": ""Cantor Fitzgerald Reaffirms Their Buy Rating on Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230905072700"", ""headline"": ""Raymond James Remains a Buy on Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230905074300"", ""headline"": ""Eterna appoints Dorothy Clarke to board of directors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230905074300"", ""headline"": ""Legal Twist In Drug Price Negotiation: Federal Judge Quits Case Amid Allegations Of Stock Ownership"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230905083900"", ""headline"": ""Novartis sues U.S. government over price regulation, Reuters reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230905084200"", ""headline"": ""Johnson & Johnson's Growth Strategy Post Tylenol Parent Kenvue Split: Paving the Way for Medical Innovation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230905094727"", ""headline"": ""Sizing Up Stereotaxis"", ""summary"": ""Stereotaxis is a medical device company with potential milestones ahead. Read more to see the financial analysis and future projections of STXS stock.""}, {""date"": ""20230905110943"", ""headline"": ""Short sellers return to profit in August as US stocks rally pauses - Ortex"", ""summary"": ""Short sellers returned to profit in August following two months of losses as U.S. stocks' rally hit a pause after a steady climb this year, data and analytics company Ortex said.  The S&P 500 snapped a five-month winning streak in August as a rise in U.S. Treasury yields weighed on shares of heavyweight growth stocks such as Apple and Microsoft , whose future cash flows are discounted more with a rise in rates.  Healthcare conglomerate Johnson & Johnson was the most profitable short trade last month, with short sellers reaping about $1.3 billion, Ortex data showed.""}, {""date"": ""20230905161930"", ""headline"": ""Facebook News To Shut Down In Europe, Warner Bros. Discovery Revises Outlook As Strike Bites, Manchester United No Longer Up For Sale: Today's Top Stories"", ""summary"": ""Benzinga Why Facebook News is Shutting Down in Europe: What It Means for Users? Meta Platforms Inc (NASDAQ: META) announced a significant development regarding Facebook News in the U.K., France, and Germany. The dedicated news tab on Facebook, known as Facebook News, will cease to exist in early December. The move is part of Meta's ongoing effort to prioritize features that users express interest in, like short-form videos, to maintain its competitive edge versus TikTok. Hollywood Strike Impact""}, {""date"": ""20230905183221"", ""headline"": ""Cantor Fitzgerald Reiterates Johnson & Johnson (JNJ) Overweight Recommendation"", ""summary"": """"}, {""date"": ""20230905183227"", ""headline"": ""Raymond James Maintains Johnson & Johnson (JNJ) Outperform Recommendation"", ""summary"": """"}, {""date"": ""20230906005000"", ""headline"": ""Stock market today: Wall Street loses ground as weak stretch continues"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230906011600"", ""headline"": ""Johnson & Johnson Cancer Drug Rybrevant Shows Improvement In Broader Lung Cancer Population"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230906021800"", ""headline"": ""The 25 Best Stocks By Shareholder Wealth Creation (1926-2022)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230906032400"", ""headline"": ""What You Missed On Wall Street On Wednesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230906034600"", ""headline"": ""Johnson & Johnson initiated with a Hold at HSBC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230906063200"", ""headline"": ""Janssen Pharmaceutical says primary endpoint met in Phase 3 MARIPOSA-2 study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230906070400"", ""headline"": ""Cidara receives election to proceed notice for CD388 from Janssen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230906070800"", ""headline"": ""GLOBAL BROKER RATINGS: Shore Capital raises B&M; HSBC likes Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230906072900"", ""headline"": ""7 Retirement Stocks That Every Long-Term Investor Should Own Now"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230906074002"", ""headline"": ""J&J lung cancer drug combo meets late-stage study goals"", ""summary"": ""Johnson & Johnson said onWednesday its drug rybrevant, along with experimental druglazertinib, met both the main goals of a late-stage study whentreating a type of lung cancer. ...""}, {""date"": ""20230906083800"", ""headline"": ""Cidara Shares Rally Premarket as J&J Moves Forward on Influenza Pact"", ""summary"": ""By Colin Kellaher Shares of Cidara Therapeutics rose sharply in premarket trading Wednesday after the biotechnology company said a Johnson &amp; Johnson unit...""}, {""date"": ""20230906084347"", ""headline"": ""Janssen to Showcase New Insights and Commitment to Accelerating Hope and Healing for Serious Mental Illness at Psych Congress 2023"", ""summary"": ""Titusville - The Janssen Pharmaceutical Companies of Johnson & Johnson will showcase data from its neuropsychiatry portfolio at Psych Congress 2023.The Company will present 15 posters, including...""}, {""date"": ""20230906094800"", ""headline"": ""Dow drops 88 points on losses for shares of Merck, Johnson & Johnson"", ""summary"": ""Shares of Merck and Johnson & Johnson are trading lower Wednesday morning, sending the Dow Jones Industrial Average into negative territory. Shares of Merck...""}, {""date"": ""20230906100000"", ""headline"": ""Is J&J a Buy After the Kenvue Separation?"", ""summary"": ""The transition prompted J&J to lower its sales and earnings per share guidance for the year to account for the lost consumer health earnings.  There's been a lot of talk about buying J&J as it heads into a new era of growth -- but the revised earnings forecast may make you think twice.""}, {""date"": ""20230906101500"", ""headline"": ""Johnson & Johnson succeeds in lung cancer trial for Rybrevant"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230906105000"", ""headline"": ""Apple, Merck share losses lead Dow's 175-point drop"", ""summary"": ""Behind negative returns for shares of Apple and Merck, the Dow Jones Industrial Average is falling Wednesday morning. The Dow was most recently trading 176...""}, {""date"": ""20230906110309"", ""headline"": ""15 Stocks to Buy with Steady Dividends"", ""summary"": ""In this article, we discuss 15 stocks to buy with steady dividends. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read 5 Stocks to Buy with Steady Dividends. Investment trends have evolved significantly over time in response to shifts in the market and the [\u2026]""}, {""date"": ""20230906115852"", ""headline"": ""UPDATE 2-J&J says drug combo contains lung cancer from spreading for longer duration"", ""summary"": ""Johnson & Johnson said on Wednesday its combination drug helped increase the duration of no progress in a type of non small-cell lung cancer in patients.  The therapy met the main goals of the study that tested a combination of antibody treatment Rybrevant and experimental drug lazertinib against chemotherapy in patients with a more common mutation in EGFR protein that causes rapid cell growth.  J&J's therapy was tested in patients in whom the disease progressed even after they were treated with AstraZeneca's Tagrisso.""}, {""date"": ""20230906123200"", ""headline"": ""IBM announces data incident for Janssen CarePath database"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230906151403"", ""headline"": ""12 Best Healthcare ETFs To Buy"", ""summary"": ""In this article, we discuss 12 best healthcare ETFs. If you want to skip our discussion on the healthcare market, head directly to 5 Best Healthcare ETFs To Buy. In December 2022, BlackRock highlighted concerns about the performance for the healthcare sector in 2023. The previous year was rather challenging for equity and fixed income [\u2026]""}, {""date"": ""20230906163200"", ""headline"": ""Johnson & Johnson stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slid 1.66% to $158.01 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""20230906172115"", ""headline"": ""J&J stops hypertension drug study"", ""summary"": ""Johnson & Johnson said onWednesday it has decided to stop a late-stage study testing itsexperimental drug to treat a type of hypertension.(Reporting by Mariam Sunny in Bengaluru; Editing by...""}, {""date"": ""20230906175032"", ""headline"": ""J&J to pull the plug on hypertension drug study"", ""summary"": ""Johnson & Johnson said onWednesday it has decided to stop a late-stage study testing itsexperimental drug to treat a type of hypertension. The study was testing the drug candidate,...""}, {""date"": ""20230906183439"", ""headline"": ""IBM notifies J&J unit Janssen CarePath's customers of unauthorized data access"", ""summary"": ""The personal information was part of a database used on the Janssen CarePath platform, according to IBM.  IBM, which manages the database, said it was unable to determine the extent of the unauthorized access.  Social Security numbers and financial account information were not contained in the database or affected, IBM said, without providing details about the number of affected customers and users.""}, {""date"": ""20230906191311"", ""headline"": ""HSBC Initiates Coverage of Johnson & Johnson (JNJ) with Hold Recommendation"", ""summary"": """"}, {""date"": ""20230906215032"", ""headline"": ""UPDATE 1-J&J to pull the plug on hypertension drug study"", ""summary"": ""Johnson & Johnson said on Wednesday it has decided to stop a late-stage study testing its experimental drug to treat a type of hypertension.  The study was testing the drug candidate, macitentan, in patients with chronic thromboembolic pulmonary hypertension, which is caused by abnormally high pressure in small blood vessels in the lungs.  The decision followed an independent data monitoring committee recommendation after a pre-planned interim analysis, the company said.""}, {""date"": ""20230907015000"", ""headline"": ""J&J's Janssen ends Phase 3 MACiTEPH study evaluating macitentan"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230907024300"", ""headline"": ""Astellas withdraws federal lawsuit over Medicare drug pricing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230907043500"", ""headline"": ""Canaccord starts Kenvue at buy; cites global reach, consumer demand"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230907044552"", ""headline"": ""FedEx: Strong Business But Risky At Current Valuations"", ""summary"": ""FedEx ranks as America's second most trusted B2B brand, bolstering its customer loyalty and market position. Find out why I'm neutral on FDX stock for now.""}, {""date"": ""20230907061000"", ""headline"": ""7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230907061500"", ""headline"": ""8 Dividend Aristocrat Stocks to Buy Now With a Recession (and Inflation) Looming Large in 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230907062900"", ""headline"": ""Canaccord starts Kenvue at Buy on 'great risk/reward opportunity'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230907080414"", ""headline"": ""Janssen Announces Update to Phase 3 MACiTEPH Study Evaluating Macitentan 75mg in Patients with Chronic Thromboembolic Pulmonary Hypertension"", ""summary"": ""RARITAN - The Janssen Pharmaceutical Companies of Johnson & Johnson today announced its decision to stop the Phase 3 MACiTEPH study evaluating macitentan 75 mg in patients with Chronic Thromboembolic...""}, {""date"": ""20230907080419"", ""headline"": ""Janssen - Phase 3 MARIPOSA-2 Study Meets Dual Primary Endpoint Resulting in Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival for RYBREVANT plus Chemotherapy"", ""summary"": ""RARITAN - The Janssen Pharmaceutical Companies of Johnson & Johnson today announced positive topline results from the three-arm Phase 3 MARIPOSA-2 study evaluating RYBREVANT , a bispecific antibody...""}, {""date"": ""20230907091900"", ""headline"": ""(JNJ) - Analyzing Johnson & Johnson's Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230907110300"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230907122500"", ""headline"": ""Dow rallies 111 points on gains in shares of Intel, UnitedHealth"", ""summary"": ""Shares of Intel and UnitedHealth are trading higher Thursday afternoon, sending the Dow Jones Industrial Average into positive territory. The Dow was most...""}, {""date"": ""20230907124300"", ""headline"": ""J&J (JNJ) to End Pulmonary Hypertension Study on Opsumit"", ""summary"": ""The decision to end the CTEPH study on J&J's (JNJ) Opsumit (macitentan) was made at the recommendation of the study's independent DMC, following a pre-planned interim analysis.""}, {""date"": ""20230907130500"", ""headline"": ""1 Brand-New Dividend Stock Income Investors Won't Want to Miss"", ""summary"": ""In its brief time on the public markets, Kenvue (NYSE: KVUE) has already shown it has all the makings of a high-quality dividend stock.  Just a short time after its official separation from healthcare giant Johnson & Johnson\u00a0(NYSE: JNJ), Kenvue is already paying a dividend that yields 3.5% at recent prices.  Kenvue is the world's largest consumer healthcare products company by revenue (over $15 billion in 2022).""}, {""date"": ""20230907131142"", ""headline"": ""Vanguard High Dividend Yield ETF: A 3.1% Yielding Dividend ETF For Your Retirement Portfolio"", ""summary"": ""Vanguard High Dividend Yield ETF is a diversified investment portfolio focused on high-quality dividend stocks. Find out if VYM is a buy.""}, {""date"": ""20230907135706"", ""headline"": ""Johnson & Johnson (JNJ) 2023 Wells Fargo Securities Healthcare Conference - (Transcript)"", ""summary"": ""Johnson & Johnson (NYSE:NYSE:JNJ) 2023 Wells Fargo Securities Healthcare Conference September 7, 2023 10:15 AM ETCompany ParticipantsMichael Bodner - Global Head of Heart RecoveryAndrew...""}, {""date"": ""20230907140941"", ""headline"": ""Dell downgraded to Sell, McDonald's upgraded: Wall Street's top analyst calls"", ""summary"": ""Dell downgraded to Sell, McDonald's upgraded: Wall Street's top analyst calls""}, {""date"": ""20230907153623"", ""headline"": ""Johnson & Johnson (JNJ): A Modestly Undervalued Gem?"", ""summary"": ""A Comprehensive Analysis of Its Market Value""}, {""date"": ""20230907163100"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Shares of Johnson & Johnson rose 1.28% to $160.03 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""20230907170647"", ""headline"": ""Healthcare Stocks Push the Dow Higher"", ""summary"": ""Healthcare stocks were gaining Thursday, helping to raise the Dow, while the Nasdaq and S&P 500 dropped. Shares of Amgen (ticker: AMGN) gained 1.7% as the biotechnology stock was the second-best performer in the Dow Jones Industrial Average.""}, {""date"": ""20230907171335"", ""headline"": ""Warren Buffett Dividend Stocks by Sectors and Industries"", ""summary"": ""In this article, we discuss Warren Buffett\u2019s dividend stocks by sectors and industries. You can skip our detailed analysis of Warren Buffett\u2019s portfolio and dividend stocks, and go directly to read 5 Warren Buffett Dividend Stocks by Sectors and Industries. Warren Buffett, one of the most successful investors in history, has shown a preference for [\u2026]""}, {""date"": ""20230907214000"", ""headline"": ""Kenvue Stock Falls 6%. It May Be Fears on Tylenol Lawsuits."", ""summary"": ""The stock dropped below its IPO price for the first time Thursday. The litigation is at an early stage but seems to be worrying Wall Street.""}, {""date"": ""20230907214520"", ""headline"": ""Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) closed the most recent trading day at $160.03, moving +1.28% from the previous trading session.""}, {""date"": ""20230908040300"", ""headline"": ""Analyst Ratings for Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230908044300"", ""headline"": ""Johnson & Johnson price target lowered to $158 from $175 at Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230908050600"", ""headline"": ""The 7 Best Dow Stocks to Buy Now: September 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230908052300"", ""headline"": ""3 Shaky Stocks to Sell in September Before It\u2019s Too Late"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230908061208"", ""headline"": ""Shareholder Derivative Suits In New Jersey"", ""summary"": ""Shareholder derivative suits have become an increasingly important tool for holding corporate executives accountable for their actions. In New Jersey, these suits allow shareholders to sue company...""}, {""date"": ""20230908061700"", ""headline"": ""The 5 Best Healthcare Stocks to Buy Now: September 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230908095000"", ""headline"": ""Biotech Alert: Searches spiking for these stocks today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230908105700"", ""headline"": ""September Rally? 3 Healthcare Stocks to Buy Before Liftoff."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230908111000"", ""headline"": ""Kroger agrees to pay $1.2B to settle opioid lawsuits"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230908115300"", ""headline"": ""J&J's Janssen submits EMA marketing application for erdafitinib"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230908163100"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.33% higher to $160.56 Friday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""20230908172900"", ""headline"": ""Kenvue, the J&J Healthcare Spinoff, Has Disappointed Investors"", ""summary"": ""Kenvue  is formerly the Consumer Healthcare division of Johnson & Johnson  .  Kenvue is the proprietor of well-known brands such as Aveeno, Band-Aid, Benadryl, Johnson's Baby, Listerine, Mylanta, Neutrogena, Tylenol, and Visine.  In this daily bar chart of KVUE, below, I can see that prices have declined since the start of their spinoff from JNJ.""}, {""date"": ""20230908203556"", ""headline"": ""Barclays Maintains Johnson & Johnson (JNJ) Equal-Weight Recommendation"", ""summary"": """"}, {""date"": ""20230908230000"", ""headline"": ""AOC Has It Right on CEO David Zaslav\u2019s Pay"", ""summary"": ""Readers weigh in on Warner Bros. Discovery CEO David Zaslav, Barron\u2019s fall market outlook, BLS statistics, and the FCC, Kenvue, and the Fed""}, {""date"": ""20230909022000"", ""headline"": ""Pfizer Vs. Gilead Sciences: COVID-19 Battle Of Pharma Titans"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230909090000"", ""headline"": ""3 No-Brainer Dividend Stocks to Buy No Matter What the Market Is Doing"", ""summary"": ""If you add both of these types of stocks to your portfolio, you're likely to benefit over the long haul.  Three great examples are healthcare companies Abbott Laboratories (NYSE: ABT) and Johnson & Johnson (NYSE: JNJ) and beverage powerhouse Coca-Cola (NYSE: KO).""}, {""date"": ""20230909120000"", ""headline"": ""Big Pharma\u2019s Battle With the Biden Administration Could Have Legs"", ""summary"": ""Wall Street should pay attention as the pharma industry mounts a widening legal campaign against the Inflation Reduction Act.""}, {""date"": ""20230910022400"", ""headline"": ""HSBC bullish on IQVIA, Zoetis, bluebird, Actinium; bearish on Gilead"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230910073000"", ""headline"": ""Kenvue shares may gain after FDA comments in Tylenol-Autisim warning label  lawsuit"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230910073600"", ""headline"": ""Kenvue shares may gain after FDA comments in Tylenol-Autism warning label  lawsuit"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230910100000"", ""headline"": ""Bargain Hunting With $100? This New S&P 500 Dividend Stock Is a No-Brainer to Buy on the Dip"", ""summary"": ""The market may be sleeping on this dividend stock, down 19% in its short history as a stand-alone business.""}, {""date"": ""20230910111900"", ""headline"": ""DTD: Almost Identical To DLN, And No Specific Edge"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230910125700"", ""headline"": ""The 7 Best Warren Buffett Stocks to Buy Now: September 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230910195307"", ""headline"": ""25 Most Biodiverse Countries in the World"", ""summary"": ""In this piece, we will take a look at the 25 most biodiverse countries in the world. To skip our analysis of global biodiversity, its ecological and economic impacts, as well as some companies that operate within this space, go ahead and see the 5 Most Biodiverse Countries in the World. Biodiversity, or biological diversity, [\u2026]""}]",{}
14,2023-09-10,159.28443908691406,2023-09-17,160.1673583984375,0.005543035569480104,U1,"[{""date"": ""20230910022400"", ""headline"": ""HSBC bullish on IQVIA, Zoetis, bluebird, Actinium; bearish on Gilead"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230910073000"", ""headline"": ""Kenvue shares may gain after FDA comments in Tylenol-Autisim warning label  lawsuit"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230910073600"", ""headline"": ""Kenvue shares may gain after FDA comments in Tylenol-Autism warning label  lawsuit"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230910100000"", ""headline"": ""Bargain Hunting With $100? This New S&P 500 Dividend Stock Is a No-Brainer to Buy on the Dip"", ""summary"": ""The market may be sleeping on this dividend stock, down 19% in its short history as a stand-alone business.""}, {""date"": ""20230910125700"", ""headline"": ""The 7 Best Warren Buffett Stocks to Buy Now: September 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230910195307"", ""headline"": ""25 Most Biodiverse Countries in the World"", ""summary"": ""In this piece, we will take a look at the 25 most biodiverse countries in the world. To skip our analysis of global biodiversity, its ecological and economic impacts, as well as some companies that operate within this space, go ahead and see the 5 Most Biodiverse Countries in the World. Biodiversity, or biological diversity, [\u2026]""}, {""date"": ""20230911001410"", ""headline"": ""DTD: Almost Identical To DLN, And No Specific Edge"", ""summary"": ""WisdomTree Total U.S. Dividend ETF is almost identical to DLN in strategy and behavior. Learn why DTD ETF has lagged S&P 500 and SCHD.""}, {""date"": ""20230911013500"", ""headline"": ""AstraZeneca's Tagrisso-Chemo Combo Data In Lung Cancer Sets High Bar For Johnson & Johnson's Cancer Drug: Analyst"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230911022119"", ""headline"": ""September Self-Indexing Strategies For A Possible Blue October"", ""summary"": ""Magic Formula is still one of my favorite broad-based indexing strategies. Find out the top 30 dividend paying Magic Formula stocks scored for September 2023.""}, {""date"": ""20230911033300"", ""headline"": ""Johnson & Johnson stock rises Monday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230911053000"", ""headline"": ""3 Bulletproof Stocks to Buy Before the Next Recession Strikes"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230911083700"", ""headline"": ""Another Arthritis Blockbuster Drug Faces Generic Competition: Novartis' Sandoz Inks Pact With Samsung Bioepis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230911092100"", ""headline"": ""Warren Buffett's Highest-Yielding Stock Isn't Citigroup at 5%. He's Netting Almost 57% Annually From Another Top Holding."", ""summary"": ""Relative to Berkshire's cost basis in the company, this longtime Buffett holding is generating more than 11 times the nominal yield of Citigroup.""}, {""date"": ""20230911100100"", ""headline"": ""JNJ January 2026 Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230911100720"", ""headline"": ""Janssen Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval of Erdafitinib for the Treatment of Patients with Locally Advanced or Metastatic Urothelial Cancer"", ""summary"": ""Belgium - The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a Marketing Authorisation Application to the European Medicines Agency seeking approval of...""}, {""date"": ""20230911104900"", ""headline"": ""Could This Issue Sink Johnson & Johnson's Stock Price?"", ""summary"": ""Pharmaceutical giant Johnson & Johnson (NYSE: JNJ) is no stranger to legal issues.  This dark cloud has hovered above Johnson & Johnson's head for a while now, but it is facing another legal obstacle of a different nature.  Among the many things that landmark legislation achieved was to grant Medicare the ability to negotiate directly with drugmakers on the prices it pays for some of the drugs the U.S. government spends the most on each year.""}, {""date"": ""20230911110600"", ""headline"": ""Sandoz to commercialize biosimilar to J&J blockbuster drug Stelara"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230911114904"", ""headline"": ""Bayer: Undervalued With Clear Catalysts"", ""summary"": ""Bayer's stock\u00c2\u00a0has had a volatile performance, reaching highs and lows since December 2022, when I first wrote about this company. Read more on BAYRY stock here.""}, {""date"": ""20230911122900"", ""headline"": ""AI Integration In Biotech & Pharma: Companies Positioned To Benefit"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230911130010"", ""headline"": ""Is Trending Stock Johnson & Johnson (JNJ) a Buy Now?"", ""summary"": ""Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.""}, {""date"": ""20230911163100"", ""headline"": ""J&J (JNJ) Seeks Approval for Bladder Cancer Drug in Europe"", ""summary"": ""J&J's (JNJ) erdafitinib is already marketed as Balversa in the United States for FGFR-altered metastatic UC. Balversa is approved by the FDA under the accelerated pathway.""}, {""date"": ""20230911193038"", ""headline"": ""10 Best Dividend ETFs"", ""summary"": ""In this article, we discuss 10 best dividend ETFs. You can skip our detailed analysis of dividend stocks and exchange-traded funds, and their performance, and go directly to read 5 Best Dividend ETFs. Investing in exchange-traded funds (ETFs) is a good investment strategy for many investors as they offer several advantages, including diversification, liquidity, and [\u2026]""}, {""date"": ""20230911234759"", ""headline"": ""Doctor asks court to toss J&J lawsuit against her over cancer research"", ""summary"": ""A medical researcher has asked a court to throw out a lawsuit that Johnson & Johnson filed against her over her 2019 study on the links between cosmetic talc products and cancer, saying that her research is sound and protected by free speech rights.  Dr. Jacqueline Moline, who has served as a plaintiffs' expert in more than 200 cases alleging that J&J talc products caused patients to develop cancer, said in a Friday court filing in federal court in Trenton, New Jersey, that the lawsuit was an effort to \""intimidate\"" scientific experts.  Scientific conclusions based on accurate descriptions of the data and methodology used to develop them are protected by the First Amendment of the U.S. Constitution's protections for free speech and academic freedom, according to Moline's court filing.""}, {""date"": ""20230912021900"", ""headline"": ""Johnson & Johnson Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230912023300"", ""headline"": ""Key drug in Sudafed, Dayquil and many other decongestants doesn\u2019t relieve congestion: FDA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230912030900"", ""headline"": ""FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230912032200"", ""headline"": ""Key ingredient in Sudafed, Dayquil and many other decongestant drugs doesn\u2019t relieve congestion: FDA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230912033300"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230912034200"", ""headline"": ""NY Consulting Firm Predicts Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230912040000"", ""headline"": ""This Proven 200% Dividend Growth Strategy Is a Peter Lynch Favorite"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230912092700"", ""headline"": ""AbbVie's Skyrizi outperforms JNJ\u2019s Stelara in Crohn's disease"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230912094355"", ""headline"": ""Janssen Pharmaceutical - Treatment with RYBREVANT and Lazertinib Plus Chemotherapy Showed Durable Progression-Free Survival in Patients with Previously Treated EGFR-Mutated Advanced Non-Small Cell Lung Cancer"", ""summary"": ""SINGAPORE - The Janssen Pharmaceutical Companies of Johnson & Johnson today announced follow-up results from the Phase 1b/2 CHRYSALIS-2 study cohort evaluating the safety and tolerability of the...""}, {""date"": ""20230912103300"", ""headline"": ""FDA panel says OTC nasal decongestant doesn't work as intended"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230912104500"", ""headline"": ""Bristol Myers, J&J invest in Boston biotech's $72M VC round"", ""summary"": ""A biotech startup incubated by GV has added two more Big Pharma firms to its already-formidable cap table.""}, {""date"": ""20230912105500"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230912111504"", ""headline"": ""Popular nasal decongestant doesn't actually relieve congestion, FDA experts say"", ""summary"": ""WASHINGTON \u2014 The leading decongestant used by millions of Americans looking for relief from a stuffy nose is likely no better than a dummy pill, according to government experts who reviewed the...""}, {""date"": ""20230912121052"", ""headline"": ""Popular nasal decongestant doesn't actually relieve congestion, FDA advisers say"", ""summary"": ""WASHINGTON \u2014 The leading decongestant used by millions of Americans looking for relief from a stuffy nose is likely no better than a dummy pill, according to government experts who reviewed the...""}, {""date"": ""20230912154900"", ""headline"": ""AstraZeneca (AZN) Posts Upbeat Data on Lung Cancer Drug Combo"", ""summary"": ""Data from a late-stage study shows that AstraZeneca's (AZN) Tagrisso combined with chemotherapy cut the risk of disease progression or death by 38% in certain lung cancer patients.""}, {""date"": ""20230912160500"", ""headline"": ""Novartis' (NVS) Sandoz Gets Rights for Stelara Biosimilar"", ""summary"": ""Novartis (NVS) announces an agreement with Samsung Bioepis for exclusive rights to commercialize the biosimilar of Stelara in Europe and North America. The company discontinues the development of GT005 in geographic atrophy.""}, {""date"": ""20230912211618"", ""headline"": ""12 Best Pharma ETFs"", ""summary"": ""In this article, we discuss the 12 best pharma ETFs. If you want to skip our discussion on the pharma industry, you can go directly to the 5 Best Pharma ETFs. As of 2023, Deloitte has valued the pharmaceutical, biotechnology, and medical technology industries at $2.83 trillion. A report on the Global Pharmaceuticals Outlook by [\u2026]""}, {""date"": ""20230913033300"", ""headline"": ""Johnson & Johnson stock underperforms Wednesday when compared to competitors despite daily gains"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230913083600"", ""headline"": ""The most popular decongestants don\u2019t actually work: FDA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230913093000"", ""headline"": ""Better Buy: J&J vs. Kenvue"", ""summary"": ""When you used to think of Band-Aid bandages and Tylenol, you probably thought of healthcare giant Johnson & Johnson (NYSE: JNJ).  This summer, J&J completed its spinoff of its consumer health business, forming a new company called Kenvue (NYSE: KVUE).  This left J&J with two other units -- pharmaceuticals and medtech -- and set Kenvue off on the road to growing the consumer health business independently.""}, {""date"": ""20230913114100"", ""headline"": ""Here's My Top Growth Stock to Buy in 2023"", ""summary"": ""The growth train is leaving the station and you don't want to miss it. Find out why this stock remains a strong buy even after doubling in 2023.""}, {""date"": ""20230913122310"", ""headline"": ""Johnson & Johnson (JNJ) Morgan Stanley 21st Annual Global Healthcare Conference (Transcript)"", ""summary"": ""Johnson & Johnson (NYSE:NYSE:JNJ) Morgan Stanley 21st Annual Global Healthcare Conference September 13, 2023 10:10 AM ETCompany ParticipantsJoaquin Duato - Chairman and Chief Executive...""}, {""date"": ""20230913154922"", ""headline"": ""Globus Medical: Almost Having My Back"", ""summary"": ""Analysis of Globus Medical, Inc.'s recent acquisition of NuVasive, its record in the spine industry, operating momentum, and valuation. Click for more on GMED.""}, {""date"": ""20230913202348"", ""headline"": ""Buy the Dip: 3 Healthcare Stocks to Snag Now for Supercharged Gains"", ""summary"": ""In the ever-evolving landscape of investing, the spotlight is on the top healthcare stocks to buy on the dip. The healthcare sector is highly known for its robust resilience and incredible growth potential. Once again, it\u2019s been thrust into the limelight due to global health challenges. With inflation rearing its head and consumers prioritizing essentials, healthcare indisputably emerges as a non-negotiable expenditure. This context has led to a surge in investors scouting the market for prime h""}, {""date"": ""20230913214517"", ""headline"": ""Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know"", ""summary"": ""In the latest trading session, Johnson & Johnson (JNJ) closed at $163.99, marking a +0.25% move from the previous day.""}, {""date"": ""20230914014000"", ""headline"": ""P&G, J&J face class action suits over cold medicine drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230914021500"", ""headline"": ""Lawsuit Against Dummy Pills For Allergy, Cold: Johnson & Johnson And Procter & Gamble Face Allegations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230914022100"", ""headline"": ""FTC warns pharma industry on improperly listed patents"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230914033300"", ""headline"": ""Johnson & Johnson stock underperforms Thursday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230914081000"", ""headline"": ""My Dividend Stock Portfolio: New August Dividend Record - 99 Holdings With 27 Buys"", ""summary"": ""The S&P 500 and Dow Jones Industrial Average both saw slim positive returns in August. Check out the latest dividend stock portfolio update.""}, {""date"": ""20230914092000"", ""headline"": ""3 Warren Buffett Stocks That Are Near Their 52-Week Lows"", ""summary"": ""Growth stocks are getting some love again in 2023, and that normally means value investments get pushed to the back burner.  Warren Buffett's Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) holds many quality value stocks, and several of them are on sale right now.  Three Buffett/Berkshire stocks that are trading near their 52-week lows are Coca-Cola\u00a0(NYSE: KO),\u00a0Johnson & Johnson (NYSE: JNJ), and\u00a0Paramount Global\u00a0(NASDAQ: PARA).""}, {""date"": ""20230914101200"", ""headline"": ""Janssen to be renamed Johnson & Johnson Innovative Medicine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230914123700"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230914140000"", ""headline"": ""Johnson & Johnson Marks New Era as Global Healthcare Company With Updated Visual Identity"", ""summary"": ""NEW BRUNSWICK, N.J., September 14, 2023--For more than 135 years, Johnson & Johnson (the \""Company\"") (NYSE: JNJ) has provided health care products and solutions to people worldwide. Now, with its exclusive focus on healthcare innovation and tackling the toughest health challenges, the Company is updating its brand and uniting both its medtech and pharmaceutical segments under the Johnson & Johnson brand name to demonstrate its collective power in healthcare.""}, {""date"": ""20230914140010"", ""headline"": ""Johnson & Johnson is getting rid of its script logo after more than 130 years"", ""summary"": ""Johnson & Johnson is signing off on a new logo.  The health care giant said Thursday that it will replace the well-known signature script it has used since 1887 with a modern look that reflects its sharpened focus on pharmaceuticals and medical devices.  The original script \u2014 based on co-founder James Wood Johnson's signature \u2014 will still be seen for now on consumer products like baby shampoo from Kenvue, a new company recently spun off from J&J.""}, {""date"": ""20230914142800"", ""headline"": ""At Johnson & Johnson, a New Look but Old Hurdles"", ""summary"": ""The company led by Joaquin Duato launches a branding as it focuses on higher-risk prescription drugs and medical devices after shedding its consumer business.""}, {""date"": ""20230914165224"", ""headline"": ""J&J, P&G sued after FDA panel ruling on cold medicine decongestant"", ""summary"": ""A new lawsuit accuses Johnson & Johnson and Procter & Gamble of deceiving consumers about decongestant cold medicines containing an ingredient that a unanimous U.S. Food and Drug Administration advisory panel this week declared ineffective.  According to a proposed class action on Wednesday filed in Pensacola, Florida, federal court, the companies knew or should have known by 2018 that their marketing claims about products containing phenylephrine were false and misleading.  That year was when new FDA guidance for evaluating symptoms related to nasal congestion demonstrated that earlier data about phenylephrine's effectiveness could no longer be relied upon, the complaint said.""}, {""date"": ""20230914181711"", ""headline"": ""UPDATE 2-J&J, P&G, Walgreens sued after FDA panel ruling on cold medicine decongestant"", ""summary"": ""Johnson & Johnson, Procter & Gamble and Walgreens are among several companies accused in lawsuits of deceiving consumers about cold medicines containing an ingredient that a unanimous U.S. Food and Drug Administration advisory panel declared ineffective.  Proposed class actions were filed on Wednesday and Thursday, after the panel reviewed several studies and concluded this week that the ingredient phenylephrine marketed as a decongestant was essentially no better than a placebo.  According to an agency presentation, about 242 million products with phenylephrine were sold in the United States last year, generating $1.76 billion of sales and accounting for about four-fifths of the market for oral decongestants.""}, {""date"": ""20230914190525"", ""headline"": ""3 Blue-Chip Stocks to Watch in the \u2018Green Zone\u2019"", ""summary"": ""Blue-chip stocks represent ownership in established, financially sound businesses, but are the blue-chips you\u2019re taking a look at today in the \u201cGreen Zone stocks\u201d category? TradeSmith offers investors valuable tools for determining which stocks to watch. A good example is its Health Indicator feature. This comprehensive indicator provides an overall rating of a stock\u2019s current health. Using this metric, you can quickly find potential opportunities to explore. Broken down into three \u201czones\u201d (gree""}, {""date"": ""20230914201257"", ""headline"": ""Johnson & Johnson ditching script logo after 130 years"", ""summary"": ""Johnson & Johnson announced that it's ditching the classic cursive script it has used for 130 years in favor of a revamped logo that pays homage to the old design.""}, {""date"": ""20230915033300"", ""headline"": ""Johnson & Johnson stock falls Friday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230915035700"", ""headline"": ""J&J investigated by South African authorities over 'excessive' drug pricing - report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230915042200"", ""headline"": ""The Dogs of the Dividend Aristocrats"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230915042700"", ""headline"": ""VTI ETF: This Diversified Powerhouse Owns Over 3,800 Stocks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230915043900"", ""headline"": ""Novartis shareholders approve 100% spinout of Sandoz unit"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230915055600"", ""headline"": ""Sandoz Pushes Product Launch Plans As Novartis Shareholders Approve The Spin-Off"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230915061249"", ""headline"": ""25 Most Admired Companies in 2023"", ""summary"": ""In this article, we will be analyzing the most admired companies in the world, their characteristics, and some recent initiatives taken by them to maintain their market position. If you wish to skip our detailed analysis, you can move directly to the 5 Most Admired Companies in 2023. What Makes A Company Admired? Companies around [\u2026]""}, {""date"": ""20230915091049"", ""headline"": ""The 3 Most Undervalued Dow Stocks to Buy in September 2023"", ""summary"": ""The Dow Jones Industrial Average has climbed 5.3% so far this year. The index is trailing the S&P 500, which has climbed 17.8%. Additionally, at least two Dow stocks, Johnson and Johnson (NYSE:JNJ) and Walgreens (NYSE:WBA), are being weighed down by potentially ruinous litigation. Meanwhile, Home Depot (NYSE:HD) is a victim of the frozen residential real estate market and Disney\u2019s (NYSE:DIS) business model is falling apart. So I would definitely not recommend buying an ETF that tracks Dow stocks""}, {""date"": ""20230915121000"", ""headline"": ""3 Great Dividend Stocks You Can Buy for Less Than $50"", ""summary"": ""These steady-Eddie operators are perfect bedrock stocks for investors despite trading for less than $50.""}, {""date"": ""20230915122623"", ""headline"": ""Big Pharma's Johnson & Johnson under investigation in South Africa over 'excessive' drug prices"", ""summary"": ""U.S.-based pharmaceuticals company Johnson & Johnson is being investigated in South Africa for allegedly charging \u201cexcessive\u201d prices for a key tuberculosis drug, the country's antitrust regulator said Friday.  J&J's Belgium-based subsidiary Janssen Pharmaceuticals is also under investigation, South Africa's Competition Commission said.  The commission, which regulates business practices, said it opened the investigation this week based on information that the companies \u201cmay have engaged in exclusionary practices and excessive pricing\u201d of the tuberculosis drug bedaquiline, which is sold under the brand name Sirturo.""}, {""date"": ""20230915130218"", ""headline"": ""AbbVie Vs. AstraZeneca: Battle Of The Pharmaceutical Behemoths"", ""summary"": ""AstraZeneca's (AZN) strong revenue growth outperforms AbbVie's (ABBV) declining sales. Click here to read more on the battle of the pharmaceutical behemoths.""}, {""date"": ""20230915131659"", ""headline"": ""This J&J exec sold Tylenol and Listerine. Now she runs its $27 billion medtech business"", ""summary"": ""Ashley McEvoy pivoted from over-the-counter products to medical devices.""}, {""date"": ""20230915165900"", ""headline"": ""Top Analyst Reports for Meta Platforms, Walmart & Johnson & Johnson"", ""summary"": ""Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), Walmart Inc. (WMT) and Johnson & Johnson (JNJ).""}, {""date"": ""20230916030500"", ""headline"": ""With ecstasy a potential PTSD therapy, psychedelic treatments could take off"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230916082636"", ""headline"": ""IXJ: Healthcare Dashboard For September"", ""summary"": ""Healthcare providers and pharmaceuticals/biotechnology look fairly valued, whereas healthcare equipment is the less attractive subsector. Read more here.""}, {""date"": ""20230917054800"", ""headline"": ""Acelyrin, MoonLake rivalry heats up as both chase blockbuster PsA market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230917070214"", ""headline"": ""Johnson & Johnson: AAA-Rated And Potentially 20% Undervalued"", ""summary"": ""Johnson & Johnson stock has shown resilience in the face of bad news. Check out what makes JNJ an appealing investment choice.""}, {""date"": ""20230917150900"", ""headline"": ""3 High-Quality Dividend Stocks Yielding 3%-Plus to Buy for Decades of Rising Income"", ""summary"": ""After years of lower yields, income-focused investors have many more attractive options these days.  While the overall dividend yield of the market remains well below its historical average (currently around 1.5% for the\u00a0S&P 500), many companies offer much more attractive yields.  American Tower\u00a0(NYSE: AMT),\u00a0Brookfield Renewable\u00a0(NYSE: BEPC)(NYSE: BEP), and\u00a0Kenvue\u00a0(NYSE: KVUE) currently offer\u00a0dividend yields more than double the market's average.""}]",{}
15,2023-09-17,160.1673583984375,2023-09-24,159.22491455078125,-0.005884119317943637,D1,"[{""date"": ""20230917054800"", ""headline"": ""Acelyrin, MoonLake rivalry heats up as both chase blockbuster PsA market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230917070214"", ""headline"": ""Johnson & Johnson: AAA-Rated And Potentially 20% Undervalued"", ""summary"": ""Johnson & Johnson stock has shown resilience in the face of bad news. Check out what makes JNJ an appealing investment choice.""}, {""date"": ""20230917150900"", ""headline"": ""3 High-Quality Dividend Stocks Yielding 3%-Plus to Buy for Decades of Rising Income"", ""summary"": ""After years of lower yields, income-focused investors have many more attractive options these days.  While the overall dividend yield of the market remains well below its historical average (currently around 1.5% for the\u00a0S&P 500), many companies offer much more attractive yields.  American Tower\u00a0(NYSE: AMT),\u00a0Brookfield Renewable\u00a0(NYSE: BEPC)(NYSE: BEP), and\u00a0Kenvue\u00a0(NYSE: KVUE) currently offer\u00a0dividend yields more than double the market's average.""}, {""date"": ""20230918020800"", ""headline"": ""AARP weighs in on Merck case challenging Medicare drug negotiation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230918033300"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230918070800"", ""headline"": ""Rani Therapeutics initiates Phase 1 study of RT-111"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230918071600"", ""headline"": ""Cantor Fitzgerald Sticks to Their Buy Rating for Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230918073551"", ""headline"": ""Johnson & Johnson's Reinvention - Is A New Logo Enough?"", ""summary"": ""Johnson & Johnson's transformation, marked by the split-off of its consumer health division, is a significant shift in strategy. Click here to see if the new logo is enough.""}, {""date"": ""20230918120300"", ""headline"": ""The Zacks Analyst Blog Highlights Meta Platforms, Walmart, Johnson & Johnson, Pfizer and Morgan Stanley"", ""summary"": ""Meta Platforms, Walmart, Johnson & Johnson, Pfizer and Morgan Stanley are part of the Zacks top Analyst Blog.""}, {""date"": ""20230918120400"", ""headline"": ""Johnson & Johnson: Kenvue Spin-Off Unlikely To Drive Market-Beating Returns"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230918121939"", ""headline"": ""Kenvue: Interesting Times"", ""summary"": ""Kenvue's shares have fallen since its IPO due to high valuations and concerns about its growth composition. Click here for more on KVUE stock.""}, {""date"": ""20230918174658"", ""headline"": ""Johnson & Johnson: A Very Cautious 'Buy'"", ""summary"": ""Johnson & Johnson is a stable dividend payer, and the stock could be slightly undervalued right now. Click here to read my analysis of JNJ stock.""}, {""date"": ""20230918203000"", ""headline"": ""Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results"", ""summary"": ""NEW BRUNSWICK, N.J., September 18, 2023--Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 17th to review third-quarter results. Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Jessica Moore, Vice President, Investor Relations will host the call. The question and answer portion of the call will also include additional members of Johnson & Johnson\u2019s executive team.""}, {""date"": ""20230919002410"", ""headline"": ""Cantor Fitzgerald Reiterates Johnson & Johnson (JNJ) Overweight Recommendation"", ""summary"": """"}, {""date"": ""20230919033300"", ""headline"": ""Johnson & Johnson stock falls Tuesday, still outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230919055307"", ""headline"": ""Kenvue Is Not The Better Johnson & Johnson, Also Not For Dividend Investors"", ""summary"": ""Kenvue faces significant challenges in the consumer healthcare sector. Read why KVUE stock might not be the ideal choice for those seeking a ""}, {""date"": ""20230919080000"", ""headline"": ""FDRR: Attractive Value And Quality, Yet Lagging In Rising Rates"", ""summary"": ""FDRR ETF holds dividend stocks showing a positive correlation to 10-year U.S. Treasury yields. Find out why I'm neutral on the fund.""}, {""date"": ""20230919082559"", ""headline"": ""10 Best Investments During A Recession"", ""summary"": ""insIn this article, we discuss 10 best investments during a recession. If you want to skip our discussion on the stock market and recessionary concerns, head directly to 5 Best Investments During A Recession. The United States economy managed to steer clear of a recession due to a robust job market. However, this is typically [\u2026]""}, {""date"": ""20230919125648"", ""headline"": ""CSQ: This Blended Fund Has Appealing Features, But Its Price Is Too High"", ""summary"": ""Calamos Strategic Total Return Fund's market performance has been decent, but there are other funds that have outperformed it. Read more on CSQ CEF here.""}, {""date"": ""20230919144533"", ""headline"": ""Regeneron Pharmaceuticals: Game-Changing Discoveries In Healthcare"", ""summary"": ""Regeneron Pharmaceuticals Q2 2023 revenue exceeded expectations despite competition and falling Eylea sales. Click here to read an analysis on REGN stock now.""}, {""date"": ""20230919153633"", ""headline"": ""7 Safe and Steady Dividend Stocks to Buy for Volatile Time"", ""summary"": ""Navigating the unpredictable waters of today\u2019s market, safe dividend stocks emerge as a beacon of reliability. Despite an optimistic kickoff this year, the broader market sentiment has chilled. For investors eager to remain engaged but wary of current volatilities, turning to trusted companies offering consistent dividends might be the savvy move. Recent data adds weight to this strategy. Recently, CNBC highlighted that August\u2019s core inflation, excluding food and energy, edged up by 0.3%, exceed""}, {""date"": ""20230919214520"", ""headline"": ""Johnson & Johnson (JNJ) Stock Moves -0.17%: What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) closed the most recent trading day at $162.20, moving -0.17% from the previous trading session.""}, {""date"": ""20230920032100"", ""headline"": ""Johnson & Johnson Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230920033400"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230920042700"", ""headline"": ""Amazon, Disney, Boeing boosted in Wells Fargo Signature Picks portfolio"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230920092100"", ""headline"": ""3 No-Brainer Stocks to Buy With $500 Right Now"", ""summary"": ""Since the beginning of the decade, Wall Street's major stock indexes have navigated their way through two bear markets.  Although they've rebounded in a big way from their 2022 bear market lows, the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite remain firmly below their all-time highs.  What this represents is an opportunity for patient investors to pounce on plain-as-day bargains.""}, {""date"": ""20230920100000"", ""headline"": ""Buying These 2 Stocks Is a Good Way to Hedge Against a Market Crash"", ""summary"": ""No one likes to think about a market crash, but the best way to stay afloat through such a time is to think ahead, plan, and be prepared.  You could hedge against a market crash by choosing stocks that probably won't plummet during the worst of times and are sure to thrive over time.  Market leaders and companies with either strong brand strength or products people can't avoid buying are good candidates.""}, {""date"": ""20230920172941"", ""headline"": ""Consumers seek consolidation of class actions against P&G, Johnson & Johnson over decongestant"", ""summary"": ""Plaintiffs suing Procter & Gamble and other drug companies over a supposedly ineffective nasal decongestant are asking a federal panel to consolidate the cases in New Jersey District Court.""}, {""date"": ""20230920185253"", ""headline"": ""Rockville life sciences firm Emmes names former J&J exec Peter Ronco as its new CEO"", ""summary"": ""Rockville clinical research organization The Emmes Co. has tapped a former Johnson & Johnson and Bristol Myers-Squibb Co. executive to be its next CEO.  The company, which conducts research for public- and private-sector clients, announced Wednesday that Peter Ronco will replace replace Dr. Christine Dingivan as CEO, effective immediately.  Dingivan, Emmes\u2019 CEO since September 2020, will serve as a senior adviser to Executive Chairman Sastry Chilukiri and Emmes\u2019 board of directors, the company said in an announcement.""}, {""date"": ""20230921081644"", ""headline"": ""Nicholas Ward's Dividend Growth Portfolio: September 2023 Fair Value Update"", ""summary"": ""I've been building my cash position in preparation for a market crash and taking advantage of high interest rates. Read more here.""}, {""date"": ""20230921120000"", ""headline"": ""Blockbuster Cancer Treatment Stymied by Supply Chain\u2014for Now"", ""summary"": ""A cell therapy for multiple myeloma promises to be a major blockbuster for J&J and partner Legend, if they can increase manufacturing.""}, {""date"": ""20230921124100"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230921163200"", ""headline"": ""Johnson & Johnson stock falls Thursday, still outperforms market"", ""summary"": ""Shares of Johnson & Johnson slipped 0.77% to $161.66 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""20230922130012"", ""headline"": ""Here is What to Know Beyond Why Johnson & Johnson (JNJ) is a Trending Stock"", ""summary"": ""Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.""}, {""date"": ""20230922153532"", ""headline"": ""Protagonist Therapeutics: There Are Reasons Behind Johnson & Johnson's Optimism"", ""summary"": ""We look at the pros and cons of J&J's oral IL-23 drug, JNJ-2113, compared to Protagonist Therapeutics, Inc.'s oral treatment. Click for more on PTGX.""}, {""date"": ""20230922155344"", ""headline"": ""The Buffett List: 5 Dividend Buys For September"", ""summary"": ""An update on Warren Buffett's holdings and dividend stocks, revealing top picks and potential gains for September. Explore more details here.""}, {""date"": ""20230922163200"", ""headline"": ""Johnson & Johnson stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson shed 0.72% to $160.50 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""20230922194755"", ""headline"": ""20 Most Innovative Companies in America"", ""summary"": ""In this article, we will take a look at the most innovative companies in America. If you want to explore similar companies, you can go to 5 Most Innovative Companies in America. Innovation and American Companies Innovation comes with new and creative ideas that bring a healthy change in society. Innovation in business and technology [\u2026]""}, {""date"": ""20230923083000"", ""headline"": ""Johnson & Johnson: The Bull Case Can No Longer Be Ignored"", ""summary"": ""JNJ's best-in-class ""}, {""date"": ""20230924114100"", ""headline"": ""3 Best Stocks to Buy in September and Hold Forever"", ""summary"": ""There will always be a healthcare industry, and it will always be a place to find great long-term stocks.  You probably know healthcare conglomerate Johnson & Johnson for some of its former brands, like Tylenol and Band-Aids.""}, {""date"": ""20230924165249"", ""headline"": ""Dividend Stock Portfolio: 15 Stocks To Buy According to Reddit"", ""summary"": ""In this article, we discuss 15 dividend stocks to buy according to Reddit. You can skip our detailed analysis of dividend stocks and the role of retail investors in today\u2019s stock market, and go directly to read Dividend Stock Portfolio: 5 Stocks To Buy According to Reddit. While tech stocks outperformed dividend stocks in the [\u2026]""}]",{}
16,2023-09-24,159.22491455078125,2023-10-01,154.5126495361328,-0.02959502303984951,D3,"[{""date"": ""20230924114100"", ""headline"": ""3 Best Stocks to Buy in September and Hold Forever"", ""summary"": ""There will always be a healthcare industry, and it will always be a place to find great long-term stocks.  You probably know healthcare conglomerate Johnson & Johnson for some of its former brands, like Tylenol and Band-Aids.""}, {""date"": ""20230924165249"", ""headline"": ""Dividend Stock Portfolio: 15 Stocks To Buy According to Reddit"", ""summary"": ""In this article, we discuss 15 dividend stocks to buy according to Reddit. You can skip our detailed analysis of dividend stocks and the role of retail investors in today\u2019s stock market, and go directly to read Dividend Stock Portfolio: 5 Stocks To Buy According to Reddit. While tech stocks outperformed dividend stocks in the [\u2026]""}, {""date"": ""20230925094500"", ""headline"": ""3M, Merck share losses lead Dow's nearly 100-point drop"", ""summary"": ""Shares of 3M and Merck are trading lower Monday morning, sending the Dow Jones Industrial Average into negative territory. Shares of 3M and Merck are...""}, {""date"": ""20230925103500"", ""headline"": ""(JNJ) - Analyzing Johnson & Johnson's Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230925105600"", ""headline"": ""Alvotech partner starts biosimilar threat to JNJ\u2019s Stelara in Japan"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230925162300"", ""headline"": ""Cooper Offers A Great Business But A Somewhat Tricky Valuation"", ""summary"": ""The Cooper Companies, Inc. has above average growth and margin leverage potential. Click here to find out why COO stock is rated as a buy.""}, {""date"": ""20230925163100"", ""headline"": ""Johnson & Johnson stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Johnson & Johnson slumped 0.15% to $160.26 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20230925182338"", ""headline"": ""Retirement Passive Income Snowball: VYM May Be All You Need"", ""summary"": ""Vanguard High Dividend Yield Index Fund's trailing 12-month dividend yield is 3.2%. Compared to major equity indexes, the yield is actually quite high. Learn more on VYM ETF here.""}, {""date"": ""20230926012400"", ""headline"": ""Immunovant drives OmniAb higher after data update; argenx slips"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230926101500"", ""headline"": ""This Is the Holy Grail of Investing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230926114100"", ""headline"": ""2 Monster Stocks to Buy Without Any Hesitation"", ""summary"": ""Johnson & Johnson, one of the largest healthcare companies in the world, has been around for decades, has historically crushed the market, and continues to generate steady revenue and profits.  First, the company is a proven innovator in healthcare.  There is always a need for better, safer, more effective therapies or medical devices.""}, {""date"": ""20230926162600"", ""headline"": ""Novartis' (NVS) Sandoz Gets EC Nod for Tysabri's Biosimilar"", ""summary"": ""Novartis' (NVS) Sandoz broadens its biosimilar portfolio with Tyruko's approval, a biosimilar of the multiple sclerosis drug Tysabri in the EU.""}, {""date"": ""20230926163200"", ""headline"": ""Johnson & Johnson stock falls Tuesday, still outperforms market"", ""summary"": ""Shares of Johnson & Johnson slipped 0.77% to $159.02 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""20230926193326"", ""headline"": ""15 Best Dividend Aristocrat Stocks To Buy Now"", ""summary"": ""In this article, we discuss 15 best dividend aristocrat stocks to buy now. You can skip our detailed analysis of dividend stocks and their performance, and go directly to read 5 Best Dividend Aristocrat Stocks To Buy Now. Dividend Aristocrats are a select group of publicly traded companies in the S&P 500 that have raised [\u2026]""}, {""date"": ""20230926214519"", ""headline"": ""Johnson & Johnson (JNJ) Stock Moves -0.77%: What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) closed the most recent trading day at $159.02, moving -0.77% from the previous trading session.""}, {""date"": ""20230927013500"", ""headline"": ""Almost 1,500 high-grade corporate bonds are on sale. Here\u2019s how you could add cheap Apple bonds to your portfolio."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230927023500"", ""headline"": ""Notable Wednesday Option Activity: JNJ, RIVN, KRTX"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230927072036"", ""headline"": ""Arm, Instacart, Birkenstock ... the IPOs of 2023 and beyond"", ""summary"": ""The most well known IPOs so far this year that have made headlines and moved the markets.""}, {""date"": ""20230927093000"", ""headline"": ""3 Things About Johnson & Johnson That Smart Investors Know"", ""summary"": ""J&J recently spun off its consumer health business into a separate entity called Kenvue, and the healthcare giant is even changing its famous logo -- red printed letters will replace the cursive.  Meanwhile, J&J's share price doesn't reflect the idea of these exciting new times.  J&J's consumer health business brought in about $14 billion in revenue last year, so you may be wondering why spinning this unit off is a good idea.""}, {""date"": ""20230927103100"", ""headline"": ""Relative Strength Alert For Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230927103500"", ""headline"": ""Looking At Johnson & Johnson's Recent Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230927104800"", ""headline"": ""Biden's Urgent Action Against Antibiotic-Resistant Bacteria - Allocates $100M to Battle Deadly Superbugs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230927105300"", ""headline"": ""Dow falls nearly 100 points on losses for Walgreens Boots, Johnson & Johnson stocks"", ""summary"": ""The Dow Jones Industrial Average is falling Wednesday morning with shares of Walgreens Boots and Johnson & Johnson delivering the stiffest headwinds for the...""}, {""date"": ""20230927120600"", ""headline"": ""Johnson & Johnson, Verizon share losses contribute to Dow's 186-point fall"", ""summary"": ""Shares of Johnson & Johnson and Verizon are seeing declines Wednesday afternoon, dragging the Dow Jones Industrial Average into negative territory. Shares of...""}, {""date"": ""20230927131200"", ""headline"": ""The Kellogg Split"", ""summary"": ""Why Kellogg is splitting up its business.  Motley Fool host Ricky Mulvey and sports journalist John Nash analyze newly listed TKO Holdings, the company that runs both WWE and UFC, and address the challenges it may face.  To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center.""}, {""date"": ""20230927132700"", ""headline"": ""Dow's 270-point fall led by losses in shares of Walgreens Boots, Johnson & Johnson"", ""summary"": ""The Dow Jones Industrial Average is falling Wednesday afternoon with shares of Walgreens Boots and Johnson & Johnson facing the biggest declines for the...""}, {""date"": ""20230927143300"", ""headline"": ""Almost 1,500 high-grade corporate bonds are on sale. Here's how you could add cheap Apple bonds to your portfolio."", ""summary"": ""Almost 1,500 high-grade corporate bonds issued by some household names are currently trading between 50 and 80 cents on the dollar.""}, {""date"": ""20230927163200"", ""headline"": ""Johnson & Johnson stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson shed 1.20% to $157.11 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""20230928024000"", ""headline"": ""What to Note in the AI Megatrend"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230928072100"", ""headline"": ""Johnson & Johnson posts Phase 3 win for lung cancer therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230928081500"", ""headline"": ""Needham medtech/diagnostics analysts hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230928085300"", ""headline"": ""SCHX ETF: A Large-Cap ETF for Large Gains"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230928092100"", ""headline"": ""Pharma Giants Shift Stance, Embrace Medicare Negotiations Amid Rising Drug Costs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230928102100"", ""headline"": ""There\u2019s a sale on corporate bonds. How to add cheap Apple, Disney and Microsoft bonds to your portfolio."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230928102800"", ""headline"": ""Interesting JNJ Put And Call Options For November 10th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230928111400"", ""headline"": ""J&J hit with 11,000 new talc complaints after settlement tossed, Bloomberg says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230928114732"", ""headline"": ""UPDATE 1-J&J's lung cancer therapy combo succeeds in late-stage study"", ""summary"": ""Johnson & Johnson said on Thursday its cancer therapy combination met the main goal in a late-stage study testing it as a treatment for patients with a type of lung cancer.  The drugmaker said an interim analysis of data from the study showed a trend \""favoring\"" the combination of its antibody treatment Rybrevant and experimental drug lazertinib, when compared to AstraZeneca's cancer drug osimertinib or Tagrisso.  J&J said it plans to submit data for an upcoming scientific conference, including additional details on certain secondary goals from the study.""}, {""date"": ""20230928123700"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230928141500"", ""headline"": ""3 Dividend Kings With Recession-Proof Payouts"", ""summary"": ""These names, which have raised their payouts for over 50 straight years, have dividends that are well-covered even during a recession.""}, {""date"": ""20230928163200"", ""headline"": ""Johnson & Johnson stock falls Thursday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson shed 0.15% to $156.88 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20230929011700"", ""headline"": ""IN BRIEF: J&J reports positive results for Rybrevant in combination"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230929042300"", ""headline"": ""IN BRIEF: Fresenius Kabi gains European marketing review for FYB202"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230929050200"", ""headline"": ""Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: Maravai Lifesciences Holdings (MRVI), Johnson & Johnson (JNJ) and Amicus (FOLD)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230929061342"", ""headline"": ""Dividend Aristocrats Ranked By Yield: Top 25"", ""summary"": ""In this article, we discuss top 25 dividend aristocrats ranked by yield. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read Dividend Aristocrats Ranked By Yield: Top 10. At the start of the year, there was a lot of excitement surrounding tech stocks. However, [\u2026]""}, {""date"": ""20230929071500"", ""headline"": ""Don\u2019t Miss Out: 3 Dividend Stocks to Buy on EVERY. SINGLE. DIP."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230929083122"", ""headline"": ""Unitaid urges Johnson & Johnson to improve access to TB drug bedaquiline"", ""summary"": ""Global health aid agency Unitaid has written to Johnson & Johnson's (J&J) CEO Joaquin Duato, urging him to take \""immediate action\"" to expand access to the company's tuberculosis drug bedaquiline.  While J&J has already lowered the price of bedaquiline which is used to treat drug-resistant tuberculosis (TB), Unitaid said this was an \""incomplete solution\"", saying countries like South Africa, Belarus and Ukraine were not benefiting.""}, {""date"": ""20230929083553"", ""headline"": ""Aid agency urges Johnson & Johnson to improve access to tuberculosis drug"", ""summary"": ""GENEVA (Reuters) -Global health aid agency Unitaid has written to Johnson & Johnson's (J&J) CEO Joaquin Duato, urging \""immediate action\"" to expand access to the company's tuberculosis drug bedaquiline, which is protected by patents hindering generic alternatives.  While J&J has already lowered the price of bedaquiline which is used to treat drug-resistant tuberculosis (DR-TB), Unitaid said this was an \""incomplete solution\"" and countries like South Africa, Belarus and Ukraine were not benefiting.""}, {""date"": ""20230929092100"", ""headline"": ""These 7 Dividend Stocks Pay $98 Billion Annually, Combined, to Their Shareholders"", ""summary"": ""Seven brand-name, time-tested businesses are doling out between $11.2 billion and $22.3 billion to their shareholders each year.""}, {""date"": ""20230929092100"", ""headline"": ""As Merck, AstraZeneca and other drugmakers sign on, Medicare price negotiations face critical moment"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230929102000"", ""headline"": ""As Merck, AstraZeneca and other drugmakers sign on, Medicare price negotiations face critical moment\u00a0"", ""summary"": ""A deadline looms to sign drug-price negotiation agreements as industry watches for legal reprieve.""}, {""date"": ""20230929104119"", ""headline"": ""UPDATE 1-Aid agency urges Johnson & Johnson to improve access to tuberculosis drug"", ""summary"": ""Global health aid agency Unitaid has written to Johnson & Johnson's (J&J) CEO Joaquin Duato, urging \""immediate action\"" to expand access to the company's tuberculosis drug bedaquiline, which is protected by patents hindering generic alternatives.  While J&J has already lowered the price of bedaquiline which is used to treat drug-resistant tuberculosis (DR-TB), Unitaid said this was an \""incomplete solution\"" and countries like South Africa, Belarus and Ukraine were not benefiting.""}, {""date"": ""20230929123159"", ""headline"": ""Recession-Proof Royals: 3 Stocks That Thrive in Tough Economic Times"", ""summary"": ""In the new century, economic uncertainty often looms. Finding investment opportunities that can weather the storm is a quest every investor undertakes. The article lists the \u201cRecession-Proof Royals\u201d, three titans of their respective industries who have not only stood the test of time but have thrived during economic downturns. These can be considered recession proof stocks. The first one\u2019s diverse product categories maintain stable demand, regardless of the economic climate. The second one\u2019s mul""}, {""date"": ""20230929163200"", ""headline"": ""Johnson & Johnson stock falls Friday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson shed 0.72% to $155.75 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""20230930093300"", ""headline"": ""LLY, ISRG, or JNJ: Which Healthcare Stock Could Generate the Best Returns?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230930105500"", ""headline"": ""3 Magnificent Dividend Stocks to Buy in October"", ""summary"": ""There's no better time than October to invest in high-quality dividend stocks.  Three Motley Fool contributors believe they've identified magnificent dividend stocks to buy in October.  Here's why they chose AbbVie (NYSE: ABBV), Gilead Sciences (NASDAQ: GILD), and Johnson & Johnson (NYSE: JNJ).""}, {""date"": ""20230930155408"", ""headline"": ""15 Warren Buffett Stocks That Are On Sale Now"", ""summary"": ""In this article, we will discuss the 15 Warren Buffett stocks that are on sale now. If you want to explore similar stocks, you can also take a look at 5 Warren Buffett Stocks That Are On Sale Now. Warren Buffett stands out as the most successful investor after nearly six decades of making waves [\u2026]""}, {""date"": ""20231001100000"", ""headline"": ""Could Kenvue Follow in the Footsteps of Johnson & Johnson and Become a Top Dividend Stock?"", ""summary"": ""When you think of the products populating your medicine cabinet -- like Band-Aid bandages or Tylenol -- you might not think of Kenvue (NYSE: KVUE).  After all, these items have Johnson & Johnson written all over them -- literally.  Speaking of rewarding shareholders, Kenvue is off to a good start, initiating a dividend during its very first months of operation as an independent company.""}]",{}
17,2023-10-01,154.5126495361328,2023-10-08,156.38763427734375,0.012134830040387623,U2,"[{""date"": ""20231001100000"", ""headline"": ""Could Kenvue Follow in the Footsteps of Johnson & Johnson and Become a Top Dividend Stock?"", ""summary"": ""When you think of the products populating your medicine cabinet -- like Band-Aid bandages or Tylenol -- you might not think of Kenvue (NYSE: KVUE).  After all, these items have Johnson & Johnson written all over them -- literally.  Speaking of rewarding shareholders, Kenvue is off to a good start, initiating a dividend during its very first months of operation as an independent company.""}, {""date"": ""20231002015200"", ""headline"": ""Cantor biotech/biopharma analysts to hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231002020100"", ""headline"": ""Drugmakers comply with Medicare pricing talks despite lawsuits"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231002043200"", ""headline"": ""Food Stocks: Worth a Bite"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231002111600"", ""headline"": ""Cantor Fitzgerald Remains a Buy on Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231002113200"", ""headline"": ""Johnson & Johnson Urged To Expand Access Tuberculosis Medication"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231002125300"", ""headline"": ""Corporate bonds are on sale. How to add cheap Apple, Disney and Microsoft bonds to your portfolio."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231002144500"", ""headline"": ""J&J's (JNJ) Rybrevant Combo Meets Primary Goal in NSCLC Study"", ""summary"": ""J&J (JNJ) meets the primary goal in the late-stage study of the combination therapy of Rybrevant and lazertinib against Tagrisso for EGFR-mutated first-line NSCLC.""}, {""date"": ""20231002163100"", ""headline"": ""Johnson & Johnson stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Johnson & Johnson sank 0.39% to $155.15 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""20231002214518"", ""headline"": ""Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) closed at $155.15 in the latest trading session, marking a -0.39% move from the prior day.""}, {""date"": ""20231002234500"", ""headline"": ""My Dividend Growth Portfolio September Update - Fall Bargains Are Here"", ""summary"": ""Discover dividend growth bargains in the market, as cash yields at 5%. Despite a slight dip in 2023, unaccounted income from a cash pile prevails. Read here for more.""}, {""date"": ""20231003005743"", ""headline"": ""Cantor Fitzgerald Reiterates Johnson & Johnson (JNJ) Overweight Recommendation"", ""summary"": """"}, {""date"": ""20231003015300"", ""headline"": ""Sanofi, Janssen Team Up to Develop, Commercialize Vaccine for E. Coli"", ""summary"": ""By Adria Calatayud Sanofi and Johnson &amp; Johnson's Janssen Pharmaceuticals have entered into an agreement to jointly develop and commercialize a vaccine...""}, {""date"": ""20231003020000"", ""headline"": ""Sanofi announces deal for potential E. coli vaccine with Janssen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003050700"", ""headline"": ""Sanofi announces pact with J&J to develop and commercialize E. coli vaccine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003070100"", ""headline"": ""Medicare drug price negotiations move forward with all drugmakers participating, White House says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003071500"", ""headline"": ""Johnson & Johnson in pact with Sanofi for E. coli vaccine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003072800"", ""headline"": ""Pharma Giants Sanofi, Johnson & Johnson Join Forces To Develop E.coli Vaccine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003080000"", ""headline"": ""Medicare drug price negotiations move forward with all drugmakers participating, White House says\u00a0"", ""summary"": ""Novo Nordisk is latest drugmaker to challenge negotiation program in court.""}, {""date"": ""20231003081800"", ""headline"": ""Higher Rates, Lower Leverage: Growth Stocks To Struggle While AI Offers Hope, Goldman Sachs Analysts Say"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003082100"", ""headline"": ""Berenberg: Get defensive with healthcare, utilities and telecoms"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003085800"", ""headline"": ""Court throws out $223.8M verdict against J&J in talc case, Reuters reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003090911"", ""headline"": ""12 Best Places to Retire in Dominican Republic"", ""summary"": ""This article looks at the 12 best places to retire in Dominican Republic. If you wish to skip our detailed analysis of Dominican Republic\u2019s economic growth and foreign investments, you may go to the 5 Best Places to Retire in Dominican Republic. Dominican Republic\u2019s Economic Growth and Foreign Investments According to the World Bank, the [\u2026]""}, {""date"": ""20231003092600"", ""headline"": ""NJ appeals court throws out $223.8M talc verdict against J&J: report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003102000"", ""headline"": ""10 U.S. drugmakers agree to participate in price negotiations with Medicare"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003110300"", ""headline"": ""See How Johnson & Johnson Ranks Among Analysts' Top Dow 30 Picks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003113000"", ""headline"": ""Video: Dow Analyst Moves: JNJ"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003120000"", ""headline"": ""Drugmakers agree to US government price talks amid pushback"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003123900"", ""headline"": ""Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003135105"", ""headline"": ""Court tosses $223.8 million verdict against J&J in talc cancer case"", ""summary"": ""(Reuters) -A New Jersey appeals court on Tuesday threw out a $223.8 million verdict against Johnson & Johnson that a jury had awarded to four plaintiffs who claimed they developed cancer from being exposed to asbestos in the company's talc powder products.  The Superior Court of New Jersey, Appellate Division found that a lower court judge should not have allowed some of the scientific expert testimony the plaintiffs presented to jurors at trial.  J&J Worldwide Vice President of Litigation Erik Haas said in a statement that the decision \""resoundingly rejects ... the 'junk science' advanced by purported 'experts' paid by the mass tort asbestos bar.\""""}, {""date"": ""20231003140730"", ""headline"": ""UPDATE 1-Court tosses $223.8 million verdict against J&J in talc cancer case"", ""summary"": ""A New Jersey appeals court on Tuesday threw out a $223.8 million verdict against Johnson & Johnson in a trial over four plaintiffs' claims that they developed cancer from being exposed to the company's talc powder products.  The Superior Court of New Jersey, Appellate Division found that a lower court judge should not have allowed some of the scientific expert testimony the plaintiffs presented to jurors in the case.  A lawyer for the plaintiffs did not immediately respond to a request for comment.""}, {""date"": ""20231003140806"", ""headline"": ""The 10 pharma companies participating in Medicare price negotiations"", ""summary"": ""Ten pharmaceutical manufacturers are signing the Inflation Reduction Act's Medicare drug price negotiation program. These companies are Bristol Myers Squibb (BMY), AstraZeneca (AZN), Boehringer Ingelheim, Immunex, Janssen Pharmaceuticals, Pharmacyclics, Merck & Company (MRK), Janssen Biotech, Novartis (NVS), and Novo Nordisk (NVO), according to the Biden administration. Yahoo Finance Health Care Reporter Anjalee Khemlani discusses the news. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.""}, {""date"": ""20231003144500"", ""headline"": ""Sanofi (SNY) Inks Deal With J&J to Develop E. coli Vaccine"", ""summary"": ""Per the terms of the deal, Sanofi (SNY) and J&J will co-fund current and future R&D costs to develop a potential first-in-class vaccine against extraintestinal pathogenic E. coli.""}, {""date"": ""20231003152910"", ""headline"": ""Behind the new malaria vaccine endorsed by the World Health Organization"", ""summary"": ""The Serum Institute of India has received a recommendation from WHO for malaria doses using a Novavax adjuvant.""}, {""date"": ""20231003161120"", ""headline"": ""'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals: Today's Top Stories"", ""summary"": ""Benzinga Microsoft's Nadella Criticizes Google's Exclusive Content Deals Amid Antitrust Case In a significant development, Microsoft Corp's (NASDAQ: MSFT) CEO, Satya Nadella, has voiced concerns over the competitive landscape of content acquisition essential for training artificial intelligence (AI). Nadella's remarks came during his testimony in a landmark antitrust trial in the U.S., where he highlighted the challenges posed by exclusive deals that tech giants, notably Alphabet Inc (NASDAQ: GO""}, {""date"": ""20231003161614"", ""headline"": ""October Dogs Of The Dow: 3 Buyable, 7 Watchable"", ""summary"": ""Discover how the Dow Jones adds and selects stocks, the highest-yielding stocks in October, and the leading performers in the Dow Industrial Index. Click for more.""}, {""date"": ""20231003163100"", ""headline"": ""Johnson & Johnson stock rises Tuesday, outperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.12% higher to $155.34 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the...""}, {""date"": ""20231003170000"", ""headline"": ""Novartis to Complete Spinoff of Generic Drug Division"", ""summary"": ""Swiss pharmaceutical maker Novartis plans to spin off its Sandoz generic drugs division starting Wednesday, to focus on its core drug R&D business.""}, {""date"": ""20231004030443"", ""headline"": ""U.S. Wide-Moat Stocks On Sale - The October 2023 Heat Map"", ""summary"": ""Discover the 3-step process of selecting wide-moat stocks, with a focus on attractively valued candidates. See a heat map of investment candidates here.""}, {""date"": ""20231004033300"", ""headline"": ""Johnson & Johnson stock rises Wednesday, still underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231004063900"", ""headline"": ""BofA\u2019s Alpha Surprise Model: Lots of Energy additions, Con. Dis. deletions"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231004075600"", ""headline"": ""Johnson & Johnson initiated with an Outperform at RBC Capital"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231004075700"", ""headline"": ""Johnson & Johnson Sees Legal Win In Talc Powder Cancer Claims"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231004112900"", ""headline"": ""Needham biotechnology analysts to hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231004130010"", ""headline"": ""Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know"", ""summary"": ""Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.""}, {""date"": ""20231004180219"", ""headline"": ""14 Best Bear Market Stocks To Buy Now"", ""summary"": ""In this article, we discuss the 14 best bear market stocks to buy now. If you want to see more stocks in this selection, go directly to the 5 Best Bear Market Stocks To Buy Now. The US economy successfully avoided a recession owing to its resilient job market. However, it\u2019s worth noting that the job [\u2026]""}, {""date"": ""20231004183739"", ""headline"": ""Palantir And PwC Team Up To Accelerate Data-Driven Operations, OpenAI Rival Secures Billions In Big Tech Backing, Six US States Brace For Healthcare Strike: Today's Top Stories"", ""summary"": ""Benzinga AI Powerhouse: Palantir And PwC Team Up To Accelerate Data-Driven Operations Palantir Technologies Inc (NYSE: PLTR) is expanding its collaboration with PwC to combine its latest AI capabilities. The collaboration will combine Palantir's latest AI capabilities with PwC's industry experience to help clients realize value with data and AI-enabled operations. Palantir has chosen the U.K. as its European headquarters for AI research and development. Anthropic Navigating The AI Landscape With""}, {""date"": ""20231005000841"", ""headline"": ""7 Top Healthcare Stocks That Pay Dividends"", ""summary"": ""Facing an uncertain market environment, investors ought to consider the top healthcare stocks that pay dividends. Sure, the Federal Reserve may be in a position to facilitate a soft landing for the economy, per bullish analysts. Genuinely, I hope that\u2019s the case. But you can wish on one hand and, well, you know the rest. Primarily, the core benefit of top healthcare stocks that pay dividends centers on the \u201cpermanent\u201d relevance of the underlying sector. To be clear, all sectors suffer the vulner""}, {""date"": ""20231005022400"", ""headline"": ""Notable Thursday Option Activity: JNJ, BE, GE"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005032200"", ""headline"": ""IN BRIEF: J&J notes study showing long-term efficacy of Spravato"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005033300"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005034100"", ""headline"": ""What You Missed On Wall Street On Thursday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005070200"", ""headline"": ""Expert Ratings for Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005073800"", ""headline"": ""Johnson & Johnson draws bullish initiation at RBC on consumer spinoff"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005081200"", ""headline"": ""Howard Hughes Holdings spinning off Seaport Entertainment to shareholders"", ""summary"": ""Houston conglomerate names former MGM executive Anton D. Nikodemus as chief executive of Seaport Entertainment as an independent company.""}, {""date"": ""20231005092100"", ""headline"": ""3 Historically Cheap Dow Stocks to Buy Hand Over Fist in October"", ""summary"": ""These profitable, time-tested Dow Jones stocks are cheaper than they've been in at least a decade, if not well beyond.""}, {""date"": ""20231005100000"", ""headline"": ""2 Magnificent Dividend Kings to Buy Now"", ""summary"": ""The three major stock market indexes have progressively declined over the past month, and the Dow Jones Industrial Average even slipped into negative territory for the year.  A look at the list of Dividend Kings is the perfect place to start because these players have track records of at least 50 years of dividend growth.  Let's take a look at two magnificent Dividend Kings that make great buys right now -- and could reward you with growing passive income over time.""}, {""date"": ""20231005100100"", ""headline"": ""November 24th Options Now Available For Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005100400"", ""headline"": ""Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005101800"", ""headline"": ""RBC Analyst Bullish on Johnson & Johnson (NYSE: JNJ) Post-Spinoff"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005110100"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005114200"", ""headline"": ""Johnson & Johnson Has Potential To Drive Its Pharma And MedTech Franchises, Says Bullish Analyst"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005120000"", ""headline"": ""3 Ways AI Can Help Healthcare Companies Grow"", ""summary"": ""If you want to invest in artificial intelligence (AI), tech stocks aren't your only options.  There are plenty of ways that AI can and will help transform the healthcare industry.  One of the big benefits of AI assistants is that they can summarize notes in meetings.""}, {""date"": ""20231005124100"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005124500"", ""headline"": ""Johnson & Johnson Wins an Analyst's Heart, but Its Charts Aren't So Hot"", ""summary"": ""The pharmaceutical giant's technical signals lean toward the bearish side even as it gains a buy recommendation.""}, {""date"": ""20231005214849"", ""headline"": ""S&P 500 Gains and Losses Today: Clorox Shares Dip After Warning of Cyberattack's Impact"", ""summary"": ""The S&P 500 was little changed on Thursday, Oct. 5, 2023 ahead of Friday's jobs report, and Clorox shares tumbled after warning a cyberattack would have a significant negative impact on its quarterly earnings.""}, {""date"": ""20231006024300"", ""headline"": ""Johnson & Johnson Dividend Stock Analysis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231006024500"", ""headline"": ""Buy/Sell: Wall Street's top 10 stock calls this week"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231006033300"", ""headline"": ""Johnson & Johnson stock rises Friday, still underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231006111245"", ""headline"": ""Job Market Keeps Humming As Payrolls Surge"", ""summary"": ""The Fed's December meeting is now uncertain, with a coin toss between a quarter-point hike and no move. Click here to read more.""}, {""date"": ""20231006113900"", ""headline"": ""IPOs are out of fashion. Here's what companies are doing instead."", ""summary"": ""Companies under pressure to unlock value unfurled a mini-flurry of spinoff activity in recent days, but some spinoff stocks have gotten a cool reception.""}, {""date"": ""20231006115200"", ""headline"": ""IN BRIEF: J&J applies for indication extension to EMA for Rybrevant"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231006121200"", ""headline"": ""Wall Street Lunch: Job Market Keeps Humming As Payrolls Surge"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231006161011"", ""headline"": ""Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report?"", ""summary"": ""Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.""}, {""date"": ""20231006180948"", ""headline"": ""Biotech-Pharma Trade: Buying Opportunities On The Horizon"", ""summary"": ""Concerns over interest rates, pricing erosion, and Medicare's drug price negotiation plan weigh on biotech and pharma sectors. Learn what investors need to know.""}, {""date"": ""20231006183137"", ""headline"": ""11 Best Stocks to Buy in Falling Markets According to Hedge Funds"", ""summary"": ""In this piece, we will take a look at the 11 best stocks to buy in falling markets according to hedge funds. For more recession-resilient stocks, head over to 5 Best Stocks to Buy in Falling Markets. Recessions are inevitable and the market has been forecasting a recession in the near future for quite some [\u2026]""}, {""date"": ""20231007093000"", ""headline"": ""5 Relatively Safe And Cheap Dividend Stocks To Invest In - October 2023"", ""summary"": ""In addition to the primary list that yields just over 3%, we present two other groups of five DGI stocks each. Explore more details here.""}, {""date"": ""20231008034000"", ""headline"": ""Wall Street's Top 10 Stock Calls This Week - Sunday, Oct. 8"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231008070600"", ""headline"": ""3 Pharma Stocks to Dump Before the Damage Is Done"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.4721, ""bookValue"": 71228, ""cashRatio"": 0.15138607167004733, ""currentRatio"": 1.2103, ""ebitPerShare"": 2.0459, ""eps"": 10.2071, ""ev"": 396807.4, ""fcfMargin"": 0.3055, ""fcfPerShareTTM"": 6.538, ""grossMargin"": 0.7012, ""inventoryTurnoverTTM"": 2.3818, ""longtermDebtTotalAsset"": 0.1569, ""longtermDebtTotalCapital"": 0.2576, ""longtermDebtTotalEquity"": 0.3657, ""netDebtToTotalCapital"": 0.2294, ""netDebtToTotalEquity"": 0.3258, ""netMargin"": 1.2191, ""operatingMargin"": 0.2443, ""payoutRatioTTM"": 0.257, ""pb"": 5.2452, ""peTTM"": 10.7903, ""pfcfTTM"": 23.7404, ""pretaxMargin"": 0.2443, ""psTTM"": 4.2712, ""ptbv"": 10.3185, ""quickRatio"": 0.8634, ""receivablesTurnoverTTM"": 5.7006, ""roaTTM"": 0.1869, ""roeTTM"": 0.471, ""roicTTM"": 0.2997, ""rotcTTM"": 0.125, ""salesPerShare"": 8.3729, ""sgaToSale"": 0.2988, ""tangibleBookValue"": 36207, ""totalDebtToEquity"": 0.4201, ""totalDebtToTotalAsset"": 0.1802, ""totalDebtToTotalCapital"": 0.2958, ""totalRatio"": 1.7511, ""period"": ""2023-10-01""}"
18,2023-10-08,156.38763427734375,2023-10-15,155.60391235351562,-0.005011405968570637,D1,"[{""date"": ""20231008034000"", ""headline"": ""Wall Street's Top 10 Stock Calls This Week - Sunday, Oct. 8"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231008070600"", ""headline"": ""3 Pharma Stocks to Dump Before the Damage Is Done"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231009014700"", ""headline"": ""3 Artificial Intelligence Stocks That Could Outperform the \u2018Godfather of AI\u2019"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231009020600"", ""headline"": ""Looking At Johnson & Johnson's Recent Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231009020800"", ""headline"": ""J&J Medtech gets FDA clearance for DePuy TriALTIS Spine System"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231009060315"", ""headline"": ""14 Best Cancer Stocks To Buy Now"", ""summary"": ""In this article, we discuss 14 best cancer stocks to buy. If you want to skip our detailed discussion on the oncology industry, head directly to 5 Best Cancer Stocks To Buy Now. The global oncology landscape continues to evolve, with ongoing efforts to discover, develop, and provide innovative treatments aimed at improving outcomes for [\u2026]""}, {""date"": ""20231009061100"", ""headline"": ""Protagonist Therapeutics announces advancement of JNJ-2113 across indications"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231009063300"", ""headline"": ""Janssen announces 30 company sponsored presentations at EADV Congress"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231009092100"", ""headline"": ""Meet the 3 Dividend Kings Warren Buffett Is Betting $21 Billion On"", ""summary"": ""Three dividend stocks that have each increased their base annual payout for more than 60 years account for $21 billion of Berkshire Hathaway's $337 billion of invested assets.""}, {""date"": ""20231009112100"", ""headline"": ""Analysts Are Bullish on Top Healthcare Stocks: Bristol-Myers Squibb (BMY), Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231009151000"", ""headline"": ""J&J (JNJ) Seeks EU Nod for Rybrevant for First-Line NSCLC"", ""summary"": ""J&J (JNJ) files an application in Europe seeking expanded approval for Rybrevant as a first-line combination treatment in patients with advanced or metastatic EGFR exon 20 insertion mutation-positive NSCLC.""}, {""date"": ""20231009163200"", ""headline"": ""Johnson & Johnson stock rises Monday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.57% higher to $158.54 Monday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""20231010030200"", ""headline"": ""Johnson & Johnson Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231010094500"", ""headline"": ""Cantor biotech/biopharma analysts to hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231010122738"", ""headline"": ""High Yield Stock Watchlist - October 2023"", ""summary"": ""The majority of the stocks on my watchlist are undervalued based on dividend yield theory. Read more here.""}, {""date"": ""20231010125500"", ""headline"": ""Johnson & Johnson (JNJ) Receives a Hold from DBS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231010140016"", ""headline"": ""Earnings Preview: Johnson & Johnson (JNJ) Q3 Earnings Expected to Decline"", ""summary"": ""Johnson & Johnson (JNJ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.""}, {""date"": ""20231010163200"", ""headline"": ""Johnson & Johnson stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson shed 0.11% to $158.36 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20231010170500"", ""headline"": ""Family Dollar recalls dozens of P&G, J&J, Colgate products in 23 states due to incorrect temperature storage"", ""summary"": ""Family Dollar voluntarily recalled dozens of OTC drugs and medical devices sold at its stores because they had been stored at improper temperatures.""}, {""date"": ""20231010171620"", ""headline"": ""DSTL: A Cash Flow-Focused ETF"", ""summary"": ""Distillate US Fundamental Stability & Value ETF picks stocks based on criteria including cash flow yield, cash flow stability & debt. Read more on DSTL ETF here.""}, {""date"": ""20231011012100"", ""headline"": ""J&J reports 510(k) clearance from FDA for TriLEAP System"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231011022200"", ""headline"": ""September 2023 Passive Income Update"", ""summary"": ""Fortis\u00c2\u00a0decided to get king status and boost their dividend by 4.4%. This raise adds $23.60 to our forward income. Check out our income update for September.""}, {""date"": ""20231011053300"", ""headline"": ""Bert's September Dividend Income Summary"", ""summary"": ""We received $3,570.87 in September dividend income. This was a 16.52% dividend increase compared to September 2022.""}, {""date"": ""20231011094500"", ""headline"": ""Needham biotechnology analysts to hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231011120851"", ""headline"": ""25 Most Innovative Companies in the World in 2023"", ""summary"": ""In this article, we will take a look at the most innovative companies in the world in 2023. If you want to explore similar companies, you can go to 5 Most Innovative Companies in the World in 2023. Innovation doesn\u2019t arrive straight away. Governments and organizations invest heavily in research and development, scientific publications, and [\u2026]""}, {""date"": ""20231011124500"", ""headline"": ""2 No-Brainer Dividend King Stocks to Buy Right Now"", ""summary"": ""Buying stocks may not seem all that attractive at the moment.  Investors, though, should bear in mind that high-quality dividend stocks have consistently outperformed most other asset classes over the long term, especially during times of economic uncertainty.  Blue chip dividend stocks, in effect, have often been a source of strength for investors in turbulent markets.""}, {""date"": ""20231011133807"", ""headline"": ""Will The Recent Spin-Off be Beneficial for Johnson & Johnson (JNJ)?"", ""summary"": ""ClearBridge Investments, an investment management company, released its \u201cClearBridge Large Cap Value Strategy\u201d third quarter 2023 investor letter. A copy of the same can be downloaded here. U.S. equities fell from the first-half highs amid fears of slowing consumer spending and higher interest rates. The strategy performed strongly in this environment outperforming the Russell 1000 Value [\u2026]""}, {""date"": ""20231011150908"", ""headline"": ""Birkenstock has an advantage that others in the 2023 IPO class don't have"", ""summary"": ""The brand's origin story is older than the United States.""}, {""date"": ""20231011161500"", ""headline"": ""Generative AI is top of mind for all types of leaders, from Treasury Secretary Janet Yellen to J&J CEO Joaquin Duato"", ""summary"": ""This week\u2019s episode of Fortune\u2018s Leadership Next podcast features conversations from the Fortune CEO Initiative conference.""}, {""date"": ""20231011163100"", ""headline"": ""Johnson & Johnson stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson shed 1.38% to $156.18 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""20231012012300"", ""headline"": ""Eli Lilly (NYSE:LLY) Slips despite Positive Phase 3 Results"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012014600"", ""headline"": ""Beat the Market With These 7 Warren Buffett Stocks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012025000"", ""headline"": ""Peering Into Johnson & Johnson's Recent Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012040500"", ""headline"": ""Where can you find entertainment, beaches, jobs, low cost of living and more? Here are some of the best places to live in Florida."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012042110"", ""headline"": ""Morgan Stanley Maintains Johnson & Johnson (JNJ) Equal-Weight Recommendation"", ""summary"": """"}, {""date"": ""20231012042110"", ""headline"": ""Cantor Fitzgerald Reiterates Johnson & Johnson (JNJ) Overweight Recommendation"", ""summary"": """"}, {""date"": ""20231012051500"", ""headline"": ""Johnson & Johnson price target raised to $162 from $158 at Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012055600"", ""headline"": ""Alvotech biosimilar for JNJ\u2019s Stelara rejected in U.S."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012073500"", ""headline"": ""Eli Lilly succeeds in Phase 3 trial for Crohn's disease therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012091500"", ""headline"": ""Attention Medicare Recipients: You Could See Lower Costs for These 10 Drugs in the Not-Too-Distant Future"", ""summary"": ""Prescription drugs can be expensive. That's especially problematic for retirees living on fixed incomes. Sure, insurance can partially offset those high costs. However, seniors age 65 and older still pay for more than half of prescription drug costs out of their own pockets, according to the Health Policy Institute.""}, {""date"": ""20231012092800"", ""headline"": ""Eli Lilly Treatment For Crohn's Tops Placebo In Latest Study, Makes Plans For 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012103200"", ""headline"": ""Stocks to watch out in the Health Care sector as earnings close in"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012104900"", ""headline"": ""Stocks to watch in the Health Care sector as earnings close in"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012123900"", ""headline"": ""Supreme Court to hear arguments on Purdue Pharma bankruptcy case on Dec. 4"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012125300"", ""headline"": ""7 High-Growth S&P 500 Stocks to Buy Now"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012135915"", ""headline"": ""Retirement Stock Portfolio: 10 Low Risk Investments"", ""summary"": ""In this article, we discuss the 10 best low-risk investment options to add to your retirement portfolio. You can skip our detailed analysis of the retirement phenomenon within the U.S., and go directly to read the Retirement Stock Portfolio: 5 Low Risk Investments. In 2021, the economy faced persistent challenges due to the COVID-19 pandemic\u2019s [\u2026]""}, {""date"": ""20231012151000"", ""headline"": ""Dow ETF in Focus Ahead of Q3 Earnings"", ""summary"": ""With some of the blue-chip companies having reasonable chances of coming up with an earnings surprise, investors should closely monitor the movement of the Dow ETF and grab any opportunity that arises from a surge in any of the 30 stocks.""}, {""date"": ""20231012163100"", ""headline"": ""Johnson & Johnson stock underperforms Thursday when compared to competitors despite daily gains"", ""summary"": ""Shares of Johnson & Johnson inched 0.10% higher to $156.33 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the...""}, {""date"": ""20231012205251"", ""headline"": ""15 Worst Performing Dow Stocks YTD"", ""summary"": ""In this article, we discuss 15 worst performing Dow stocks year-to-date. If you want to skip our detailed discussion on stock market performance overall, head directly to 5 Worst Performing Dow Stocks YTD. In a July report by J.P. Morgan, it was stated that global economic growth is expected to slow down in the latter [\u2026]""}, {""date"": ""20231012233735"", ""headline"": ""Barclays Maintains Johnson & Johnson (JNJ) Equal-Weight Recommendation"", ""summary"": """"}, {""date"": ""20231013020500"", ""headline"": ""Catalyst watch: Tesla earnings, Jerome Powell speech, UAW drama and Baidu event"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231013033900"", ""headline"": ""Israel-Hamas War Shakes Middle East, Inflation Reawakens, Oil Surges: The Week In The Markets"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231013112100"", ""headline"": ""Over Delivering: Big Banks Beat Expectations After Tough Quarter, But Market Eyes Middle East Warily"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231013115606"", ""headline"": ""Johnson & Johnson Q3 Earnings Preview: Don't Count On Different Proposition Post Kenvue Spin-Out"", ""summary"": ""Johnson & Johnson (JNJ) will announce its Q3 earnings on October 17. Read why I would not be surprised to see an earnings miss followed by a selloff.""}, {""date"": ""20231013134900"", ""headline"": ""J&J (JNJ) to Report Q3 Earnings, Its First After Unit Spin-Off"", ""summary"": ""J&J's (JNJ) third-quarter results are the first quarterly update for the new company after the Consumer Health spin-off.""}, {""date"": ""20231013163200"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.33% higher to $156.85 Friday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""20231013164641"", ""headline"": ""Top 30 Oncology Companies in the World"", ""summary"": ""In this article, we shall cover the top 30 oncology companies in the world. To skip our detailed analysis of the global oncology industry in 2023, go directly and see Top 10 Oncology Companies in the World. According to a report by McKinsey and Company, the economic outlook for the US healthcare industry in 2023 [\u2026]""}, {""date"": ""20231013190204"", ""headline"": ""How big companies from EY to Johnson & Johnson are learning to master AI prompts"", ""summary"": ""Embracing AI is the easy part\u2014firms have already moved on to harder parts like making AI actually work for their business.""}, {""date"": ""20231014080600"", ""headline"": ""Johnson & Johnson Stock: Is Now the Time to Sell?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231014105200"", ""headline"": ""3 Dividend Growth Stocks You Can Buy and Hold Forever"", ""summary"": ""What's better than a stock that pays dividends?  A stock with growing dividends and a business that's built for long-term success.  Here's why they believe that AbbVie (NYSE: ABBV), Eli Lilly (NYSE: LLY), and Johnson & Johnson (NYSE: JNJ) are dividend growth stocks that you can buy and hold forever.""}, {""date"": ""20231015070300"", ""headline"": ""Earnings week ahead: Tesla, Bank of America, AT&T, Netflix, American Airlines and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231015124400"", ""headline"": ""ClearBridge Large Cap Value Strategy Q3 2023 Portfolio Manager Commentary"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.4721, ""bookValue"": 71228, ""cashRatio"": 0.15138607167004733, ""currentRatio"": 1.2103, ""ebitPerShare"": 2.0459, ""eps"": 10.2071, ""ev"": 396807.4, ""fcfMargin"": 0.3055, ""fcfPerShareTTM"": 6.538, ""grossMargin"": 0.7012, ""inventoryTurnoverTTM"": 2.3818, ""longtermDebtTotalAsset"": 0.1569, ""longtermDebtTotalCapital"": 0.2576, ""longtermDebtTotalEquity"": 0.3657, ""netDebtToTotalCapital"": 0.2294, ""netDebtToTotalEquity"": 0.3258, ""netMargin"": 1.2191, ""operatingMargin"": 0.2443, ""payoutRatioTTM"": 0.257, ""pb"": 5.2452, ""peTTM"": 10.7903, ""pfcfTTM"": 23.7404, ""pretaxMargin"": 0.2443, ""psTTM"": 4.2712, ""ptbv"": 10.3185, ""quickRatio"": 0.8634, ""receivablesTurnoverTTM"": 5.7006, ""roaTTM"": 0.1869, ""roeTTM"": 0.471, ""roicTTM"": 0.2997, ""rotcTTM"": 0.125, ""salesPerShare"": 8.3729, ""sgaToSale"": 0.2988, ""tangibleBookValue"": 36207, ""totalDebtToEquity"": 0.4201, ""totalDebtToTotalAsset"": 0.1802, ""totalDebtToTotalCapital"": 0.2958, ""totalRatio"": 1.7511, ""period"": ""2023-10-01""}"
19,2023-10-15,155.60391235351562,2023-10-22,151.7845001220703,-0.02454573393224213,D3,"[{""date"": ""20231015070300"", ""headline"": ""Earnings week ahead: Tesla, Bank of America, AT&T, Netflix, American Airlines and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231015124400"", ""headline"": ""ClearBridge Large Cap Value Strategy Q3 2023 Portfolio Manager Commentary"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016020000"", ""headline"": ""Stock market today: Wall Street rises, and oil and gold slip as some of last week's moves unwind"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016021800"", ""headline"": ""Tesla, Netflix Grab Earnings Spotlight This Week As Analysts Divided On Q3 Reporting Season: What's On Investors' Radar?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016025347"", ""headline"": ""Pfizer's Sequel: Return Of The Value Stock"", ""summary"": ""Pfizer focuses on core growth and strategic acquisitions in oncology to offset downgraded revenue projections. Learn why I rate PFE stock a hold.""}, {""date"": ""20231016035100"", ""headline"": ""LONDON MARKET OPEN: Stocks steady as eyes on oil, Israel, US earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016063700"", ""headline"": ""US Stocks On Track For A Strong Start To Week, Buoyed By Earnings Optimism: Analyst Flags 13-14% Upside As Bull Market Enters Its Second Year"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016070300"", ""headline"": ""LONDON MARKET MIDDAY: Stocks mixed on conflict and US earnings nerves"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016070500"", ""headline"": ""Johnson & Johnson: A Conservative High-Yield Dividend Aristocrat Buy"", ""summary"": ""Johnson & Johnson is a defensive pick with a renewed focus on its pharmaceutical and medtech segments. Find out why JNJ stock is a Buy.""}, {""date"": ""20231016090000"", ""headline"": ""WSJ\u2019s Take on the Week Podcast: A Key Fed Official on What\u2019s Next for Interest Rates"", ""summary"": ""This week, we\u2019re looking at what the Federal Reserve is focused on as it plots the course of interest rates. Minutes revealed that in their most recent meeting a majority of rate-setting officials said one more rate hike would be appropriate.""}, {""date"": ""20231016092400"", ""headline"": ""Notable earnings before Tuesday's open"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016104428"", ""headline"": ""AbbVie: Successfully Navigating Humira's Patent Cliff With 4% Yield And 270% DGR Since 2014"", ""summary"": ""Despite declining Humira sales, AbbVie remains resilient, focusing on new therapies, M&A, and R&D for sustained growth. Find out why ABBV stock is a Hold.""}, {""date"": ""20231016104500"", ""headline"": ""Johnson & Johnson Resumed The Bearish Cycle"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016110300"", ""headline"": ""Companies with lower implied volume have higher potential for earnings surprise - BofA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016115000"", ""headline"": ""Monday's Market Minute: This Week's Focus: Earnings & Consumer Spending"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016115300"", ""headline"": ""LONDON MARKET CLOSE: Europe boosted by bullish open in New York"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016120800"", ""headline"": ""Pendulum Swings: Markets Recover Slightly After Friday's Anxious Trading, But Middle East Worries Dominate"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016121200"", ""headline"": ""4 Dividend Stocks Yielding 4% or More to Buy Without Hesitation"", ""summary"": ""The Federal Reserve has significantly ratcheted up interest rates over the past several quarters to help cool inflation.  As their share prices have fallen, their dividend yields have increased, which compensates investors for their higher risk profiles relative to bonds and CDs.  Kenvue is new to paying dividends.""}, {""date"": ""20231016122600"", ""headline"": ""My Dividend Growth Portfolio - Q3 2023 Summary"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016154928"", ""headline"": ""Bank of America reports, Johnson & Johnson, retail sales: 3 things to watch"", ""summary"": ""Investing.com -- Stocks surged on Monday as investors turned their attention to a wave of earnings reports from big banks, big tech firms such as Netflix (NASDAQ:NFLX), and Tesla (NASDAQ:TSLA) this week.""}, {""date"": ""20231016163200"", ""headline"": ""Johnson & Johnson stock rises Monday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.43% higher to $157.53 Monday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""20231016210000"", ""headline"": ""Johnson & Johnson\u2019s Earnings Are Coming. They\u2019ll Be the First Since the Kenvue Spinoff."", ""summary"": ""An update in August after the split leaves investors with fewer questions for Tuesday's results.""}, {""date"": ""20231016213405"", ""headline"": ""Bank earnings, Fedspeak, House Speaker: What to watch"", ""summary"": ""Goldman Sachs (GS) and Bank of America (BAC) report their third-quarter earnings on Tuesday, October 17. September retail sales data is also expected out tomorrow while Fed regulators are set to speak. Lastly, House lawmakers will vote on Rep. Jim Jordan's (R-Oh.) candidacy as the next Speaker of the House. Yahoo Finance's Josh Lipton previews what investors should pay attention to tomorrow. For more expert insight and the latest market action,\u00a0click here\u00a0to watch this full episode of Yahoo Finance Live.""}, {""date"": ""20231016224200"", ""headline"": ""Markets Pop on Bargain Hunting, Stronger Economy"", ""summary"": ""The small-cap Russell 2000, still under water over the past month, led the way higher today.""}, {""date"": ""20231017013500"", ""headline"": ""Johnson & Johnson's Q3 2023: $21.3B Rise In Sales, 'Sharpened Focus' On Innovation & Biotech Solutions"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017014100"", ""headline"": ""Back for Another Round: Rate Hike Fears Grow After Strong Retail Sales Sends Yields Spinning Higher"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017014500"", ""headline"": ""Cantor biotech/biopharma analysts hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017015000"", ""headline"": ""LONDON MARKET EARLY CALL: FTSE to edge lower; wage data due"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017015700"", ""headline"": ""Johnson & Johnson\u2019s Strong Q3 Performance and Upward Guidance Evokes Buy Rating: An Analysis of the Innovative Medicine Sector\u2019s Influence"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017020200"", ""headline"": ""J&J lung cancer drug combo had superior progression-free survival in study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017021500"", ""headline"": ""Johnson & Johnson earnings: What to expect"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017033700"", ""headline"": ""Stock market today: Wall Street drifts after a strong retail sales report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017034900"", ""headline"": ""LONDON MARKET OPEN: Stocks rise as UK wage inflation eases"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017043300"", ""headline"": ""S&P 500 futures drift as Goldman Sachs and Bank of America earnings awaited"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017052100"", ""headline"": ""As Q3 earnings season revs into high gear, here's what to expect"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017052100"", ""headline"": ""Johnson & Johnson reports Q3 adjusted EPS $2.66, consensus $2.51"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017052300"", ""headline"": ""Johnson & Johnson raises FY23 adjusted EPS to $10.07-$10.13 from $10.00-$10.10"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017052500"", ""headline"": ""Genmab reports Q3 worldwide net sales of DARZALEX $2.499B"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017053200"", ""headline"": ""Johnson & Johnson Non-GAAP EPS of $2.66 beats by $0.14, revenue of $21.35B beats by $300M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017053953"", ""headline"": ""Intuitive Surgical: When Paying A Premium Makes Sense"", ""summary"": ""Intuitive Surgical is launching new products to complement its flagship da Vinci product line, pointing to continued growth. Find out why ISRG stock is a Buy.""}, {""date"": ""20231017054500"", ""headline"": ""Johnson & Johnson\u2019s stock climbs after company beats earnings estimates and raises profit guidance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017055000"", ""headline"": ""Johnson & Johnson in charts: Segment sales continue to grow in Q3, while regional sales decline"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017060800"", ""headline"": ""Johnson & Johnson (NYSE:JNJ) Gains After Impressive Q3 Results"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017060900"", ""headline"": ""Earnings Scheduled For October 17, 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017061300"", ""headline"": ""Johnson & Johnson powers to Q3 beat as pharma outperforms"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017063700"", ""headline"": ""Johnson & Johnson in charts: Sales grow Y/Y for both major segments"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017063800"", ""headline"": ""US Stock Futures Slide As Traders Look Past Positive Earnings News Flow; Analysts Predict Year-End Rally And Strong 2024 Ahead"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017063900"", ""headline"": ""J&J\u2019s stock rallies after profit and sales rise above expectations, full-year outlook increased"", ""summary"": ""Shares of Johnson & Johnson rallied 0.8% in premarket trading Tuesday, after the drug maker and medical technology company reported third-quarter profit and...""}, {""date"": ""20231017064600"", ""headline"": ""TOP NEWS: J&J raises full-year sales outlook after \""solid\"" quarter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017064800"", ""headline"": ""Johnson & Johnson (NYSE:JNJ) Gains on Impressive Q3 Results"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017072300"", ""headline"": ""Morning Brew: Microsoft's Accelerated Growth, Lockheed Martin's Q3 Earnings Beat, and Apple ..."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017080000"", ""headline"": ""Johnson & Johnson says continues to make progress on new product launches"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017080200"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Johnson & Johnson (JNJ) and Thermo Fisher (TMO)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017081500"", ""headline"": ""U.S. stock futures lower amid earnings beats and strong retail sales"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017081500"", ""headline"": ""Invest in millennials and these \u2018once-in-a-lifetime opportunity\u2019 stocks, says this fund manager"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017081500"", ""headline"": ""Johnson & Johnson says continues to pursue four-pronged talc litigation strategy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017081900"", ""headline"": ""5 stocks to watch on Tuesday: J&J, Bank of America, United Airlines and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017083235"", ""headline"": ""These Stocks Are Moving the Most Today"", ""summary"": ""Johnson & Johnson, Bank of America, and Goldman Sachs are scheduled to report third-quarter earnings on Tuesday, Ericsson slumps after withdrawing margin guidance, and NetScout reduces its outlook for fiscal 2024.""}, {""date"": ""20231017084000"", ""headline"": ""Unusually active option classes on open October 17th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017084100"", ""headline"": ""Johnson & Johnson says 'confident' in product pipeline for 2024/2025"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017085400"", ""headline"": ""Johnson & Johnson expects flat procedures in MedTech in 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017085700"", ""headline"": ""U.S. stocks open lower as strong retail sales overshadow earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017085700"", ""headline"": ""Dividend Income Summary: Lanny's September 2023 Summary"", ""summary"": ""In September, we (my wife and I) received a dividend income total of $4,987.23. So close to $5,000 this month for our family.""}, {""date"": ""20231017094554"", ""headline"": ""Bank of America, Johnson & Johnson And 3 Stocks To Watch Heading Into Tuesday"", ""summary"": ""With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Johnson & Johnson (NYSE: JNJ) to report quarterly earnings at $2.51 per share on revenue of $21.04 billion before the opening bell. Johnson & Johnson shares gained 0.3% to $158.00 in after-hours trading. NetScout Systems, Inc. (NASDAQ: NTCT) reported weak preliminary results for the second quarter and lowered its FY24 guidance. NetScout Systems""}, {""date"": ""20231017101000"", ""headline"": ""Johnson & Johnson beats earnings estimates and downplays obesity drugs\u2019 impact on its med-tech business"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017102000"", ""headline"": ""Johnson & Johnson Reports Q3 2023 Results"", ""summary"": ""NEW BRUNSWICK, N.J., October 17, 2023--Johnson & Johnson (NYSE: JNJ) today announced results for third-quarter 2023. \""Johnson & Johnson delivered strong results and significant pipeline advances in the third quarter, providing a solid foundation for future sustained growth,\"" said Joaquin Duato, Chairman of the Board and Chief Executive Officer. \""With a sharpened focus on Innovative Medicine and MedTech solutions, Johnson & Johnson is innovating across the spectrum of healthcare and is poised to""}, {""date"": ""20231017102001"", ""headline"": ""J&J raises annual profit forecast on strong cancer drug demand"", ""summary"": ""Johnson & Johnson on Tuesday raised its 2023 profit forecast, banking on growing demand for its newer cancer treatments such as Carvykti and Tecvayli and recorded a $21 billion gain from the spin off of its consumer health unit.  Investors are focused on how Johnson & Johnson, now a standalone pharmaceutical and medical devices company, will reach its goal of $57 billion in drug sales by 2025.  Excluding its consumer health unit, the company now expects 2023 adjusted profit of $10.07 to $10.13 per share, compared with its previous outlook of $10.00 to $10.10 per share.""}, {""date"": ""20231017102100"", ""headline"": ""U.S. stocks stay lower as strong retail sales overshadow earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017102227"", ""headline"": ""J&J begins restructuring at medical device unit after sales miss"", ""summary"": ""(Reuters) -Johnson & Johnson on Tuesday said it has embarked on a two-year restructuring program for its orthopedic business after third-quarter medical devices sales fell short of Wall Street expectations, reflecting the company's narrowed focus since spinning off its consumer health unit.  J&J said it plans to exit certain markets and stop selling some products under its orthopedic business as part of the  restructuring program.  Without its consumer health business and medical devices undergoing restructuring, pressure on J&J's large pharmaceutical unit is likely to intensify as the company aims to reach its goal of $57 billion in drug sales by 2025.""}, {""date"": ""20231017102227"", ""headline"": ""J&J lifts profit outlook on strong demand for top-seller Stelara"", ""summary"": ""(Reuters) -Johnson & Johnson raised its 2023 profit forecast in its first earnings report since spinning off its consumer health business, with the company's fortunes now tied more closely to sales of blockbusters like its arthritis drug Stelara.  Investors are focused on how J&J, now a standalone pharmaceutical and medical devices company, will reach its goal of $57 billion in drug sales by 2025.  Johnson & Johnson recorded a $21-billion gain in the third quarter from the spin-off of its consumer health unit.""}, {""date"": ""20231017102800"", ""headline"": ""These Stocks Are Moving the Most Today: J&J, Bank of America, Goldman, Lockheed, Ericsson, NetScout, and More"", ""summary"": ""Johnson & Johnson's third-quarter adjusted earnings beat analysts' estimates. Bank of America and Goldman Sachs also are scheduled to report third-quarter earnings Tuesday.""}, {""date"": ""20231017103400"", ""headline"": ""Johnson & Johnson earnings top forecasts, shares jump, on new cancer drug boost"", ""summary"": ""Johnson & Johnson's newly-structured business, which no longer includes a consumer healthcare unit, is seeing solid demand for its new cancer-focused treatments Carvykti and Tecvayli.""}, {""date"": ""20231017104000"", ""headline"": ""Johnson & Johnson Stock Rises. It Lifts Guidance in First Post-Kenvue Earnings."", ""summary"": ""The company raises its expected annual adjusted earnings to a range of $10.07 to $10.13 a share and now expects annual sales of $83.6 billion to $84 billion.""}, {""date"": ""20231017110500"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017111300"", ""headline"": ""Johnson & Johnson sees GLP-1 impact on weight loss surgeries"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017112859"", ""headline"": ""5 Things to Know Before Markets Open"", ""summary"": ""Bank of America shares rose after reporting better-than-expected earnings on higher interest income and Johnson & Johnson delivered an earnings beat on medical device and pharmaceutical sales. Here\u2019s what investors need to know today.""}, {""date"": ""20231017114002"", ""headline"": ""Johnson & Johnson (JNJ) Q3 Earnings and Revenues Surpass Estimates"", ""summary"": ""Johnson & Johnson (JNJ) delivered earnings and revenue surprises of 5.56% and 1.67%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?""}, {""date"": ""20231017115200"", ""headline"": ""Dow rises as investors digest strong retail sales and earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017121800"", ""headline"": ""Johnson & Johnson Raises Its Profit Outlook, but Its Charts Still Don't Impress"", ""summary"": ""The technical indicators of the pharmaceutical and medical device giant suggest that the bump it stands to get from its latest earnings announcement may not be sustainable.""}, {""date"": ""20231017124800"", ""headline"": ""Stocks Rise On Positive Earnings; Treasury Volatility Returns, Nvidia Stumbles: What's Driving Markets Tuesday?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017125600"", ""headline"": ""Wall Street Lunch: Sept. Retail Sales Spark Treasury Yield Surge"", ""summary"": ""The 10-yr yield surges close to 4.85%, 30-yr close to 5% after Sept. retail sales; Goldman Sachs Q3 revenue beat estimates; Bank of America posts results beat. Read more.""}, {""date"": ""20231017125700"", ""headline"": ""J&J Sees Boom in Heart Device Sales in Third Quarter"", ""summary"": ""A standout performer in Johnson & Johnson\u2019s third quarter was the group of special catheters and other [electrophysiology products](https://www.wsj.com/articles/j-j-makes-a-16-6-billion-bet-on-heart-pumps-to-lift-medical-device-sales-11667388513) used to diagnose and treat irregular heart rhythms.  \u201cWe continue to take market share with our existing products and we have plans for new products [in that space](https://www.wsj.com/articles/surge-in-heart-procedures-help-drive-johnson-johnson-revenue-1d49d5c2) to come out as early as 2024,\u201d J&J Chief Financial Officer Joseph Wolk told The Wall Street Journal.""}, {""date"": ""20231017131149"", ""headline"": ""Johnson & Johnson (JNJ) Reports Strong Q3 2023 Results with Notable Sales and EPS Growth"", ""summary"": ""Company increases full-year guidance for sales and adjusted EPS""}, {""date"": ""20231017133008"", ""headline"": ""Johnson & Johnson (JNJ) Reports Q3 Earnings: What Key Metrics Have to Say"", ""summary"": ""Although the revenue and EPS for Johnson & Johnson (JNJ) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.""}, {""date"": ""20231017135454"", ""headline"": ""Johnson & Johnson raises guidance, Q3 results top estimates"", ""summary"": ""Johnson & Johnson (JNJ) reported third quarter results that topped analyst estimates on both the top and bottom lines. The health care company also raised its full-year guidance. The report was the company's first earnings release since it spun off its consumer health business, Kenvue (KVUE). Yahoo Finance Live breaks down the numbers.\u00a0 For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.""}, {""date"": ""20231017140022"", ""headline"": ""Johnson & Johnson Is Falling, but This Tech Stock Is Really Getting Hit Hard"", ""summary"": ""Already, market participants have had a chance to respond to the latest results from some of the biggest banking institutions in the country, and now the focus will shift to other segments of the economy.  One company that a lot of market participants wanted to look at closely was Johnson & Johnson (NYSE: JNJ), as the healthcare giant offers a pulse on what's becoming an increasingly important sector of the market.  Shares of Johnson & Johnson were down almost 1% Tuesday morning.""}, {""date"": ""20231017143200"", ""headline"": ""Retail Sales Hotter at +0.7%; JNJ, BAC, GS All Beat in Q3"", ""summary"": ""Retail Sales infer a consumer willing to spend, and the outlook for Q3 GDP is likely up somewhat on this news.""}, {""date"": ""20231017143500"", ""headline"": ""The 'New' Johnson & Johnson Reports, But Where Are the Rest of the Numbers?"", ""summary"": ""On Tuesday morning, Johnson & Johnson  reported the firm's third quarter financial results.  For the three month period ended October 1st, Johnson & Johnson posted an adjusted EPS from continuing operations of $2.66  $1.69  on revenue of $21.351B.  Both the top line and adjusted bottom line results exceeded Wall Street's expectations.""}, {""date"": ""20231017144526"", ""headline"": ""J&J Stock Dips After Healthcare Giant Posts Earnings"", ""summary"": ""Johnson & Johnson ([JNJ](https://www.wsj.com/market-data/quotes/JNJ?)) raised its adjusted earnings outlook for the year after posting higher third-quarter revenue, despite a drop in sales of its Covid-19 vaccine.""}, {""date"": ""20231017145239"", ""headline"": ""Stocks to Watch Tuesday: J&J, Lockheed Martin, Goldman Sachs, Bank of America, VF"", ""summary"": ""\u2198\ufe0f [**Goldman Sachs (GS)**](https://www.wsj.com/market-data/quotes/GS): The bank posted declines in quarterly profit and revenue, but narrowly [beat consensus estimates](https://www.wsj.com/livecoverage/stock-market-today-dow-jones-10-17-2023/card/goldman-sachs-profit-falls-33--6x5YoO6CkK0jiZWvWVtB) for both.""}, {""date"": ""20231017145400"", ""headline"": ""Retail Sales Increased More Than Expected"", ""summary"": ""Retail Sales Increased More Than Expected""}, {""date"": ""20231017150216"", ""headline"": ""S&P 500 falls as Nvidia slip, rising yields overshaddow quarterly earnings"", ""summary"": ""Investing.com -- The S&P 500 fell Tuesday as investor sentiment was soured by Nvidia-led weakness in chip stocks and a jump in Treasury yields following stronger retail sales data that boosted bets on a Fed rate hike by year end.""}, {""date"": ""20231017150834"", ""headline"": ""Johnson & Johnson Raises Outlook As The Health Care Bellwether Beats Views"", ""summary"": ""Johnson & Johnson beat third-quarter forecasts Tuesday and raised its outlook for the year. JNJ stock skidded lower after the open.""}, {""date"": ""20231017155613"", ""headline"": ""J&J Beats Profit Estimates on Pharmaceutical, Medtech Sales as COVID-19 Shot Revenue Slows"", ""summary"": ""Johnson & Johnson beat profit and sales estimates and boosted its outlook as pharmaceutical and medical device sales gain while demand for COVID-19 vaccines wanes.""}, {""date"": ""20231017161331"", ""headline"": ""Stock Market Today: Dow ekes out gain, but rising Treasury yields stifle upside"", ""summary"": ""Investing.com -- The Dow eked out a gain Tuesday, but upside momentum was stifled by a jump in Treasury yields following stronger retail sales data that underscored ongoing strength in the economy, stoking fresh fears about another Federal Reserve rate hike before year end.""}, {""date"": ""20231017162400"", ""headline"": ""NEW YORK MARKET CLOSE: Blue-chips end flat but chip curbs rattle tech"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017163100"", ""headline"": ""Johnson & Johnson stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson dropped 0.91% to $156.09 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...""}, {""date"": ""20231017163200"", ""headline"": ""J&J (JNJ) Beats Q3 Earnings & Sales Estimates Post Spin-Off"", ""summary"": ""J&J (JNJ) beats estimates for third-quarter earnings and sales. It raises full-year sales and earnings guidance.""}, {""date"": ""20231017173022"", ""headline"": ""Johnson & Johnson (JNJ) Q3 2023 Earnings Call Transcript"", ""summary"": ""This is Jessica Moore, vice president of investor relations for Johnson & Johnson.  As a reminder, you can find additional materials including today's presentation and associated schedules on the Investor Relations section of the Johnson & Johnson website at investor.jnj.com.  Please note that this presentation and forward-looking statements regarding, among other things, the company's future operating and financial performance, market position, and business strategy.""}, {""date"": ""20231017191616"", ""headline"": ""Johnson & Johnson Was Saved By Its Focus On MedTech And Innovative Medicine"", ""summary"": ""Johnson & Johnson (NYSE: JNJ) reported its third quarter results that topped Wall Street\u2019s expectations while also lifting its full year guidance fueled by a strong performance of its pharmaceutical and medical devices businesses. This is the company\u2019s first quarterly report since the biggest shakeup in its 13- year-old history when it completed the separation from its consumer health spinoff Kenvue back in August. JNJ Reported A Better Than Expected Third Quarter During the third quarter, JNJ g""}, {""date"": ""20231017200000"", ""headline"": ""Johnson & Johnson's Sharper Focus Is Already Paying Dividends for Investors"", ""summary"": ""Johnson & Johnson\u00a0(NYSE: JNJ) has spent several quarters working toward sharpening its focus on its innovative medicine and medical technology (MedTech) businesses. It took a huge step forward by completing the spin-off of its former consumer healthcare business,\u00a0Kenvue\u00a0(NYSE: KVUE), to shareholders during the third quarter.""}, {""date"": ""20231017202300"", ""headline"": ""These Stocks Moved the Most Today: Nvidia, VMware, VF Corp., Bank of America, Lucid, Wyndham, and More"", ""summary"": ""Nvidia tumbles as the Biden administration is tightening its restriction on exports of artificial intelligence chips to China, earnings from Bank of America beat Wall Street forecasts, and Lucid's third-quarter production falls.""}, {""date"": ""20231017205520"", ""headline"": ""S&P 500 Gains and Losses Today: Chipmaker Shares Drop Amid Tightening Export Rules"", ""summary"": ""The S&P 500 dipped 0.01% on Tuesday, Oct. 17, 2023, as news that retail sales jumped more than expected in September renewed concerns about more Fed rate hikes.""}, {""date"": ""20231017233000"", ""headline"": ""Stocks Face Bumpy Road As Macro Risks Remain"", ""summary"": """"}, {""date"": ""20231018003237"", ""headline"": ""J&J Weighs Third Bankruptcy Try to Settle Baby Powder Suits"", ""summary"": ""(Bloomberg) -- Johnson & Johnson is weighing a third attempt to use bankruptcy for an $8.9 billion settlement of tens of thousands of lawsuits that allege tainted talc in the company\u2019s baby powder caused cancer, the health-care giant told investors Tuesday.Most Read from BloombergGaza Hospital Blast Kills Hundreds as Israel, Hamas Trade BlameIsrael Latest: Biden to Visit as Oil Climbs After Hospital BlastTreasury Yields Climb as Hot Data Fuel Fed Wagers: Markets WrapWill Xi Jinping\u2019s Gamble on V""}, {""date"": ""20231018012800"", ""headline"": ""Hold Rating for Johnson & Johnson: A Balance of Strong Performance and Ongoing Challenges"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018013700"", ""headline"": ""Positive Analyst Outlook on Johnson & Johnson: Accelerated Growth and Raised Guidance Despite Potential Challenges"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018014500"", ""headline"": ""Positive Outlook On Johnson & Johnson's Partner Legend Biotech: Analyst Confident On Blood Cancer Drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018040355"", ""headline"": ""Q3 2023 Johnson & Johnson Earnings Call"", ""summary"": ""Q3 2023 Johnson & Johnson Earnings Call""}, {""date"": ""20231018043900"", ""headline"": ""J&J considers third bankruptcy attempt over talc claims"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018053000"", ""headline"": ""Dividend Income Update September 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018060100"", ""headline"": ""Beyond Market Price: Uncovering Johnson & Johnson's Intrinsic Value"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018065700"", ""headline"": ""Johnson & Johnson (NYSE:JNJ)\u00a0to Boost MedTech Division\u2019s Margins"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018071600"", ""headline"": ""Cantor Fitzgerald Sticks to Their Buy Rating for Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018075000"", ""headline"": ""Johnson & Johnson price target lowered to $171 from $174 at Morgan Stanley"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018080700"", ""headline"": ""Johnson & Johnson price target lowered to $178 from $186 at Wells Fargo"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018081500"", ""headline"": ""My Dividend Stock Portfolio: New September Dividend Record - 98 Holdings With 22 Buys"", ""summary"": ""The S&P 500 and Dow Jones Industrial Average saw sharp losses for the month and the quarter. Click here to read my analysis.""}, {""date"": ""20231018090200"", ""headline"": ""Analysts Are Bullish on Top Healthcare Stocks: Ligand Pharma (LGND), Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018093500"", ""headline"": ""Dow remains lower with Treasury yields near 16 year highs, oil jumping and tech earnings ahead"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018095100"", ""headline"": ""Is the \""New\"" Johnson & Johnson Stock a Buy With Its Improved Profit Outlook?"", ""summary"": ""Some things are different about J&J. But other things remain the same as they've been for a long time.""}, {""date"": ""20231018095300"", ""headline"": ""FDA approves UCB's Bimzelx for plaque psoriasis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018114800"", ""headline"": ""Genmab hits 52-week low after Q3 Darzalex sales"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018131001"", ""headline"": ""Johnson & Johnson (NYSE:JNJ) Q3 2023 Earnings Call Transcript"", ""summary"": ""Johnson & Johnson (NYSE:JNJ) Q3 2023 Earnings Call Transcript October 17, 2023 Operator: Good morning, and welcome to Johnson & Johnson\u2019s Third Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode until the question-and-answer session of the conference. This call is being recorded. If anyone has any objections, you may disconnect [\u2026]""}, {""date"": ""20231018133000"", ""headline"": ""1 Warren Buffett Stock to Buy Hand Over Fist Right Now"", ""summary"": ""Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) CEO Warren Buffett is a defensive investor at heart.  As a result, Berkshire Hathaway's portfolio is heavily tilted toward dyed-in-the-wool value stocks \u2013 many of which pay generous and sustainable dividends.  Underscoring this point, a $1,000 investment in Berkshire Hathway stock at the start of Buffett's tenure as CEO would be worth an astonishing $1.82 million today.""}, {""date"": ""20231018140500"", ""headline"": ""JNJ Beats Q3 Earnings Estimates, Raises View: ETFs in Focus"", ""summary"": ""The world's biggest healthcare products maker continued with its long streak of earnings beat and lifted the full year outlook.""}, {""date"": ""20231018163200"", ""headline"": ""Johnson & Johnson stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slipped 2.15% to $152.73 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P...""}, {""date"": ""20231018173057"", ""headline"": ""Cantor Fitzgerald Reiterates Johnson & Johnson (JNJ) Overweight Recommendation"", ""summary"": """"}, {""date"": ""20231018173101"", ""headline"": ""Raymond James Maintains Johnson & Johnson (JNJ) Outperform Recommendation"", ""summary"": """"}, {""date"": ""20231018214646"", ""headline"": ""Why Johnson & Johnson Stock Flopped Today"", ""summary"": ""Johnson & Johnson (NYSE: JNJ) stock had a bit of a hangover Wednesday.  Following the estimates-beating third-quarter results that the company posted Tuesday, its share price fell by more than 2%.  Before the market open Wednesday, a pair of pundits tracking Johnson & Johnson stock lowered their fair value estimations of the healthcare giant.""}, {""date"": ""20231019010800"", ""headline"": ""Check Out What Whales Are Doing With JNJ"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019022557"", ""headline"": ""Morgan Stanley Maintains Johnson & Johnson (JNJ) Equal-Weight Recommendation"", ""summary"": """"}, {""date"": ""20231019031100"", ""headline"": ""Johnson & Johnson declares $1.19 dividend"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019031200"", ""headline"": ""CVS removing certain cold medicines containing phenylephrine, CNBC reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019031500"", ""headline"": ""7 Healthcare Stocks That Can Cure a Lackluster Portfolio"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019034000"", ""headline"": ""The 7 Best Forever Stocks To Buy Now: October 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019051300"", ""headline"": ""Johnson & Johnson price target raised to $165 from $162 at Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019054700"", ""headline"": ""7 Dividend Aristocrats That Are Built to Last"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019065900"", ""headline"": ""GLOBAL BROKER RATINGS: DZ Bank cuts P&G, but raises PepsiCo"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019070100"", ""headline"": ""Johnson & Johnson\u2019s Stock Receives Buy Rating Amid Promising MARIPOSA Trial Results and Potential Market Share Gain"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019071500"", ""headline"": ""AT&T Is Still A Mess, So Buy These 9%-Yielding Dividend Aristocrat Bargains"", ""summary"": ""AT&T stock has been a value trap for four decades. Find out two other 9%-yielding dividend aristocrat bargains capable of doubling in value every 5 years""}, {""date"": ""20231019072400"", ""headline"": ""Drug retailers, makers face mounting litigation over decongestant products"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019091500"", ""headline"": ""Video: Dow Movers: JNJ, MCD"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019101800"", ""headline"": ""Dow drops nearly 100 points on losses in shares of Merck, Amgen"", ""summary"": ""Shares of Merck and Amgen are posting losses Thursday morning, dragging the Dow Jones Industrial Average into negative territory. The Dow was most recently...""}, {""date"": ""20231019103000"", ""headline"": ""'Things were way tougher': Charlie Munger gets blunt with whiners worried about 'hardship' \u2014 plus 3 stocks Warren Buffett's right-hand man uses to supercharge his finances in tough times"", ""summary"": ""The 99-year-old investing legend has spoken.""}, {""date"": ""20231019103500"", ""headline"": ""Johnson & Johnson Enters Oversold Territory"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019104200"", ""headline"": ""Eli Lilly, Novo among notable decliners in pharma weakness"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019105300"", ""headline"": ""Is Johnson & Johnson Still a Good Dividend Stock to Buy?"", ""summary"": ""Investors wonder if the healthcare giant can keep raising its payout now that it no longer sells the consumer health brands that made it famous.""}, {""date"": ""20231019132218"", ""headline"": ""ChatGPT Stock Advice: 15 Recent Stock Recommendations"", ""summary"": ""In this article, we will take a look at the ChatGPT stock advice: 15 recent stock recommendations. To see more such companies, go directly to ChatGPT Stock Advice: 5 Recent Stock Recommendations. More and more hedge funds are starting to deploy AI for stock picking and financial analysis. And the logic behind this practice is [\u2026]""}, {""date"": ""20231019140900"", ""headline"": ""Big-Name Stock Spinoffs Are Going Mainstream. Here\u2019s Why."", ""summary"": ""Globalization and easier access to capital are encouraging prominent companies to consider spinoffs, writes Allan Sloan.""}, {""date"": ""20231019150219"", ""headline"": ""Kenvue: Very Profitable And Significantly Undervalued"", ""summary"": ""Kenvue is significantly undervalued vs. peers of similar size and with a similar product mix. Find out if now is a good time to buy KVUE stock.""}, {""date"": ""20231019163200"", ""headline"": ""Johnson & Johnson stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Johnson & Johnson slid 0.27% to $152.32 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""20231019174300"", ""headline"": ""Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2023"", ""summary"": ""NEW BRUNSWICK, N.J., October 19, 2023--Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the fourth quarter of 2023 of $1.19 per share on the company\u2019s common stock. The dividend is payable on December 5, 2023 to shareholders of record at the close of business on November 21, 2023. The ex-dividend date is November 20, 2023.""}, {""date"": ""20231020012300"", ""headline"": ""New Dengue Pill from Johnson & Johnson (NYSE:JNJ) Gives Shares a Boost"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020054300"", ""headline"": ""IN BRIEF: J&J's Janssen notes \""promising\"" data for dengue antiviral"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020063458"", ""headline"": ""Wall Street Breakfast Podcast: CVS Pulls Phenylephrine Amid Legal Woes"", ""summary"": ""Drug retailers, makers face mounting litigation over decongestant products. Toyota works out deal with Tesla to adopt NACS charging standard. Jazz Pharmaceutical exploring strategic options.""}, {""date"": ""20231020064800"", ""headline"": ""GLOBAL BROKER RATINGS: DZ likes Roche; Metzler likes Mercedes"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020080000"", ""headline"": ""First pill for dengue shows promise in human challenge trial"", ""summary"": ""A pill for dengue fever developed by Johnson & Johnson appeared to protect against a form of the virus in a handful of patients in a small human challenge trial in the United States, according to data presented by the company on Friday.  There are currently no specific treatments for dengue, a growing disease threat, the company said ahead of presentation of the data at the American Society of Tropical Medicine and Hygiene Annual Meeting in Chicago.  \u201cIt is the first ever to show antiviral activity against dengue,\u201d Marnix Van Loock, who oversees emerging pathogens research for J&J\u2019s Janssen division, said of the drug.""}, {""date"": ""20231020085700"", ""headline"": ""3 Mutual Funds to Invest in for Pro Management and Low Fees"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020091209"", ""headline"": ""Johnson & Johnson: Q3 Earnings Unveils Life After Kenvue Spinoff"", ""summary"": ""Johnson & Johnson reported Q3 earnings with a 6.8% surge in sales, reaching $21.4 billion in revenue. Click here to read my earnings analysis of the JNJ stock.""}, {""date"": ""20231020091400"", ""headline"": ""CVS Health pulls some cough-and-cold treatments with ingredient deemed ineffective by doctors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020093000"", ""headline"": ""Alvotech upgraded at Citi citing FDA nod for biosimilars"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020093300"", ""headline"": ""Janssen announces Phase 3b Week 16 results from Cohort A of VISIBLE trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020112000"", ""headline"": ""Johnson & Johnson shows antiviral effects of dengue pill in mid-stage trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020114100"", ""headline"": ""IN BRIEF: J&J's Tremfya shows positive results in psoriasis study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020135553"", ""headline"": ""Buffett's 6 Dividend Buys For October"", ""summary"": ""The article discusses Warren Buffett's dividend stocks, highlighting the top performers and providing investment insights based on YCharts data. Click here for more.""}, {""date"": ""20231020141854"", ""headline"": ""Medical device makers see limited hit from weight-loss drugs"", ""summary"": ""Intuitive, which makes a surgical robot used in several procedures including bariatrics, said on an earnings call that the U.S. growth rate for weight-loss surgery was slowing as patients consider using the new drugs instead.""}, {""date"": ""20231020163000"", ""headline"": ""Abbott Labs: Fear Is In The Air - That's Why I'm Bullish"", ""summary"": ""Abbott Laboratories reported solid growth across all segments in its third-quarter results, excluding its COVID diagnostics portfolio. Read more here.""}, {""date"": ""20231020163200"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.45% higher to $153.00 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P...""}, {""date"": ""20231020212200"", ""headline"": ""Johnson & Johnson Considers Ditching Texas Two-Step for Third Talc Bankruptcy"", ""summary"": ""The healthcare giant is exploring another bankruptcy and a Supreme Court appeal to try to resolve its mass talc liabilities.""}, {""date"": ""20231021092700"", ""headline"": ""Intuitive Surgical's Revenue Dipped: Is It Time to Sell?"", ""summary"": ""A stagnating top line isn't what investors want to see, but things might not be as bad as the surgical robot specialist's stock price performance would suggest.""}, {""date"": ""20231021102700"", ""headline"": ""These 2 Dow Stocks Moved Markets This Week"", ""summary"": ""When any of the 30 companies that are in the Dow Jones Industrials report their latest financial results, it has the potential to move the entire market.  On Tuesday morning, both Johnson & Johnson (NYSE: JNJ) and Goldman Sachs (NYSE: GS) gave investors their quarterly reports for the third quarter.""}, {""date"": ""20231021130000"", ""headline"": ""2 Attractive High Dividend Yield Buys For Your Dividend Income Portfolio"", ""summary"": ""This week, two additional companies have been added to The Dividend Income Accelerator Portfolio.""}, {""date"": ""20231021140700"", ""headline"": ""2 Warren Buffett Dividend Stocks to Buy and Hold Forever"", ""summary"": ""Famed investor Warren Buffett is known for several things, including his love for dividends and his penchant for companies whose shares he can hold forever.  It's not surprising, then, to find great dividend stocks worth holding on to for good among Berkshire Hathaway's (NYSE: BRK.A) (NYSE: BRK.B) holdings.  Two of the most attractive are Johnson & Johnson (NYSE: JNJ) and Visa (NYSE: V).""}, {""date"": ""20231021150933"", ""headline"": ""Analysts find strength in consumer stocks Hershey, P&G, J&J"", ""summary"": ""Consumer staples is the third worst performing sector this year, but early earnings results show sentiment towards the sector may soon shift.""}, {""date"": ""20231021190000"", ""headline"": ""Bank Bonds That Cut Risk Draw Ares and Blackstone: Credit Weekly"", ""summary"": ""(Bloomberg) -- Banks are reviving the sale of credit-linked notes, a type of synthetic securitization that\u2019s been relatively uncommon in the US since the financial crisis, ahead of new rules that will require them to hold more regulatory capital.Most Read from BloombergCar Owners Fall Behind on Payments at Highest Rate on RecordIsrael Latest: Gaza Air Strikes to Intensify Before \u2018Next Stage\u2019Web Summit CEO Cosgrave Quits After Israel ControversyModerna Shaves Off $7 Billion in Value After Pfizer""}, {""date"": ""20231022022000"", ""headline"": ""Psyched: Jada Pinkett-Smith's Ayahuasca Journey, RIP Dr. Roland Griffiths, Congressional VA Hearings Halted"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231022090300"", ""headline"": ""3 Foundational Blue Chip Dow Dividend Stocks for Building Generational Wealth"", ""summary"": ""When looking at potential dividend stocks, investors often compare dividend yield and a company's track record for increasing its payout.  The Home Depot (NYSE: HD), Johnson & Johnson (NYSE: JNJ), and Chevron (NYSE: CVX) have both of these qualities in abundance.  All three are also components of the Dow Jones Industrial Average (DJINDICES: ^DJI).""}, {""date"": ""20231022105000"", ""headline"": ""Down in the Double Digits, These 2 Classic Warren Buffett Stocks Make Great Buys Now"", ""summary"": ""Warren Buffett has an investing track record anyone would love.  As chairman of Berkshire Hathaway, he's delivered a compounded annual gain of nearly 20% over more than 50 years.  The billionaire has always stood by the same investing principles: Choose solid companies that are undervalued and stick with them for the long term.""}, {""date"": ""20231022133929"", ""headline"": ""11 Best Low-Risk Dividend Stocks To Invest In"", ""summary"": ""In this article, we discuss 11 best low-risk dividend stocks to invest in. You can skip our detailed analysis of dividend stocks and their performance, and go directly to read 5 Best Low-Risk Dividend Stocks To Invest In. American investors are feeling the pain as the fourth quarter begins, following a tough September that dimmed [\u2026]""}, {""date"": ""20231022164400"", ""headline"": ""Retail products giant plans a new bankruptcy filing"", ""summary"": ""The big-name brand openly talked about a potential Chapter 11 filing during its most recent earnings call.""}]","{""assetTurnoverTTM"": 0.4721, ""bookValue"": 71228, ""cashRatio"": 0.15138607167004733, ""currentRatio"": 1.2103, ""ebitPerShare"": 2.0459, ""eps"": 10.2071, ""ev"": 396807.4, ""fcfMargin"": 0.3055, ""fcfPerShareTTM"": 6.538, ""grossMargin"": 0.7012, ""inventoryTurnoverTTM"": 2.3818, ""longtermDebtTotalAsset"": 0.1569, ""longtermDebtTotalCapital"": 0.2576, ""longtermDebtTotalEquity"": 0.3657, ""netDebtToTotalCapital"": 0.2294, ""netDebtToTotalEquity"": 0.3258, ""netMargin"": 1.2191, ""operatingMargin"": 0.2443, ""payoutRatioTTM"": 0.257, ""pb"": 5.2452, ""peTTM"": 10.7903, ""pfcfTTM"": 23.7404, ""pretaxMargin"": 0.2443, ""psTTM"": 4.2712, ""ptbv"": 10.3185, ""quickRatio"": 0.8634, ""receivablesTurnoverTTM"": 5.7006, ""roaTTM"": 0.1869, ""roeTTM"": 0.471, ""roicTTM"": 0.2997, ""rotcTTM"": 0.125, ""salesPerShare"": 8.3729, ""sgaToSale"": 0.2988, ""tangibleBookValue"": 36207, ""totalDebtToEquity"": 0.4201, ""totalDebtToTotalAsset"": 0.1802, ""totalDebtToTotalCapital"": 0.2958, ""totalRatio"": 1.7511, ""period"": ""2023-10-01""}"
20,2023-10-22,151.7845001220703,2023-10-29,144.44329833984375,-0.048365951571619714,D5,"[{""date"": ""20231022022000"", ""headline"": ""Psyched: Jada Pinkett-Smith's Ayahuasca Journey, RIP Dr. Roland Griffiths, Congressional VA Hearings Halted"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231022090300"", ""headline"": ""3 Foundational Blue Chip Dow Dividend Stocks for Building Generational Wealth"", ""summary"": ""When looking at potential dividend stocks, investors often compare dividend yield and a company's track record for increasing its payout.  The Home Depot (NYSE: HD), Johnson & Johnson (NYSE: JNJ), and Chevron (NYSE: CVX) have both of these qualities in abundance.  All three are also components of the Dow Jones Industrial Average (DJINDICES: ^DJI).""}, {""date"": ""20231022105000"", ""headline"": ""Down in the Double Digits, These 2 Classic Warren Buffett Stocks Make Great Buys Now"", ""summary"": ""Warren Buffett has an investing track record anyone would love.  As chairman of Berkshire Hathaway, he's delivered a compounded annual gain of nearly 20% over more than 50 years.  The billionaire has always stood by the same investing principles: Choose solid companies that are undervalued and stick with them for the long term.""}, {""date"": ""20231022133929"", ""headline"": ""11 Best Low-Risk Dividend Stocks To Invest In"", ""summary"": ""In this article, we discuss 11 best low-risk dividend stocks to invest in. You can skip our detailed analysis of dividend stocks and their performance, and go directly to read 5 Best Low-Risk Dividend Stocks To Invest In. American investors are feeling the pain as the fourth quarter begins, following a tough September that dimmed [\u2026]""}, {""date"": ""20231022164400"", ""headline"": ""Retail products giant plans a new bankruptcy filing"", ""summary"": ""The big-name brand openly talked about a potential Chapter 11 filing during its most recent earnings call.""}, {""date"": ""20231023042800"", ""headline"": ""J&J MedTech head stepping down in wake of lower-than-expected sales"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231023070300"", ""headline"": ""J&J report slew of positive trial results focused on various cancers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231023071600"", ""headline"": ""Cantor Fitzgerald Keeps Their Buy Rating on Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231023074900"", ""headline"": ""Quanterix announces new agreement to advance blood-based Alzheimer's detection"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231023080800"", ""headline"": ""IN BRIEF: J&J sees positive results for Tremfya in ulcerative colitis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231023090200"", ""headline"": ""See Which Of The Latest 13F Filers Holds Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231023093700"", ""headline"": ""Janssen says Rybrevant combination study showed 30% risk reduction"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231023130010"", ""headline"": ""Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It"", ""summary"": ""Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.""}, {""date"": ""20231023141000"", ""headline"": ""Charles River (CRL) Offers Access to Preclinical Cancer Research"", ""summary"": ""Charles River (CRL) contributes to 84 percent of the FDA-approved cancer medicines and provides partners with 16 oncology prospects.""}, {""date"": ""20231023160745"", ""headline"": ""Cantor Fitzgerald Reiterates Johnson & Johnson (JNJ) Overweight Recommendation"", ""summary"": """"}, {""date"": ""20231023161100"", ""headline"": ""Big name brand plans a new bankruptcy filing"", ""summary"": ""The company, which has tried to file Chapter 11 through its LTL Management affiliate but was denied by a bankruptcy court in New Jersey, has a new plan to resolve its massive liabilities.  This case has nothing to do with Johnson & Johnson's ongoing operations.""}, {""date"": ""20231023163200"", ""headline"": ""Johnson & Johnson stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slid 1.05% to $151.39 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""20231023201500"", ""headline"": ""Johnson & Johnson Announces Departure of Ashley McEvoy, Tim Schmid Named Executive Vice President, Worldwide Chairman of MedTech"", ""summary"": ""NEW BRUNSWICK, N.J., October 23, 2023--Johnson & Johnson (NYSE: JNJ) (the Company) announced today that Ashley McEvoy, Executive Vice President, Worldwide Chairman of MedTech, informed the company on October 20, 2023, that she is stepping down from her position to pursue other opportunities. Ms. McEvoy will remain with the Company into Q1 2024 to support a successful transition. Tim Schmid has been appointed Executive Vice President, Worldwide Chairman of MedTech, joining the Company\u2019s Executive""}, {""date"": ""20231024055000"", ""headline"": ""Johnson & Johnson inks licensing deal with Quanterix for Alzheimer's testing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231024055700"", ""headline"": ""Johnson & Johnson\u2019s Stock: A Stable Transition and Promising Future Despite Leadership Change"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231024084400"", ""headline"": ""VTV: A Great ETF for Value Investors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231024084500"", ""headline"": ""VTV: A Must-Watch ETF for Value Investors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231024092100"", ""headline"": ""2 Historically Cheap Dow Dividend Kings That Are Ripe for the Picking"", ""summary"": ""These inexpensive Dow components have achieved royalty status among income stocks -- more than 60 consecutive years of dividend increases.""}, {""date"": ""20231024093000"", ""headline"": ""The Best Stocks to Invest $5,000 In Right Now"", ""summary"": ""Vertex Pharmaceuticals (NASDAQ: VRTX) brings you a solid track record of growth -- plus potential for more ahead.  The company is testing a new CF treatment in phase 3 studies that may even beat Trikafta, paving the way for Vertex to hold onto its leadership at least until the late 2030s.  Meanwhile, Vertex may be about to launch its first potential blockbuster beyond CF.""}, {""date"": ""20231024114500"", ""headline"": ""3 High-Yielding Dividend Stocks Near Their 52-Week Lows"", ""summary"": ""Due to their declining share prices, Johnson & Johnson, Bank of America, and Target all yield more than 3% right now.""}, {""date"": ""20231024163200"", ""headline"": ""Johnson & Johnson stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slipped 0.11% to $151.23 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20231024181400"", ""headline"": ""Johnson & Johnson Stock Skirts a 52-Week Low. Here\u2019s What\u2019s Ailing Healthcare."", ""summary"": ""Shares of  Johnson & Johnson  approached a 52-week low Tuesday, just over a week after the drugmaker reported better than expected third-quarter financial results and raised its forecast for full-year earnings.  Johnson & Johnson  (ticker: JNJ) has entirely given up the gains it clocked in the first half of the year, when shares climbed from $150.11 in late March to $174.01 in late August.  More than one malady has struck the healthcare sector, and there\u2019s no panacea in sight.""}, {""date"": ""20231024213437"", ""headline"": ""Dividend Capture Strategy: 10 High Yield Stocks To Buy in November"", ""summary"": ""In this article, we discuss dividend capture strategy and high yield stocks to buy in November. You can skip our detailed analysis of the dividend capture approach and the performance of dividend stocks, and go directly to read Dividend Capture Strategy: 5 High Yield Stocks To Buy in November. Investing in dividend stocks is easier [\u2026]""}, {""date"": ""20231025011800"", ""headline"": ""Positive Prospects for Johnson & Johnson: Buy Rating Assigned Due to Superior Performance of Rybrevant in MARIPOSA Trials"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231025030000"", ""headline"": ""Bond Yields May Have Peaked. Consider These Stocks."", ""summary"": ""Bond yields may have peaked, making a host of stocks look attractive.""}, {""date"": ""20231025091900"", ""headline"": ""2 Exceptional Dividend Stocks Near 52-Week Lows. Are They Bargains Now?"", ""summary"": ""This hasn't been a sensational year for the dividend stocks already in investors' portfolios, but you could hardly pick a better time to be a buyer.  The risk-free returns institutional investors can receive from long-term Treasuries have risen to levels we haven't seen since before the global financial crisis kicked off about 15 years ago.  While higher interest rates are wreaking havoc on stock prices, they won't unravel the competitive advantages that allow these companies to consistently outperform.""}, {""date"": ""20231025101500"", ""headline"": ""The 7 Best Forever Stocks to Buy for October 2023"", ""summary"": ""Navigating the thunderstorm of fluctuating markets, savvy investors anchor their portfolios with the best forever stocks. These stocks have proven resilient in the face of economic uncertainties and continue to flourish amid influential megatrends. These paragons of consistency boast tremendous histories of relentless expansion rooted in sectors indispensable to our daily grind. What sets them apart is a formidable moat, be it robust brand equity, cutting-edge technology, or potent network effec""}, {""date"": ""20231025113000"", ""headline"": ""Here's what Wall Street is saying about IBM ahead of earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231025114500"", ""headline"": ""Cantor biotech/biopharma analysts hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231025163100"", ""headline"": ""Johnson & Johnson stock underperforms Wednesday when compared to competitors despite daily gains"", ""summary"": ""Shares of Johnson & Johnson inched 0.22% higher to $151.57 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the...""}, {""date"": ""20231025200404"", ""headline"": ""Dow Jones Bear Market: 3 Cheap Stocks to Buy Now"", ""summary"": ""The stock market has entered a slump. The Federal Reserve continues its campaign to limit inflation. In doing so, interest rates have soared which is likely to hurt the housing market and consumer spending. Given the uncertainty, investors have been trimming positions in vulnerable stocks. The sell-off, however, is creating an opportunity. Particularly for these three cheap Dow Jones stocks to buy, the current economic headwinds are setting up an excellent buy-the-dip situation. Johnson & Johnso""}, {""date"": ""20231026041900"", ""headline"": ""TOP NEWS: GSK subsidiary ViiV receives HIV drug approval in China"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231026052700"", ""headline"": ""ViiV Healthcare receives approval from NMPA of China for Vocabria with Rekambys"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231026065300"", ""headline"": ""Kenvue\u2019s stock slides premarket as company reports slow start to flu and cold season"", ""summary"": ""Kenvue Inc.\u2019s stock fell 2.4% in premarket trade Thursday, after the company posted in-line third-quarter earnings but tightened its full-year guidance after...""}, {""date"": ""20231026070500"", ""headline"": ""The Passive Income Snowball Path To Wealth: VYM Vs. DGRW"", ""summary"": ""WisdomTree US Quality Dividend Growth ETF and Vanguard High Dividend Yield ETF are 2 popular dividend growth ETFs. Read our take on which is the better buy right now.""}, {""date"": ""20231026094500"", ""headline"": ""Cantor biotech/biopharma analyst to hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231026104350"", ""headline"": ""UPDATE 2-Kenvue cuts annual profit forecast on soft demand for cold, flu medicines"", ""summary"": ""Kenvue on Thursday cut the higher end of its annual profit forecast, as Benadryl maker saw weakness in demand for its cold and flu medicines and an increased impact from a stronger dollar.  The consumer health company said its third-quarter net sales were hurt by a slow start to the flu season and soft demand for its products in China.  Kenvue, the spun-off unit of Johnson & Johnson, said it expects full-year organic sales growth between 5.5% and 6%, compared with its prior forecast of 5.5% to 6.5% growth.""}, {""date"": ""20231026113000"", ""headline"": ""3 Pharma Stocks That Are Screaming Buys in October"", ""summary"": ""It hasn't been the easiest of years for Johnson & Johnson (NYSE: JNJ), Amgen (NASDAQ: AMGN) and Gilead Sciences (NASDAQ: GILD).  Continued uncertainty regarding talc lawsuits is weighing on Johnson & Johnson.  Amgen's huge pipeline hasn't been fully appreciated by the market, and Gilead's settlement of an antitrust lawsuit resulted in lowering yearly earnings per share guidance.""}, {""date"": ""20231026114500"", ""headline"": ""2 Magnificent Dividend Stocks That Could Deliver a Lifetime of Passive Income"", ""summary"": ""High-quality dividend stocks are always worth loading up on.  This is doubly true for companies that offer shareholders an attractive mix of reliable income and reasonable levels of growth.  With risk-free assets, like the 10-year Treasury note, offering a near 5% yield, dividend stocks have generally underperformed growth plays in 2023.""}, {""date"": ""20231026163100"", ""headline"": ""Johnson & Johnson stock falls Thursday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slid 1.70% to $149.00 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""20231026172152"", ""headline"": ""3 Stocks to Buy (and Never Ever Sell)"", ""summary"": ""Investors have seen it all in the past three years: a pandemic, lockdown, supply chain issues, inflation, war and high interest rates. The market has shown high volatility and put investors in a state where they are only looking to invest in stocks that have already proven themselves and can survive through market turmoil. The best way to do this is to find forever stocks that have strong fundamentals, proven track records and a solid history. This will ensure that they continue to grow, no matt""}, {""date"": ""20231027012000"", ""headline"": ""Goldman Sachs Reaffirms Their Sell Rating on Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231027021700"", ""headline"": ""Is Ozempic Killing Liposuction? A Stock That Could Get Hit Hard From New Weight-Loss Drugs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231027073500"", ""headline"": ""10 High-Yield Dividend Aristocrats Perfect For What's Coming Next"", ""summary"": ""Investors are worried about soaring interest rates, a pending government shutdown, wars around the world, and a recession looming next year. Read more here.""}, {""date"": ""20231027082600"", ""headline"": ""SNY Stock Sinks 15% as Sanofi Plans Consumer Unit Spinoff"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231027083100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Universal Health (UHS), Insmed (INSM) and Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231027093200"", ""headline"": ""FDA Gives Nod To Eli Lilly's First Treatment For Type Of Inflammatory Bowel Disease, To Compete With JNJ, Pfizer, AbbVie"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231027095300"", ""headline"": ""Chevron, JPMorgan Chase share losses lead Dow's 100-point drop"", ""summary"": ""Behind negative returns for shares of Chevron and JPMorgan Chase, the Dow Jones Industrial Average is falling Friday morning. Shares of Chevron and JPMorgan...""}, {""date"": ""20231027122700"", ""headline"": ""Dow down nearly 200 points on losses for shares of Chevron, Verizon"", ""summary"": ""Shares of Chevron and Verizon are trading lower Friday afternoon, dragging the Dow Jones Industrial Average into negative territory. The Dow was most...""}, {""date"": ""20231027123900"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231027145100"", ""headline"": ""AbbVie (ABBV) Q3 Earnings Beat, Shares Down Despite Raised View"", ""summary"": ""AbbVie's (ABBV) third-quarter 2023 earnings and sales beat estimates. Though the company raised its EPS outlook for both 2023 and 2024, share price dives as some key drugs misses out on estimates.""}, {""date"": ""20231027163200"", ""headline"": ""Johnson & Johnson stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slipped 2.28% to $145.60 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""20231027213424"", ""headline"": ""UPDATE 1-J&J says DoJ seeking information related to eye products in civil investigation"", ""summary"": ""Johnson & Johnson disclosed on Friday that the U.S. Department of Justice (DOJ) in July had sought documents and information related to the drugmaker's free and discounted eye surgery products in connection with a civil investigation.  The company said it had begun complying with the DoJ's civil investigative demands.  J&J said it is in ongoing discussion with DOJ regarding the inquiry.""}, {""date"": ""20231028020300"", ""headline"": ""The Johnson & Johnson (JNJ) Company: A Short SWOT Analysis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231028090000"", ""headline"": ""Have $500? 2 Absurdly Cheap Stocks Long-Term Investors Should Buy Right Now"", ""summary"": ""Coca-Cola (NYSE: KO) is the world's largest non-alcoholic beverage company, selling drinks in more than 200 countries, but this leader still is growing.  In the most recent quarter, Coca-Cola's case volume, total revenue, and earnings per share all advanced -- and the company now expects to deliver full-year revenue growth in the double digits.  History has shown you can count on Coca-Cola's brand strength to keep customers coming back to its eponymous drink and its other popular products, such as Minute Maid juices and Dasani water.""}, {""date"": ""20231028090300"", ""headline"": ""Got $2,500? 2 Top Stocks That You Can Buy and Hold for a Lifetime"", ""summary"": ""The average holding period is less than a year.  This short-term mindset is unfortunate because frequently trading in and out of stocks can eat into investors' long-term returns by locking in losses and increasing taxes.  Holding a high-quality company long term enables investors to capitalize on its ability to compound shareholder value.""}, {""date"": ""20231029110500"", ""headline"": ""Pharma, PBMs spar over rising drug costs amid public scrutiny"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231029213506"", ""headline"": ""14 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds"", ""summary"": ""In this article, we discuss the 14 most undervalued healthcare stocks to buy according to hedge funds. To skip the detailed analysis of the healthcare industry, go directly to the 5 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds. The indispensable nature of the healthcare industry makes it an ever-growing industry. According to [\u2026]""}]",{}
21,2023-10-29,144.44329833984375,2023-11-05,150.13768005371094,0.03942295543867691,U4,"[{""date"": ""20231029110500"", ""headline"": ""Pharma, PBMs spar over rising drug costs amid public scrutiny"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231029213506"", ""headline"": ""14 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds"", ""summary"": ""In this article, we discuss the 14 most undervalued healthcare stocks to buy according to hedge funds. To skip the detailed analysis of the healthcare industry, go directly to the 5 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds. The indispensable nature of the healthcare industry makes it an ever-growing industry. According to [\u2026]""}, {""date"": ""20231030045100"", ""headline"": ""Analysts Are Bullish on Top Healthcare Stocks: Arcellx Inc (ACLX), Biogen (BIIB)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231030060200"", ""headline"": ""Johnson & Johnson: An Exploration into Its Intrinsic Value"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231030090000"", ""headline"": ""The Litigation Joker In Johnson & Johnson's Deck"", ""summary"": ""Johnson & Johnson, America's oldest and bluest chip corporation, is facing significant recurring litigation troubles. Explore more details here.""}, {""date"": ""20231030090600"", ""headline"": ""Warren Buffett's $690 Million Secret Portfolio Is Buying 3 Historically Cheap Stocks"", ""summary"": ""The Oracle of Omaha's under-the-radar investment portfolio is buying shares of three industry-leading businesses.""}, {""date"": ""20231030092541"", ""headline"": ""11 Best Immunotherapy Stocks To Buy Now"", ""summary"": ""In this article, we discuss 11 of the best immunotherapy stocks to buy now. If you want to skip our detailed discussion on the cancer and oncology industry, head directly to the 5 Best Immunotherapy Stocks To Buy Now. The global oncology landscape is continually transforming, driven by persistent efforts to explore, create, and deliver [\u2026]""}, {""date"": ""20231030094635"", ""headline"": ""11 Best Pharma Stocks To Buy Now"", ""summary"": ""In this article, we discuss the 12 best pharma stocks to buy now. You can skip our detailed analysis of the pharmaceutical sector and its outlook this year, and go directly to read the 5 Best Pharma Stocks To Buy Now. Shortly following the onset of the COVID-19 pandemic, it became evident that the world [\u2026]""}, {""date"": ""20231030095000"", ""headline"": ""Nearly 70% of Warren Buffett's $326 Billion Portfolio Is Invested in These 9 Megacap Stocks"", ""summary"": ""Warren Buffett thinks big.  It's not surprising that he has led Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) to put a lot of money into some of the biggest companies on the planet.  Nearly 70% of Buffett's $326 billion Berkshire portfolio is invested in these nine megacap stocks.""}, {""date"": ""20231030101112"", ""headline"": ""11 Best November Dividend Stocks To Buy"", ""summary"": ""In this article, we discuss 11 best November dividend stocks to buy. You can skip our detailed analysis of dividend stocks and their performance over the past years, and go directly to read 5 Best November Dividend Stocks To Buy. Dividend-paying stocks have been a preferred choice among investors for quite some time. They offer [\u2026]""}, {""date"": ""20231030120500"", ""headline"": ""Is This Year-End Rally, Like Waiting For Godot?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231030124200"", ""headline"": ""Cancer Victims Support Sen. Richard Blumenthal in Urging Johnson & Johnson to Accept Responsibility"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231030141442"", ""headline"": ""13 Best Warren Buffett Stock Picks for Beginners"", ""summary"": ""In this article, we discuss the 13 best Warren Buffett stock picks for beginners. To skip reading Warren Buffett\u2019s investment strategy and Q2 bets of Berkshire Hathaway, go directly to the 5 Best Warren Buffett Stock Picks for Beginners. The Oracle of Omaha, Warren Buffett, might not be the wealthiest man in the world, but [\u2026]""}, {""date"": ""20231030163200"", ""headline"": ""Johnson & Johnson stock rises Monday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.98% higher to $147.03 Monday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""20231030194552"", ""headline"": ""Western Digital Shares Soar as Company Splits Off Flash Memory Business"", ""summary"": ""Shares of Western Digital Corp. (WDC) surged more than 10% in early trading Monday before giving back gains, after the company said it would spin off its flash memory business into a separate company.""}, {""date"": ""20231031013100"", ""headline"": ""Analysts Conflicted on These Healthcare Names: Johnson & Johnson (JNJ), Boston Scientific (BSX) and PTC Therapeutics (PTCT)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031033557"", ""headline"": ""PPH: A 'Shot In The Arm' For Investors Looking To Capitalize On Recent Pharmaceutical Advances"", ""summary"": ""VanEck Pharmaceutical Fund has had the strongest one-year performance of four major pharmaceutical ETF competitors. Read why I rate PPH ETF a Buy.""}, {""date"": ""20231031051359"", ""headline"": ""Is Johnson & Johnson Stock Worth Buying Following Q3 2023 Earnings?"", ""summary"": ""Johnson & Johnson's management raised its financial guidance for full-year 2023. Read why we continue upgrading JNJ stock to Outperform from Hold for next 12 months.""}, {""date"": ""20231031060900"", ""headline"": ""GSK, Arrowhead announce deal with Janssen for rights to JNJ-3989"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031093700"", ""headline"": ""GSK inks $1B deal to obtain rights to hepatitis B drug from J&J"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031100800"", ""headline"": ""Johnson & Johnson Offloads Rights For Hepatitis B Candidate To GSK"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031115704"", ""headline"": ""Ozempic, Wegovy, and other weight loss drugs\u2019 real business impact"", ""summary"": ""The potential of weight loss drugs is too appetizing for Wall Street to pass up. But they may not have the doomsday effect on food and health as some feared.""}, {""date"": ""20231031123009"", ""headline"": ""UPDATE 1-GSK to pay $1 bln for exclusive license to J&J's hepatitis B therapy"", ""summary"": ""GSK will pay about $1 billion for exclusive rights to further develop and commercialize Johnson & Johnson's hepatitis B therapy, the British drugmaker said on Tuesday.  JNJ-3989 was initially developed by Arrowhead Pharmaceuticals and licensed to Johnson & Johnson-owned Janssen in 2018.  Exclusive rights to the therapy will fuel the expansion of GSK's own hepatitis B treatment, bepirovirsen, which is currently in late-stage development, the company said.""}, {""date"": ""20231031163200"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.89% higher to $148.34 Tuesday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""20231101053900"", ""headline"": ""Amgen cleared in U.S. to market biosimilar to J&J\u2019s Stelara"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231101114400"", ""headline"": ""Can Kenvue Be a Reliable Dividend Stock to Hold for the Long Haul?"", ""summary"": ""Kenvue's operations are diverse, boasting many strong brands. Is that enough to make this a solid dividend stock to own?""}, {""date"": ""20231101141200"", ""headline"": ""3 Dividend Kings Whose Growth Streaks Could Break Before 2030"", ""summary"": ""Investors should be careful with these high-yielding dividend stocks, as they aren't as safe as they may have been even a few years ago.""}, {""date"": ""20231101163200"", ""headline"": ""Johnson & Johnson stock rises Wednesday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.24% higher to $148.69 Wednesday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""20231101183100"", ""headline"": ""Chart of the Day: Is This Bullpen Name Ready for a Call-Up?"", ""summary"": ""Johnson & Johnson  has been in the Action Alerts PLUS Bullpen for awhile now.  As one of the biggest pharmaceutical names in the world with great brand recognition, research/development and tremendous sales growth, Johnson & Johnson has our attention.  While the company still does tremendous business in drugs and medical devices, its famous consumer brands are now part of Kenvue  , a recent spinoff that includes the company's former consumer products.""}, {""date"": ""20231101201924"", ""headline"": ""Unusual Put Option Trade in Johnson & Johnson (JNJ)  Worth $4,108.00K"", ""summary"": """"}, {""date"": ""20231102012900"", ""headline"": ""EXCLUSIVE: Roundhill Launches Dividend Kings ETF With 'The Gold Standard Of Dividend Growers,' Companies With 'Incredible Resilience'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102020300"", ""headline"": ""Amgen Wins Big With FDA, Analyst Sees Soaring Potential"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102055300"", ""headline"": ""Johnson & Johnson Stock (NYSE:JNJ): Time to Buy the Dip?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102080000"", ""headline"": ""New Biosense Webster QDOT MICRO\u2122 Catheter Data Demonstrate Very High-Power, Short-Duration Ablations Improved Quality of Life and Reduced Healthcare Utilization for AFib Patients"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102082700"", ""headline"": ""Vor Bio announces clinical data on treating AML to be presented at ASH meeting"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102090000"", ""headline"": ""Pfizer: Value Investment Opportunity After Recent Price Decline"", ""summary"": ""Pfizer still generates significant gross profit and has a strong revenue growth rate. Read why I feel PFE stock presents a value investment opportunity now.""}, {""date"": ""20231102115000"", ""headline"": ""Looking Into Johnson & Johnson's Recent Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102122709"", ""headline"": ""Smith+Nephew plays down concerns about weight-loss drugs"", ""summary"": ""British medical products maker Smith+Nephew said weight-loss drugs could help previously ineligible overweight patients get approval for joint replacement surgery, playing down concerns about the impact of the new therapies on its business.  that healthcare companies, including Smith+ Nephew that treat obese and overweight patients for knee-related issues, will be hurt by powerful new obesity drugs known as GLP-1s like Novo Nordisk's Wegovy.  \""As patients presumably benefit from GLP-1, you could actually see some of these patients who are previously ineligible for joint replacement become eligible for that surgery,\"" CEO Deepak Nath told Reuters in an interview.""}, {""date"": ""20231102163200"", ""headline"": ""Johnson & Johnson stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson rose 1.04% to $150.24 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20231102171400"", ""headline"": ""Johnson & Johnson's Long-Term Charts Got a Boo-boo"", ""summary"": ""Johnson & Johnson  is a household name and I used to live near its corporate headquarters.  The company is a major employer in New Jersey, and a member of the Dow Jones industrial average, with a 2.94% weight at the moment.  The Moving Average Convergence Divergence (MACD) oscillator has been correcting to the downside since early 2021 and is below the zero line.""}, {""date"": ""20231102191800"", ""headline"": ""Key Lawyer in Johnson & Johnson Talc Litigation Supports Call to Rethink Legal Strategies in Light of Failure of Texas Two-Step"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231103090000"", ""headline"": ""3 Healthcare Stocks to Buy Hand Over Fist in November"", ""summary"": ""Biotech CRISPR Therapeutics (NASDAQ: CRSP) may soon score its first product approval.  Healthcare giants Johnson & Johnson (NYSE: JNJ) and Medtronic (NYSE: MDT) have increased earnings over time -- and they've both gone through recent transformations that should spur growth in the coming quarters.  CRISPR Therapeutics might soon reach a major milestone.""}, {""date"": ""20231103124256"", ""headline"": ""The 3 Best Forever Stocks to Buy in November"", ""summary"": ""Anytime you bring up the concept of \u201cforever stocks,\u201d you\u2019re running the risk of incurring a serious tail risk. Obviously, forever is a long time \u2013 long enough for something to go wrong. Still, certain entities stand out because they basically command permanent relevance. To be sure, my ideas for forever stocks are boring \u2013 there\u2019s no way getting around that. And while I could elect some spicier enterprises, here\u2019s the problem: I just don\u2019t know if such entities would be around for the long haul""}, {""date"": ""20231103130010"", ""headline"": ""Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.""}, {""date"": ""20231103163200"", ""headline"": ""Johnson & Johnson stock rises Friday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.73% higher to $151.34 Friday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""20231104090000"", ""headline"": ""5 Relatively Secure And Cheap Dividend Stocks To Invest In - November 2023"", ""summary"": ""This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering large discounts to their historical norms. Read more here.""}, {""date"": ""20231104093000"", ""headline"": ""Looking for a Lifetime of Passive Income? 2 Top Dividend Stocks to Buy and Hold Forever"", ""summary"": ""Dividend stocks are great because they offer you payments no matter how they perform -- and no matter how the market performs.  High levels of free cash flow, paired with a reasonable cash dividend payout ratio, suggest the company can afford to make these payouts and even lift its dividend.  AbbVie (NYSE: ABBV) formed in 2013 when it split from healthcare giant Abbott Laboratories.""}, {""date"": ""20231105025400"", ""headline"": ""Pharmacy Workers Strike At CVS and Walgreens, Echoing Wider Pharma Sector Unrest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231105120600"", ""headline"": ""Compass Pathways: Private Placement Buys Less Time Than Expected"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231105132400"", ""headline"": ""Beloved, albeit controversial brand back from bankruptcy brink"", ""summary"": ""The beloved institution filed for bankruptcy in 2020 after over 80,000 men made claims that they were sexually abused while they were Boy Scouts.  A court allowed the BSA to keep operating while it reached a $2.4 billion settlement deal that will include payment to most who claimed abuse.  \""This is a significant milestone for the BSA as we emerge from a three-year financial restructuring process with a global resolution approved with overwhelming support of more than 85% of the survivors involved in the case,\"" said then-CEO Roger Mosby.""}, {""date"": ""20231105175700"", ""headline"": ""Beloved brand back from Chapter 11 bankruptcy brink"", ""summary"": ""The beloved institution filed for bankruptcy in 2020 after over 80,000 men made claims that they were sexually abused while they were Boy Scouts.  A court allowed the BSA to keep operating while it reached a $2.4 billion settlement deal that will include payment to most who claimed abuse.  \""This is a significant milestone for the BSA as we emerge from a three-year financial restructuring process with a global resolution approved with overwhelming support of more than 85% of the survivors involved in the case,\"" said then-CEO Roger Mosby.""}]",{}
22,2023-11-05,150.13768005371094,2023-11-12,146.08018493652344,-0.02702516194293103,D3,"[{""date"": ""20231105025400"", ""headline"": ""Pharmacy Workers Strike At CVS and Walgreens, Echoing Wider Pharma Sector Unrest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231105120600"", ""headline"": ""Compass Pathways: Private Placement Buys Less Time Than Expected"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231105132400"", ""headline"": ""Beloved, albeit controversial brand back from bankruptcy brink"", ""summary"": ""The beloved institution filed for bankruptcy in 2020 after over 80,000 men made claims that they were sexually abused while they were Boy Scouts.  A court allowed the BSA to keep operating while it reached a $2.4 billion settlement deal that will include payment to most who claimed abuse.  \""This is a significant milestone for the BSA as we emerge from a three-year financial restructuring process with a global resolution approved with overwhelming support of more than 85% of the survivors involved in the case,\"" said then-CEO Roger Mosby.""}, {""date"": ""20231105175700"", ""headline"": ""Beloved brand back from Chapter 11 bankruptcy brink"", ""summary"": ""The beloved institution filed for bankruptcy in 2020 after over 80,000 men made claims that they were sexually abused while they were Boy Scouts.  A court allowed the BSA to keep operating while it reached a $2.4 billion settlement deal that will include payment to most who claimed abuse.  \""This is a significant milestone for the BSA as we emerge from a three-year financial restructuring process with a global resolution approved with overwhelming support of more than 85% of the survivors involved in the case,\"" said then-CEO Roger Mosby.""}, {""date"": ""20231106020300"", ""headline"": ""J&J\u2019s patent win against Viatris referred back to lower court"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231106030200"", ""headline"": ""The doctor lowering drug prices for 1 million patients, with help from Mark Cuban, Sam Altman \u2013 and Martin Shkreli"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231106085700"", ""headline"": ""Mind-altering ketamine becomes latest pain treatment, despite little research or regulation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231106085700"", ""headline"": ""Mind-altering ketamine becomes new pain treatment, despite little research or regulation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231106113700"", ""headline"": ""J&J links radiofrequency catheter to improved quality of life in atrial fibrillation study"", ""summary"": ""Scores on a quality-of-life scale improved and use of antiarrhythmic drugs fell after people underwent treatment with the device.""}, {""date"": ""20231106134531"", ""headline"": ""Quanterix Corporation: Going For Three In A Row"", ""summary"": ""Learn about Quanterix Corporation, a life sciences company with strong financials, positive quarterly results, and insider buying. Click here for more on QTRX.""}, {""date"": ""20231106154453"", ""headline"": ""IHE: You Better Like Eli Lilly And Johnson & Johnson To Buy This"", ""summary"": ""The iShares U.S. Pharmaceuticals ETF offers targeted exposure to the pharmaceutical industry with a concentrated portfolio. Read more about IHE here.""}, {""date"": ""20231106162812"", ""headline"": ""November Dogs Of The Dow: 3 Buyable, 4 Watchable"", ""summary"": ""Learn about the Dow Jones Industrial Average and the top-performing stocks in November. Click to see our exclusive list of dividend stocks we consider buyable now.""}, {""date"": ""20231106163200"", ""headline"": ""Johnson & Johnson stock underperforms Monday when compared to competitors despite daily gains"", ""summary"": ""Shares of Johnson & Johnson inched 0.24% higher to $151.70 Monday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""20231106183058"", ""headline"": ""Long-Term Winners: Ray Dalio\u2019s Top 3 Stock Recommendations for a Prosperous Future"", ""summary"": ""Amid the intricacies in the investment realm, Ray Dalio stock picks continue to resonate with both budding and seasoned investors. Since he stepped down from active leadership at Bridgewater Associates, Dalio, with his wealth of experience and visionary outlook, has continued to guide its strategy from the boardroom. His recent warnings about an overbought U.S. stock market after its bull run in the first half of the year shouldn\u2019t be ignored. Citing political and economic risks, he paints a pic""}, {""date"": ""20231106210200"", ""headline"": ""Controversial brand back, survives Chapter 11 bankruptcy"", ""summary"": ""The beloved institution filed for bankruptcy in 2020 after over 80,000 men made claims that they were sexually abused while they were Boy Scouts.  A court allowed the BSA to keep operating while it reached a $2.4 billion settlement deal that will include payment to most who claimed abuse.  \""This is a significant milestone for the BSA as we emerge from a three-year financial restructuring process with a global resolution approved with overwhelming support of more than 85% of the survivors involved in the case,\"" said then-CEO Roger Mosby.""}, {""date"": ""20231107081000"", ""headline"": ""Johnson & Johnson to seek FDA nod to trial general surgery robot in H2 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231107082200"", ""headline"": ""Morning Brew: Johnson & Johnson's Ottava Delay, Uber's Q3 Miss, and Intel's Foundry Business"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231107103700"", ""headline"": ""2 Magnificent Dividend Stocks Trading Near 52-Week Lows to Buy Now and Hold at Least a Decade"", ""summary"": ""Taking advantage of the discounted prices these stocks have been trading at could do wonders for your passive income stream.""}, {""date"": ""20231107115400"", ""headline"": ""J&J targets 2024 for Ottava FDA filing"", ""summary"": ""The company expects to file a submission for an\u00a0investigational device exemption\u00a0in the second half of 2024 that will allow it to begin clinical trials for the robotic surgery system.""}, {""date"": ""20231107132823"", ""headline"": ""High Yield Stock Watchlist - November 2023"", ""summary"": ""The majority of the 22 stocks on my high yield watchlist for November 2023 are undervalued based on dividend yield theory. Click here for the complete list.""}, {""date"": ""20231107163200"", ""headline"": ""Johnson & Johnson stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slumped 0.53% to $150.90 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20231107190624"", ""headline"": ""ESSA Pharma: Unique N-Terminal Domain Approach Might Hinder mCRPC Resistance"", ""summary"": ""ESSA's EPI-7386 shows promise in treating advanced prostate cancer, with positive PSA data presented. Read my analysis of EPIX stock here.""}, {""date"": ""20231108041300"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Bluebird Bio (BLUE), Biogen (BIIB) and Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231108042118"", ""headline"": ""5 Kings And Aristocrats Selling At Decade High Dividend Yields"", ""summary"": ""Long-duration US Treasuries may not be a good investment. Find out a better alternative to buying long duration government debt.""}, {""date"": ""20231108053000"", ""headline"": ""Johnson & Johnson\u2019s Growth Potential: Ottava Robotic System and Untapped General Surgery Robotics Market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231108064100"", ""headline"": ""Grab these 2 funds with rich 11%-12% yields while you can"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231108073800"", ""headline"": ""Jim Cramer Asks Why The World's Largest Healthcare Products Company Has 'An Ill-Advised Strategy'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231108112800"", ""headline"": ""IN BRIEF: J&J reports positive data for arthritis treatment, Tremfya"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231108122300"", ""headline"": ""Bausch + Lomb: Not A Good Time To Buy (Rating Downgrade)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231108144500"", ""headline"": ""3 Brilliant Artificial Intelligence Stocks to Buy and Hold Forever"", ""summary"": ""Healthcare stocks are widely expected to be a prime beneficiary of the AI revolution. These three names could be the best of the bunch.""}, {""date"": ""20231108161000"", ""headline"": ""Pharma ETFs in Focus Post Q3 Earnings"", ""summary"": ""Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.""}, {""date"": ""20231108163200"", ""headline"": ""Johnson & Johnson stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Johnson & Johnson slid 0.36% to $150.35 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""20231108195348"", ""headline"": ""15 Best American Dividend Stocks To Buy Now"", ""summary"": ""In this article, we discuss 15 best American dividend stocks to buy now. You can skip our detailed analysis of dividend stocks and their previous performance, and go directly to read 5 Best American Dividend Stocks To Buy Now. In the third quarter of this year, the U.S. economy expanded at a rate of 4.9% [\u2026]""}, {""date"": ""20231109083100"", ""headline"": ""7 Safe Stocks to Buy if You Think Q3\u2019s Gangbuster Growth Won\u2019t Last"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231109090639"", ""headline"": ""11 Best S&P 500 Stocks To Buy According to Ray Dalio\u2019s Bridgewater Associates"", ""summary"": ""In this article, we discuss the 11 best S&P 500 stocks to buy according to Bridgewater Associates. To skip the details about the firm\u2019s performance and Q2 bets, go directly to the 5 Best S&P 500 Stocks To Buy according to Bridgewater Associates. Bridgewater Associates was founded by Ray Dalio in 1975, merely two years [\u2026]""}, {""date"": ""20231109100000"", ""headline"": ""Did Warren Buffett Trade Stocks Berkshire Hathaway Owned In His Private Stock Portfolio?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231109102100"", ""headline"": ""2 Magnificent Dow Stocks to Buy in November and 1 to Avoid Like the Plague"", ""summary"": ""Two of the Dow's 30 components are historically cheap, while concerns are mounting for another time-tested business.""}, {""date"": ""20231109103500"", ""headline"": ""3 Dividend Stocks to Buy for Consistent Income"", ""summary"": ""In the dynamic world of investing, dividend stocks have always been a consistent way for investors to generate income. These stalwarts not only offer a steady income stream but also demonstrate the power of compounding returns. Imagine a scenario where your portfolio receives a consistent boost, safeguarding your investments against the unpredictable waves of market fluctuations. Moreover, the dividends from these stocks carry a positive connotation, often reflecting the underlying company\u2019s fin""}, {""date"": ""20231109103600"", ""headline"": ""JNJ December 29th Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231109125237"", ""headline"": ""3 Dividend Stocks That Could Pay for Your Holiday Shopping"", ""summary"": ""The holiday season is here, and if you haven\u2019t budgeted for your shopping, now is the perfect time to do so. With inflation under control and consumer spending slowly improving, we will have a good holiday season. If you do not want to use your credit card for purchases or haven\u2019t set aside an amount, you might want to consider making your money work for you. Investing in dividend stocks allows you to enjoy passive income to help pay for your holiday shopping. Savvy investors know that certain s""}, {""date"": ""20231109163200"", ""headline"": ""Johnson & Johnson stock falls Thursday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson shed 1.95% to $147.42 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""20231110023000"", ""headline"": ""Cantor biotech/biopharma analysts hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231110105200"", ""headline"": ""Big Players' Recent Trades in JNJ Options"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231110123800"", ""headline"": ""12 Dogs of the Dow Dividend Stocks to Buy"", ""summary"": ""In this article, we discuss 12 Dogs of the Dow dividend stocks to buy. You can skip our detailed analysis of the dogs of the Dow strategy and its returns over the years, and go directly to read 5 Dogs of the Dow Dividend Stocks to Buy. Many investors who prioritize dividends find dividend yields [\u2026]""}, {""date"": ""20231110124846"", ""headline"": ""13 Best DRIP Stocks To Own"", ""summary"": ""In this article, we discuss 13 best DRIP stocks to own. You can skip our detailed analysis of the dividend reinvestment plan and the overall performance of dividend stocks, and go directly to read 5 Best DRIP Stocks To Own. A dividend reinvestment plan, or DRIP, is a strategy where investors use the dividends earned [\u2026]""}, {""date"": ""20231110160535"", ""headline"": ""U.S. Wide-Moat Stocks On Sale - The November 2023 Heat Map"", ""summary"": ""Discover our 3-step process for identifying attractive, undervalued stocks with wide economic moats - Morningstar approved. Click here to read more.""}, {""date"": ""20231110163200"", ""headline"": ""Johnson & Johnson stock falls Friday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson shed 0.12% to $147.25 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20231111090000"", ""headline"": ""Why You Should Aim For $2 Million For Retirement"", ""summary"": ""Retirement goals should be set based on individual situations and factors like your pre-retirement earnings. Explore more details here.""}, {""date"": ""20231111100000"", ""headline"": ""Cautious Investor? 2 Safe Stocks You Also Can Count on For Growth"", ""summary"": ""Eli Lilly (NYSE: LLY) may be a big pharma company, but it's looking like a high-growth player with a lineup of products driving double-digit percentage revenue growth.  In Q3, new products accounted for $1.44 billion of sales, and growth products, most of which won't lose patent protection in the near future, represented nearly $5 billion in revenue.  Zepbound is the same molecule as Lilly's type 2 diabetes drug, Mounjaro -- which was already one of the blockbusters driving the company's growth.""}, {""date"": ""20231111130000"", ""headline"": ""Strategic Portfolio Allocation With Risk/Reward Optimization: A Deep Dive Into My Dividend Portfolio"", ""summary"": ""Exploring the concentration and risk levels of a financial writer's personal investment portfolio, and its deviation from a new investment approach.""}, {""date"": ""20231111194055"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of November 12"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read more to see the November 12 weekly update.""}, {""date"": ""20231112054732"", ""headline"": ""High-Quality Dividend Growth Near 52-Week Lows: Pfizer Is Phenomenal"", ""summary"": ""Pfizer appears to be a good investment opportunity due to its high quality, future growth projections, and sustainable dividend. Explore more details here.""}, {""date"": ""20231112064807"", ""headline"": ""Imminent Magic Catheter Approval Will Spike Stereotaxis Stock"", ""summary"": ""Stereotaxis will soon submit a PMA for FDA approval of the Magic catheter 180 days after submission. Find out why STXS stock is a Strong Buy.""}, {""date"": ""20231112220615"", ""headline"": ""Passive Income Snowball: How Does VYM Stack Up Against 6 Competing ETFs?"", ""summary"": ""Vanguard High Dividend Yield Index Fund ETF is a well-diversified, low-cost dividend growth fund for passive income. Find out why VYM is a Hold.""}]",{}
23,2023-11-12,146.08018493652344,2023-11-19,148.59999084472656,0.017249470962116265,U2,"[{""date"": ""20231112054732"", ""headline"": ""High-Quality Dividend Growth Near 52-Week Lows: Pfizer Is Phenomenal"", ""summary"": ""Pfizer appears to be a good investment opportunity due to its high quality, future growth projections, and sustainable dividend. Explore more details here.""}, {""date"": ""20231112064807"", ""headline"": ""Imminent Magic Catheter Approval Will Spike Stereotaxis Stock"", ""summary"": ""Stereotaxis will soon submit a PMA for FDA approval of the Magic catheter 180 days after submission. Find out why STXS stock is a Strong Buy.""}, {""date"": ""20231112220615"", ""headline"": ""Passive Income Snowball: How Does VYM Stack Up Against 6 Competing ETFs?"", ""summary"": ""Vanguard High Dividend Yield Index Fund ETF is a well-diversified, low-cost dividend growth fund for passive income. Find out why VYM is a Hold.""}, {""date"": ""20231113030400"", ""headline"": ""FMC Corp Takes the Spotlight in Tweedy Browne's Latest 13F Filing with a 1.56% Portfolio Impact"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231113030500"", ""headline"": ""Meta Platforms Inc Takes a Hit in Jeremy Grantham's Latest Portfolio Adjustments"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231113044500"", ""headline"": ""LONDON BROKER RATINGS: Diageo gets price target cuts; JPMorgan ups M&G"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231113050300"", ""headline"": ""Unlocking Intrinsic Value: Analysis of Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231113112000"", ""headline"": ""MedTech stocks gain after Novo Nordisk data for weight loss therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231113112400"", ""headline"": ""Investors seeking triple-A rated U.S. corporate debt only have these two choices \u2014 for now"", ""summary"": ""If Moody's downgrades the U.S. rating, it may not bode well for the two remaining triple-A corporate credits.""}, {""date"": ""20231113150300"", ""headline"": ""4 Large Drug Stocks Likely to Sail Through Industry Woes"", ""summary"": ""Drug, biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), J&J (JNJ) and AbbVie (ABBV) are worth retaining in your portfolio.""}, {""date"": ""20231113163100"", ""headline"": ""Johnson & Johnson stock underperforms Monday when compared to competitors despite daily gains"", ""summary"": ""Shares of Johnson & Johnson inched 0.26% higher to $147.63 Monday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""20231113191412"", ""headline"": ""Dividend Kings Ranked By Yield: Top 25"", ""summary"": ""In this article, we discuss 25 dividend kings with the highest dividend yields. You can skip our detailed analysis of dividend-growing stocks and their performance over the years, and go directly to read Dividend Kings Ranked By Yield: Top 10. Dividend Kings are a select group of publicly traded companies that have consistently increased their [\u2026]""}, {""date"": ""20231113210502"", ""headline"": ""Ray Dalio's Bridgewater Associates Adjusts Portfolio, Notably Reduces Johnson & Johnson Stake"", ""summary"": ""Insight into Bridgewater's Q3 Moves: Dalio's Strategy Reflects in Latest 13F Filings""}, {""date"": ""20231114013600"", ""headline"": ""UCB launches newly approved psoriasis drug Bimzelx in US"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231114024900"", ""headline"": ""Johnson & Johnson's Monarch approved in China for lung cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231114044900"", ""headline"": ""Addex Therapeutics completes recruitment of patients in ADX71149"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231114074800"", ""headline"": ""Berkshire Hathaway buys Sirius XM, exits General Motors in Q3"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231114081100"", ""headline"": ""Analysts Have Conflicting Sentiments on These Healthcare Companies: Cormedix (CRMD), Immatics (IMTX) and Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231114084733"", ""headline"": ""Turner Awarded $65 Million in Contracts to Expand Johnson & Johnson Vision Manufacturing Plant"", ""summary"": ""Turner Construction Company was chosen as the contractor for a $65 million expansion to the Johnson & Johnson disposable contact lens manufacturing plant in Jacksonville, Florida.The expansion is...""}, {""date"": ""20231114092500"", ""headline"": ""It\u2019s Time to Buy These 3 Dividend Aristocrats Trading Near 52-Week Lows"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231114102400"", ""headline"": ""Blue-Chip Bargains: Top 3 Oversold Aristocrats for Value Investors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231114103000"", ""headline"": ""3 Dividend Giants to Grow Wealth no Matter What the Market Is Doing"", ""summary"": ""It's a great idea to include a bit of both in your portfolio to support performance through any market environment.  You can either keep these payments and enjoy the passive income or reinvest the dividends to further grow your position in a particular stock.  Now, the big question is: How should you choose a winning dividend player for your portfolio?""}, {""date"": ""20231114111900"", ""headline"": ""Merck: Tracking Well Above The Industry"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231114124200"", ""headline"": ""Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, J&J and AbbVie"", ""summary"": ""Eli Lilly, Novo Nordisk, J&J and AbbVie are part of the Zacks Industry Outlook article.""}, {""date"": ""20231114130000"", ""headline"": ""All Dividend Companies Have One Big Problem In Common"", ""summary"": ""Dividend investing is struggling in the current macroeconomic environment due to high interest rates. Click here to read more.""}, {""date"": ""20231114161700"", ""headline"": ""Why a derailed $11 trillion corporate bond market looks ripe for a comeback as U.S. inflation slows"", ""summary"": ""Bonds issued by America's most valuable companies are steaming ahead after sinking to their lowest prices in about 20 years.""}, {""date"": ""20231114163200"", ""headline"": ""Johnson & Johnson stock rises Tuesday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.02% higher to $147.66 Tuesday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""20231115012100"", ""headline"": ""Buffett\u2019s Berkshire Sells JNJ and UPS Stocks; Should You Follow?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231115014300"", ""headline"": ""A Quick Look At Berkshire Hathaway\u2019s Recent Moves"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231115014900"", ""headline"": ""Buffett's Berkshire Trimmed Chevron Stake While Cashing Out Of GM And This COVID Stock: Here's How The Sage Of Omaha Adjusted His Portfolio In Q3"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231115034000"", ""headline"": ""Ray Dalio's Bridgewater Bets Big On Retail With Stakes In Coca-Cola, Costco, And Walmart Among Top Holdings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231115035100"", ""headline"": ""Warren Buffett's Berkshire Hathaway exits GM, Activision bets in Q3"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231115053000"", ""headline"": ""Donville Kent Asset Management October 2023 Insights"", ""summary"": ""In Q3 newsletter, DKAM discusses the phenomenon of market cycles, the current cycle, the impact on stock valuations, and inflation implications. Click here to read more.""}, {""date"": ""20231115081000"", ""headline"": ""My Dividend Stock Portfolio: New October Dividend Record - 98 Holdings With 23 Buys"", ""summary"": ""S&P 500 and Dow Jones dropped for the third straight month in October, just before staging a remarkable reversal in November. Click here to read more.""}, {""date"": ""20231115090458"", ""headline"": ""Janssen Pharmaceutical - New VOYAGER PAD Analyses Reinforce Benefit of XARELTO plus Aspirin across High-Risk and Complex Patient Populations with Peripheral Artery Disease"", ""summary"": ""TITUSVILLE - The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses from the Phase 3 VOYAGER PAD clinical trial reinforcing the benefit of XARELTO over...""}, {""date"": ""20231115095700"", ""headline"": ""JNJ February 2024 Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231115121500"", ""headline"": ""Greece fines local branches of J&J and Colgate-Palmolive for allegedly breaching a profit cap"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231115130100"", ""headline"": ""Buffett's firm sells off several smaller investments, including GM and UPS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231115134449"", ""headline"": ""Arcellx: A Strong Contender In The CAR-T Multiple Myeloma Market"", ""summary"": ""Arcellx's CART-ddBCMA reported strong and competitive data in late-line multiple myeloma patients. Read more to see our analysis on ACLX stock.""}, {""date"": ""20231115140009"", ""headline"": ""Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know"", ""summary"": ""Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.""}, {""date"": ""20231115145705"", ""headline"": ""Berkshire Hathaway exits GM, Johnson & Johnson positions"", ""summary"": ""Warren Buffett's Berkshire Hathaway (BRK-A, BRK-B) has exited positions and sold its stakes in several companies like General Motors (GM) and Johnson & Johnson (JNJ) that recently underwent or announced new business ventures. Meanwhile, Apple (APPL), Bank of America (BAC), and American Express (AXP) continue to stand as Berkshire's top holdings. Yahoo Finance's Rachelle Akuffo and Akiko Fujita analyze Berkshire Hathaway's portfolio adjustments. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.""}, {""date"": ""20231115150700"", ""headline"": ""2 Dividend Stocks Near Their 52-Week Lows to Buy and Hold Forever"", ""summary"": ""If size were directly correlated with stock market performance, CVS Health (NYSE: CVS) and Johnson & Johnson (NYSE: JNJ) would always perform well as they are among the largest healthcare stocks in the U.S. However, both corporations have faced company-specific issues that have held them back, and as of this writing, they aren't that far off from their 52-week lows.  Despite their struggles, CVS Health and Johnson & Johnson have some major redeeming qualities, especially for income-seeking and long-term investors.  Let's find out why these healthcare stocks are still worth buying and holding forever.""}, {""date"": ""20231115163200"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.77% higher to $148.80 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""20231115165701"", ""headline"": ""12 Monthly Dividend Stocks with Over 5% Yield"", ""summary"": ""In this article, we discuss 12 monthly dividend stocks with over 5% yield. You can skip our detailed analysis of dividend stocks and their performance in the past, and go directly to read 5 Monthly Dividend Stocks with Over 5% Yield. During periods of financial instability, investors often focus on stocks that generate consistent income [\u2026]""}, {""date"": ""20231115213124"", ""headline"": ""15 Developed Countries with Lowest Autism Rates"", ""summary"": ""In this article, we will discuss 15 developed countries with lowest autism rates. If you want to skip our discussion on the autism industry, you can go directly to the 5 Developed Countries with Lowest Autism Rates. According to Fortune Business Insights, the autism spectrum disorder market was assessed at $1.93 billion in 2022. The [\u2026]""}, {""date"": ""20231116020000"", ""headline"": ""Pharma Is Out of Favor. 5 Drug Stocks With Room to Grow."", ""summary"": ""Despite Eli Lilly's monster 66.8% gain on the year because of weight-loss drugs, the S&P 500 Pharmaceuticals index is down 2.3%.""}, {""date"": ""20231116020722"", ""headline"": ""Storm-Proof Income: 7 Dividend Aristocrats to Fortify Your Portfolio"", ""summary"": ""With the possibility that the fourth quarter\u2019s economic results might disappoint given the stellar print of Q3, investors may want to consider dividend aristocrats. If you\u2019re looking for some of the best dividend stocks for income, you can\u2019t go wrong with this label. It refers to S&P 500 companies that have increased their payouts to shareholders for at least 25 years. Fundamentally, the major benefit of dividend aristocrats centers on incentivized performance. No one wants to lead the team that""}, {""date"": ""20231116033000"", ""headline"": ""Kenvue initiated with a Neutral at Piper Sandler"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116044700"", ""headline"": ""Thoughts For Thursday: The Market Is Firming Higher, Tread Carefully"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116060000"", ""headline"": ""Major Buyout Firms Eye Sanofi's Consumer Health Division Spinoff Valued Over $20B"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116085700"", ""headline"": ""Pfizer: Undervalued At Peak Pessimism in the Post-COVID-19 Era"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116090100"", ""headline"": ""Ex-Dividend Reminder: Johnson & Johnson, STERIS and Prudential Financial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116105000"", ""headline"": ""Looking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On"", ""summary"": ""Maybe you could find out which stocks a well-known company that has been successful for a long time really likes -- a company such as Johnson & Johnson (NYSE: JNJ).  Here are the three stocks that J&J is betting the most on.  As of Sept. 30, 2023, Johnson & Johnson's biggest investment was in Legend Biotech (NASDAQ: LEGN).""}, {""date"": ""20231116111700"", ""headline"": ""Johnson & Johnson(JNJ) 2022 CEO Joaquin Duato's Shareholder Letter: Navigating Challenges ..."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116112600"", ""headline"": ""JNJ July 2024 Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116121800"", ""headline"": ""Buffett, Dalio, Einhorn, Ackman: The Masters Of Wall Street Shuffle Their Stock Decks In Q3"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116123000"", ""headline"": ""Johnson & Johnson to Host Enterprise Business Review"", ""summary"": ""NEW BRUNSWICK, N.J., November 16, 2023--Johnson & Johnson (NYSE: JNJ) (the \u2018Company\u2019) will hold an Enterprise Business Review for the investment community on Tuesday, December 5, 2023. During the event, Company leaders will share a detailed review of the Innovative Medicine and MedTech businesses and their respective pipelines as well as discuss the Company\u2019s long-term strategy to deliver sustained growth and value to shareholders.""}, {""date"": ""20231116163009"", ""headline"": ""Johnson & Johnson (JNJ) Down 2.6% Since Last Earnings Report: Can It Rebound?"", ""summary"": ""Johnson & Johnson (JNJ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.""}, {""date"": ""20231116163200"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.87% higher to $150.10 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""20231116171351"", ""headline"": ""10 States With The Most Doctors Per Capita In 2023"", ""summary"": ""In this article, we will discuss the 10 states with the most doctors per capita in 2023. If you want to skip our discussion on the healthcare industry in the United States, you can go directly to the 5 States With The Most Doctors Per Capita In 2023. In the ever-changing healthcare landscape in the [\u2026]""}, {""date"": ""20231116180948"", ""headline"": ""3 Strong-Buy Dividend Stocks That Analysts Love"", ""summary"": ""For much of 2022 and 2023, investors could take shelter in dividend stocks. They were, as the saying goes, the best houses in a bad neighborhood (the equity markets). It\u2019s not that the analysts loved these stocks, but they hated them less. That sentiment is changing which makes it a good time to look for strong buy dividend stocks. What are analysts seeing? For starters, they\u2019re noticing that interest rates may have peaked. That doesn\u2019t mean they\u2019ll come down anytime soon, but the Federal Reserv""}, {""date"": ""20231116183157"", ""headline"": ""3 Must-Buy Stocks on Every Market Dip"", ""summary"": ""The stock market is flying high in November, propelled by economic data showing that inflation and the U.S. economy are slowing. Another catalyst lies in expectations that the U.S. Federal Reserve is likely finished raising interest rates. After declining for three consecutive months, the benchmark S&P 500 index has risen 7% so far in November as a year-end Santa Claus rally appears to be taking hold. Investors welcome this news as stocks of many well-known companies climbing higher. Yet despite""}, {""date"": ""20231116233028"", ""headline"": ""J&J settles first talc cases to go to trial after failed bankruptcies"", ""summary"": ""Johnson & Johnson on Thursday said it has settled two lawsuits claiming its talc products caused cancer, the first such cases to go to trial since a federal court rejected the company's plan to move its talc liabilities into bankruptcy court.  The settlements resolved lawsuits brought by two men, Rosalino Reyes and Marlin Eagles, who said they developed mesothelioma related to asbestos in J&J talc powder, and was part of a broader deal to settle all talc cases brought by the law firm representing them, Kazan, McClain, Satterley & Greenwood, the company said.""}, {""date"": ""20231117010800"", ""headline"": ""Senator's Bearish Tesla Bet Under Scrutiny As He Buys Put Options Ahead Of Elon Musk-Led Company's Q3 Results That Set Stock Slide In Motion"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231117020400"", ""headline"": ""21 Analysts Have This to Say About Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231117021100"", ""headline"": ""The Buckle (NYSE:BKE) Blasts Up After a Mixed Earnings Report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231117023000"", ""headline"": ""Notable Friday Option Activity: JNJ, VRT, PLL"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231117024000"", ""headline"": ""Intuitive Surgical (NASDAQ:ISRG) Gains after Analyst Approval"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231117062600"", ""headline"": ""Dividend Roundup: General Mills, Nike, Johnson & Johnson, Marriott, and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231117070000"", ""headline"": ""Why Warren Buffett, Ray Dalio's Hedge Funds Are Selling Top-Ranking Dividend King"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231117070600"", ""headline"": ""Warren Buffett, Ray Dalio's Hedge Funds Are Selling Top-Ranking Dividend King"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231117074300"", ""headline"": ""J&J settles first talc-related lawsuits since dismissal of bankruptcy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231117083200"", ""headline"": ""Johnson & Johnson Resolves 2 Major Talc Cases As Legal Battles Continue"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231117094500"", ""headline"": ""Cantor biotech/biopharma analysts hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231117110300"", ""headline"": ""Johnson & Johnson Is Eyeing Intuitive Surgical's Market, But Can It Win?"", ""summary"": ""Johnson & Johnson (NYSE: JNJ) won't be breathing down Intuitive Surgical's (NASDAQ: ISRG) neck anytime soon.  With J&J's plans to produce a robotic surgical unit in full swing, a competitive showdown is now inevitable, and it'll play out over the rest of the decade.  The stakes are quite high for Intuitive, so let's evaluate what's going on.""}, {""date"": ""20231117120500"", ""headline"": ""Talc Lawyer: Johnson & Johnson Settlements Undermine Bankruptcy Strategy, Serve as Acknowledgment That Baby Powder Contained Asbestos"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231117142118"", ""headline"": ""Morning Brew: Market Eyes Late-Cycle Quality Stocks and Housing Gains"", ""summary"": ""Market Eyes Late-Cycle Quality Stocks and Housing Gains""}, {""date"": ""20231117163200"", ""headline"": ""Johnson & Johnson stock falls Friday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slipped 0.21% to $149.79 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""20231117202334"", ""headline"": ""7 High-Yield Blue Chips Suitable for Any Retiree"", ""summary"": ""Before extolling the benefits of high-yield blue-chip stocks, it\u2019s important to acknowledge the reality that many investors are feeling. Long-term stock investors have had to muddle through challenging macroeconomic headwinds in 2023. High inflation, rising interest rates, bank failures, two government shutdowns averted, and a new war that is fueling concerns about a broader conflict. Have I missed anything? Probably. 2023 has been a year many investors would like to forget. It\u2019s times like thes""}, {""date"": ""20231118022600"", ""headline"": ""Cantor Fitzgerald Sticks to Its Buy Rating for Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231119024100"", ""headline"": ""Stock Market This Week \u2013 Sunday, Nov. 19"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231119110200"", ""headline"": ""M&A, GLP-1s to dominate healthcare themes in 2024 as COVID fades: survey"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231119190545"", ""headline"": ""Ray Dalio\u2019s Latest 13F Portfolio: Top 15 Stocks"", ""summary"": ""In this piece, we will take a look at Ray Dalio\u2019s latest 13F portfolio: top 15 stocks. If you want to skip our introduction to the well-known investor and want to jump ahead to the top stocks in this list, then head on over to Ray Dalio\u2019s Latest 13F Portfolio: Top 5 Stocks. Ray Dalio is [\u2026]""}]",{}
24,2023-11-19,148.59999084472656,2023-11-26,152.5,0.026245016120819198,U3,"[{""date"": ""20231119024100"", ""headline"": ""Stock Market This Week \u2013 Sunday, Nov. 19"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231119110200"", ""headline"": ""M&A, GLP-1s to dominate healthcare themes in 2024 as COVID fades: survey"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231119190545"", ""headline"": ""Ray Dalio\u2019s Latest 13F Portfolio: Top 15 Stocks"", ""summary"": ""In this piece, we will take a look at Ray Dalio\u2019s latest 13F portfolio: top 15 stocks. If you want to skip our introduction to the well-known investor and want to jump ahead to the top stocks in this list, then head on over to Ray Dalio\u2019s Latest 13F Portfolio: Top 5 Stocks. Ray Dalio is [\u2026]""}, {""date"": ""20231120032900"", ""headline"": ""What You Missed On Wall Street On Monday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231120093205"", ""headline"": ""Thinking about trading options or stock in Meta Platforms, Johnson & Johnson, PENN Entertainment, Bristol-Myers Squibb, or Cadence Design Systems?"", ""summary"": ""NEW YORK, Nov. 20, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for META, JNJ, PENN, BMY, and CDNS. ...""}, {""date"": ""20231120094200"", ""headline"": ""Suit says J&J, Kenvue failed to flag decongestant issue in IPO, Bloomberg reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231120100420"", ""headline"": ""Johnson & Johnson's Dividend Analysis"", ""summary"": ""Johnson & Johnson (NYSE:JNJ) recently announced a dividend of $1.19 per share, payable on 2023-12-05, with the ex-dividend date set for 2023-11-20.  As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates.  Using the data from GuruFocus, let's look into Johnson & Johnson's dividend performance and assess its sustainability.""}, {""date"": ""20231120101900"", ""headline"": ""Kenvue may be activist target amid recent 13-F filing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231120105649"", ""headline"": ""25 States with the Highest Poverty Rates in the US"", ""summary"": ""In this article, we will be navigating through the poverty situation in the US, the disparity in state-level poverty, while covering the 25 states with the highest poverty rates in the country. If you wish to skip our detailed analysis, you can move directly to the 5 States with the Highest Poverty Rates in the [\u2026]""}, {""date"": ""20231120110700"", ""headline"": ""Behind the Scenes of Johnson & Johnson's Latest Options Trends"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231120115224"", ""headline"": ""20 Most Valuable Healthcare Companies in the World"", ""summary"": ""In this article, we will look into the 20 most valuable healthcare companies in the world. If you want to skip our detailed analysis, you can go directly to the 5 Most Valuable Healthcare Companies in the World. Healthcare Services Industry: A Market Analysis According to a report by Verified Market Research, the global healthcare [\u2026]""}, {""date"": ""20231120121500"", ""headline"": ""Bayer ends large blood thinner trial for \u2018inferior efficacy\u2019"", ""summary"": ""Company shares fell by one-fifth after study monitors called for halting a planned 18,000-person trial because Bayer\u2019s\u00a0experimental drug wasn\u2019t working as well as Eliquis.""}, {""date"": ""20231120122100"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231120124200"", ""headline"": ""Bristol Myers slumps as Bayer trial failure casts doubt on $5 billion drug"", ""summary"": ""German drugmaker Bayer scrapped a late-stage trial of an experimental blood thinner that could have major implications for Bristol Myers.""}, {""date"": ""20231120131400"", ""headline"": ""J&J's Janssen submits FDA application for Rybrevant for cancer form"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231120170219"", ""headline"": ""Bristol-Myers Squibb, 2seventy Bio Shares Fall as FDA Delays Decision on Cancer Drug"", ""summary"": ""Bristol-Myers Squibb and 2seventy bio shares dropped after the FDA said it would not make a decision on expanded use of the companies' cancer drug next month.""}, {""date"": ""20231121004938"", ""headline"": ""Tracking Ray Dalio's Bridgewater Associates 13F Portfolio - Q3 2023 Update"", ""summary"": ""Bridgewater Associates' 13F portfolio value increased by approximately 2% to $16.55 billion in Q3 2023. Click here for a detailed analysis.""}, {""date"": ""20231121011100"", ""headline"": ""Pfizer (NYSE:PFE) Sued Re:Low-Quality ADHD Drug for Kids"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231121011700"", ""headline"": ""How Is The Market Feeling About Johnson & Johnson?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231121015100"", ""headline"": ""Dividend Aristocrats In Focus: Kenvue"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231121022726"", ""headline"": ""Intuitive Surgical: Monopoly Days May Be Over"", ""summary"": ""Intuitive Surgical's Da Vinci Surgical Systems excel in performing precise surgeries and are positioned in a growing market. See why ISRG stock is hold rated.""}, {""date"": ""20231121043144"", ""headline"": ""Merck: A Dividend Growth Stock Worth Considering"", ""summary"": ""Merck reports positive quarterly earnings and consistent dividend growth over 12 years. Read why MRK stock is well-positioned for potential future success.""}, {""date"": ""20231121060000"", ""headline"": ""A Golden Age of Vaccines Is Here. What It Means for You."", ""summary"": ""Pharmaceutical companies are currently developing vaccines for a range of purposes, from preventing disease to treating cancers.""}, {""date"": ""20231121113700"", ""headline"": ""J&J, Merck, Bristol Myers CEOs asked to testify before Senate panel on drug prices"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231121124900"", ""headline"": ""Pfizer (NYSE:PFE) Sued for Low-Quality ADHD Drug for Kids"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231121163100"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.81% higher to $151.12 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the...""}, {""date"": ""20231121165340"", ""headline"": ""17 Stocks Warren Buffett Just Bought and Sold"", ""summary"": ""In this article, we will take a look at the 17 stocks Warren Buffett just bought and sold. To see more such companies, go directly to 5 Stocks Warren Buffett Just Bought and Sold. Warren Buffett is one of the most successful investors of all time. His net worth stands at about $120 billion as [\u2026]""}, {""date"": ""20231121174100"", ""headline"": ""J&J (JNJ) Seeks Expanded Use of Lung Cancer Drug Rybrevant"", ""summary"": ""J&J's (JNJ) sBLA seeks label expansion for Rybrevant plus chemotherapy to treat patients with EGFR-mutated NSCLC whose disease progressed on or after treatment with AstraZeneca's Tagrisso (osimertinib).""}, {""date"": ""20231121190700"", ""headline"": ""Top Analyst Reports for Novo Nordisk, Bank of America & Netflix"", ""summary"": ""Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), Bank of America Corporation (BAC) and Netflix, Inc. (NFLX).""}, {""date"": ""20231121194435"", ""headline"": ""Hormel Foods Corporation: Thankful For 57 Years Of Growing Dividends"", ""summary"": ""Hormel Foods stock offers potential for capital appreciation and a high yield on cost for long-term holders. Read here to know why we rate HRL stock a buy.""}, {""date"": ""20231121211515"", ""headline"": ""Tracking Jeremy Grantham's GMO Capital Portfolio - Q3 2023 Update"", ""summary"": ""Jeremy Grantham's 13F portfolio value declined by 2% to $21.17B in Q3 2023. Microsoft, UnitedHealth, Alphabet, J&J, and Meta Platforms are top holdings.""}, {""date"": ""20231122015100"", ""headline"": ""Market Whales and Their Recent Bets on JNJ Options"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231122085900"", ""headline"": ""GSK: Undervalued At Peak Pessimism"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231122100600"", ""headline"": ""5 Longtime Holdings Warren Buffett Completely Sold During the Third Quarter"", ""summary"": ""These brand-name companies had been fixtures in Berkshire Hathaway's portfolio for the past 11 to 18 years.""}, {""date"": ""20231122102200"", ""headline"": ""JNJ January 2024 Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231122144300"", ""headline"": ""The Zacks Analyst Blog Highlights Novo Nordisk  Bank of America, Netflix, Johnson & Johnson and TotalEnergies"", ""summary"": ""Novo Nordisk, Bank of America, Netflix, Johnson & Johnson and TotalEnergies are part of the Zacks top Analyst Blog.""}, {""date"": ""20231122163200"", ""headline"": ""Johnson & Johnson stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slipped 0.20% to $150.82 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""20231122180118"", ""headline"": ""Worried About Market Volatility? Invest In These High-Yield Dividend Stocks For Consistent Passive Income"", ""summary"": ""While the stock market has been recovering since the pullback last year, market volatility remains high as geopolitical tensions persist. The recent crisis in the Middle East has sparked concerns regarding broader regional instability. The weakening economy has caused investors to cause the November rally to halt, with the Dow Jones Industrial Average index declining marginally intraday on Tuesday. The National Retail Federation expects retail sales to grow at the slowest pace in the last five y""}, {""date"": ""20231123105000"", ""headline"": ""Thoughts On 35 Stocks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231123180000"", ""headline"": ""How To Build A Dividend Portfolio Allocating $100,000 Among November's Top 20 Dividend Companies"", ""summary"": ""I will show you how you can build a dividend portfolio by allocating $100,000 among November\u00e2\u0080\u0099s top 20 dividend companies as well as one ETF. Read more here.""}, {""date"": ""20231123221138"", ""headline"": ""15 Best Income Stocks To Invest In"", ""summary"": ""In this article, we discuss 15 best income stocks to invest in. You can skip our detailed analysis of income stocks and the performance of dividend stocks in the past, and go directly to read 5 Best Income Stocks To Invest In. On November 22, the U.S. stock market closed with gains, driven by the positive [\u2026]""}, {""date"": ""20231124033300"", ""headline"": ""Johnson & Johnson stock rises Friday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231124050739"", ""headline"": ""South Africa, Colombia and others are fighting drugmakers over access to TB and HIV drugs"", ""summary"": ""South Africa, Colombia and other countries that lost out in the global race for coronavirus vaccines are taking a more combative approach towards drugmakers and pushing back on policies that deny cheap treatment to millions of people with tuberculosis and HIV.  In the COVID-19 pandemic, rich countries bought most of the world\u2019s vaccines early, leaving few shots for poor countries and creating a disparity the World Health Organization called \u201ca catastrophic moral failure.\u201d  Now, poorer countries are trying to become more self-reliant \u201cbecause they\u2019ve realized after COVID they can\u2019t count on anyone else,\u201d said Brook Baker, who studies treatment-access issues at Northeastern University.""}, {""date"": ""20231124084922"", ""headline"": ""Goldman Sachs Value Stocks: Top 12 Stock Picks"", ""summary"": ""In this piece, we will take a look at the top value stock picks of the investment bank Goldman Sachs. If you want to skip our introduction to the investment bank, some relevant news, and a primer on value investing, then you can skip ahead to Goldman Sachs Value Stocks: Top 5 Stock Picks. Value investing [\u2026]""}, {""date"": ""20231124090000"", ""headline"": ""AVLV: Add A Quality Tilt To Your Broad Market Index Funds With This Active Large Cap ETF"", ""summary"": """"}, {""date"": ""20231124113700"", ""headline"": ""Pneumonia outbreak in China is no reason for alarm: WHO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231124132000"", ""headline"": ""3 Dividend Stocks You Can Safely Hold for Decades"", ""summary"": ""Many high-profile stocks can come with risks and uncertainties that make them less than ideal for investors who prioritize reliable dividend income.  While it's impossible to know where a stock will be in 20 years, certain attributes in a company increase the likelihood that it will be able to maintain its dividends well into the future.  Emerson Electric (NYSE: EMR) is a diversified industrial company that offers a broad range of products, including electrical equipment, valves, control and measurement devices, regulators, welding equipment, and automation software.""}, {""date"": ""20231125052232"", ""headline"": ""3 Reasons You Should Stay The Course With Dividend Stocks"", ""summary"": ""With bond yields at levels last seen before the Great Recession, it is difficult to argue against the attractiveness of fixed-income investments. Read more here.""}, {""date"": ""20231125115300"", ""headline"": ""See Which Of The Latest 13F Filers Holds Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231125212254"", ""headline"": ""11 Best Fortune 500 Dividend Stocks To Buy Now"", ""summary"": ""In this article, we discuss 11 best Fortune 500 dividend stocks to buy now. You can skip our detailed analysis of large-cap dividend stocks and their performance in the past, and go directly to read 5 Best Fortune 500 Dividend Stocks To Buy Now. The Fortune 500 is an annual list compiled and published by [\u2026]""}, {""date"": ""20231126105608"", ""headline"": ""12 Best Medical Technology Stocks To Buy Now"", ""summary"": ""In this article, we discuss 12 of the best medical device stocks to buy now. If you want to skip our detailed healthcare and medical technology industry discussion, head directly to the 5 Best Medical Technology Stocks To Buy Now. The medical technology (MedTech) sector plays a significant role in healthcare, focusing primarily on developing [\u2026]""}, {""date"": ""20231126113000"", ""headline"": ""Johnson & Johnson and Intuitive Surgical Might Become Ozempic's Next Victims. Are They Still Worth Buying?"", ""summary"": ""It's a bit of a harrowing time to be in the business of selling solutions for bariatric surgery.  Thanks to Novo Nordisk's drugs like Ozempic and Wegovy for type 2 diabetes and obesity, and competing medicines like Mounjaro and Zepbound made by Eli Lilly, people now have access to powerful and noninvasive weight-loss tools.  In fact, leaders of two of the largest companies in healthcare, Intuitive Surgical (NASDAQ: ISRG) and Johnson & Johnson (NYSE: JNJ), are already explicitly linking the rise of treatments like Ozempic to new headwinds for certain segments of their businesses.""}, {""date"": ""20231126115103"", ""headline"": ""15 Best Drug Stocks To Invest In"", ""summary"": ""In this article, we discuss the 15 best drug stocks to invest in. You can skip our detailed analysis of the drug and pharmaceutical sector and its outlook this year, and go directly to read the 5 Best Drug Stocks To Invest In. Healthcare expands on the defensive concept, encompassing a myriad of companies. This [\u2026]""}, {""date"": ""20231126120019"", ""headline"": ""Johnson & Johnson's (NYSE:JNJ) Intrinsic Value Is Potentially 60% Above Its Share Price"", ""summary"": ""Key Insights Using the 2 Stage Free Cash Flow to Equity, Johnson & Johnson fair value estimate is US$244 Johnson...""}, {""date"": ""20231126121500"", ""headline"": ""Got $1,500? You Can Confidently Add These 3 Stocks to Your Portfolio"", ""summary"": ""There's a lot of uncertainty in the world today. Higher interest rates have many investors growing worried that the economy could slow down considerably over the next year and potentially experience a recession.""}]",{}
25,2023-11-26,152.5,2023-12-03,152.11000061035156,-0.002557373046874978,D1,"[{""date"": ""20231126105608"", ""headline"": ""12 Best Medical Technology Stocks To Buy Now"", ""summary"": ""In this article, we discuss 12 of the best medical device stocks to buy now. If you want to skip our detailed healthcare and medical technology industry discussion, head directly to the 5 Best Medical Technology Stocks To Buy Now. The medical technology (MedTech) sector plays a significant role in healthcare, focusing primarily on developing [\u2026]""}, {""date"": ""20231126113000"", ""headline"": ""Johnson & Johnson and Intuitive Surgical Might Become Ozempic's Next Victims. Are They Still Worth Buying?"", ""summary"": ""It's a bit of a harrowing time to be in the business of selling solutions for bariatric surgery.  Thanks to Novo Nordisk's drugs like Ozempic and Wegovy for type 2 diabetes and obesity, and competing medicines like Mounjaro and Zepbound made by Eli Lilly, people now have access to powerful and noninvasive weight-loss tools.  In fact, leaders of two of the largest companies in healthcare, Intuitive Surgical (NASDAQ: ISRG) and Johnson & Johnson (NYSE: JNJ), are already explicitly linking the rise of treatments like Ozempic to new headwinds for certain segments of their businesses.""}, {""date"": ""20231126115103"", ""headline"": ""15 Best Drug Stocks To Invest In"", ""summary"": ""In this article, we discuss the 15 best drug stocks to invest in. You can skip our detailed analysis of the drug and pharmaceutical sector and its outlook this year, and go directly to read the 5 Best Drug Stocks To Invest In. Healthcare expands on the defensive concept, encompassing a myriad of companies. This [\u2026]""}, {""date"": ""20231126120019"", ""headline"": ""Johnson & Johnson's (NYSE:JNJ) Intrinsic Value Is Potentially 60% Above Its Share Price"", ""summary"": ""Key Insights Using the 2 Stage Free Cash Flow to Equity, Johnson & Johnson fair value estimate is US$244 Johnson...""}, {""date"": ""20231126121500"", ""headline"": ""Got $1,500? You Can Confidently Add These 3 Stocks to Your Portfolio"", ""summary"": ""There's a lot of uncertainty in the world today. Higher interest rates have many investors growing worried that the economy could slow down considerably over the next year and potentially experience a recession.""}, {""date"": ""20231127015100"", ""headline"": ""This Is What Whales Are Betting On Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231127022900"", ""headline"": ""Biden Plans to Boost Drug Production Using Cold-War Era Law"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231127050400"", ""headline"": ""Johnson & Johnson: An Exploration into Its Intrinsic Value"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231127060900"", ""headline"": ""Gracell initiated with an Outperform at Evercore ISI"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231127075311"", ""headline"": ""Buy 6 December Dividend Kings, 4 More On Watch"", ""summary"": ""An analysis of the top Dividend Kings and their impressive long-term dividend payouts is presented. Click here to find out the six December Dividend Kings.""}, {""date"": ""20231127083300"", ""headline"": ""The Shocking Stock That Warren Buffet Just Bought (and 2 He Sold)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231127101603"", ""headline"": ""J&J : applies for an extended indication for Rybrevant"", ""summary"": ""J&J announces that its Janssen pharmaceutical companies have applied to the European Medicines Agency for an extension of the indication for Rybrevant in combination with chemotherapy for the...""}, {""date"": ""20231127103000"", ""headline"": ""5 Stocks You Can Confidently Invest $500 In Right Now"", ""summary"": ""Amazon (NASDAQ: AMZN) is the leader in two markets growing in the double-digits: e-commerce and cloud computing.  Amazon recently improved its cost structure, which should pay off over time.  The company's moves in e-commerce include making its fulfillment process more efficient, and in cloud computing include major investments in artificial intelligence (AI).""}, {""date"": ""20231127121500"", ""headline"": ""President Biden to use 1950 law to boost essential drug production"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231127145646"", ""headline"": ""Roku upgraded, Lucid Group downgraded: Wall Street's top analyst calls"", ""summary"": ""Roku upgraded, Lucid Group downgraded: Wall Street's top analyst calls""}, {""date"": ""20231127153843"", ""headline"": ""3 Biotech Stocks To Watch Before December 2023"", ""summary"": ""Biotech stocks to check out in the stock market today.""}, {""date"": ""20231127163200"", ""headline"": ""Johnson & Johnson stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson sank 0.80% to $151.28 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""20231128041100"", ""headline"": ""3 Robotics Stocks That Could Be Multibaggers in the Making"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231128041200"", ""headline"": ""Google Alum's Biotech Startup Cradle Raises $24M To Boost AI-Powered Protein Design And Engineering"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231128042100"", ""headline"": ""Analysts Conflicted on These Healthcare Names: Johnson & Johnson (JNJ), Masimo (MASI) and Regeneron (REGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231128051100"", ""headline"": ""Johnson & Johnson price target lowered to $170 from $178 at Wells Fargo"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231128080606"", ""headline"": ""10 Dividend Growth Stocks For November 2023"", ""summary"": ""Discover the top 10 dividend growth stocks for potential investment, ranked by their defensiveness scores. Click here to read my analysis.""}, {""date"": ""20231128095800"", ""headline"": ""FDA investigating serious risk of T-cell malignancies in CAR-T cell therapy patients"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231128100102"", ""headline"": ""J&J : Wells Fargo remains positive, lowers target"", ""summary"": ""Wells Fargo reaffirms its 'overweight' recommendation on Johnson & Johnson despite a price target lowered from $178 to $170, based on a ratio of around 15 times its 2025 EPS assumption for the...""}, {""date"": ""20231128103700"", ""headline"": ""Cabaletta Bio, Gracell slide as FDA probes risk of CAR T cell immunotherapies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231128104100"", ""headline"": ""2 Unstoppable Dividend Stocks Trading Near 52-Week Lows to Buy Now"", ""summary"": ""With clear advantages over the competition, these divided payers could deliver market-beating gains to patient investors.""}, {""date"": ""20231128112600"", ""headline"": ""FDA probing serious risk of T-cell malignancies in CAR-T cell therapy patients (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231128163200"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.23% higher to $151.63 Tuesday, on what proved to be an all-around positive trading session for the stock market, with...""}, {""date"": ""20231128183441"", ""headline"": ""AWS expands big pharma partnerships in manufacturing, AI, and R&D"", ""summary"": ""Pfizer and Amazon Web Services are just another example of how artificial intelligence is working in the background in healthcare.""}, {""date"": ""20231129044300"", ""headline"": ""Alvotech stock gains on positive results for J&J arthritis drug biosimilar"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231129054300"", ""headline"": ""The 7 Biggest Dividend Stocks in Warren Buffett\u2019s Portfolio"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231129062300"", ""headline"": ""Why Johnson & Johnson is a Top 25 Dividend Giant (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231129073400"", ""headline"": ""Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell Therapies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231129100000"", ""headline"": ""3 medtech spinoffs that reshaped the industry in 2023, and what to expect next"", ""summary"": ""GE HealthCare, Johnson & Johnson and Danaher completed transactions this year. Baxter, 3M and Medtronic are now on deck.""}, {""date"": ""20231129101711"", ""headline"": ""J&J : to present its medical advances in San Diego"", ""summary"": ""Johnson & Johnson announced today that more than 85 abstracts from its hematology portfolio and pipeline will be presented at the 65th annual meeting of the American Society of Hematology , to be held...""}, {""date"": ""20231129112526"", ""headline"": ""Why I Made Big Changes To My Dividend Growth Portfolio"", ""summary"": ""How to make significant changes to your portfolio, for when buying a new house and selling stocks for cash? Click here to read about my strategy.""}, {""date"": ""20231129140010"", ""headline"": ""Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It"", ""summary"": ""Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.""}, {""date"": ""20231129150001"", ""headline"": ""Biogen: LAQEMBI's $10 Billion Potential"", ""summary"": ""Biogen's latest Alzheimer's drug, Aduhelm, faced challenges after FDA approval. Click here to read why we still rate the BIIB stock as a 'Strong Buy'.""}, {""date"": ""20231129163200"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.32% higher to $152.11 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""20231129164835"", ""headline"": ""Johnson & Johnson, Ben Graham, And Defensive Stocks"", ""summary"": ""Johnson & Johnson satisfies all the requirements that Benjamin Graham promoted for picking defensive stocks. Read more on JNJ stock here.""}, {""date"": ""20231129221840"", ""headline"": ""15 States with the Best Economy Right Now"", ""summary"": ""In this article, we will discuss the 15 states with the best economy right now. If you want to skip our detailed analysis, you can go directly to the 5 States with the Best Economy Right Now. According to a report by Goldman Sachs, the economy of the United States is on track to beat expectations [\u2026]""}, {""date"": ""20231129224508"", ""headline"": ""Johnson & Johnson (JNJ) Ascends While Market Falls: Some Facts to Note"", ""summary"": ""In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $152.11, denoting a +0.32% change from the preceding trading day.""}, {""date"": ""20231129230442"", ""headline"": ""20 Countries With The Lowest Retirement Ages in The World"", ""summary"": ""This article takes a look at the 20 countries with the lowest retirement ages in the world. If you wish to skip our detailed analysis on navigating aging populations, you may go to 5 Countries with The Lowest Retirement Ages in The World. On Navigating Aging Populations According to the World Health Organization, the population [\u2026]""}, {""date"": ""20231130005033"", ""headline"": ""Tracking Tweedy, Browne Portfolio - Q3 2023 Update"", ""summary"": ""Tweedy, Browne's 13F portfolio value decreased by 2% to $1.87B this quarter. Click here to read more about its holdings and trades for Q3 2023.""}, {""date"": ""20231130033200"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Hyperfine (HYPR) and Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130034100"", ""headline"": ""J&J appoints Eugene Woods to its board"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130080600"", ""headline"": ""Fresh on the Market: 3 Top Picks From the Renaissance IPO ETF"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130081800"", ""headline"": ""J&J revises EPS guide after $400M deal to buy Laminar"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130082859"", ""headline"": ""Johnson & Johnson highlights its preeminent leadership in hematology through differentiated blood cancer portfolio and pipeline with new clinical and real-world data at ASH"", ""summary"": ""RARITAN - Johnson & Johnson announced today that more than 85 presentations from the Company's robust hematology portfolio and pipeline will be presented at the 65th Annual American Society of...""}, {""date"": ""20231130083500"", ""headline"": ""Texas Sues Pfizer For \""Misrepresenting COVID-19 Vaccine Efficacy\"" And \""Conspiring To Censor Public Discourse\"""", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130084000"", ""headline"": ""Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: Johnson & Johnson (JNJ) and Walgreens Boots Alliance (WBA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130090600"", ""headline"": ""Johnson & Johnson buys medical device maker Laminar, cuts full-year earnings guidance"", ""summary"": ""Johnson & Johnson said Thursday that its medical technology segment has acquired medical device maker Laminar Inc. in a deal that will reduce its full-year...""}, {""date"": ""20231130092204"", ""headline"": ""Johnson & Johnson Buys Laminar For $400 Million, Trims Profit Outlook"", ""summary"": ""By Will Feuer Johnson & Johnson said it has bought Laminary, a privately held medical device company, for an upfront payment of $400 million. J&J also cut its full-year adjusted profit...""}, {""date"": ""20231130095600"", ""headline"": ""JNJ January 2024 Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130101100"", ""headline"": ""Income Kings: 7 Blue-Chip Dividend Stocks for Reliable Returns"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130103000"", ""headline"": ""J&J Hired Thousands of Data Scientists. Will The Strategy Pay Off?"", ""summary"": ""The 137-year-old pharmaceutical and medical-device company is taking a new direction in its efforts to discover drugs""}, {""date"": ""20231130104532"", ""headline"": ""Johnson & Johnson : By the numbers"", ""summary"": ""Each year, more people die of lung cancer than colon, breast and prostate cancers combined. Learn how Johnson & Johnson is dedicated to improving outcomes by integrating the company's MedTech and...""}, {""date"": ""20231130105602"", ""headline"": ""J&J : EPS target lowered after Laminar acquisition"", ""summary"": ""Johnson & Johnson announced on Thursday that it had lowered its earnings per share target for 2023 to take into account the acquisition of Laminar, made official today.This transaction, valued at...""}, {""date"": ""20231130110018"", ""headline"": ""Johnson & Johnson (NYSE:JNJ) is largely controlled by institutional shareholders who own 71% of the company"", ""summary"": ""Key Insights Institutions' substantial holdings in Johnson & Johnson implies that they have significant influence over...""}, {""date"": ""20231130110400"", ""headline"": ""Johnson & Johnson (NYSE:JNJ) Revised Earnings Don\u2019t Balk Investors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130112600"", ""headline"": ""7 Blue-Chip Stocks to Buy for 2024, According to AI"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130113100"", ""headline"": ""Johnson & Johnson\u2019s (NYSE:JNJ) Revised Earnings Don\u2019t Worry Investors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130115900"", ""headline"": ""IN BRIEF: Johnson & Johnson MedTech business acquires Laminar"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130122100"", ""headline"": ""J&J heats up LAA closure competition with $400M Laminar buy"", ""summary"": ""Just days after Medtronic announced it would launch a LAA device, J&J said it has acquired a company that is developing a new treatment for LAA closure.""}, {""date"": ""20231130134000"", ""headline"": ""Johnson & Johnson MedTech Acquires Laminar, Inc."", ""summary"": ""NEW BRUNSWICK, N.J., November 30, 2023--Johnson & Johnson MedTech1 today announced the completion of the acquisition2 of Laminar, Inc., a privately-held medical device company focused on eliminating the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation (AFib). Johnson & Johnson MedTech acquired Laminar for an upfront payment of $400 million, subject to customary adjustments, with additional potential clinical and regulatory milestone payments in 2024 and beyond. Lamin""}, {""date"": ""20231130151159"", ""headline"": ""Johnson & Johnson: Sleep Well At Night With The Only AAA-Rated Dividend Aristocrat"", ""summary"": ""JNJ maintains a rock-solid balance sheet, which operationally shields it from the higher for longer rate narrative. Click here to read my analysis of the stock.""}, {""date"": ""20231130163200"", ""headline"": ""Johnson & Johnson stock rises Thursday, outperforms market"", ""summary"": ""Shares of Johnson & Johnson advanced 1.68% to $154.66 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P...""}, {""date"": ""20231130173700"", ""headline"": ""Johnson & Johnson Names Eugene Woods as Board Member"", ""summary"": ""By Sabela Ojea Johnson &amp; Johnson added Eugene Woods, chief executive of Advocate Health, to the board of directors. The healthcare company's chief...""}, {""date"": ""20231130213000"", ""headline"": ""Johnson & Johnson Names Eugene A. Woods, Chief Executive Officer of Advocate Health, to its Board of Directors"", ""summary"": ""NEW BRUNSWICK, N.J., November 30, 2023--Johnson & Johnson (NYSE: JNJ) announced today that Eugene A. Woods, MBA, MHA, Chief Executive Officer of Advocate Health, has been appointed to its Board of Directors.""}, {""date"": ""20231130221624"", ""headline"": ""UPDATE 2-Pfizer is sued by Texas over COVID vaccine claims"", ""summary"": ""Pfizer has been sued by Texas Attorney General Ken Paxton, who on Thursday accused the drugmaker of misrepresenting the efficacy of its widely-used COVID-19 vaccine.  In a complaint filed in a Lubbock County state court, Paxton said it was misleading for Pfizer to claim its vaccine was 95% effective because it offered a \""relative risk reduction\"" for people to who took it.  Paxton said the claim was based on only two months of clinical trial data, and vaccine recipients' \""absolute risk reduction\"" showed that the vaccine was just 0.85% effective.""}, {""date"": ""20231201020300"", ""headline"": ""Catalyst Watch: McDonald's event, Lululemon earnings and GameStop volatility redux"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231201032500"", ""headline"": ""What You Missed On Wall Street On Friday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231201035200"", ""headline"": ""Johnson & Johnson upgraded to Buy from Neutral at UBS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231201040600"", ""headline"": ""Analysts Are Bullish on Top Healthcare Stocks: Johnson & Johnson (JNJ), Humana (HUM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231201051200"", ""headline"": ""Johnson & Johnson upgraded to Buy at UBS ahead of analyst day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231201053600"", ""headline"": ""J&J gets upgrade from UBS with \""high conviction\"" in outlook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231201054200"", ""headline"": ""J&J gets upgrade from UBS with 'high conviction' in outlook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231201060400"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Harmony Biosciences Holdings (HRMY) and Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231201063603"", ""headline"": ""J&J : Eugene A. Woods joins the Board of Directors"", ""summary"": ""Johnson & Johnson has announced the appointment of Eugene A. Woods, CEO of Advocate Health, to its Board of Directors. Woods, CEO of Advocate Health, to the Board of Directors.'M. Woods has an...""}, {""date"": ""20231201080100"", ""headline"": ""Wealth From Wellness: 7 Healthcare Stocks to Inoculate Your Portfolio"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231201080800"", ""headline"": ""Investors Should Not Pay More Than A 15 P/E Ratio When Buying A Stock"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231201094403"", ""headline"": ""Johnson & Johnson : the stock benefits from a positive opinion from UBS"", ""summary"": ""Johnson & Johnson shares are bucking the downward trend on Wall Street on Friday, thanks to a recommendation upgrade from UBS, which sees the American healthcare giant exceeding market expectations.A...""}, {""date"": ""20231201120200"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231201121100"", ""headline"": ""Johnson & Johnson Gets Analyst Upgrade Noting Bullish Pharma & MedTech Projections"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231201143235"", ""headline"": ""Elastic upgraded, Alibaba downgraded: Wall Street's top analyst calls"", ""summary"": ""Elastic upgraded, Alibaba downgraded: Wall Street's top analyst calls""}, {""date"": ""20231201162012"", ""headline"": ""My Dividend Growth Portfolio November Update - Thankful For Dividend Raises"", ""summary"": ""Don't miss out on potential bargains in a rising market.""}, {""date"": ""20231201163200"", ""headline"": ""Johnson & Johnson stock rises Friday, outperforms market"", ""summary"": ""Shares of Johnson & Johnson rallied 2.41% to $158.38 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20231201173300"", ""headline"": ""Johnson & Johnson Stock Gains a Bull Ahead of Analyst Day"", ""summary"": ""Shares are lower this year, thanks to an ongoing legal situation, but UBS says those worries are factored into the stock.""}, {""date"": ""20231201234330"", ""headline"": ""UBS Upgrades Johnson & Johnson (JNJ)"", ""summary"": """"}, {""date"": ""20231202090000"", ""headline"": ""5 Relatively Secure And Cheap Dividend Stocks To Invest In - December 2023"", ""summary"": ""Discover five large-cap dividend-paying companies with discounts to their historical norms, selected from over 7,500 U.S. traded companies. Click for our picks!""}, {""date"": ""20231202100000"", ""headline"": ""Stocks To Watch: Big Week On Tap For McDonald's, Shopify, GameStop, And Johnson & Johnson"", ""summary"": ""Stay informed on upcoming key events in the market with Seeking Alpha's Stocks to Watch newsletter, covering IPOs, earnings reports, and more.""}, {""date"": ""20231202140000"", ""headline"": ""How To Build A High-Potential Dividend Portfolio Combining Dividend Income With Dividend Growth"", ""summary"": ""Learn how to build a diversified dividend portfolio that combines income and growth for an attractive total return. Read the article for more details on the portfolio.""}, {""date"": ""20231202190553"", ""headline"": ""JP Morgan\u2019s Top 15 Stock Picks for 2023 and Now"", ""summary"": ""In this piece, we will take a look at JP Morgan\u2019s top 15 stock picks for 2023 and most recent stock picks. If you want to skip our introduction to the world\u2019s biggest bank in terms of assets, its latest performance, and other details, then check out JP Morgan\u2019s Top 5 Stock Picks for 2023. [\u2026]""}, {""date"": ""20231203013500"", ""headline"": ""Supreme Court Decision Looms Over Purdue Pharma's $6B Opioid Settlement And Sackler Family Immunity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231203040032"", ""headline"": ""Abbott Laboratories: A 'Must-Have' In A Defensive Dividend Growth Portfolio"", ""summary"": ""Abbott Laboratories had a difficult last three years, with its stock price trading sideways as sales driven by COVID-19 plummeted. Read more on ABT stock here.""}, {""date"": ""20231203071023"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of December 3"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read more to see the update for the week of December 3.""}, {""date"": ""20231203103000"", ""headline"": ""Warren Buffett Just Closed His Position in This Dividend Giant. Should You?"", ""summary"": ""Warren Buffett is known for owning shares in some of America's leading companies, in industries from financials to oil.  One particular area he hasn't invested too heavily in, though, is healthcare -- the risks of drug development, high costs of research, and complexity of the science behind many pharma pipelines are all elements that don't go hand-in-hand with the billionaire's investment strategy.  Considering Buffett's top stock picking skills and long-term performance, you may be temped to sell or avoid J&J too.""}, {""date"": ""20231203120000"", ""headline"": ""Warren Buffett sold a whopping $7B worth of stock in Q3 \u2014 and even unloaded 2 giant American 'dividend kings.' But here's why the Oracle of Omaha could be dead wrong"", ""summary"": ""It's surely a bad sign for the US economy, right? Not so fast.""}, {""date"": ""20231203130000"", ""headline"": ""Second-Largest U.S. Pension Sold AMC, NIO, Spotify, and JNJ Stock"", ""summary"": ""California State Teachers' Retirement System, or Calsters, cut positions in AMC Entertainment, NIO, Spotify, and Johnson & Johnson in the third quarter.""}, {""date"": ""20231203130000"", ""headline"": ""The Second-Largest U.S. Pension Slashed Its AMC Stock Stake"", ""summary"": ""California State Teachers' Retirement System, or Calsters, cut positions in AMC Entertainment, NIO, Spotify, and Johnson & Johnson in the third quarter.""}]",{}
